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" Come in under the shadow of this red rock,
And I will show you something different from either
Your shadow at morning striding behind you
Or your shadow at evening rising to meet you:
I will show you fear in a handful of dust."
(From the Waste Land:
The burial of the Dead,
T.S.Eliot, 1922)
Abstract
This study has described the psychosocial impact of lung
cancer and its treatment of patients and their "primary carers".
The subjects have been identified and assessed at three
different stages of the illness using a battery of scales and
questionnaires. The first group of patients were interviewed at
the mid point of their first line chemotherapy regimen. The
second group have completed a full course of chemotherapy
and have been on follow up observation for at least one month.
The third group of patients have received a full course of
chemotherapy, a period of follow up observation and were
interviewed at the mid point of palliative radiotherapy. There
were 40 patients in each group and their "primary carers". (In
this study the "primary carer" has been defined as the person
who undertakes to provide the majority of the physical and
emotional care of the patient.)
There was no statistically significant difference in mean
anxiety and depression scores (HAD scale) between the three
groups of patients, but a significant number of patients in each
group scored in the "case level" range. Similarly, there were no
statistically significant differences in mean anxiety and
depression scores (HAD scale) between the three groups of
"primary carers". The mean anxiety scores of carers werer J J scores
significantly higher than the patients'* in each of the three
groups and a significantly greater number scored in the "case
level" range. The psychological state of the patient and the
carer are significantly correlated during certain stages of the
illness.
Lung cancer is viewed as being composed of multiple stresses
for patients and their carers and a number of multiple
stepwise regression analyses and factor analyses support this
view. These analyses suggest that one of the principle
contributory factors to distress in the carer is distress in the
patients and vice versa. In addition, the psychological state of
the significant other combines with a range of other factors
such as the amount and severity of symptomatology,
personality variables, age and psychological adjustment to
illness.
Of particular interest in this study was the role of perceived
emotional social support in "buffering" or reducing distress in
both patients and their carers. In patients, high levels of
support were not found to be associated with reducing levels
i
of distress. In the carer, at certain stages of the illness, high
levels of social support were associated with high levels of
distress implying that social support might be stressful in
itself. In the multiple stepwise regression analyses, perceived
social support was found to contribute significantly to carer
distress.
The concept of social support was found to be more complex
than was previously thought and these results suggest that the
multiple stresses imposed by lung cancer and its treatment
cannot be reduced by the presence of a single type of social
support alone. The implications of these results for service
provision are discussed as well as the potential for future
research in this area. In particular, the plight of the carer in
lung cancer and the high levels of distress that they experience
warrants further investigation particularly with a view to the
implementation of psychosocial interventions.
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Chapter One
EPIDEMIOLOGY, AETIOLOGY AND TREATMENT OF
LUNG CANCER.
Lung cancer presents a large and growing problem in the
Western World. In 1989 it is estimated that there will be
approximately 120,000 deaths from the disease in the United
States of America, a rate of 70 per 100,000 (Loeb et al., 1984)
and around 40,000 in the United Kingdom [Minna et al., 1985].
The incidence in Scotland is probably the highest in the world
[HMSO, 1987]. In 1987, for example, there were approximately
4,290 deaths in Scotland due to lung cancer, a rate of 120 per
100,000 [OPCS, 1987], almost 50 per cent more than that found
in the USA.
In Scotland the number of lung cancer deaths accounted for 7
per cent of the total number of deaths in the country in 1987
and represented almost 24 per cent of all cancer deaths [OPCS,
1987].
In the United Kingdom the incidence of the disease has
increased every year and by 50 per cent over the last decade
[Spiro, 1986]. Lung cancer is the leading cause of cancer death
in men aged 35 years and older and the second leading cause
of cancer deaths in women aged between 35 and 74 years of
age, (after breast cancer), [Silverberg, 1984]. Recent years
1
however have seen a dramatic rise in the incidence of lung
cancer amongst women. The male to female ratio in 1952 was
13:1, but by 1984 had risen to 4:1 [Loeb et al., 1984]. A
number of more recent studies however have described a male
to female ratio of 2:1 [Spiro, 1986]. Vincent de Vita [1985] in a
seminal work on cancer and its treatment has hypothesised
that lung cancer will replace breast cancer as the most
common malignant disease in women by the end of the
century.
A recent paper from the Edinburgh Lung Cancer Group [1987],
reviewed 2,586 patients registered with the group between 1
January 1981 and 31 December 1984. Of this number 72 per
cent were male and 28 per cent were female (2.5:1). These
figures aptly demonstrate the change in the sex ratio for this
disease which was discussed earlier. In the same study the age
distribution of the patients was also representative of the
overall picture found in the Western World. At the time of
diagnosis 4 per cent of patients were aged under 50 years, 20
per cent were aged 50-59, 39 per cent were aged 60-69, and
36 per cent were aged 70 years and over. The median age was
66.8 years with a range of 23-94 years. Females in the study
were significantly younger than the men with 79 per cent aged
less than 70 compared with 61 per cent of the men; 7 per cent
of the women were aged less than 60 compared with 3 per
cent of the men. This data broadly supports the conclusion of
the National Institute for Health over a decade ago in 1977
when they concluded that the disease is uncommon but not
unknown before the age of 40 and the incidence is highest in
2
both sexes between the ages of
also a significant gradient in
across social classes which is
smoking.
55 to 65 years of age. There is
the incidence of lung cancer
intrinsically linked to cigarette
Aetiological Factors
A number of aetiological factors have been implicated in lung
cancer including exposure to radioactivity and radioactive
minerals, exposure to asbestos, nickel, chromium, coal gas,
metallic iron and iron oxides [Doll and Peto, 1981].
The most significant association has been shown to be with
cigarette smoking. When tobacco was first introduced into
Europe at the end of the sixteenth century, smoking was
recommended for medicinal purposes; its use soon became
controversial and it was condemned as a noxious vice as often
as it was praised for its prophylactic value. Little scientific
evidence was obtained about its adverse effects until the late
1940's. At this time medical textbooks either tended to ignore
the subject completely or began referring to tobacco
amblyopia, a form of blindness associated with heavy pipe
smoking and poor nutritional status, to tobacco angina (a rare
form of angina in which chest pain was precipitated by
smoking), and to cancers of the lip and tongue, which
experienced surgeons had, for many years, suspected were
associated with the smoking of pipes.
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In 1950 five papers appeared in the U.K. and the U.S.A. in
which the smoking habits of large numbers of patients with
cancer of the lung or, in some studies, with cancers of the
mouth, pharynx or larynx were compared with the smoking
habits of apparently healthy people [Doll and Hill, 1950; Levin
et al., 1950; Mills and Porter, 1950; Shrek et al., 1950; and
Wynder and Graham, 1950]. In the classic paper by Doll and
Hill [1950], the authors concluded that "smoking is a factor,
and an important factor, in the production of carcinoma of the
lung". The results of these early studies proved to be the
catalyst for a series of worldwide prospective studies which
clearly demonstrated the association of smoking not only with
lung cancer but also with a significant increase in overall
mortality [United States Public Health Service, 1982],
Since the 1950's the increased publicity concerned with the
adverse effects of smoking, coupled with the steadily
increasing price of cigarettes has led to a decline in cigarette
smoking both in the United Kingdom and the United States of
America. In the U.K. cigarette consumption amongst men
reached a peak in 1941 (4,420 cigarettes per adult male per
year, or 12 cigarettes per day), and did not change materially
until about 1973 (3,980 cigarettes per male adult per year, or
10 cigarettes per day). Thereafter it declined rapidly to 2,600
(7 cigarettes per day) in 1982 - a fall of 35 per cent and this
pattern continues. Among women, however, cigarette
consumption increased to a zenith in 1974 (2,630 cigarettes
per adult female per year, 7 per day) and thereafter declined
to 2050 (5 per day) in 1982- a decrease of 22 per cent. There
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are fears now, however, that among women the number of
smokers is increasing again [Yessey and Gray, 1985]. In the
past five years in the U.K. the most rapid rate of decrease of
cigarette consumption has been among the upper
socioeconomic classes [Spiro, 1986]. It is currently estimated
that 35 per cent of men smoke and about 36 per cent of
women Smoke, and a particularly worrying figure, despite
health education, is the estimate that 25 per cent of children
under the age of 15 in state schools smoke [Spiro, 1986].
A great deal of political debate has surrounded the
demonstration of an association between cigarette smoking
and lung cancer. Discussion has been concerned with such
diverse aspects as cost of treatment, methods of health
education, loss of tax revenue, reduction in productivity
resulting from ill health, no smoking in public areas and the
infringement of personal liberty. A confusing array of
apparently contradictory points of view have been given a
public forum in the popular press and media.
Internationally a wide variety of approaches have been
adopted, aimed at the restriction of smoking. In many
Scandinavian countries, for example, it is socially unacceptable
to smoke in public places and dramatic rises in the cost of
cigarettes are now beginning to produce a decline in smoking
related illnesses. In Britain, however, the restriction of
smoking in areas has been protracted and cigarette advertising
still proliferates in popular magazines and journals. At present
the British Health Education Council has an annual budget of
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approximately half a million pounds to spend on its anti-
smoking campaign, compared with an estimated seventy
million pounds spent on advertising by the tobacco industry
[Souhami and Tobias, 1986]. This discordant level of financial
power has led to vociferous criticism of government policy
from such organisations as Action on Smoking and Health
(A.S.H.). These debates have had wide public exposure so that
the smoker has been placed under enormous pressure to give
up, a fact that may complicate reactions to a diagnosis of lung
cancer.
In the U.K. lung cancer mortality is tending to follow the trend
in cigarette consumption. As has already been mentioned lung
cancer in women has increased dramatically and, indeed,
continues to increase. The rate in women has more than
doubled over the last thirty years [Wald, 1985]. This rise is
particularly noticeable in the 55 years old and above age
group [Wald, 1985]. Male lung cancer mortality on the other
hand in England and Wales is declining in all age groups from
30 to 69 years [Wald, 1985].
Since the 1950's, many studies have examined the relationship
between smoking and lung cancer; it is not appropriate,
however, to discuss this past literature in detail here.
Summarising this body of work, it has been found across
studies that the risk of lung cancer increases with number of
cigarettes smoked, with years of smoking, with earlier age at
onset of cigarette smoking, with degree of inhalation, with tar
6
and nicotine content of cigarettes smoked and with use of
filtered compared with non filtered cigarettes. In contrast to
these factors it has been found that risk decreases with the
number of years since smoking cessation.
A further factor which is worth comment is the issue of
passive smoking. This has been given increasing attention
during the past decade. A number of studies show an
association between respiratory illness in young children and
exposure to parents' cigarette smoke [United States Public
Health Service, 1979]. In examining the effects of passive
smoking in adults there have been major methodological
problems in attempting to measure exposure in a non smoking
adult partner of a smoker. This has resulted in the publication
of equivocal results from research centres around the world
and a great deal of controversy. Thus, the conclusions that can
be drawn from these studies must be viewed with caution.
They are, however, summarised in the following quote from
the International Agency for Research on Cancer Working
Group in 1986:
"The observations on non smokers that have been made
so far are compatible with either an increased risk from
'passive' smoking or an absence of risk. Knowledge of the
nature of sidestream and mainstream smoke, of the
materials absorbed during 'passive' smoking, and of the
quantitative relationships between dose and effect are
commonly observed from exposure to carcinogens leads
to the conclusion that passive smoking gives rise to some
risk of cancer." [IARC, 1986].
7
This discussion regarding passive smoking has been included
because it is an issue which has been given increasing media
coverage in recent years and may, therefore, present itself as
an issue to patients diagnosed as suffering from lung cancer as
well as to their relatives.
Lung cancer is also known to occur in non smokers but the
incidence is very much lower than in smokers and is often
related to occupational exposure to toxic chemicals.
Screening programmes for lung cancer aimed at early
detection of the disease have met with very little success. They
have been conducted in high risk groups such as smokers, at
risk occupational groups (asbestos workers), and most
importantly smokers in these occupational groups who run a
very high risk of developing the disease. The rate of detection
of lung tumours using 6 monthly chest radiographs has been
poor and even when detection has been successful at an early
stage this has not improved long term survival [Spiro, 1986].
Screening is therefore no longer recommended.
Pathology of Lung Cancer
There are four main histological type of bronchial carcinoma:
1. Squamous (epidermoid) cell carcinomas
This accounts for approximately 50 per cent of all lung cancers
and is therefore the commonest type. These tend to present in
the major bronchi as obstructing lesions.
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2. Adenocarcinomas
This type of lung cancer appears to be less clearly related to
cigarette smoking than other types of lung cancer as it was
probably the predominant cell type before the advent of
widespread cigarette smoking (Spiro, 1986). These tumours
often originate in the periphery of the lung and may grow to a
large size before giving rise to symptoms. Unlike other forms
of lung cancer it is slightly more common in females and there
is some evidence that it is increasing in frequency. It accounts
for about 20 per cent of all lung cancers.
3. Small cell (oat cell) carcinoma
This tends to be a very rapid growing tumour which quickly
spreads, if left untreated, invading blood vessels, the lymph
system and soft tissues. They are often widely disseminated
before symptoms are produced and a diagnosis is made. They
also account for about 20 per cent of all lung cancer cases.
4. Large cell carcinomas
These tend to be bulky tumours and like the small cell type
invade locally and disseminate widely. They are a less common
type of tumour and account for about 8-10 per cent of all lung
cancer cases.
For the purposes of this review and study, lung cancer will be
considered as two major types of disease. Firstly, small cell
9
lung cancer and secondly, non small cell lung cancer which is a
combination of squamous cell, adenocarcinoma and large cell
carcinoma. The groups are considered in this way reflecting
current clinical practice and treatment strategies among
inoperable patients.
The Natural History of Lung Cancer
Small cell lung cancer is a disease which spreads rapidly so
that by the time many patients are diagnosed the disease has
already infiltrated other organs. The disease most commonly
metastasises to liver, brain, bone, adrenal glands and
abdominal lymph nodes. Untreated, death is rapid. The median
survival from diagnosis is approximately five weeks for
patients with extensive disease (i.e. having spread to organs
other than the thorax) and twelve weeks for patients with
limited disease (i.e. confined to one hemithorax), with only 4
per cent of patients still alive at one year [Hyde et al., 1965;
Roswit et al., 1968; Zelen, 1973]. In a study by Nou [1984], of
50 patients diagnosed as having small cell lung cancer, none
were alive at five years.
Non small cell lung cancer presents a slightly different picture.
Nou [1984] in a sample of 223 untreated patients with non
small cell lung cancer limited to the thorax, found a median
survival of six months. In a similar study looking at patients
with extensive disease Cormier et al. [1982], found a median
1 0
survival of 8.5 weeks with 100 per cent mortality at one year
from diagnosis.
Hyde et al. [1973] examined a large group of patients with non
small cell cancer of the bronchus. They found that the different
subtypes of this disease had different survival times. Patients
with adenocarcinoma of the bronchus survived longer than
those with squamous cell or large cell carcinoma. The median
survival for these three groups was 13 weeks, 9.5 weeks and
6.75 weeks respectively. This data, however, does not
distinguish patients on the basis of the extent of the disease
spread. In a similar study of 828 patients who did not receive
treatment, Bangma [1963] reported that only 8 survived to
three years (less than 1 per cent).
The effect of treatment on the survival time of both small cell
and non small cell cancer of the bronchus will be dealt with
later in this chapter.
Clinical Features
Patients presenting with lung cancer may have three types of
symptoms: local (primary) symptoms; metastatic symptoms;
and non metastatic extra pulmonary symptoms.
1 1
Local (primary) Symptoms
Patients most commonly present with chest symptoms, the
most common being a flu like illness associated with a cough
which affects about 80 per cent of patients. Other chest
symptoms include haemoptysis (70 per cent of patients),
dyspnoea (60%), chest pain (40%), wheeze (15%) and blood
stained sputum. Patients may experience these symptoms for
several weeks before consulting their doctor [Spiro, 1986].
Metastatic signs and symptoms
Intrathoracic metastatic spread and/ or distant metastases are
present in up to 50 per cent of patients presenting with
bronchial carcinoma [Hande, 1983] and in about 30 per cent of
these cases the patient presents with symptoms caused by the
metastases.
The symptoms of metastatic spread vary depending on the site
involved and they may include respiratory, cardiac or
neurological problems. The disease may spread to a wide range
of vital organs sometimes presenting a complex array of
symptoms. Patients often present with non-specific features
such as weight loss, anorexia, or lassitude which are indicative
of the presence of occult metastases.
Extra-pulmonary symptoms
A number of abnormalities may occur in other organ systems
as a result of the primary tumour in the lung. For example,
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about 12 per cent of patients develop endocrine abnormalities,
extreme weight loss of several stones may occur as well as
blood disorders and vascular problems, any of which may
prompt the patient to visit their doctor.
Asymptomatic presentation
Approximately 5 per cent of patients with primary bronchial
carcinoma are diagnosed on routine radiography. These
patients may have no symptoms at all and the tumour may be
found by chance at an "annual check up", for example.
On the other hand, they may present to their family doctor
with what the patient may regard as minor flu like symptoms
and then following further investigation be presented with a
diagnosis of lung cancer: a disease with an extremely poor
prognosis and relatively short duration.
Investigation
Before the patient can be fully informed of the diagnosis,
prognosis and potential treatment options, a series of
investigations must be performed to determine the type of
tumour and the extent of spread.
The patients will undergo various chest X-rays taken from
different angles to examine the size of the tumour. They will
then undergo a bronchoscopy which is the passage of the fibre
optic tube into the lung. This enables the direct visualisation of
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the tumour but also enables samples of tissue to be taken in
order to establish a histological diagnosis.
The extent of the spread of the tumour may be assessed using
a variety of investigative techniques; bone scans, brain and
liver scans and mediastinoscopy are all used to investigate the
spread of the disease. Based on the results of these
investigations treatment options can be considered by the
patient and his/her doctors.
Treatment
The principles of treatment of small cell and non small cell
lung cancer are different. Small cell lung cancer is seldom
surgically resectable, usually it is widespread at presentation
and is both more chemosensitive and radiosensitive than non
small cell lung cancer. For these reasons the treatment options
will be considered separately.
Small cell lung cancer
The majority of patients present with extensive disease. That
is disease involving more than one hemithorax or with
metastatic spread. This means that surgery is rarely, if ever,
an option for patients with small cell cancer of the lung.
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Chemotherapy
Because this type of lung cancer spreads rapidly due to the
rapidly dividing cells, it is sensitive to cytotoxic drugs. In fact
it is more sensitive to chemotherapy than any other lung
cancer type. Early studies using a single drug found that the
median survival in patients was raised from 5 weeks to 12
weeks for patients with extensive disease [Bergsagel et al.,
1972; Broder et al., 1977; Bunn et al., 1977]. During the late
1970's and early 1980's, however, it was demonstrated that
combinations of drugs were superior to a single agent [Smyth
et al., 1986]. Combinations of three or four drugs tend to be
favoured as the anti tumour effects are increased. However,
the toxic side effects experienced by the patient are more
prononounced.
In patients with limited disease treated with combination
chemotherapy, median survival improves from three months
to fourteen months. Approximately 10 per cent of patients
remain disease free for two years and later relapse after this
period is uncommon, but still can and does occur [Morstyn et
al., 1984]. In recent years, attention has centred on identifying
those patients who would benefit from this approach, and in so
doing increase the numbers of long term survivors. In patients
with extensive disease, a group with a very bleak outlook,
median survival improves from about 5 weeks to about 8
months with around 5 per cent of patients still alive at 2 years
[Morstyn et al., 1984]. The aim of treatment here is to obtain
maximum relief from the disease with a minimum of toxicity.
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These apparently modest gains in median survival are
achieved at some cost in terms of treatment side effects
resulting in a great deal of controversy concerning the optimal
balance of quantity versus quality of life (which will be
addressed in a later chapter).
Radiotherapy
Small cell tumours in the lung are extremely radiosensitive
and a disappearance of the tumour on X-ray is seen in about
80 per cent of patients. Although the initial response to
radiotherapy is usually gratifying, recurrence of the tumour is
frequent. A British Medical Research Council trial
demonstrated that radiotherapy extended median survival
time to 11 months but that less than 4 per cent of patients
lived to 5 years [Fox and Scadding, 1973].
Radiotherapy is of great palliative value in small cell lung
cancer and is the treatment of choice for painful metastases to
the bones and for metastases of the brain. Radiotherapy can
give swift relief for these distressing symptoms with a
minimum of side effects [Souhami and Tobias, 1986].
Non Small Cell Lung Cancer
Surgery
For non small cell lung cancer, surgical resection of the tumour
offers the best hope of 'cure', but less than 30 per cent of
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patients will be suitable for this. Of those patients who do
undergo surgery, however, 80-85 per cent will survive at 5
years [Martini and Beattie, 1977] and even in the patient with
more advanced disease a five year survival rate of 50-60 per
cent can be achieved [Williams et al., 1981]. Despite the good
results achieved through surgical treatment in the early stages,
the overall 5 year survival rate for this disease is very poor
(less than 4 per cent) [Huhti et al., 1981].
Radiotherapy
Although patients with non small cell lung cancer have always
formed a large part of the work of the radiotherapist, there is
continued debate regarding the indications for its use. The
majority of patients presenting with non small cell cancer of
the bronchus are unsuitable for radical radiotherapy, the aim
in these patients is to palliate their symptoms.
If, however, all locally inoperable lung cancer patients are
irradiated with curative intent, median survival time is only
slightly prolonged: a 4 per cent increase in one year survival,
compared with untreated patients [Roswit et al., 1968]. In
highly selected subgroups of patients, five year survival rates
of 10 per cent can be obtained, which is more to do with better
patient selection than improved radiotherapy [Cox et al., 1983],
When radiotherapy is used to palliate the symptoms of non
small cell lung cancer, immediate clinical benefit may be
produced but this approach does not prolong life. In a study by
Durrant et al. [1971], radiotherapy, chemotherapy or a
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combination of both were compared to a group of patients
receiving no treatment at all. The survival time was the same
in both groups, yet radiotherapy proved to be superior in
palliating patients with specific symptoms such as severe
cough or pain.
Therefore, despite the fact that the palliative potential of
irradiation in this form of lung cancer is beyond doubt, and
despite its potential to achieve a 'cure' in a very small number
of patients, the employment of radiotherapy has not led to an
improvement in the overall survival in lung cancer.
Chemotherapy
Approximately 50 per cent of patients with non small cell lung
cancer have distant metastases at the time of diagnosis and
another 40 per cent will develop locally recurrent or distant
spread of their disease following initial treatment with surgery
or radiation therapy [Hande and Malcolm, 1983].
Reviews of chemotherapy in non small cell cancer of the lung
have demonstrated that regimens using multiple drugs are no
better that those that employ single agents [Bleehen, 1980].
Recent reports using the very toxic drugs cisplatin in
combination with etoposide indicate a possible therapeutic
benefit compared to other combinations [Sculier and
Klastersky, 1984], these findings, however, have yet to be
confirmed in controlled clinical trials. This combination did,
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however, produce a median survival of 12 months in this
particular patient group, a finding still to be replicated.
Although combination chemotherapy can produce responses in
this disease, its impact on survival has not been convincingly
demonstrated in a sufficiently large number of patients from
different institutions under different clinical conditions
[Hansen and Rorth, 1984]. It has been claimed that:
"if any 'progress' has been made in the treatment of non
small cell lung cancer with combination chemotherapy, it
is too small to be measured in clinical trials using
survival as an end point and also too small to justify the
use of chemotherapy in the routine treatment of non
small cell lung cancer."[Bakker, 1986, p26].
A damming statement concerning the treatment of this disease
with cytotoxic drugs
Conclusion
This chapter summarises the situation which faces a patient
who has a diagnosis of lung cancer. The patient may have
developed some symptoms, a cough or wheeze and consulted
his or her general practitioner. Further tests will have revealed
the tumour and the histological type of that tumour. These
results, coupled with possible referral to an oncologist, then
indicates therapeutic options available to the patient, the
family and the doctor. Thus the patient and the family may be
presented with the diagnosis, the various treatment options
and perhaps the appalling prognosis. Given this picture, it is
1 9
not surprising that many patients are devastated first of all by
the word "cancer" but also by the information that
accompanies this concerning therapy and survival.
Studies describing the psychosocial sequelae of these events
will be critically reviewed in the chapters that follow, dealing




THE PSYCHOLOGICAL IMPACT OF CANCER ON THE
PATIENT
Much of the research conducted in the area of psychological
impact of cancer on the patient has been concerned with
breast cancer and its treatment [Maguire, 1976; Maguire et al.,
1978]. The body of literature concerned with psychosocial
aspects of cancer of the breast is vast, stretching back over
many years. This literature has proved to be very helpful in
highlighting the psychosocial sequelae of a life threatening
illness but is limited in its application to other types of cancer.
Cancer is a complex disease; it has many forms and consists of
many stages. The literature concerning breast cancer contains
methodological problems which make this simple statement
difficult to appreciate. The disease has specific implications
regarding sexuality, body image and body function [Maguire,
1984]. It is also predominantly a disease of women. These
facts alone make it difficult to use the findings from research
in this area to make generalisations about other forms of
cancer especially lung cancer which is still predominantly
affects males and is concerned with an internal vital organ.
The methodology of this literature is also lacking in that many
research studies concentrate on a single point in time, often
not specified and often not linked to disease related variables
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[Freidenbergs, 1981-82]. These criticisms limit the usefulness
of this body of work. This chapter will deal with literature of a
more general nature investigating aspects of other types of
cancer. Where appropriate research in the field of breast
cancer will be utilised but this field will not be reviewed
independently in this thesis.
The structure of this literature review will be to portray
cancer as a life threatening disease consisting of stages and
therefore "a process". This "process" will be shown to consist of
so called "normal" reactions and "abnormal" reactions
mediated by various factors. The findings of various studies
will be shown to be be limited and inconclusive due to the
research methodology employed which include poor research
design and a reliance on opinion rather than hard data.
Cancer as a "process"
To a medical practitioner the concept of an illness as a process
is obvious. In the field of psychosocial oncology research, this
has not been apparent. Few researchers have addressed this
question and, in consequence, little data exists concerning the
psychological impact of cancer at different stages of the
disease.
Weisman [1979] and his colleagues from the Omega Project in
Boston, postulated that an illness such as cancer could be
conceptualised as consisting of a "process" or a trajectory along
which the patient progresses. This "process" commences at the
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time a label is applied to the patients' symptoms i.e. the point
of diagnosis and continues through treatment, post treatment,
palliative treatment to death or in some cases cure.
Accompanying the physical dimensions of the disease, were
the psychological sequelae and psychological adjustment,
which occurred over time, in tandem with the physical
changes. This concept of "the process", therefore, was
important in imposing a framework on the experience of the
patient.
Weisman devised a model to relate psychosocial events in the
cancer patient to their clinical and therapeutic counterparts.
This model proposed by Weisman is shown in Figure 1 with
the psychosocial events superimposed on the clinical events.
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Figure 1:
PSYCHOSOCIAL PHASES OF CANCER
PHASE I EXISTENTIAL PLIGHT
DIAGNOSTIC IMPACT
PLIGHT PROPER







PHASE III RECURRENCE AND RELAPSE
RELAPSE DURING PHASE II TREATMENT
RESPONSIVE (+)
RESISTIVE (-)
RECURRENCE AFTER PHASE II TREATMENT
RESPONSIVE (+)
RESISTIVE (-)
LIMBO (NO ACTIVE TREATMENT)





PHASE I Existential Plight
The first stage of this model was described by Weisman and
Worden [1976-77]. It begins with the diagnosis and continues
in its extreme form for about three or four months,
approximately 100 days. This entity was described by the
authors in a descriptive study of 120 patients with a range of
different types of cancer. They were interviewed and followed
up from ten days after diagnosis at four to six week intervals
until three to four months had elapsed. This study is shown in
Figure 2.
FIGURE 2
Existential Plight: 100 Days.

















(MMPI = MINNESOTTA MULTIPHASIC PERSONALITY INVENTORY, TAT
THEMATIC APPERCEPTION TEST, POMS = PROFILE OF MOOD STATES)
The patient group completed a range of tests and a semi
structured interview to collect demographic data and assess
mood disturbance, personality traits, coping concerns,
vulnerability, and support. The tools used were standardised
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assessment scales except for the semi structured interview
which was devised by the researchers.
The results of this study are difficult to interpret due to their
vague unsatisfactory presentation. It is not clear, for example
what treatment patients are receiving, the degree of
symptomatology they are experiencing or how they were
selected. It is, however, clear that patients with lung cancer
were significantly more distressed as a group than the other
diagnostic categories during the study period. During the first
100 days following diagnosis the distress in lung cancer
patients rose steadily. They were less concerned about family,
friends and religion than about existential, work and personal
health matters. In contrast, the distress levels of patients with
Hodgkin's disease diminished during the study period. This
difference presumably reflects the poor therapeutic response
and appalling prognosis facing patients with lung cancer.
The chief preoccupations of the patients with lung cancer
during this period of "existential plight" were concerned with
life and death, health and physical symptoms such as pain and
breathlessness. The most vulnerable groups of patients in this
study were those who were widowed or divorced and those
who anticipated little or no support from significant others.
Although the concept of existential plight is useful, the study
itself contains a number of methodological weaknesses. The
study period was only four months so that it is difficult to
ascertain the duration of the "existential plight" and whether it
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is affected by the experience of treatment. It also appears that
in certain types of cancer, for example, lung cancer, the period
of initial distress is still increasing at the end of the study
time. Finally, some of the tools used to assess function such as
coping concerns and vulnerability were developed by the
researchers and no figures for their validity or reliability were
given, making it difficult to judge the factors that are actually
being measured.
Distress as measured by the profile of mood states, was found
to be high at diagnosis and persisted at this level for at least
three months.
PHASE II ACCOMMODATION AND MITIGATION
Weisman describes the beginning of this second phase,
following the completion of treatment, or at a point when the
patient returns to a more routine life. It is a phase concerned
with a broad range of adaptive efforts and tactics for
alleviating or coming to terms with residual effects of cancer.
Weisman does concede that the time period at which this
phase may begin may vary enormously: for some patients
their initial treatment may last two months; for others the
period of therapy may be considerably longer. Also, patients
may require additional treatment, for example surgery
followed by radiotherapy or chemotherapy followed by
radiotherapy.
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According to Weisman, this second phase is a period of
optimism following treatment but also a period of low level
anxiety due to the continued monitoring of disease status by
the physicians and the constant surveillance that the patient
subjects himself or herself to. This surveillance is a period in
which the patient assesses physical signs and symptoms for
any indications of the return of the disease.
PHASE in RECURRENCE AND RELAPSE
For many patients, their disease returns or spreads either
during treatment (relapse) or at some point after treatment
(recurrence). Often more treatment is given but with lower
probability of success. During this phase, reassurance for the
patient may be difficult. Optimism, high morale and according
to Weisman even denial are extremely difficult to maintain.
The challenge to accommodation and mitigation is that earlier
treatment and probably the most effective treatment has
failed.
Phase III can, therefore, be viewed as a secondary existential
plight even though another remission may be possible. This is
the phase of pessimism and vulnerability often leading to a
state referred to by Weisman as "limbo" for the patient.
Following this period more moderate expectations may be
employed by the patient so that the hoped for "cure" may be
replaced by desire for respite, control and extra time.
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PHASE IV DETERIORATION AND DECLINE
Weisman claims that during the time referred to as "limbo"
patients "are inclined to become more passive and compliant,
as if realizing that there are fewer options and less
time"(pl92). The deterioration may be abrupt or insidious and
at some point in this process palliative treatment may be
instituted to alleviate troublesome symptoms.
According to Weisman, psychosocial problems during this time
become more apparent as deterioration progresses. There is
"unfinished business" to be dealt with and a feeling in patients
that time may be short. As symptomatology worsens, then the
issue of death looms large for many patients and psychological
problems may ebb and flow depending on the severity of the
symptoms.
Whilst this concept of psychosocial phasing is difficult to
substantiate and the methodology of Weisman and Wordens'
research problematic, the concept of an illness as a "process" is
an important and useful one. It helps to indicate periods of
potential distress and also suggests that research in the area of
psychological impact of cancer on the patient should attempt
to capture this dynamic pattern. Such a process would start
when the patient suspects their diagnosis (before it is
established) and progress until death or many years following
"cure".
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How and when does adjustment take place?
The revelation of the diagnosis of cancer is inevitably
traumatic and devastating. Patients may experience a range of
emotions regarded as "normal" and others which are regarded
as "abnormal" such as clinical anxiety and depression. Patients
probably begin a process of psychological adjustment before a
firm diagnosis has been made when they are experiencing
various symptoms which prompt them to consult a doctor. The
information imparted thereafter and their appraisal of the
threat of the disease dictate their emotional reaction to the
stresses.
Aitken-Swan and Paterson [1955] found that the majority of
patients with breast cancer suspected their diagnosis before it
was confirmed. This is further supported by studies examining
delay in seeking a medical opinion. Approximately 25 per cent
of women may delay up to three or four months before
consulting their general practitioner regarding a lump in the
breast [Green, 1976; Margarey et al., 1977]. The principal
reasons given for such delay were fear of diagnosis and fear of
treatment and its effects [Green, 1976]. (Coping strategies and
their relationship to adjustment to be discussed in detail in
Chapter 5 in relation to Social Support.)
Normal reaction to a diagnosis of cancer
The revelation of the diagnosis of cancer creates its own
psychological sequelae. Lloyd et al. [1984] interviewed 40
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patients within two weeks of being given their diagnosis of
lymphoma. Patients in this study were examined using the
standardised psychiatric interview and a number of visual
analogue scale measuring pain, anorexia, nausea, fatigue,
general health, concern and hopelessness.
The study revealed that in the two weeks following diagnosis,
15 of the 40 patients (37.5%) could be regarded as
experiencing clinically significant psychiatric morbidity. In
this group of patients depression and anxiety were the
predominant symptoms, the content of these being concerned
with the implications of the tumour on future health and life
expectancy. The remainder of the patient group scored within
the normal range on the standardised psychiatric interview,
but most showed some degree of distress at being given their
diagnosis. Nevertheless all of the patients approved of having
been told this information and favoured an open approach to
communication.
Senescu [1964] has identified several categories based on
certain fundamental reactions to disease:
1. The dependency response: Complex prolonged
investigation and treatment tend to make a patient dependent
on the medical services. This may provoke two extremes of
response: either a complete loss of initiative and responsibility
so that the patient comes to rely totally on the medical and
support services for all his needs; or a struggle to retain total
independence as the need for reliance on others is seen as
humiliating and threatening.
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2. Loss of self esteem: This involves the feeling or belief
that having cancer is a major physical imperfection and that
one is irreparably damaged as a result.
3. Anger: As an anticipatory response to actual or threatened
pain or damage. This may be non specific and directed against
fate or the "unfairness of it all" or focussed on a particular
aspect of the disease or treatment or even an individual.
4. Guilt: This may exist in addition to other responses and
may have many sources. This may include the belief that the
disease is some form of punishment for a previous wrongdoing
or misdemeanour, thereby invoking a feeling guilt.
5. Loss of gratification: the patients can no longer enjoy
previous pleasures and withdraws into a state of total lack of
interest in outside stimuli.
The stress reaction resulting in the patient when the diagnosis
of cancer is confirmed is similar to that seen in victims of
other types of trauma [Horowitz, 1979]. Falek and Britton
[1974] have postulated that this type of psychological
disturbance is a necessary process leading to readjustment
and can therefore be viewed as appropriate and normal.
During this period of early adjustment, the patient experiences
many conflicting emotions of numbness, disbelief, anger,
protest, fear, hope and despair [Renneker and Cutler, 1952;
Sutherland and Orbach, 1953; Bard and Sutherland, 1955;
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Peck, 1972]. It can be a time of emotional turmoil and
disorganisation. Patients may see their world as fragmented
and uncertain and issues regarding death, which up until this
point have been avoided may be thrust upon them. Part of the
stress reaction has been said to invoke a desperate attempt to
give sense and meaning to a "disintegrated " world [Weisman
and Worden, 1976-77]. The idea, however, that these
emotional reactions follow a particular sequence with fixed
stages through which everyone must pass is highly
questionable [Silver and Wortman, 1980].
Within the time span of a few days, a patient can progress
from the suspicion of cancer to the firm diagnosis and
beginning of treatment. The reactions occurring at this time
are responses to the stress which is most salient at any given
time. For example, in breast cancer the stress response pre¬
operative^ is predominantly related to the loss of the breast,
one of anxiety, with insomnia and difficulty in concentrating
on routine matters - a response to the uncertainty of the
situation. Following treatment the stress response may be a
preoccupation with every ache or pain in the body as the
patient is preoccupied with the possibility of recurrence
[Maguire, 1976].
The very word "cancer" produces fear in the patient on a
number of levels, leading to a feeling of disorganisation. As
previously described, the threat of death looms large, but
there are also uncertainties concerning the future, fear of pain,
fear of disfigurement, disability and loss of function, fear of
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losing family and work and a feeling of stigma and alienation
[Spikes and Holland, 1975; Holland, 1975]. This initial period
following diagnosis is characterised by features such as
anxiety, insomnia, irritability and poor concentration. The
acute phase is thought to resolve when a feeling'* alliance with
the doctor(s) occurs and a treatment plan is initiated. In so
doing, the patient feels that some degree of "control" is being
exerted over the situation [Holland, 1973].
When cancer recurs
The literature concerning the psychological impact of cancer
following the initiation of treatment is sparse, particularly,
when considering the range of "normal" reactions.
Facing a diagnosis of cancer is a time of reappraisal of
priorities and of life itself but the occasion of recurrence of the
disease may be a time of even greater psychological stress.
Silberfarb et al. [1980] found that feelings of depression and
anxiety were more frequent in the patients at a time of
recurrence than in the terminal stage of the illness. For many
patients the disease does not respond to treatment but in the
case of recurrence, the disease has disappeared (or is at least
undetectable) and the patient may believe that they are
"cured". The reappearance, therefore, of the tumour may
result in a catastrophic reaction on the part of the patient and
their relatives. The lack of systematic literature with respect
to this aspect of psychosocial oncology makes it difficult to
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draw any firm conclusions and is an area where more research
would be extremely valuable.
The terminal phase
The "normal" reactions in the terminal phases of an illness
have likewise received scant attention. Linn and Linn [1986]
state that "fear of death or death anxiety, is present in all
people to varying degrees, and there is nothing abnormal
about it". They continue to acknowledge that clinical states
such as anxiety and depression exist in the terminal stage of
an illness but that dying itself is not a psycho-pathological
process. Linn and Linn [1986] describe dying as something
which takes place over time. A view adapted from the work of
Glaser and Strauss [1968] who developed the concept of the
"dying trajectory". Glaser and Strauss demonstrated that the
term "dying" in the context of a disease such as cancer is a
social construction. To be regarded as "dying", the patient must
fall within some set of circumstances as defined by the staff.
Once patients had been given this label then staff
unconsciously "managed" their interactions with the patient in
such a way as to exert control over how much patients were
aware of their own condition and how much patients could
express of their awareness [Glaser and Strauss ,1965].
Kubler-Ross [1969] has described fully the phases that dying
patients go through. Much of this work is based on observation
and has not been subjected to more rigourous scrutiny. Other
researchers in this area have found that the dying patient
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does not fear death as much as the process of dying [Cramond,
1970]. This is borne out by more recent studies which have
found that patients' fear the possibility of a painful lingering
death. Symptoms of pain, weakness, anorexia and the loss of
functions such as bowel and bladder control, lead to major
functional limitations which can be frustrating and humiliating
for the patient [Bukberg et al., 1984].
Kastenbaum and Aisenburg [1972] have found that with
diminishing physical capabilities, the dying patient wants to
talk, keep communication open and have a part in the
management of his death, while the taboos of death and its
discussions may isolate fatally ill patients so that they are
unable to realise these goals. This dichotomy, the researchers
claim, isolate the patient and further heighten his fear and
anxiety.
Once again, the literature in the area of "normal" reaction to
the terminal phase of cancer is sadly lacking and opens a
number of avenues for useful research.
Those who "survive"
The final part of this discussion concerning the psychological
impact of cancer during the illness process is concerned with
"survivors".
The psychological effects of long term survival have only
recently been examined. Having been diagnosed and treated
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for the disease and been forced to face one's own mortality,
the survivor may experience a tenuous sense of longevity.
This may produce feelings of anxiety, depression, damaged
body image, and of course fears of recurrence of the tumour.
This has been termed the "Damocles Syndrome" [Koocher and
Malley, 1981] and has been likened to an anticipatory grief
reaction reported in the families of patients dying from
prolonged illness [Futterman and Hoffman, 1973]. Patients
may show difficulties in effecting the transition from "patient"
to "healthy individual". The reactions displayed in this
situation include decreased stamina, social estrangement and
job insecurity. At the same time the person may be vividly
reminded of their former illness by continued hospital follow-
up appointments and difficulties in obtaining new
employment or taking out health insurance [Stone, 1975;
Wheatley et al.,1974].
In general, however, distress has been found to decrease with
time from diagnosis, affording the survivor greater emotional
distance from the acute traumas of diagnosis and active
treatment [Kennedy et al., 1976; Li and Stone, 1976; Mages
and Mendelsohn, 1979]. It must be recognised that the term
cancer encompasses a wide spectrum of different diseases
invoking different treatments, potential outcomes and factors
such as age at diagnosis. Because of this a number of former
patients may demonstrate that distress can increase with time
since diagnosis either because of the gradual lifting of
psychological defences against distress or because of the
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intensification of stress associated with potential re-entry into
the patient role [Polivy, 1977].
A final perspective in this area is that some former cancer
patients appear to experience significant existential gains in
life experience from the cancer experience, arising from
confrontation with mortality (diagnosis), sickness and struggle
for health (treatment) and, finally, illness free survival. They
show no major psychopathology and in fact have better levels
of adjustment than non-patients [Craig et al., 1974; Kennedy et
al., 1976; Cella and Tross, 1986].
The variety of responses seen in survivors reflects the wide
range of disease and biographical factors that are influential
on the psychology of the cancer patients.
Positive psychological changes
A minority of patients have been found to derive marked
psychological benefit from their experience of suffering from
cancer. Even though these patients may be entering the
terminal phase of the disease having not responded to
treatment they say that the experience of the illness has
changed their lives for the better. The enhancement in life
quality in these patients has been found to be due to a
realisation of priorities in life, fulfilling long standing
ambitions and formulating plans and ideas to augment the life
available to them. These patients also report improved
relationships with people and a feeling akin to euphoria whilst
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still accepting the gravity of their situation [Kennedy et al.,
1976; Roud, 1986; Hughes, 1987]. This positive aspect of the
disease must be treated with caution as it only applies to a
small number of patients and must not be confused with
denial which will be discussed later in this chapter.
"Abnormal" reactions to a diagnosis of cancer
A large part of the research carried out in the field of
psychosocial oncology is concerned with "abnormal" reactions
to the disease. This literature encompasses such reactions as
depression, anxiety, denial and more generalised emotional
disturbance. Despite the large number of published papers in
this area, the majority fail to address the concept of the illness
as a process and therefore tend to use single assessments of
the psychological state of the patient using heterogeneous
groups of patients at different stages of their illness and do
not acknowledge this fact when presenting their results. This
often makes interpretation of the data difficult in terms of
comprehension for the reader and in assessing the
applicability of the findings. The literature also often fails to
elucidate the severity of these "abnormal" reactions so that the
reader is not able to discover if the effect is so severe that it
warrants psychiatric intervention. This is partly due to the
plethora of assessment tools that have been used by various
studies. Many of these tools do not give levels of "caseness" for
psychological disorder and others are instruments that are not
standardised and therefore have poor reliability and validity
making interpretation difficult. This applies particularly to
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assessment scales that have been developed for use with
psychiatric patients and contain somatic items relating to
anxiety and depression. In the field of oncology these somatic
items serve merely to confuse the issue as factors such as
weight loss or loss of appetite are features of a disease such as
cancer and therefore cannot accurately be attributed solely to
a diagnosis of depression [Maguire, 1984].
Perhaps the most valuable contribution in this area has been
made by Maguire and his colleagues in Manchester. They have
laid the theoretical foundations by studying the psychiatric
problems of breast cancer patients over a five year period
[Maguire, 1976; Maguire et al., 1976a; Maguire et al., 1978].
This type of study then led to further studies by these
researchers with a variety of different cancer patient groups
but also prompted other people to carry out similar studies in
other parts of the world. This early work has influenced and
continues to influence most of the subsequent research
conducted in this area of psychosocial oncology. It was
Maguire who first drew attention to the problems of cancer
patients suffering from an affective disorder.
Depression
Studies of the prevalence of psychiatric disorder in adult
cancer patients suffering from leukemia, Hodgkin's disease,
lymphoma, melanoma or sarcoma have found that up to one in
four patients develop an anxiety state, depressive illness or
mixed affective disorder [Craig and Abeloff, 1974; Plumb and
Holland, 1977; Davies et al., 1986]. This statement although
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apparently easy to comprehend in this bold form, fails to take
into account the numerous methodological and theoretical
problems that exist in this area of psychosocial oncology.
In these studies different criteria have been used to make a
diagnosis of depression. Some have used self report
inventories to assess its incidence such as the SCL-90 [Craig
and Abeloff, 1974] or the Beck depression inventory [Plumb
and Holland, 1977] whilst others have used clinical interviews
by researchers or psychiatrists [Perrin and Pierce, 1959;
Fraser et al., 1967; Levine et al., 1978]. This variety of
assessment methods makes comparison of the data across
studies very difficult, even when standardised tools such as
the Beck depression inventory and the SCL-90 are used, we
have no knowledge concerning their comparability. A further
problem in the use of these tools is the inclusion and weight
given to somatic items, which, as described earlier may
confuse the diagnosis of depression in the cancer patient.
The stage of disease is another problem in this literature as
many studies will use a group of patients at different points in
the illness process. Jaffe et al. [1986] for example present data
on a group of 21 patients with pancreatic cancer but give no
indication of when they were diagnosed, what treatment they
have had or the severity of their physical symptoms.
Depression identified in patients may be a transient stress
reaction rather than a depressive illness. Maguire [1984]
makes the point that it is important to distinguish the severity
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and duration of symptoms when assessing psychopathology in
cancer patients. Plumb and Holland [1981], in an elegant study
looking at patients with advanced cancer, found that the levels
of depression varied depending on which assessment scale
was used. They also found that the numbers of patients
identified as "depressed" varied according to whether it was a
single assessment of the here and now or whether the patients
had experienced significant depressive symptoms during the
preceding 30 days [Plumb and Holland, 1977; 1981]. The final
criticism of research in this area is the often unproven
assumption that depression in cancer patients is related to the
diagnosis of cancer. Peck [1972], for example, found that 27 of
50 patients were diagnosed as having a psychiatric disorder,
and in all but one of these it antedated their current medical
illness. Peteet [1979] in reviewing the assessment of
depression in cancer patients concludes that "depression
among patients with cancer is a prevalent clinically important
although not universal phenomenon that may or may not be
primarily related to the diagnosis and prognosis of the cancer
itself"(pl489).
Perhaps the most extensive study looking at the prevalence of
depression in cancer patients was conducted by Derogatis et al.
[1983]. In this study 215 cancer patients undergoing active
treatment for their disease were assessed using a formal
psychiatric interview, the SCL-90, and the Raskin Depression
Screen (a self report rating scale). Forty four per cent of the
patients assessed manifested a recognised clinical psychiatric
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syndrome and of these 13 per cent diagnosed as suffering
from a major affective disorder.
Studies looking at the prevalence of depression of patients
with lung cancer are of particular interest in this review, but
there are few reports to date. Hughes [1985a] assessed 134
lung cancer patients at diagnosis using a combination of a self
assessment questionnaire and a structured clinical interview
with specific criteria for the assessment of depression. 16 per
cent of this group of patients fulfilled the criteria for a
depressive illness. 58 per cent of the depressed lung cancer
patients, however, gave a clear history of having been
depressed before their physical symptoms began, apparently
in reaction to life stress unrelated to the illness. The
prevalence of depression in the patients with lung cancer was
higher than in a comparison group of patients with benign
chest disease, a sample of patients attending hospital without
serious illness and a sample of people from the general
population. Hughes found that the most significant correlates
of depression in the cancer patients were a past history of
psychiatric illness and the presence of metastatic disease.
Hughes then followed up these patients 2-3 months after
diagnosis and re-assessed then using the same assessment
tools [Hughes, 1985b]. In this study 50 patients were included
in the study. Of this group 16 per cent fulfilled the criteria for
depressive illness. This was a lower prevalence then that
recorded of the time of initial presentation when 26 per cent
of the same patients had been depressed. Eight of the 13 who
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were depressed originally had recovered, five had remained
depressed and three new cases of depression had arisen.
Hughes found that the patients who had not received any
active treatment were more likely to be depressed than those
patients receiving either radiotherapy or chemotherapy.
Cella et al. [1987] in a different type of study investigated the
relationship between a general concept of psychological
distress, extent of disease and performance status in 455
patients with lung cancer. Psychological distress was measured
using the Profile of Mood States (POMS), which gives a
measure of mood distress. This group of researchers were not
attempting to measure "caseness" but the effect of disease
related variables on distress.
The study found that there was a statistically significant
association between the extent of physical impairment and
mood disturbance. There was also an interactive effect with
the extent of disease so that the increase in mood disturbance
seen in patients who have a more impaired physical status is
more pronounced for patients with extensive disease.
These two papers form the body of knowledge of the
psychological impact of lung cancer. A further study by
Silberfarb et al. [1983] (to be discussed later) examines the
impact of chemotherapy for lung cancer on psychological
response. Obviously many studies using heterogeneous
samples of cancer patients will include lung cancer in their
samples but do not analyse these patients separately.
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Other factors besides the extent of physical impairment have
been found to contribute to affective disorders in cancer
patients. Symptomatology, such as pain, breathlessness, weight
loss and fatigue which could be regarded as an aspect of
physical disability, has been found to raise the prevalence of
depression. Hinton [1963], for example, found that 40 per cent
of terminally ill cancer patients with pronounced symptoms
were depressed in contrast to 20 per cent of patients where
symptoms were not a feature.
Sex differences have also been investigated. Leiber et al.
[1976] found that in a variety of cancer types, female patients
were more depressed than male patients with a similar
diagnosis. Findings such as this must be treated with caution,
however, because other evidence suggests that women may be
more willing to disclose their problems and feelings of low
mood even though the men may be experiencing this type of
distress [Kennedy et al., 1976].
A previous history of psychiatric problems has been reported
as predicting the development of depressive illness in cancer
patients. This has been reported with such groups of patients
as breast cancer [Maguire, 1982], lung cancer [Hughes, 1985a],
and advanced leukemia and Hodgkin's disease [Plumb and
Holland, 1977; 1981].
The lack of a confiding relationship has also been found to
increase the vulnerability of people experiencing a wide range
of stressful life events not just life threatening disease [Brown
and Harris, 1978]. Maguire [1982] found that the presence of a
confidant was a protective factor against developing an
affective disorder.
A central theme throughout this thesis is the importance of
looking at an illness such as cancer as a "process" rather than a
single event in time. Maguire and his colleagues have
conducted a study which gives a picture of a proportion of this
"process". They investigated the psychiatric problems of breast
cancer patients over a five year period. Results indicate that
psychiatric morbidity is the highest in the first year after
diagnosis. Data derived from 75 women with breast cancer
were compared with that of fifty women with benign disease
one year after initial diagnosis. It was found that 25 per cent
of the cancer patients were in need of psychiatric treatment
[Maguire et al., 1976a]. Morris et al. [1977] continued to study
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the psychological and social adjustment of these same"patients
over a two year period. Results indicated that two years after
diagnosis, whilst 71 per cent of cancer patients were no longer
distressed, 22 per cent had significant depressive symptoms.
This study clearly shows that in the early years following
diagnosis of breast cancer patients experience significant
psychiatric morbidity.
The studies described and discussed in this section
demonstrate that despite methodological problems in its
assessment, depressive illness does occur in cancer patients.
The changing pattern of depression throughout the course of
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the disease has not been described fully but the prevalence it
appears, is known to be higher in patients with more
advanced disease, increasing levels of physical disability and
symptoms and the incidence is also higher in those patients
with a previous psychiatric history.
Anxiety
The same methodological problems that have been discussed
in the assessment of depression can be applied to the
assessment of anxiety states in cancer patients.
Maguire et al. [1978] found that about 20 per cent of women
were at risk of developing an anxiety state in the early period
following a diagnosis of breast cancer. Derogatis et al. [1983]
found that of their 215 mixed cancer patients, 4 per cent were
diagnosed as having an anxiety disorder and approximately 85
per cent of these patients with a positive psychiatric condition
were experiencing a disorder with depression or anxiety as
pf-Z-i-C rjfj
the control symptom.
Devlen et al. [1987b] in a prospective study of 120 patients
newly diagnosed as having Hodgkin's disease and non-
Hodgkin's lymphoma found that 36 per cent of the group
exhibited symptoms of anxiety and depression. In fact, during
the first three months following diagnosis anxiety was the
most common psychiatric disorder found. In the 61 patients
who exhibited psychiatric symptoms, 73 per cent suffered
from an anxiety state [Devlen et al., 1987a]. These researchers
found that although the incidence of symptoms of anxiety was
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the same as in breast cancer patients the incidence of
symptoms of anxiety was considerably lower. The conclusion
of the authors is that this "may reflect the better prognosis of
lymphomas"(p957). It was also striking that although the
initial level of anxiety was high after the diagnosis was made
these states resolved once the patients had been given a clear
account of their diagnosis and treatment. This demonstrates
the importance of information in helping patients to make an
appraisal of the threat and thereafter develop appropriate
coping strategies as time progresses.
Davies et al. [1986] studied 38 patients with a malignancy of
the head and neck. Patients were assessed before they
underwent a biopsy and therefore before they had had the
diagnosis confirmed. This group of patients were compared to
an identical group of patients undergoing investigation for a
head and neck tumour but whose lesion had turned out to be
benign. The number of patients who experienced a clinical
level of anxiety (pre diagnosis), as defined by the Leeds
assessment scale was comparable, 40 per cent in the
malignant group and 41 per cent in the benign group. The
level of depression in the malignant group (pre diagnosis), on
the other hand, was double that of the benign group.
Unfortunately the design of this particular study makes it
impossible to explain the marked difference between the two
groups in terms of depression. The data does demonstrate that
any sort of diagnostic investigation is likely to lead to elevated
anxiety levels, even in those patients who are subsequently
found not to have a malignant neoplasm.
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A number of studies have highlighted factors which can lead
to higher or lower levels of anxiety. Symptoms, and in
particular pain and breathlessness have been found to elevate
levels of anxiety in cancer patients [Gibbs and Achterberg-
Lawlis, 1978]. In the terminal phases of the illness patients
who reported having a sense of fulfilment in life had better
adjustment and lower anxiety levels [Hinton, 1975] and prior
experience with the death of a close friend or relative (due to
illness), have been found to offer the individual the chance to
develop a healthy understanding of death before having to
face his or her own. This experience has been found to lead to
lower levels of death anxiety and fear in cancer patients
[Gibbs and Achterberg-Lawlis, 1978; Carey, 1974a]. There is
also some evidence to suggest that individuals claiming
religious affiliation have lower levels of anxiety following
diagnosis [Breugel, 1971; Carey, 1974b; Yates et al., 1981].
Anxiety, like depression is a significant problem for cancer
patients. There are methodological problems in its assessment
and the pattern of anxiety throughout the course of the illness
has not been described fully. Anxiety is evident before a firm
diagnosis is established and is heightened by investigation and
symptomatology. It is, however, responsive to information
concerning treatment and prognosis and its prevalence




Denial is concerned with defence against overwhelming
anxiety. It is a psychoanalytic concept which covers a wide
range of phenomenon rather than being an all or nothing
entity. Patients may minimise, ignore or completely reject
evidence of disease or its significance.
Denial and its assessment is a controversial area in
psychosocial oncology as there is considerable evidence that in
certain situations denial is adaptive [Hamberg et al., 1953;
Hacket et al., 1968; Hackett et al., 1969; Hackett and Cassem,
1970] and may prolong life [Hackett et al., 1968]. Where denial
results in delaying medical consultation and the start of
treatment [Aitken-Swan and Paterson, 1955; Gold, 1964;
Greer, 1974], it is clearly maladaptive, increasing the risk of
morbidity and probably mortality. Denial may inhibit
communication between family members who adopt different
coping strategies creating serious emotional problems between
patients and their relatives [Stedeford, 1981].
Methodological critique
Cancer is a complex disease; it has many forms and goes
through many stages following diagnosis. The study of the
impact of the disease on the patient and concomitant
adjustment is thereby complicated by the difficulties inherent
in studying the disease process. There are various
methodological problems in the literature on this subject that
make comprehension difficult. Familiarisation with this body
50
of literature does not necessarily result in an understanding of
the psychological impact of the disease on the patient. The
methodological shortcomings of this literature have already
been alluded to earlier in this chapter but can be broadly
summarised thus:
1. Clustering cancer patients as a single group:
Many studies take a heterogeneous group of cancer patients
and study them as if they represented a single disease entity
[Derogatis et al., 1983; Farber et al., 1985]. Consequently such
factors as site of cancer, staging of the disease and prognosis
are not examined or reported. This merely serves to cause
confusion in interpreting the findings because as discussed
earlier factors such as site of disease or stage of disease may
be important in the adjustment process. These factors
therefore must be considered in the design of any study in
psychosocial oncology.
2. Demographic factors: these factors must be considered
when examining the impact of cancer. Factors such as age
[Craig and Abeloff, 1974; Plumb and Holland, 1977], religious
affiliation [Yates et al., 1981] and previous psychiatric history
[Maguire, 1982] have been found to be important in the
adjustment to cancer. Most studies routinely record the age of
the patient group but other demographic variables are often
ignored.
3. Assessment of psychiatric disorders: statements
concerning the psychosocial impact of cancer are often based
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on a test score. This raises a number of issues. Firstly, any
tests used should be standardised, valid and reliable. Certain
studies have employed unstandardised tests or unstructured
interviews from which the authors infer "caseness" [Schmale
and Iker, 1966a; 1966b]. Secondly, any tests used must have
been developed for use with physically ill patients. Studies
employing scales originally devised for use with psychiatric
patients may give erroneous results due to the presence of
somatic items included in them [Koenig et al., 1967]. Thirdly,
papers reporting the prevalence of psychiatric disorders may
use tests that do not detect "caseness" such as the MMPI
[Koening et al., 1967]. This makes comparison difficult, as the
raw scores from the numerous scales and interviews used in
the literature are not easy to equate. This in turn, complicates
issues such as planning and evaluating appropriate
psychological interventions. For example, Hughes [1985a;
1985b] used a psychiatric interview, Davies et al. [1986] used
the Leeds self assessment scales, Devlen et al. [1987a] used the
present state examination, Jaffe et al. [1986] used the schedule
for affective disorders and Plumb and Holland [1977; 1981]
used the Beck depression inventory. Finally control groups or
even comparison groups of patients have often not been used
[Perrin and Pierce, 1959; Fox, 1978] and it is therefore difficult
to place these results in any type of framework or context.
These methodological problems need to be addressed,
therefore, when considering psychiatric disorders in cancer
patients. A more rigorous approach to assessment needs to be
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taken and the psychometric properties of any scales used
must be carefully considered.
4. Opinion and anecdote: whilst many studies have used
test scores to examine the psychosocial impact of cancer,
others have used unstructured interviews and anecdotes
[Hinton, 1963; Hackett and Weismann, 1969; Holland et al.,
1977; Leigh et al., 1980; Brooks, 1985; Forester et al., 1985].
Plumb and Holland [1977] have drawn attention to this
difficulty and have commented that terms such as
"depression", "denial" and "anticipatory grief" are not
operationally defined and that data are not provided on the
reliability of response classification. Furthermore, not only is it
important to reliably report the presence of a phenomenon,
but it is equally important to know who is making the
determination. Different judges may view the same
phenomenon differently, resulting in discordant findings
[Worden and Weismann, 1977; Slevin et al., 1988].
5. "Process"; many of the studies in the field of psychosocial
oncology do not take into account the fact that the disease can
be seen as a process. Frequently, studies use a "snapshot"
technique, assessing patients on a single occasion [Peck, 1972;
Koenig et al., 1967]. Whilst Maguire and his colleagues have
attempted to look at changes in the psychological state of
patients during the five year period following diagnosis of
breast cancer, this approach is almost unique in the literature.
The concept of the disease as a "process" is axiomatic to
medical practitioners, but is a major omission in research
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studies conducted by those working in the area of psychosocial
oncology.
Future studies in this area must address these methodological
shortcomings in order to develop a complete and coherent
picture of the psychological impact of cancer on the patient.
Assessment must be made at different stages of the disease
with valid and reliable instruments in specific cancer types.
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Chapter Three
THE PSYCHOLOGICAL IMPACT OF TREATMENT FOR
CANCER
Cancer treatment consists of three principal modalities:
surgery, chemotherapy and radiotherapy. Patients may
receive one or a combination of these treatment modalities
depending on the type of cancer that they suffer from. The
treatments often have physical side effects, such as hair loss,
nausea, vomiting, loss of a limb or disfigurement depending on
the modality. In addition to these physical side effects,
however, a considerable body of knowledge has been
developed relating to the psychosocial sequelae. Much of this
literature relates to breast cancer where patients may
experience all three treatment types over the course of their
disease. This literature will not be reviewed extensively due to
the highly specific nature of breast cancer and its treatment
but reference will be made to it, in order to demonstrate
methodological points and deficiencies in the literature
relating to cancer treatment as a whole.In addition' the psycho¬
logical sequelae of surgery will not be reviewed as only a very small
number of patients with lung' cancer undergo this treatment approach.
(In the current study no patients had surgery for their disease.)
Radiotherapy
Radiotherapy is a commonly used treatment option for many
types of cancer. Numerous studies have reported psychological
reactions as a result of this type of therapy. Peck [1972] used
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psychiatric interviews to study the affective reactions of 50
cancer patients with varying sites of disease who were
undergoing radiation treatment. He found that anxiety (98 per
cent of the sample) and depression (75 per cent) were
common.
In a further study, 50 patients interviewed before and after
their radiation treatment [Peck and Boland, 1977]
demonstrated that 62 per cent of the patients were depressed
and 66 per cent were anxious pre-treatment. However, 22 per
cent of the patients had a continuing psychiatric disorder
which began well before they had cancer. Following treatment,
80 per cent of patients exhibited a mild or moderate anxiety
state and 74 per cent a mild or moderate depressive illness.
Other reactions noted by the psychiatrist were irritability (36
per cent), suspicion (30 per cent) and euphoria (10 per cent).
The second interview took place at the end of treatment when
radiation reactions, both systemic and local are at their peak.
The authors conclude that these reactions undoubtedly
augment pre existing anxiety and depression and that the
increase in psychological problems are a result of the
treatment rather than the knowledge of the diagnosis.
Forester et al. [1978] administered a modified version of the
Schedule for Affective disorders to 200 cancer patients with
different cancer types. These questionnaires were
administered at the beginning, midpoint, and conclusion of
radiotherapy, and again two weeks following the completion of
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treatment. The scores of the cancer patients were then
compared to those of 84 psychiatric patients.
The results demonstrated that although the patients
undergoing radiotherapy were depressed and anxious, their
levels of distress were significantly lower than the psychiatric
comparison group. In order to determine if the type of
radiation treatment was associated with differentially
elevated negative affect scores, the scores derived from the
100 patients who received betatron therapy (large loud
machine; daily treatment of two to three minutes) were
compared with those derived from 100 patients receiving
linear acceleration therapy (a small quiet machine; daily
treatment of two to three minutes). It was found that as
radiotherapy continued the intensity of anxiety and
depression symptomatology decreased among patients treated
with the linear accelerator while they increased in patients
treated with betatron. The authors conclude that certain
aspects of the treatment employed are associated with
psychological distress.
Andersen and Tewfik [1985] conducted an elegant study of 45
mixed cancer patients undergoing radiation therapy with
curative intent. The study was designed to determine
individual differences in psychological responses to treatment.
Patients were divided into those with high, moderate, and low
levels of anxiety at the start of treatment using the
Spielberger State Trait Anxiety Inventory.
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The results revealed that patients with an initial high level of
pretreatment anxiety reported a significant reduction in their
state anxiety, although at post treatment follow up they
remained the most anxious subgroup. Patients with a
moderate level of pretreatment anxiety reported little change
in their state anxiety responses. Finally, patients with low
levels of anxiety prior to radiation therapy reported
significant increases in state anxiety at post treatment such
that they equalled the state-anxiety level maintained by the
group with moderate pretreatment anxiety.
The authors suggest in their conclusion that the expression of
moderate fear or distress may have substantial benefits for
cancer patients. It may begin to herald the beginning of an
adaptive type of "worry" which may include attending to
information concerning treatment, accepting reassurances
from others and coping with feelings of helplessness. All such
responses may facilitate adjustment to the treatment process.
The moderate level of anxiety at the end of treatment may be
indicative of a level appropriate to a life threatening illness
like cancer. It may be anxiety that can facilitate adaptation
should further treatment be required for the patient's disease.
This data demonstrated that the concept of anxiety related to
the treatment of disease is not as straightforward as has been
postulated in earlier studies. It is clear that the pretreament
level of anxiety may be important in the patients later
adaptation and further research is required to describe the
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patterns of psychological response to treatment given at a
later time in the disease process.
Chemotherapy
Chemotherapy consisting of combinations of drugs often have
severe side effects such as nausea, vomiting, hair loss and a
wide range of other sequelae such as skin rashes, sore throats
and secondary infections [De Vita, 1985]. Many studies
examining the psychological impact of chemotherapy have
used women undergoing treatment for breast cancer as
subjects [Maguire et al., 1978; Morris et al., 1977]. This data is
highly specific and is therefore difficult to apply to other types
of cancer treatments. The data is complicated further by the
fact that the subjects in these papers may have undergone a
mastectomy as well as cytotoxic chemotherapy. More recently
a number of papers have been published in which patients
have been able to choose their own treatment types [Ashcroft
et al., 1985; Steinberg et al., 1985; Morris and Ingham, 1988;
Margolis et al., 1989]. Patients described in these studies may
undergo chemotherapy in particular treatment regimes and
the element of choice appears to play a role in mediating
psychological distress [Ashcroft et al., 1985], although in
studies where no choice is available high levels of psychiatric
distress have been reported in patients receiving
chemotherapy, in the order of 38 per cent [McArdle et al.,
1981]. Maguire et al. [1980], conducted a randomised clinical
trial of breast cancer patients treated with mastectomy plus a
combination of chemotherapy drugs versus treatment with
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mastectomy alone. In the group of patients receiving the
combination chemotherapy it was found that 81 per cent
suffered from psychiatric morbidity (anxiety and depression)
requiring treatment, compared with 50 per cent receiving
surgery only. The psychiatric sequelae were particularly
evident in those patients who experienced the more severe
forms of drug toxicity.
Studies of a more general nature, however, have been
conducted. Silberfarb et al. [1980a] studied 50 consecutive
patients with a variety of cancer types admitted to a medical
oncology ward and treated with chemotherapy, radiotherapy
or nothing. On tests of cognitive function, 35 per cent of those
receiving chemotherapy were found to have deficits compared
to only 4 per cent of patients not receiving chemotherapy.
Interestingly, none of the patients in this study were found to
have significant levels of anxiety or depression.
Devlen et al. [1987b] assessed 120 patients with Hodgin's
disease and non-Hodgkin's lymphoma. Patients were treated
using a combination of cytotoxic drugs. It was found that
episodes of depression lasting from one to three days occurred
at the administration of treatment. In total, 25 (21 per cent) of
the sample experienced such episodes with the majority
receiving one particular treatment regimen (this included the
drugs mustine,vinblastine, prednisolone and procarbazine).
Lloyd et al. [1984] found similarly high rates of anxiety and
depression before and during treatment. These authors did not
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find an elevation of psychiatric symptomatology during the
course of chemotherapy however. Love et al. [1989]
investigated the impact of treatment side effects on emotional
distress in a sample of 238 patients undergoing treatment for
breast cancer or lymphoma.
Patients were interviewed at five points during their first six
cycles of therapy. The side effects most frequently reported
were hair loss, nausea and tiredness and each of these was
experienced by more than 80 per cent of patients at some
time during the six cycles of treatment. In addition, vomiting,
sleep disturbance, weight gain, mouth sores and numbness/
tingling were a consequence for more than 40 per cent of the
sample.
Interviews were conducted with patients to assess emotional
distress. The interview was unstandardised and inter-rater
reliability was calculated at 80 per cent between four raters.
90.3 per cent of patients reported some degree of emotional
distress from chemotherapy as assessed by a ten point scale.
Higher levels of distress were reported as treatment
progressed and a highly significant correlation was found
between the number and severity of the side effects and the
level of emotional distress. The side effects of treatment were
severe enough to prompt 46 per cent of patients to have
considered stopping therapy by the final cycle of treatment,
yet only three of the total patients group discontinued
treatment, against the advice of their physician.
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This paper contains numerous methodological flaws both in
the use of unstandardised assessment tools and in the use of a
heterogeneous group of cancer patients, but it is useful in that
it relates patients' emotional distress over time to treatment
related effects.
Gilbar and Kaplan de-Nour [1989] in a refinement of the
previous study examined factors which led to a dropout from
chemotherapy. These researchers put forward the hypothesis
that the presence of severe treatment side effects would not
be sufficient to cause patients to discontinue treatment, but
that they would demonstrate a number of other symptoms of
maladjustment.
Gilbar and Kaplan de-Nour matched 53 cancer patients who
had dropped out of chemotherapy with 53 patients who had
completed treatment. Patients were assessed using the
Psychosocial Adjustment to Illness Scale (PAIS) and the Brief
Symptom Inventory (BSI).
The results demonstrate clearly that those patients who
dropped out of chemotherapy exhibited more adjustment
problems in a number of areas of life functioning. The patients
who dropped out also had significantly higher levels of
psychosocial distress than those completed treatment. The
psychosocial difficulties experienced by those patients
undergoing chemotherapy are not simply due to the side
effects imposed on them by the treatment but are a much
more complex interaction between emotional distress,
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treatment side effects, feelings, thoughts and perceptions of
treatment. Indeed, a number of other studies have
demonstrated that increased emotional distress is not simply
related to the number and severity of side effects and extent
of the disease but is probably the result of the interaction of
physical, psychological and social variables [Davies et al., 1973;
Silberfarb et al.,1980a; Schmale et al., 1982-3].
Cain et al. [1983] examined some of the complexities of this
relationship. Sixty women were studied within one month of
being diagnosed with cervical, uterine and ovarian
malignancies. The women were assessed using the Hamilton
Anxiety and Depression Rating Scales and the Psychosocial
Adjustment to Illness Scale.
The authors found that the scores of all the patient groups
(cervical, uterine, and ovarian malignancies) demonstrated the
presence of mild depressive symptomatology. The symptoms
of depression however in women receiving triple agent
chemotherapy and, therefore, having a higher level of side
effects and physical symptomatology approached the level
typically obtained by people entering outpatient psychiatric
clinics. On closer inspection of this group, however, it was
found that these women exhibited less knowledge of their
illness and treatment than other women, had a significantly
lower level of education and demonstrated a poorer
adjustment to their illness generally. The authors conclude
that these women with higher levels of depression suffer from
a much greater disruption of "social role function" which when
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interacting with the increased level of side effects and
physical symptoms could lead to greater levels of
psychological distress.
Other studies have tried to refine the factors implicated in
adjustment still further. Silberfarb et al. [1983] investigated
the effects of specific chemotherapy regimens in patients.
Seventy seven patients with small cell lung cancer were
randomly assigned to two regimens. Depression and fatigue
were assessed in the patients using the Profile of Mood States
questionnaire.
The results of the study showed that one regimen produced a
greater degree of depression and fatigue than the other. This
effect could not be accounted for in terms of tumour reduction
as there was no difference between the two groups in terms of
tumour response. The major difference between the two
treatments was that one contained the agent vincristine, a
vinca alkaloid known to cause disturbances in the biogenic
amines in the brain. The vinca alkaloids have been reported to
block the transport of dopamine beta hydroxylase which is
responsible for converting dopamine to norepinephrine
[Poisner and Bernstein, 1971; Van Praag, 1982]. Changes in
this neuro-transmitter are thought to affect mood, leading to
depression. Therefore, the authors speculate that the regimen
containing vincristine was responsible for the higher level of
depression than the treatment without the drug.
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A number of other anti cancer drugs have been investigated in
the same way. Adams et al. [1984] examined ten patients with
metastatic renal cell carcinoma receiving treatment with
human leukocyte interferon alpha therapy. The majority of
the patients exhibited severe behavioural changes such as
psychomotor retardation, social withdrawal and decreased
energy as well as mild to moderate cognitive, affective and
personality changes, particularly in the first week of
treatment. A finding more recently replicated by McDonald et
al. [1987] in a group of patients receiving alpha interferon for
chronic hepatitis B infection.
Other compounds that have been investigated in a similar way
include L-asparaginase [Holland et al., 1974], vinblastine
[Peterson and Papkin, 1980], mechlorethanine [Calabresi and
Parks, 1975], methotrexate [Bleyer, 1977], fluorouracil
[Greenwald, 1976] and steroids [Ling et al., 1975].
Another aspect of treatment that must be taken into account
when considering the psychological impact of cancer is that of
nausea, vomiting and the anticipatory aspects of this.
Chemotherapy induced nausea and vomiting
The pharmacological side effects of cancer chemotherapy are
extremely varied. Gastro-intestinal side effects particularly
nausea and vomiting have been reported as being the most
noxious. Coates et al., [1983] in a study examining patients
perceptions of the side effects of chemotherapy found that
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being sick and feeling sick were reported as being the most
severe side effects.
These side effects usually begin one or two hours following
chemotherapy and last for six to twelve hours although in
some patients they may last for several days. These
pharmacological side effects are usually treated with anti¬
emetic drugs such as metoclopramide; however, such drugs do
not control nausea and vomiting in all cases and may have
unacceptable side effects of their own such as drowsiness,
diarrhoea and extrapyramidal symptoms [Gralla et al., 1981;
Allan et al., 1984; Warrington et al., 1986].
One of the results of this chemotherapy induced nausea and
vomiting can be conditioned effects [Burish and Carey., 1986].
They can occur before, during, or after chemotherapy
treatment. When they occur before the treatment they are
usually referred to as anticipatory side effects. When they
occur during or after the treatment they are often intermixed
with (and are difficult to distinguish from) pharmacologically
caused nausea and vomiting. Conditioned side effects can be as
aversive as pharmacological side effects, and once they
develop they are usually refractory to medical intervention.
These psychological side effects are believed to be relatively
common and develop through a process of classical
conditioning. In a study conducted in Sweden by Olafsdottir et
al., [1986] it was found that anticipatory nausea occurred in 40
per cent of patients and 14 per cent showed anticipatory
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vomiting. Following the completion of four cycles of
chemotherapy these numbers had increased so that 47 per
cent experienced anticipatory nausea and 49 per cent
experienced anticipatory vomiting.
These symptoms can be extremely distressing for patients so
that some patients eventually discontinue chemotherapy (and
therefore abandon hope for remission and cure rather than
suffer such discomfort). Wilcox et al. [1982] studied 52 women
receiving adjuvant chemotherapy for breast cancer. They
reported that 27 per cent of the patients discontinued the
adjuvant chemotherapy and 71 per cent of those who
discontinued cited nausea and vomiting as the major reason
for stopping. Of those patients who had terminated treatment
because of nausea and vomiting, 70 per cent had experienced
anticipatory vomiting.
A number of reviews of this aspect of chemotherapy have
shown that these extremely severe side effects can in many
instances be prevented or ameliorated using psychological
techniques [Redd, 1982; Burnish and Carey, 1986; Carey and
Burish, 1988]. In addition, it is not uncommon for patients to
become depressed as a result of these disabling, conditioned
effects, particularly when they do not understand the causes
of this phenomenon [Carey and Burish, 1988].
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"Quality of life"
In recent years more attention has been focussed on the
impact of the illness and its treatment on specific areas of life
functioning. The has led to a rapid increase in the literature X
concerned with defining and measuring the "quality of life" in
cancer patients [Najman and Levine, 1981].
There appears to be no agreed definition of the term "quality
of life" [de Haes and van Knippenberg, 1985] although it
clearly involves concepts of physical and psychological well
being. This lack of a clear definition has created problems in
the design of tools to measure it. A number of approaches
however have been developed.
The most commonly used index developed to measure "quality
of life" is the Karnofsky Performance Index [Karnofsky and
Burchenal, 1949]. The scale consists of ratings from 0-100
which take account of the presence of symptoms, the ability to
carry out work and physical activity and self care. Whilst this
scale is frequently used and has been influential since its
inception its reliability has been questioned by several
authors [Hutchison et al., 1979] and its validity as a "quality of
life" measure has been a controversial issue [Clark and
Fallowfield, 1986].
Researchers and clinicians have tried to develop more
comprehensive scales capable of measuring more than just
physical well being and also able to detect changes over time.
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The Functional Living Index: cancer scale (FLIC) is one such
tool [Schipper et al., 1984].
This scale is composed of 22 items. Each item is assessed by a
graded linear analogue scale which give a measure of physical
and psychological function and is therefore regarded as a
"quality of life" index.
A number of other scales exist which have been labelled
"quality of life" measures. Scales such as the Q-L index [Spitzer
et al., 1981], the Barthel Index [Mahoney and Barthel, 1965]
and the Rotterdam Symptom Checklist [de Haes et al., 1986].
Numerous scales exist purporting to measure "quality of life"
but each has methodological and psychometric problems
primarily due to the lack of definition of the concept. This area
is comprehensively reviewed byd*flaes and Knippenberg,
[1985], Aaronson and Beckman, [1987] and Kind, [1988].
A different perspective on this problem has been to develop
tools to examine the impact of an illness and its treatment on
different areas of patients lives. One of the most
comprehensive scales developed in this area has been the
Psychosocial Adjustment to Illness Scale [Morrow et al., 1978].
The scale examines a patients' global adjustment to an illness
and its treatment in seven principal psychosocial areas or
"domains". These domains include: health care orientation;
vocational environment; domestic environment; sexual
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relationships; extended family relationships; social
environment and psychological distress.
The instrument is not solely concerned with an attempt to
define and measure quality of life but is fundamentally
concerned with "adjustment" to illness.
Recent years have seen an increased emphasis on the concept
of "quality of life" particularly in diseases such as lung cancer
where increasingly toxic therapies are being administered to
patients and where there is little chance of long term survival
[Leonard, 1989].
Bakker et al. [1986] used the Karnofsky Performance Index as
a measure of "quality of life" in 28 patients with non small cell
lung cancer receiving combination chemotherapy. Patients
who responded to treatment were compared with patients
who did not respond (i.e. did not experience a decrease in
tumour size). It was found that the "quality of life" measure
dropped significantly during chemotherapy among responders
and non responders and after discontinuation of treatment
approached pre-treatment scores in responders only. The
authors conclude that "treatment-associated toxicity and
deterioration of the patients' well-being offset any potential
survival advantage for the majority of patients."
One of the shortcomings of the above study is that the "quality
of life" measure was stopped following the cessation of
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chemotherapy thus leaving a significant part of the illness
process unaccounted for.
Minet et al. [1987] used the same assessment scale to compare
patients with non small cell lung cancer receiving
radiotherapy alone with those receiving radiotherapy and
chemotherapy. The authors evaluated the "quality of life" of
patients every month from initial randomisation for treatment
until death or the last follow up clinic before death.
In this study the authors found no statistically significant
difference between the median survival of the two groups of
patients. However, in terms of "quality of life", the group of
patients receiving both chemotherapy and radiotherapy
experienced a "better outcome" in terms of quality of survival
during and after treatment.
In other studies, authors have developed their own
questionnaires to answer questions concerning the "quality of
life" advantage of treatment regimens. Kaasa and Mastekaasa
[1988] and Kaasa et al. [1988] developed a ten question index
which they refer to as the "psychosocial well-being
questionnaire" to measure psychosocial well-being, medical
side effects, physical function and everyday activity. This scale
has been utilised in two studies comparing patients with non
small cell lung cancer undergoing treatment with either
combination chemotherapy or radiotherapy alone. In these
two studies [Kaasa and Mastekaasa, 1988; Kaasa et al., 1988] it
was found that the total well-being index score was
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significantly higher in patients receiving radiotherapy than in
patients receiving combination chemotherapy during the
period of treatment. No differences, however, in the "quality of
life" were detected in the follow up period of 52 weeks.
The most recent studies addressing this question have again
use "quality -of life" measures to assess the efficacy of different
treatments. Fernandez et al. [1989] combined the Karnofsky
Performance Index with a number of visual analogue scales.
They studied 31 patients with advanced non small cell lung
cancer and found that prior to therapy the entire group
considered themselves to have a significantly reduced "quality
of life" as a result of their illness. Following treatment
however 75 per cent of this group reported improvement
from their pre-treatment level.
The Medical Research Council Lung Cancer Working Party
[1989] reported a multi-centre trial in the United Kingdom
that compared patients with small cell lung cancer randomly
allocated to either combination chemotherapy and
radiotherapy started at diagnosis and selective treatment of
radiotherapy or chemotherapy only started when it was
necessary to control symptoms. This study utilised a diary
card completed every day by the patients during the first six
weeks of treatment. This assessed vomiting, activity, mood,
anxiety and overall condition. Compliance with this approach,
however, was poor and it became necessary to use a "quality
of life" measure based on assessment by a physician at each
clinic visit.
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The results demonstrated that the policy of immediate
treatment led to a longer survival time and a better "quality of
life" as assessed by the clinicians. However, the data from the
patients diary card demonstrated a worse "quality of life".
Despite the methodological problems of assessing "quality of
life" this latter study demonstrated that it is important to
make some measure of the impact of an illness and its
treatment on the patient and, that the patients' view is
extremely important as it may be at odds with the view of the
physician. A view shared and demonstrated by Slevin et al.
[1988] who found that "doctors could not adequately measure
the patients' quality of life Quality of life is a concept that
includes many subjective elements, and it is therefore perhaps
not surprising that a doctor may not have the necessary
knowledge of the patients feelings to assess their quality of
life accurately "(pi 10). This is confirmed by more recent work
in lung cancer. Physicians were found to be poor judges of the
"quality of life" of a patient at presentation, as time from
diagnosis increased, however, physicians improved in their
assessment of the change in specific aspects of a patients'
illness. This included aspects such as changes in physical
symptoms and overall physical condition [Regan et al., 1991].
These authors while stressing the importance of the
assessment of "quality of life", particularly in clinical trials
suggest that the perceptions of both the physician and the
patient need to be taken into account.
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The importance of this concept in any study of the
psychological impact of an illness and its treatment is further
elucidated by Schipper and Levitt, [1985]."To the extent we
are unable to prevent disease, the ultimate goal of medicine is
to effect a cure and return the patient to a life-style not
diminished by the illness and its treatment. The scientific
power of modern medicine provides the biologic rationale to
intervene with a force never before possible. The rigorous
application of quality of life assessment is neither unscientific
nor in competition with basic medical science as we know it. It
merely serves to emphasize that the proper study of mankind
is man"(pll22).
The psychological impact of treatment on the patient:
a methodological critique
The methodological problems inherent in studying the
psychological impact of treatment for cancer in many ways
parallel those described at the end of Chapter 2 which
considered the psychological impact of cancer on the patient.
1. Heterogeneous groups of patients
Studies often describe the psychological sequelae of a
particular treatment modality using patients with varying
types of cancer [Peck, 1972; Forester et al., 1978; Anderson
and Tewfik, 1985; Silberfarb, 1980a]. The difficulty in
interpreting this type of study is that different cancers often
have a very different prognosis and a very different
presentation [DeVita, 1985]. This makes accurate comparison
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of these patients difficult despite the fact that they may
receive the same treatment modality.
It is important, therefore, in planning future studies to
consider the use of a homogeneous group of patients with one
particular type of cancer undergoing a particular type of
treatment. The value of this approach has been aptly
demonstrated in studies conducted in the field of breast
cancer [Morris et al., 1977; Maguire et al., 1978] where the
impact of a disease entity and its treatment have been clearly
described.
2. Treatment intent
The intent of treatment i.e. whether it is curative of palliative
may be an important factor when considering the
psychological impact. Many studies [Peck, 1972; Peck and
Boland, 1977; Silberfarb, 1980a] do not specify either the
intent of treatment or the patients understanding of this
intent. A study assessing patients during different phases of
treatment would be important in illuminating the patients
reaction at these times and would separate out the
psychological sequelae of treatment intent.
A further consideration in investigating treatment aims would
be to preserve the concept of a treatment "process".
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3. Side effects
The significance of treatment side effects on the psyche have
been demonstrated in previous studies in the field of
psychosocial oncology [Davies et al., 1973; Cain et al., 1983;
Gilbar and Kaplan de Nour, 1989]. Future studies must be
prepared to examine the effects of specific drug regimens and
specific side effects such as nausea and vomiting as it is
important to be able to disentangle the relative contributions
of physical, psychological and social variables when
considering the impact of cancer.
4. "Quality of life"
The concepts of "quality of life" has gained considerable
importance in recent studies in oncology, despite the problems
of definition and assessment. In view of the difficulties
inherent in utilising the plethora of scales and questionnaires
in this area researchers have turned their attention to
assessing adjustment to an illness and its treatment and the
impact of that illness on the patients' life [Morrow et al., 1978].
In order to understand more fully the complexities of the
psychosocial impact of an illness and its treatment, it is
important to undertake this type of assessment, particularly at
different stages of the disease/ treatment "process".
Methodological concepts such as those outlined above must be
considered in designing future research studies using valid,
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reliable tools to describe fully the experience of the cancer
patient at different points during the treatment process.
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Chapter Four
THE PSYCHOLOGICAL IMPACT OF CANCER ON THE
FAMILY.
Cancer presents a dilemma for the patient and his or her
family. Cassileth and Hamilton [1979] have referred to it as a
"family disease" with immediate impact on family functioning,
roles, relationships and because of the potential for loss. The
diagnosis, Cassileth and Hamilton postulate "reverberates
throughout the family system."
The patients' family play two distinct and potentially
contradictory roles during the illness and its treatment. They
function as the patients first line of emotional support and are
so perceived and encouraged by health care professionals
[Regan, 1965; Giacquinta, 1977]. Simultaneously, and
paradoxically, they are viewed along with the patient as the
unit requiring care and therefore equally in need of attention
and support [Huth, 1978]. In fact it has been postulated that
the position in which family members find themselves when a
member develops cancer is even more stressful than in the
patient [Dyk and Sutherland, 1965].
It is surprising, therefore, that the area of impact of cancer on
the family of the adult cancer patient has been largely
neglected. The patient has been the focus of research into
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psychosocial oncology and the family has on the whole been
the subject of personal opinion and anecdotal case reports.
These reports often acknowledge the importance of the family
as a whole in cancer care, yet few of the authors continue to
study the impact on the family in any systematic way
although, papers are often concluded with a hypothetical plan
for future research in this direction. Sheldon et al. [1970] state
"the patient, in addition, remains a part of an ongoing family
unit that must live with the disease and an indefinite sentence
of death"(p744). Freidenbergs et al. [1981-82] in their major
review of psychosocial oncology claim that "unfortunately,
there are few studies documenting the actual psychosocial
impact of cancer on either the patient or his/her
family"(p304). Naysmith et al. [1983] in a further review
conclude, "there is surprisingly little data regarding family
interactions while an adult member of the family deals with
cancer"(p26). Cassileth et al. [1985], in one of the most
important research studies in this area concludes that,
"additional assessment of this kind is required to document
relationships between patients' and their relatives' emotional
status and to methodically assess the psychosocial status of
relatives"(p72).
Many studies, however, examine the effects on the family of
diagnosis and treatment of cancer in children [Lansky and
Cairns, 1978; Spinetta et al., 1981; Spinetta, 1982; Monaco,
1986]. In general, these studies have been conducted from a
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family therapy or developmental perspective which does not
have immediate relevance for this review.
The illness as a "process"
Cancer and its treatment can be viewed as a "process", not
only for the patient but for the family also. Giacquinta [1977]
has developed a model consisting of "stages" and "phases" for
the systematic description of the functioning of family
members. This model consists of ten phases of family
functioning within four stages. This model is shown
diagrammatically in Figure 3.
Figure 3.
Phases and stages of family functioning in cancer care
(Giacquinta, 1977).
Points of Transition in
Individual with cancer
Family Stage Family Phase
Individual receives initial
diagnosis of cancer,
continues to carry out role
obligations with the family
and functions in varying











ceases to perform familiar
roles and is cared for either







Individual with cancer dies Bereavement i. Separation
ii. Mourning
Re-establishment Expansion of the
social network
This concept was based, according to the author, on an analysis
of 100 families coping with the diagnosis and treatment of
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cancer. This conceptualisation is consistent with the literature
previously reviewed in Chapter 2 which demonstrated that
the patient with cancer experiences different phases of an
"illness trajectory".
Giacquinta [1977], unfortunately, presents no data from tjie
analysis of 100 families to explain the development of this
model of phases and stages. It is,however, quoted extensively
by a number of authors in reviews of 'cancer and the family
[Freidenberg et al., 1981-2; Northouse 1984; Cassileth et al.,
1986; Lichtman and Taylor, 1986].
Despite the support for this model of family functioning in the
field of psychosocial oncology, research endeavours to date
have not attempted to validate the notion of a "process" with
respect to the family.
The small body of literature concerning the family of the adult
cancer patient can be divided into two types;
anecdotal/discursive and 'scientific' or empirical.
Anecdotal/discursive literature
This type of literature consists of either observations of a
single case or the personal view of a particular author. The
papers are often emotionally laden and are not based on the
results of research studies or any theoretical perspective. This
approach often has strong support, but because of the way in
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which it is generated its usefulness in terms of application is
difficult to ascertain.
Worby and Babineau [1974] for example, describe a family
interview technique that encourages them to "verbalise
suppressed feelings". This approach, the authors speculate will
help the "family adjust to the impending death". In this paper,
sections of dialogue are reported and the conclusions are
based on the authors observation rather than on any objective
end points.
Similarly, Snee [1979] discusses, at some length, her own
views concerning the support needed by the families of cancer
patients. Whilst this approach has obvious face validity and is
written with care and sensitivity the article is based on a
number of broad generalisations that need to be evaluated
and examined in a more rigorous manner before they are put
into clinical practice.
A common approach in this body of literature is the use of
emotive phraseology and powerful literary quotes [Nordlicht,
1982, Earnshaw-Smith, 1982]. Whilst this increases the
"popular" appeal of such articles it does not further our
understanding of the impact of the illness on the family.
The final perspective to be considered in this section is that of
family systems theory. This approach sits astride the
anecdotal and "scientific" approaches in the literature. Family
systems theory is based on psychotherapeutic principles and
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has been developed and validated over many years in child
psychiatry [Barker, 1986]. In the field of cancer care, however,
this perspective has been employed on a more ad hoc basis
producing articles that sit more easily in the area of anecdotal
literature than with those of a more "scientific", research
orientated nature. Various papers exist which describe the
application of this approach to oncology but make no attempt
to assess its efficacy or applicability to the area of cancer care.
Brenner [1985] for example, discusses its potential use in the
domain of hospice care, whilst Johnson [1988] describes its
application in the field of oncology generally. These papers are
much less emotionally laden than papers described previously
in this section, but fail to produce validation of the use of this
approach in these settings.
"Scientific" or empirical literature
The studies examining the psychosocial impact of cancer on
the family have broadly looked at three areas: communication,
terminal illness and general psychological effects at
unspecified time points during the illness.
Communication
Krant and Johnston [1977-78] studied the patterns of
communication in the families of 75 cancer patients at
approximately two years following the diagnosis. The
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researchers interviewed a range of different family members
using an unstandardised, semi-structured interview. Krant and
Johnston found that 46 per cent of the "first order relatives"
(spouses, children, siblings) did not have a communication link
to the patients' physician and that if a link was not established
at diagnosis then this situation tended to remain unchanged. It
was also found that communication and information between
the family members was often discordant and guarded and
that this led to the perception amongst them that the patient
was withdrawing. More than half of the family members felt
uncomfortable visiting the patient in hospital and experienced
feelings of helplessness, in particular many felt that they did
not know what to say.
Early studies such as this proved to very influential in
changing hospital practice and emphasising communication
with the whole family. They were viewed as useful
descriptions which prompted similar projects to be
undertaken in many cancer centres.
Hinton [1980] assessed the awareness of dying and the
communication pattern between 80 married couples, where
the patient was suffering from a fatal neoplastic disease.
Sixty-six per cent of the patients recognised that they might or
would soon die while 26 per cent spoke only of improvement,
the remainder (8 per cent) were non-committal. Of the
patients who recognised that they were dying, 69 per cent had
spoken to their spouse about this issue. Hinton observed that
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all of the patients who were certain that they were dying had
discussed it with their spouse.
A surprising finding in this study was that anxiety level had
no consistent effect in preventing communication between
partners. Hinton emphasises this finding as the ethos in
hospitals at the time was that troubled or anxious patients
were believed to have poor communication with family,
friends and staff.
These studies, although displaying methodological problems in
terms of lacking comparison groups, using unstandardised
assessment tools and including heterogeneous groups of cancer
patients, laid the foundation for numerous studies in the area
of communication between family members. Stedeford [1981],
Fobair et al. [1986] and Hughes [1987] have all examined
communication and the effect of the disease on communication
between family members the results demonstrate the
shortcomings in the health care system as well as suggesting
ways in which improvements in communication styles and
patterns can bring families closer together.
Terminal illness
The literature on the terminal phases of cancer is vast,
although very variable in its quality. In the writings of
Kubler-Ross [1969], Parkes [1972], Benoliel [1978], Kalish
[1979], Mortocchio [1982] and Raphael [1984] the experiences
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of dying patients and their families have been discussed from
a variety of different perspectives.
In fact most of the research that has been conducted
concerning the family's response to cancer, focuses on the
terminal phase of the illness.
This literature addresses three principal areas: communication
about death which has already been dealt with, the provision
of care and support for the family and dealing with feelings of
loss and separation.
Providing care and support for the family of the
cancer patient
Family members often assume the primary caretaking role for
the dying person, particularly in the community. Numerous
studies have described this situation. Rose [1976] interviewed
26 families who were caring for a terminally ill family
member. Not surprisingly it was found that these carers were
the people most likely to help the patient with physical care
and emotional support. Only one of the 26 families received
assistance from a visiting nurse. This finding surprisingly was
replicated by Parsons [1977] who reported that few people
other than family members were involved in meeting the
needs of the dying person.
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The demands of caring for a terminally ill patient on their
carer has been investigated by a number of researchers [Rose,
1976; Googe and Varrichio, 1981]. Family members in these
studies reported decreased sleep due to factors such as worry,
concern and having to provide physical care during the night.
Vachon et al. [1977] found that family members developed
their own health problems as they tried to cope with the
stressful burden of care. Vachon et al. [1977] also found that
the carers of terminal cancer patients often developed
psychological problems such as anxiety and depression in
response to feelings of impotence and helplessness as they
watched their husbands die.
In this latter study the widows of 73 cancer patients were
compared with the widows of 51 patients with chronic
cardiovascular disease. The widows of the cancer patients
thought that there was little they could do to help their
husbands whereas the widows of the cardiac patients felt that
they had an essential practical role in providing aid to their
husbands. This latter group focussed particularly on
encouraging their husbands to make lifestyle changes (diet
and exercise) that they felt would be beneficial to their
husbands' health. In addition, many of the cancer widows
reported that their social support network had decreased as
people had found the pattern of constant visiting too stressful
to maintain.
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Knowledge and information regarding care has been found to
be important. Rose [1976] found that the majority of families
interviewed, said that they needed more information about
providing care in areas that required expertise and judgement
on their part, such as pain control. Other studies have found
that information is important for relatives in other aspects of
physical care such as lifting, ambulation, wound dressings, and
comfort measures as well as how to cope with the family
changes that occur during the patients' illness [Edstrom and
Miller, 1981; Googe and Varricchio, 1981; Grobe et al., 1981].
Problems experienced by the patient such as physical
symptoms, anxiety and depression and the inability to
communicate have been shown to be a major preoccupation
for the spouse. As these symptoms worsen in the terminal
phases of the illness the physical and psychological health of
the spouse also deteriorates [Howell, 1986]. The concerns of
the spouses, in this latter study, concerning changes in future
lifestyle were found to be particularly potent in the
development and maintenance of anxiety.
Wright and Dyck [1984] investigated the concerns of 45 adult
family members at different stages during the illness
"process". The four concerns most frequently identified were;
problems created by the disease, fear of the future, waiting for
results of tests and difficulties with obtaining information.
Distress concerning symptoms increased with each progressive
stage of the illness from 20 per cent at diagnosis to 53 per
cent at the terminal stage. Fear of the future and waiting for
results of tests were more acute at diagnosis and were cited
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less frequently as the disease progressed, difficulty in
obtaining information, however, remained a problem at all
stages of the disease (diagnosis, recurrence, terminal stage).
When asked to specify the importance of certain needs six
were regarded as important at all stages of the illness. These
included: 1. the need to be kept informed of the patients'
condition, 2. the need to be assured that the patient is
comfortable, 3. the need to be informed of any changes, 4. the
need to be with the patient as much as possible, 5. the need to
communicate with the patient, 6. the need for acceptance,
support, and comfort from nursing staff.
Since families provide a large part of the physical and
emotional care of the patient, it is perhaps not surprising that
they ascribe a high priority to symptom control, patient
comfort and information regarding this aspect of care. If the
patient develops symptoms the family will be the first to be
aware of them and they will feel it their duty to act in order to
alleviate the patients' suffering through direct or indirect
action.
In view of the range, severity and distressing nature of the
symptoms of the disease, it is not surprising that, if given the
choice, carers would prefer that the patient died in hospital.
Krant and Johnston [1977-78] in their study of communication
in late stage cancer found that 20 per cent of the families
interviewed preferred that the patient die at home, 16 per
cent were uncertain and 55 per cent preferred the hospital
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with an additional 9 per cent choosing hospital if the patient
had pain (the study did not ask about the perceptions of
hospice care in symptom relief). The symptoms experienced
by the patient are important in dictating these responses, a
study by Putnam et al. [1980], found that 50 per cent of
family members would prefer the patient died at home
providing symptoms such as pain were well controlled. The
main factor being that hospital was felt to be better able to
provide expert care and comfort.
Dealing with feelings of separation and loss
The final aspect of terminal illness to be dealt with is the
feelings of separation and loss that co-exist with the provision
of care for the patient.
The realisation in family members that they are losing their
most important significant other is a time of anxiety, fear and
confusion [Thomas, 1978]. A sense of helplessness often
pervades [Krant and Johnston, 1977-78] and it is at this time
that spouses have been found to perceive that health care
professionals are less available to them and that they are
being left to deal with the situations alone [Vachon et al.,
1977].
In many of the descriptive studies undertaken during this
time the widows report that the stress of the terminal phases
of the illness was worse than the stress of bereavement
[Vachon et al., 1977; Molter, 1979; Howell, 1986; Stetz, 1987].
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The principal reason put forward for this has been the
anticipation of loss and changes in lifestyle which people find
extremely anxiety provoking [Howell, 1986; Stetz, 1987].
One of the major methodological problems in these papers is
the use of unstandardised questionnaires often administered
at unspecified times with families of heterogeneous groups of
cancer patients. This complicates interpretation of the data
and makes it impossible to develop a coherent picture of the
experiences of cancer patients and their relatives.
"Psychometric" studies examining the impact of
cancer on the family
The majority of the studies reviewed in this chapter have
demonstrated that there are repercussions of an illness such
as cancer on the family. The perspective that they have
adopted is to emphasise the interrelatedness among family
members and the mutual effect that they have on one another.
From a family systems theory perspective, therefore, changes
that occur in one part of the family system are accompanied
by compensatory changes in another part of the system. In
response to cancer, anxiety, depression or distress are not
confined to the sick individual but reverberate throughout the
family unit [Minuchin, 1974].
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This view has prompted attempts to quantify the
psychological impact on the family using reliable and valid
psychometric tests and a rigorous research methodology.
An early study by Coursey et al. [1975] assessed 187 patients
with various cancer types before the initiation of treatment
(either chemotherapy or radiation therapy). Both patient and
accompanying family member completed the Spielberger
State-Trait Anxiety Inventory on a single occasion.
The data demonstrated that female patients were significantly
more anxious than male patients in terms of state anxiety but
no difference was found in trait anxiety. Family members on
the other hand, scored higher on both measures than the
patient. Female family members showed a trend towards
higher state levels of anxiety but not on trait levels.
This early study is wholly inadequate in its design using a
single measure of psychological distress administered to a
wide range of patients at different stages of their illness on a
single occasion. The results, however, do indicate that family
members may experience higher levels of distress than
patients and these results prompted the initiation of a number
of more refined studies.
Leiber et al. [1976] interviewed 15 female patients and their
husbands and 21 male patients and their wives who were
already receiving chemotherapy for a variety of different
tumours. The patients and their spouse completed the Beck
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depression inventory, the Affectional Needs and Behaviour
Scale (this scale measures the respondents needs for physical
contact and the way in which these needs are expressed) and
the Current State of Health Questionnaire (this measures the
degree of pain, discomfort, incapacitation and worry
experienced by the patient during the previous two days).
The results demonstrated that as a group neither the patients
nor their spouses were suffering from severe depression at
the time of the study. Women patients were the only sub
group whose scores on the Beck Depression Inventory
approached the depressive range while the husbands were the
least depressed of the four subgroups.
With regard to "affectional needs", patients and spouses of
both sexes reported a decrease in the desire for sexual
intercourse but the desire for non-sexual closeness increased
following the diagnosis of the illness. Forty nine per cent of the
sample reported an increased desire for physical closeness and
only 5.6 per cent reported lessened desire for this. Not
surprisingly, a trend for sexual desire to decrease as
depression increased was found.
The correspondence between changes in desires and changes
in actual affectional behaviour was greater for patients than
for spouses and was greater for female patients than for male.
Thus, women patients, although significantly more depressed
than the other three sub-groups were most likely to have
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their affectional needs met while their husbands were least
likely to have their needs met.
This study although using a single "snapshot" approach in
monitoring depression and affectional needs does raise some
important issues. It indicates that the needs of patients'
husbands are poorly met, perhaps because they are
infrequently expressed. It also suggests that patients and their
spouse may experience increased intramarital tension as a
consequence of disparate needs and altered roles.
There are methodological difficulties with this study. The
psychometric assessment is only performed on one occasion
and the requirement for both husband and wife to participate
may have eliminated from the sample those couples with
problems in marital adjustment. This latter bias may explain
why so few of the patients were depressed for example.
Despite these difficulties in the study design the data makes
an important contribution in describing a group of individuals
who may be at risk of developing later psychological and
marital difficulties.
Other studies followed looking at the levels of psychological
distress in both the patient and their spouses and produced
some contradictory findings.
Plumb and Holland [1977] assessed depressive symptoms
using the Beck Depression Inventory in 66 cancer patients
with various types of cancer and their next of kin. All the
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patients were undergoing chemotherapy treatment for their
disease. Unfortunately, it was not possible in this study to
control for the length of time since diagnosis of the illness or
for the number of previous hospital admissions for treatment.
The results showed that 77 per cent of the cancer patients and
82 per cent of the next of kin scored in the "not depressed
range". Nineteen per cent of patients and 18 per cent of their
next of kin scored in the moderately depressed range and 4
per cent of patients and none of the next of kin scored in the
severely depressed range using the cut off scores suggested by
the authors of the Beck Depression Inventory. The authors in
this study conclude that, "Based on their own reports on a
standard measure of depression, hospitalised patients with
advanced cancer were not significantly more depressed than
their presumably healthy next of kin"(p272). The depressive
symptomatology that did exist was more prevalent in the
younger patients than the older and the severity of these
symptoms did not systematically increase with nearness to
death in 57 of the patients who died during the study.
Interestingly, this early study found that overall the self
esteem of the cancer patient and their next of kin was
relatively intact so that although the patient may loathe his or
her situation they do not loathe themselves. This, the authors
postulate, is the reason why very few of the patients in the
study or their next of kin reported even considering suicide as
a viable option for themselves.
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Wellisch et al. [1978] investigated the reactions of 31 men to
their wives' mastectomies using a variety of psychological
tests: the Locke-Wallace Marital Adjustment Test, the Rotter
Locus of Control Scale and the Eysenck Personality Inventory.
The results showed that psychosomatic and psychological
reactions after the womens' surgery were frequent among the
men and tended to be expressed from the time of the
procedure until the woman was discharged from hospital.
Sleep disorders and the presence of nightmares were reported
in 40 per cent of the sample. Twenty seven per cent reported
a loss of appetite and 6.7 percent reported an increase in their
appetite. Forty three per cent of the men indicated that their
ability to work was temporarily adversely affected by the
experience, principally because of their inability to
concentrate. In general, the men indicated that sexuality and
sexual intimacy were severely stressed and often negatively
altered after the mastectomy. This effect on sexuality was also
found to be prevalent in the wives who underwent the
mastectomy [Jamison et al., 1978].
The authors conclude that, "the results of this study showed
that a sizeable proportion of this sample of 31 men either
coped well with mastectomy in their spouses or denied
psychosocial stresses. It was also evident that a smaller
subgroup of this sample was distressed, remains distressed
and reported a downward spiralling of the quality of their
relation ship" (p545).
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One of the methodological problems with this study was the
use of a single assessment. As a result the study is unable to
indicate if the stressed sexual relationships may have
recovered over time. The small sample size also makes
multivariate analysis difficult to undertake as dividing the
groups up by age, attitude or personality type, for example,
would result in extremely small sub groups. The final problem
in this experimental design is the lack of any standardised
measure of mood, this should be an essential feature in any
study designed to examine the psychological impact of cancer
and its treatment.
Goldberg et al. [1984] in attempting to overcome some of the
methodological difficulties inherent in previous studies
selected patients with a single type of cancer and their
spouses, used a selection of well validated and reliable
psychological tests and obtained a measure of physical health
status.
Goldberg et al. selected patients with newly diagnosed lung
cancer and their spouses and assessed them within six weeks
of their diagnosis and at two monthly intervals thereafter for
a period of four months. The number of patients for which
complete data was available was 21 patients and 18 spouses
all of whom completed the test battery on three occasions over
the six month period.
The psychological tests used included the Profile of Mood
States, The Psychosocial Adjustment to Illness Scale and the
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Karnofsky Performance Index. This battery assessed six
different mood states, adjustment to illness in a number of
different areas of life and physical health status.
The study, therefore attempted to investigate the relative
contributions of physical health and social interests and
involvement, to depression in patients with lung cancer and
their spouses over a period of six months following diagnosis.
The results demonstrated that the level of depression as
measured by the Profile of Mood States decreased in patients
and their spouses from the first assessment to the second and
third. This suggests that diagnosis produces an acute increase
in depressive symptoms which then subside over the four to
six months following this.
No consistent relationship was found to exist between
physical health, as assessed by the Karnofsky Scale and
depression, or between depression and social interests and
involvement in this period. At the final assessment conducted
at six months post diagnosis, however, physical health status
accounted for one half of the variance in patients' depression
scores. This demonstrates that physical status was an
important determinant of depression in the patients at that
time whereas social interests and involvement continued to
play no apparent role in the patients depression.
Factors contributing to depression in the spouses, however,
were the reverse of this. High levels of depression were
consistently associated with low levels of social interest and
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involvement throughout the six month evaluation period but
showed inconsistent associations with the patients physical
health during that time.
These results are important in that they demonstrate that
social involvement for the spouse, (in this study
predominantly women), may be of special importance in
contributing to depression. The study used reliable and valid
assessment scales and examined both patients and their
spouses. Unfortunately the period of the study ceased
following administration of treatment, thus leaving a large
part of the illness and future treatment "process" unaccounted
for. The design of the study does, however, demonstrate the
value of a longitudinal assessment of both the patient and
their partner.
Gotay [1984] attempted to assess coping mechanisms and the
resolution of problems at different points in the illness process
in patients and their partners. She used a group of patients
with "early stage" cervical cancer and their partners as well as
a group of patients with "advanced stage" breast or
gynaecological cancer and their partners.
Unfortunately the data for this study was collected using an
unstandardised questionnaire designed by Gotay herself and
no measures of mood or symptomatology were used. The
study, therefore, is difficult to interpret but does view the
illness as consisting of a "process" rather than a single point in
time.
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The results demonstrate that the spouses were more likely
than the patients to dwell on the possibility of the patient
dying and were more disturbed by this possibility than the
patients. In fact, the most common concern reported by
patients and their partners was their fear of the disease which
was ranked as the principal response in both the early and
advanced stages. The content of the fear was concerned with
potential progression and recurrence of the tumour. The
coping strategies employed to deal with these fears were
consistent among the family. Both patients and their spouses
used "action taking" as a common coping strategy with
"information seeking" being the most commonly reported
behaviour particularly in the early stages of the disease. The
patients and spouses in the advanced stage group also found
religious faith to be important as an effective coping strategy
in relieving stress.
This study was extended by Gotay [1985] to examine
attributions patients and their spouses made for the cause of
the disease and its effect on their level of adjustment. In this
study an unstandardised questionnaire was used but also
some standardised measures of mood (Bradburn Affect
Balance Scale) and social adjustment (Weissman's Social
Adjustment - self report scale) were employed. Gotay utilised
the same groups of patients as previously and interviewed
them at two stages of the disease (early and advanced).
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The results indicated that the majority of individuals cited
chance as the cause of their cancer. This belief was not found
to affect social adjustment negatively. In fact, the adjustment
scores were not significantly different from the general
population. Patients and the spouses in both groups were more
stressed than the general population but were not as
disturbed as a group of individuals receiving psychotherapy
"for stress reactions". The attribution of causation did not
affect mood negatively and Gotay concludes "it is suggested
that not making strong causal attributions may be adaptive for
cancer patients and their families"(p825).
Cassileth et al. [1985], recognising many of the shortcomings of
studies in this area adopted a more rigorous research design
than previous researchers. This study explored anxiety, mood
disturbance and global mental health in a representative
sample of cancer patients and their matched relatives.
The study assessed 201 mixed cancer patient-relative pairs at
different point during the illness/ treatment "process", during
active first line treatment, whilst patients were on follow-up
observation and when they were receiving palliative therapy.
The test battery used to assess each patient-relative pair
consisted of the Spielberger State Anxiety Scale, The Profile of
Mood States and The Mental Health Index.
The psychological status of patients and their relatives were
closely correlated in terms of anxiety, mood disturbance and
global mental health. This similarity was found to persist
101
between patient and relative across diagnostic group. As a
group, patients displayed greater mood disturbance than their
matched relatives. Treatment status ( active, follow-up,
palliative) was found to be significantly associated with
psychological response in both patients and relatives.
Psychological state was found to deteriorate according to the
treatment status of the patient. Those receiving palliative care
displayed the highest anxiety levels, the most severe
disturbance in mood and the poorest overall mental health.
This trend was observed for relatives and patients alike.
Psychological well-being decreased when patients were
receiving active treatment as opposed to follow-up care and
decreased further when patients were receiving palliative
therapy.
The explanation of this data by Cassileth et al. is that
"palliation therapy, which is geared to attain comfort rather
than cure or remission, coincides with nearness to death. This
phase of treatment and of life offers minimal if any hope for
recovery and, not surprisingly, is associated with significant
degrees of anxiety, mood disturbance and poor mental
health"(p75). The authors put forward the view that "patients
who are not in an active phase of therapy but who are under
follow-up medical care display, as do their relatives
comparatively good psychological status. These patients and
relatives are freed from the disruption and stress associated
with cancer therapy itself, and generally have reason to
believe that remission or cure has been obtained. Under
circumstances of active treatment, however, patients and their
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relatives have yet to attain that security, and are faced also
with fears, inconvenience, treatment related toxicity and
massive uncertainty"(p75). Thus the emotional status of this
group reflects their situation and they show greater emotional
distress than those people under follow-up care but less
distress than those receiving palliative treatment.
The correlation between patients and their relatives
demonstrates an interaction of family members in terms of
psychological state. Undoubtedly relatives provide a
psychosocial environment to which the patient reacts and,
conversely, patients similarly influence the level of distress or
adaptability exhibited by the relatives. Social support is not
dealt with in this particular study but it may have a role in
mediating distress particularly in view of the study reported
by Goldberg et al. [1984] (discussed earlier in this chapter)
which demonstrated the importance of social involvement for
the relatives of lung cancer patients.
Cassileth et al. [1985a] repeated this study with a group of 374
patients with mixed cancer types and 378 of their relatives.
The results demonstrated a robust effect in that palliative
treatment as opposed to active or follow-up care was
associated with a greater mood disturbance in both patients
and their matched relatives. A poor performance status was
also associated with a greater mood disturbance in the patient
and their partner.
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Baider et al. [1986] examined the impact of family
environment on psychological distress in two groups of women
with breast cancer and their husbands. Twenty five women
underwent a lumpectomy and 26 underwent a mastectomy.
Patients and their husbands were interviewed at about two
years following the surgical procedure using the Spielberger
State-Trait Anxiety Inventory, The Beck Depression Rating
Scale, The Psychosocial Adjustment to Illness Scale and the
Moos Family Environment Scale.
The two groups of husbands showed identical levels of
adjustment which was not significantly different from the
general population. Similarly, no differences were found
between the two groups in terms of depression. In terms of
anxiety, however, the post-lumpectomy husbands were found
to score significantly higher that the post mastectomy group.
And in terms of the family environment (cohesion,
expressiveness, conflict etc.) scores of both groups were within
the normal range for both groups of husbands but women in
the post mastectomy group described significantly more
organisation, cohesion, and less conflict than those in the post
lumpectomy group, thus a more supportive family
environment.
A comparison between the patients and their husbands also
demonstrated that there were no significant differences
between them on any of the measures.
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This study used a comprehensive battery of psychometric
assessment tools to monitor the psychosocial impact of the two
operative procedures. Unfortunately the study uses a single
assessment of psychological state and family relationships
which limits the applicability of the findings. The single
assessment point however does not enable tfee-influence of time
and stage of disease on adjustment and family environment to
be assessed. The results suggest that the concept of "family
environment" does not correlate significantly with
psychological distress in this study at the point of assessment
but this may effect may change as time from surgery
increases, for example.
The concept of "social support" used in this study also
warrants further consideration. The Family Environment Scale
monitors the perception of family members of certain aspects
of family function such as independence, conflict, achievement,
religious activity and intellectual/ cultural activity. In using
this type of measure to investigate social support a careful
definition of the term based on a theoretical perspective is
required and an appropriate tool selected. Multiple
administrations are then necessary to monitor any fluctuations
in levels of support throughout the illness and to assess its
relationship to adjustment and psychological state.
The concepts of social activity, social interaction and social
support have increasingly been regarded as useful in the
amelioration of psychological distress. Evaluation of these
concepts has been haphazard and unsystematic. Studies have
105
on occasion made the assumption that to increase the social
interaction of family members would be beneficial even
though evidence on this issue is equivocal, as will be discussed
in the next chapter.
A study by Haggmark et al. [1987] encouraged relatives to
increase their level of participation in the care of the patient.
This would necessarily increase contact with a greater range of
health care professionals as well as other patients' relatives in
the same position. The relatives in this study reported an
increase in social activities with family and friends as a result,
but the study failed to include any measures of mood in its
design so that the value of increased social interaction cannot
be properly assessed. Such conceptual leaps in research design
are not uncommon but in complex multifaceted concepts such
as social support they can distort and confuse important
questions and lead to confusion in interpreting the results of
other research studies.
Goldberg et al. [1984] found that the distress in the family
members of patients with lung cancer reduced over time.
Cassileth et al. [1985], however, reported that if during the
passage of time the patients treatment status changed i.e. the
patient embarked on a different type of treatment or was
given palliative therapy, then distress increased. Goldberg et
al. [1984] also found that social interest and involvement were
important in reducing depression in the patients spouse.
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Ell et al. [1988] in an attempt to elucidate further the effects of
time and social support examined 143 pairs of patients and
their "significant others" at 3-6 months following initial
diagnosis of breast, colorectal or lung cancer and again 6
months later. The measures used included the role limitation
scale, the interview schedule for social interaction, the
personal control inventory and the mental health inventory as
well as measures of physical status and symptomatology. This
battery assessed the availability and adequacy of social
support, effects on lifestyle, the degree of feelings of personal
mastery of the situation and level of mood disturbance.
The results of this study reveal some interesting differences
from earlier data. A significant decline in mental health was
observed in the patients and their carers over time and a
group of carers who appeared to be psychologically vulnerable
were clearly identifiable. They were consistently distressed
over time and experienced no relief from this as time
progressed.
Poorer psychological functioning among carers was associated
with patients having more physical symptoms at initial
diagnosis. It was noteworthy, however, that declining mental
health status in the carer was not related to an increase in the
patients role limitation or physical symptomatology over time.
The early mental health status of patient and carer was found
to be a strong predictor of subsequent psychological state. In
contrast to earlier studies [Cassileth et al., 1985], the
psychological status of patient and carer were not significantly
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correlated either in those who were functioning poorly from
the outset or in those who showed change over time.
The principal significant effect in this study was a strong
association between declining mental health and declining
social integration. At the same time, carers whose mental
health improved over time experienced a significant increase
in perceived adequacy of support and in social integration.
This data leads Ell et al. to conclude," taken together these
results suggest that individual personal and social resources
rather than patient's physical condition, are primary factors in
declining mental health status among significant
others"(p436).
This data demonstrates that the relationship between
psychological state, physical state and social support is far
from clear and requires further study. The paper by Ell and
her colleagues does however contain certain methodological
problems. The study population contains three diagnostic
groups all of which have very different prognoses in terms of
survival time. This fact complicates the interpretation of the
data as prognosis and site of disease are factors known to
affect psychological adjustment [Weisman and Worden 1976-
77; Cassileth et al., 1985].
A second problem in the design of the study is that the
assessment points do not allow the researchers to control for
treatment status effects which have been shown to be
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important in determining psychological state [Cassileth et al.,
1985].
Finally, no attempt was made to control for the type of
treatment that the patients received. With the three diagnostic
groups used in this study the treatment modalities of surgery,
chemotherapy, radiotherapy and indeed no treatment may
have been used. The psychological impact of treatment has
been discussed earlier and is an important variable in
research in this field.
One particular phase of the illness "process" that has received
scant attention is the period following discharge from hospital
when the patient has received treatment and thereafter, is
regularly monitored at follow-up outpatient visits. Oberst and
James [1985] undertook a preliminary study of needs in
patients and their spouses following discharge home after
surgery for cancer. This reported anger and frustration in
spouses concerning a perceived lack of support from all
sources including health care professionals.
This study was later extended and a more rigorous research
design utilised [Oberst and Scott, 1988]. The subjects consisted
of 40 patients undergoing surgery for cancer of the bowel or
urinary system, and their spouses. Half of the group had a
permanent ostomy as a result of surgery and the remainder
did not. The subjects were assessed using the Spielberger State
Anxiety Index, the Brief Symptom Index and the Vulnerability
index at 10, 30, 60, 90 and 180 days following discharge from
109
hospital. The intensity of psychological distress experienced by
patients and their spouses was remarkably similar and
correlated, although the temporal pattern of occurrence was
significantly different. Prior to discharge, spouse anxiety was
significantly higher than that of the patients due to the
anticipated worries and concerns about their own ability to
cope. Spouses were least distressed after ten days at home, but
thereafter experienced a significant rise in distress
culminating in observable clinical depression at 90 and 180
days. Peak distress for the patients, however, occurred 10
days after discharge as a function of physical symptoms that
were unexpected or more severe than anticipated.
The authors reported that the distress which spouses began to
experience two months following discharge "appeared to be a
response to the patients' continued egocentricity regarding
symptoms and a perceived lack of support and understanding
of their own plight."
This paper demonstrated a combined effect of physical
symptoms and lack of support which contrasts with previous
data. The period of study is highly specific and does not
investigate patients at relapse or during palliative treatment.
It does, however, provide valuable longitudinal information
during the post discharge period. One major methodological
shortcoming of the study is the way in which social support
was assessed. This took the form of a series of semi-structured
questions relating to problems and concerns and this relied on
the respondents volunteering the fact that they lacked a social
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support network. The study on the other hand does overcome
many of the shortcomings of previous attempts using a single
disease and valid and reliable assessment scales.
Finally Baider et al. [1989] have reported the adjustment of 39
couples in which one partner had undergone surgery for colon
cancer in the previous three years. These researchers were
particularly interested in the gender of the patient and spouse
as this was felt to be a variable neglected by previous studies.
Patients completed the Psychosocial Adjustment to Illness
Scale and the Brief Symptom Inventory on a single occasion.
Male patients were found to adjust better than female patients
while the opposite was true of spouses i.e. the adjustment of
husbands was much worse than that of wives. Overall the
adjustment of the group of patients and their spouses was
strongly correlated.
This latter paper is a preliminary communication of research
findings and presents no data on the effects of symptom
severity and social support. It does, however, raise the
question of the effects of gender in investigating the
psychosocial impact of cancer on the family.
Other factors which have been examined in relation to impact
of cancer on the family are concerned with support from
health care professionals and offering patients a choice of
treatment.
1 1 1
Maguire [1981] interviewed 52 men whose wives had
undergone simple mastectomy and radiotherapy and 40 men
whose wives had been treated for benign breast disease.
Thirteen per cent of the husbands in the mastectomy group
were rated by a psychiatrist as having moderate anxiety and 4
per cent as having severe anxiety when assessed three months
after the operation, and a further 49 per cent experienced
mild anxiety. In the husbands of women with benign breast
disease 2 per cent had mild anxiety and 5 per cent moderate
anxiety. When assessed one year after the surgery symptoms
of anxiety were evident in 36 per cent of the spouses of
mastectomy patients and 13 per cent of the "benign" group.
However, these were mild in severity in all but 6 per cent of
"mastectomy" spouses and 3 per cent of the 'benign' group.
Depression was found to be much less of a problem, and in
those spouses who did manifest depressive symptomatology it
tended to be rated as "mild". At the one year assessment
following surgery there was no significant difference between
the levels of depression in the "mastectomy" and "benign"
groups.
Only seven per cent of the husbands who were distressed and
anxious had been able to discuss their fears and worries with
the medical or nursing staff and 82 per cent considered that
they had not been allowed to play sufficient part in the
decision making about mastectomy. Seventy two per cent
believed that they should have been allowed to discuss the
impending surgery more fully with their wives and the
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medical staff. This lack of opportunity to discuss fears, worries
and treatment with an "expert" were found to increase levels
of anxiety and distress in the spouses.
Morris and Royle [1987, 1988] studied two groups of women
with early breast cancer and their husbands. The first group
were offered a choice of surgery (simple mastectomy or wide
excision plus radiotherapy) and the second group were not.
The levels of anxiety and depression were assessed using the
Hospital Anxiety and Depression scale, before surgery and
then post operatively at 2-3 monthly intervals for a total of
10-12 months.
The results demonstrated that a significantly higher
percentage of the patients not offered a choice of surgery
experienced clinical levels of distress (anxiety and depression),
pre-operatively and up to 2 months post operatively
compared with patients offered a choice; the results also
proved to be identical for the husbands of these patients. At
six months the differences between the two groups were not
significant although the trend remained towards elevated
levels of anxiety and depression in those patients who had not
been offered a choice of treatment.
The main emphasis of the research in this area has been to
assess the relative contributions of physical symptoms and
social support to psychological distress resulting from the
diagnosis and treatment of cancer on the family. The results
113
to date, unfortunately leave the picture far from clear and
further research of a more rigorous nature is required.
The impact of cancer on family life
Studies have often used a methodology combining a
"psychometric" approach with questionnaires examining a
more global impact on family life. These studies examine
aspects such as the effect of work, sexual relationships and
marital relationships and will be reviewed briefly here as they
add an important dimension to this field.
Work
Much of the research concerned with the impact of the disease
on employment has been conducted in the United States. In
the economic environment of the U.S.A. a significant
proportion of former cancer patients are denied work or
discriminated against because of the disease [Feldman, 1978],
although other studies have shown that these prejudices are
not universal and may vary between companies [Wheately et
al., 1974]. Fobair et al. [1986] found that 42 per cent of their
sample of cancer patients reported difficulties at work often
due to lassitude following treatment or problems with
insurance.
Maguire [1981], examining the repercussions of mastectomy
on the family, found that of 43 spouses regularly employed
before the surgery 26 per cent were experiencing difficulties
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in their work at three months after the operation and that 25
per cent of the 43 spouses were still experiencing work
difficulties a year later. They found it more difficult to
concentrate, make decisions and generally enjoy their work.
The impact of cancer on employment, therefore, affects the
spouse as well as the patient. The patient may experience
difficulties with mortgages and insurance for work (USA data),
whereas the spouse may experience difficulties in terms of
their psychological state and attitude.
Social and leisure activities
Maguire [1981] has shown that effects on body image may
cause the patient to withdraw from former social and leisure
activities. The spouse also may be adversely affected. Maguire
[1981] found that 16 per cent of husbands felt that their social
life had diminished since their wives' mastectomy three
months earlier. They attributed this to their wives reluctance
to go out and their unwillingness to pressure them to do so.
Ten per cent of the spouses claimed that relationships with
friends outside of their immediate family had deteriorated
seriously. Seventeen per cent of this group of husbands when
assessed one year after the surgery were found to have
experienced a restriction of their social and leisure activities
and 12 per cent suffered obvious deterioration in their
relationships with people outside of the family.
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Families have also reported that their social and leisure
activities decline because friends treat them differently which
results in feelings of alienation and isolation [Peters and
Golden, 1982].
Marital and Sexual Relationships
Investigators have tried to determine what effects cancer has
on the relationship between spouses. The results are mixed.
Grandstaff [1976], Leiber et al. [1976], Spiegel et al. [1983]
found that some marriages improve following cancer and that
there is an increased closeness between the partners. Leiber et
al. [1976] in their study of 38 patients receiving chemotherapy
for advanced cancer noted that even in this group, the stresses
of illness did not produce emotional alienation or withdrawal
of affection between the partners.
While cancer does not appear to alter marital relationships
appreciably, Checkryn [1984] found that the strain in marital
relations occurs at certain times, for example at the time of
recurrence. Fobair et al. [1986] on the other hand,
interviewing patients with Hodgkin's disease nine years after
treatment found that 29 out of 69 patients had divorced since
their initial diagnosis and that of these 49 per cent attributed
their divorce to their disease.
Other studies have found that those couples who had an
unstable relationship before their illness are more adversely
affected and that the higher separation rates in certain studies
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reflect this [Bard and Sutherland, 1955; Grandstaff, 1976; Ray,
1977; Jamison et al., 1978].
Investigators looking at the impact of breast cancer and its
treatment have been particularly interested in the effects on
sexual relationships. Wellisch et al. [1978] reported that
sexuality and intimacy were altered following mastectomy.
Thirty six per cent of the husbands in this study reported a
negative effect on the sexual relationship. However, the
husbands who reported more sexual problems following
mastectomy also reported lower sexual satisfaction prior to
the surgery.
Maguire [1981] found that 21 per cent of the 38 husbands
whose wives underwent a mastectomy and who had a good
sexual relationship before surgery reported a moderate to
marked deterioration three months after surgery. At a follow-
up interview one year later 29 per cent of the husbands
reported moderate or severe sexual difficulties. The husbands
attributed these to their wives loss of interest and their own
unwillingness to pursue the issue.
The effect of the disease and its treatment on sexual activity
depends upon the disease site and the type of treatment.
Many patients feel that their illness has made then sexually
unattractive particularly if they have had operations such as
colostomy [Devlin et al., 1971; Thomas et al., 1987]
orchidectomy [Rieker et al., 1985] or limb amputation
[Sugarbaker et al., 1982] but these effects are not confined
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solely to patients who have undergone mutilating surgery. For
example, Fobair et al. [1986] found that 36 per cent of the
sample reported a decrease in sexual activity and of this group
56 per cent felt that it was related to the illness and its
treatment. Younger patients reported less change than older
patients and patients with longer follow up times were more
likely to have recovered normal sexual frequency. Treatment
was found, in this study to have some effect, patients treated
with radiation alone were less likely to report a decrease in
sexual frequency than patients treated with a combination of
radiotherapy and chemotherapy. It was also found that loss of
energy and symptoms of depression were correlated
significantly with decrease in sexual frequency.
The effects on family life are, therefore, varied and complex
and it is essential that future studies conducted in this field
take into account the potential impact of the disease and its
treatment on the family's psychosocial functioning.
Summary and methodological critique
The literature concerned with the psychosocial impact of
cancer and its treatment of the family is relatively sparse and
much of it uses flawed research methodologies. Psychological
distress has been shown to exist in the patients' spouse but
the relationship between the two members is unclear at
present. Similarly, the changes in distress during the course of
the disease have still to be fully elucidated as well as the role
of factors such as physical health status and social support in
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contributing to this. The available literature also indicates that
cancer has an impact on various aspects of the lives of
families, such as employment, marital and sexual relationships
and that these effects vary during the course of the illness.
There are a number of methodological problems with the
research conducted to date in this area:
1. Much of it is based on anecdotal or unstructured interviews
making interpretation and comparison of studies difficult.
Standardised assessment tools are required that are valid and
reliable and that are appropriate for use in the field of
oncology.
2. Assessment of psychosocial functioning is often limited to
mood or return to work. This type of assessment needs to be
broader in content in order to investigate the impact of a wide
range of factors.
3. Many studies use a group of patients and their relatives
suffering from a variety of cancer types. Thus, it is not
possible to examine the effects of specific treatments, specific
sites of disease and stages of disease accurately. It is
important in designing studies in this area to use a single
disease group so that these variables can be controlled as
accurately as possible and their contribution assessed.
4. Single assessments of patients and their relatives are
inadequate but are often used in research studies. Repeated
examinations of the subjects are required in order to monitor
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changes in the psychosocial status during the course of the
disease and its treatment.
5. Studies have tended to assess either, the spouse or the
patient. This means that the relationship between them in
terms of psychological state cannot be examined. Both patient
and spouse should be assessed through the illness in order to
obtain a coherent picture of interrelationship between them
over time.
It is perhaps a salutary note that many of these
methodological problems were described over a decade ago by
Plumb and Holland [1977]. The conclusion of this paper is as
valid now as it was then as many researchers in this field
have failed to heed their recommendation:
"We are aware that any fully adequate study in cancer
must be longitudinal, with repeated ratings of mood
throughout the illness course"(p274).
Not to be deterred the authors conclude in a later paper with a
similar plea:
"Further studies of the psychological functioning of
cancer patients are needs that are longitudinal and that
assess patients' coping skills as well as their psychologic
impairment."[Plumb and Holland, 1981 ](p253)
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Chapter Five
SOCIAL SUPPORT AND COPING WITH CANCER.
Coping with cancer can be facilitated by a number of factors
and in order to understand the role of social support in this
area it is necessary to understand the general concepts
involved in coping with stress.
Coping with cancer
Coping with the stress of cancer can be explained using a
model put forward by Lazarus and Folkman [1984]. This
model is composed of three stages:
1. Primary appraisal - is there a threat?
2. Secondary appraisal - what can be done about it?
3. Coping - implementing strategies for coping.
This process of appraisal and coping can be viewed as a
continuing series of reactions to the varying stresses which
cancer imposes and the "process" will vary with the course of
the illness. Greer [1985] has hypothesised that at the time of
diagnosis the person needs to decide the degree of life threat
that the disease brings with it. Initially, the diagnosis is seen
as a "catastrophic threat tantamount to a death sentence".
As time progresses, however, and the patient is able to
assimilate further information about the treatment and the
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options available, a more optimistic appraisal of the situation
may be made.
Appraisal of threat and the social interpretation of
cancer
A number of different factors are important in helping the
patient make an appraisal of the degree of threat that cancer
presents them with and as a result play a part in the
development of the coping response. Initially, patients
evaluate the threat that the illness poses to their life (primary
appraisal). This is then tempered by the patients' perceptions
of their own ability to cope with the disease as well as the
ability of their family and the medical team (secondary
appraisal).
Indeed, other studies [Feifel et al., 1987; McCorkle et al., 1983;
Kneier et al., 1984] have noted that patients reactions to life
threatening illness is very different from patients facing
severe, non-life threatening conditions or potentially life
threatening conditions. The view of an illness or disease held
by society is thought to be responsible for this difference.
McCorkle et al. [1983] for example studied 56 patients with
cancer and 65 patients who had suffered a myocardial
infarction within the previous two months. Striking
differences were found to exist between the two groups. The
cancer patients perceived their plight as being much bleaker
than that of the heart attack patients. They experienced more
symptom distress, reported considerably more health and
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existential concerns and suffered more mood disturbance than
the heart attack group.
This data supports the view that cancer patients are able to
discriminate the degree of life threat that they are exposed to,
at least in a cognitive sense. They probably use information
gleaned from the media and beliefs of the general population
to make a judgement regarding the severity of the situation.
Indeed, cancer patients have been shown to adopt specific
categories of mental adjustment to cancer [Greer et al., 1979].
Greer et al. studied 69 consecutive female patients with early
breast cancer, from diagnosis until five years after initial
surgery. They found that in terms of their cognitive style
patients could be placed in one of the following groups:
1. Fighting spirit - the patient shows no apparent emotional
distress, fully accepts the diagnosis of cancer, adopts an
optimistic attitude, seeks information about the cancer and is
determined to fight the disease. This group accounted for
approximately 17 per cent of patients in the study.
2. Denial - the patient shows no apparent emotional distress
but either rejects the diagnosis of cancer or evidence of the
disease or denies/minimises its seriousness. Seventeen per
cent of patients in the sample fell into this group.
3. Stoic acceptance - the patient shows initial emotional
distress followed by an acknowledgement of the diagnosis and
a determination to carry on a "normal" life, seeking no further
information about their illness and ignoring its presence as far
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as possible. Fifty six per cent of patients in the sample fell into
this group.
4. Helplessness/hopelessness - the patient is obviously
distressed and is engulfed by the knowledge of the disease,
daily life is disrupted by a preoccupation with cancer and the
fear of impending death. Ten per cent of patients in the
sample fell into this group.
This study continued to look at the effect of coping style on
survival. The data showed that there was a statistically
significant association between patients initial psychological
response to the diagnosis (as assessed three months after
operation) and outcome at five years. A favourable outcome
(i.e. being alive) was more frequent in patients whose
responses had been categorised as showing denial or fighting
spirit (75 per cent) than in patients who had shown either
stoic acceptance or helpless/hopeless response (35 per cent).
Pettingale et al. [1985] re-examined the status of this group of
patients after ten years. He found that of those who had
adopted denial or fighting spirit, 55 per cent were alive with
no recurrence, compared with only 22 per cent of patients
who showed stoic acceptance or helpless/hopelessness at
diagnosis.
The tentative conclusion drawn from this data is that the
coping style adopted by patient affects the outcome in terms
of survival. The hypothesis for the mechanism of such a
finding is that the effect is mediated through biological
mechanisms, possibly neuroendocrine or immune pathways.
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An alternative explanation could be that the psychological
responses associated with unfavourable outcome were
themselves the result of occult metastatic disease. This is a
plausible hypothesis as occult metastases are notoriously
difficult to detect using standard medical investigations [de
Vita, 1985]. The number of patients in the study was
relatively small and it would be erroneous to make sweeping
generalisations from one patient group, those with breast
cancer. Particularly as some malignant breast tumours have
been shown to be hormone sensitive and there is a clear link
between certain psychological factors and hormone release (de
Vita, 1985), other types of cancer may not be so susceptible to
these potential influences.
Some of these criticisms have been answered by a replication
study carried out in a series of 117 newly diagnosed patients
with malignant melanoma [Di Clemente and Temoshok, 1985].
They found that women showing stoic acceptance and men
with high helpless/hopeless scores had a greater risk of
disease progression. It was found in this study that these
psychological predictors were independent of the two
biological prognostic factors measure, namely tumour
thickness and clinical stage of the disease.
Greer and his researchers at the Royal Marsden Hospital are
continuing to study the concept that psychological coping
strategies affect survival. To this end they have developed a
scale, the mental adjustment to illness scale which is a self
rating questionnaire measuring fighting spirit, fatalism
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(formerly called stoic acceptance), helplessness/hopelessness,
avoidance (formerly called denial) and a new category
referred to as "anxious preoccupation". This scale is being used
in a large prospective study to select patients who might
benefit from a psychological intervention programme and in
this way clarify the effect of coping style on survival [watson
et al. , 19881 .
Thus, the patient who views cancer as a challenge and feels
that they may have some influence over the disease makes a
better adjustment. Once patients have achieved this way of
coping with stress, appropriate strategies can be implemented
based on the coping style that predominates.
The way of coping adopted by patients is not fixed or mutually
exclusive. One of the strengths of the Mental Adjustment to
Cancer scale is that it enables a profile of the respondents
coping style to be obtained rather than trying to force them
neatly into a "pigeonhole". Research in this area suggests that
the picture is complex and attempts to document a consistent
fixed style or response to traumatic events have failed to do
so. The measurement of personality traits, for example poorly
predicts response to such events [Cohen and Lazarus, 1973;
1979]. In addition, an earlier study conducted by Morris et al.
[1977] indicates that the patients exhibiting denial or "fighting
spirit" characteristics originally, moved into the stoic category
over the next two years. She found the category of "stoic
acceptance" to be the most stable category over the two year
study period: only three of the patients placed in this category
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at three months were not so placed at two years, whereas
patients with other types of response tended to change
category. Similarly, the work of Weisman [1979] puts forward
the view that "coping styles" and strategies may change over
the course of the disease. More sophisticated theories of coping
demonstrate that people are more variable than consistent in
their coping patterns [Folkman and Lazarus, 1980].
Folkman and Lazarus [1980] analysed the ways in which 100
men and women coped with stressful life events over a period
of one year. These researchers state that "coping is also a
shifting process in which a person must at certain times, rely
more heavily on one form of coping"(p221). The complexity of
this concept is perhaps best exemplified by Moos and Tsu
[1977] who postulate that in coping with physical illness a
patient must deal with many sources of stress, including pain
and incapacity, hospital environments and the demands
imposed by the treatment procedures. At the same time, the
patient must also try to preserve emotional balance, a
satisfactory self image and good relationships with family and
friends. These multiple tasks require an array of coping
strategies, the complexity of which simply cannot be captured
in a unidimensional measure.
Folkman and Lazarus found that the meaning of an event, the
potential to change this event, coupled with certain
psychological characteristics of the individual are the most
important factors in shaping or changing the coping response.
Coping and adjustment is clearly a complex area and is
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influenced by a wide range of factors. It continues to be an
area of fruitful research particularly in relation to an
individual adaptation to severe life events such as cancer.
Locus of control
The concept of locus of control has been applied with
increasing frequency to health and in particular to the area of
coping and adjustment. People with internal expectancies of
reinforcement ("internals") generally perceive that their
outcomes are contingent on their own behaviour, whereas
those with external expectancies ("externals") perceive a lack
of contingency between their actions and subsequent
reinforcement and believe that external sources such as
chance, fate, others, are responsible for their outcomes
[Lefcourt, 1976; Rotter, 1954,1966].
A review by Strickland [1978] demonstrates that patients with
tuberculosis with internal expectancies were more
knowledgeable about their disease (controlling for
intelligence) than were those with external expectancies. Other
research has shown that "internals" are more likely than
"externals" to assume responsibility for their postoperative
care [Johnson et al., 1971], to practice preventive dental care
[Williams, 1972], to hold positive attitudes toward physical
exercise [Sonstroem and Walker, 1973] and to report better
health and have fewer illness episodes [Seeman and Seeman,
1983].
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With respect to psychological well-being a more external
orientation has been found to be directly related to mood
disturbance [Kilpatrick, Dubin and Marcatte, 1974] depression
[Calhoun et al., 1974], anxiety [Watson, 1967] and lowered goal
expectations [Strassberg, 1973].
Research in this area has also extended into the field of
oncology. Taylor et al. [1984] found that breast cancer patients
who believed that they could exert control over their illness
showed better short and long term adjustment than did
patients who did not hold these beliefs. More recently Marks
et al. [1986] studied a group of 137 patients with
haematological malignancies. They found that the relationship
between cancer patients perceptions of the severity of their
illness and depression was markedly less for those who
believed that they could personally control their health and
for those who held positive expectations about the effect of
complying with medical treatment. The researchers conclude
that "beliefs and expectations about the role self plays in
controlling one's health can indeed have functional value for
someone with a serious illness"(p448).
The concept of locus of control is regarded as being stable over
time in healthy individuals [Lau, 1982] but little is known
about the stability of the concept in patients suffering from a
serious illness such as cancer. It has been postulated that
there may be a complex interaction between locus of control
and information given about the illness, its treatment and
prognosis [Marks et al., 1986]. For example, one could consider
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the scenario where a patient with lung cancer who has strong
beliefs in self control is told that he has an incurable condition
that does not usually respond to treatment. The interaction in
this case is potentially complex and is an area in which further
research is required.
The role of information in adjustment to cancer
The last 25 years have seen a dramatic shift in the stated
policies of physicians regarding the disclosure of information
to cancer patients. A survey conducted in 1961, for example,
found that 88 per cent of the physicians questioned had a
policy of not disclosing the diagnosis of cancer to the patient
[Oken, 1961]. In 1979, however, 98 per cent of those surveyed
had a policy of telling the cancer patients their diagnosis
[Novack et al., 1979; Veatch, 1980]. This clearly demonstrates
a considerable change in physicians' stated policies over the
past two decades.
Slevin [1987] feels that the public perceives doctors as being
divided into two groups: "tellers" and "non-tellers" of bad
news. The former, Slevin claims are stereotyped as believing
that patients should be given all available information and the
latter as believing that patients would be harmed by such
information.
Slevin [1987] postulates that some doctors deliberately
withhold information on the grounds that patients will ask
questions if they want to know the answers and that too much
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information will only be upsetting for the patient, maybe even
causing the onset of depression.
Certainly reports in the literature have shown that patients
are dissatisfied with the information given to them by their
doctors [Freeman et al., 1971; Stiles et al., 1979; Tuckett and
Williams, 1984; Fallowfield et al., 1986]. A large discrepancy
exists between the stated policy of physicians with respect to
giving information and the receiving or recalling of that
information by the patient.
Information has been shown by a number of authors to be
linked to a positive adjustment in cancer patients [Feldman,
1978; Weisman and Worden, 1980; Hogbin and Fallowfield,
1989]. Lazarus [1966] regards information seeking as the
principal method of coping with threatening events. He also
suggests that it is one of the early processes of adjustment and
coping, in the appraisal and re-appraisal of a harmful or
threatening situation. Both appraisal and reappraisal occur for
the most part, through the interpretation of data and are not
simple perceptions of harms, threats or resources for coping
[Cohen and Lazarus, 1979; Folkman and Lazarus, 1980].
Therefore, information seeking may precede and/or co-exist
with appraisal and reappraisal.
The information needs of patients are likely to vary
throughout the illness process. Mages and Mendelsohn [1979]
for example, found that the major issues in the "diagnostic
phase" of the illness are the recognition of the disease and its
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implications and that the major tasks are the appraisal of the
discovery's significance and the initiation of appropriate
treatment. Cassileth et al. [1980] found that cancer patients
generally seek maximum information about the disease after
the diagnosis, as a means of gaining control. The inference that
the latter researchers make is that appraisal and information
seeking are among the early attempts of coping with the
diagnosis.
A number of other studies have looked at the nature and
scope of information required by patients soon after diagnosis.
The body of research broadly demonstrates four major
categories of patient concerns:
1. Disease related concerns which includes information
concerning diagnosis, tests assessing the nature and extent of
disease, treatments and prognosis [Feldman, 1978; Greenleigh
Associates, 1979; Mages and Mendelsohn, 1979].
2. Personal related concerns that include physical and
psychological well being and information regarding current
and future employment and appropriate plans and goals for
the future [Jones, 1981; Weisman and Worden, 1980].
3. Family related concerns which include the need for
information regarding the effects of the illness and its
treatment on the spouse, children, parents and siblings
[Feldman, 1978; Jones, 1981].
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4. Social related concerns which includes the need for
information regarding the effect of illness and treatment on
leisure activities, socialising and sexual relationships
[Greenleigh Associates, 1979].
There is very little information, however, regarding the
changing importance of these informational needs through the
course of the illness and there is also a dearth of research
during the later stages of the disease.
The body of research demonstrates that information is very
important in the early adjustment of the cancer patient.
Information concerning the diagnosis, treatment and its side
effects and prognosis, are necessary to help form an appraisal
of the likely threat of the disease. This then helps the patient
implement coping strategies and hopefully adjust to the
situation.
The complex nature of the relationship between personality
traits such as locus of control, information given by health care
workers and the "popular" beliefs of society is not fully
understood. Undoubtedly they all have a role to play in the
development of adjustment and coping with a malignant
disease.
Social support and cancer
The past decade has seen the integration of social support into
the concept of coping. It is regarded as a multidimensional
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construct by a number of authors [Pinneau, 1975; Caplan et al.,
1978; Walker et al., 1977; Murawski et al., 1978] and contains
within it elements essential to the development of coping
strategies.
Numerous authors have developed taxonomies or lists of
components of social support and drawing from these, it is
possible to identify several distinct types. One involves the
expression of positive affect which may include information
that one is cared for, loved and esteemed [Cobb, 1976]. A
second, involves encouraging the open expression of beliefs
and feelings [Wortman and Dunkel-Schetter, 1979; Dunkel-
Schetter, 1981]. A third, closely related aspect of support,
involves expressing agreement with or acknowledging the
appropriateness of a person's beliefs, interpretations or
feelings [Walker et al., 1977; Kahn and Antonucci, 1980; House,
1981]. A fourth type is the offering of advice and/or
information which can be from both formal and informal
sources or the access to new and diverse information (this
aspect, dealt with earlier in this chapter, has been shown to be
essential in the development of effective coping strategies)
[Caplan, 1974; Barrera, 1981; House, 1981]. A fifth type of
support is the provision of material aid and tangible resources
[Caplan, 1974; Kahn and Antonucci, 1980; House, 1981].
Finally, support may be conveyed by providing information
that the person is part of a network or support system of
mutual obligation or reciprocal help [Walker et al., 1977; Kahn
and Antonucci, 1980; Barrera, 1981].
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Researchers have maintained that despite the apparent
overlap among these components, each should be considered
as potentially important and that its impact on health and well
being should be treated as an empirical question [House,
1981].
There are several reasons which it is desirable to assess
distinct types of social support. Thoits [1982] for example, has
reviewed evidence suggesting that not all types of support are
equally effective in reducing distress. In the field of cancer
care, emotional support has been identified as being most
helpful to patients in reducing distress and giving reassurance
[Moos and Tsu, 1977]. However, in terms of physical recovery
following treatment, tangible support was found to be the
most helpful over and above other types [Raphael, 1977].
In considering the role of social support for the cancer patient
it is important to consider which types of support may be
particularly important in helping them cope with the stresses
imposed by the illness and, therefore, relevant to examine and
measure.
Structural and Functional Aspects of Social Support
Precise definition is essential when considering social support.
For example, a clear indication of structural versus functional
aspects must be made. Structural measures indicate the range
and interconnectedness of support. These measures are often
regarded as objective indicators, to the extent that they assess
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the presence or absence of fundamental social relationships
and ties [Berkman, 1985]. The structural aspects of social
support range from evidence of simply the presence of others
[Cassel, 1974] to indices of social network [Berkman and
Breslau, 1983]. They include factors such as marital status,
membership of formal organisations, attendance in church and
the number of people generally encountered, and the
frequency of those encounters. They do not, however, give any
indication of the quality of these interactions or their
perceived value.
In contrast to the structural measures of social support, are
the functional measures. These identify the qualities of social
relationships and are generally operationalised as, the
perceptions of the recipient; an approach derived from
psychological (cognitive) and social psychological paradigms.
The functions of social support that have been assessed have
included very general measures such as the overall quality of
social relationships [Blazer, 1982; House and Kahn, 1985] and
social companionship [Wills, 1985]. The measures also include
specific social support functions such as esteem, instrumental
and information support [Wills, 1985] the intimacy of social
relations [House et al., 1982] and the availability, quantity,
timing and satisfaction with social support [Cohen and Syme,
1985].
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Main Effect versus Buffering Hypothesis of Social
Support
As well as defining the type of social support under
examination, one must also consider the model of social
support effect that is being used. Social support has been
formulated in two principal ways with respect to health.
The first model proposes that social support has a beneficial
effect on health per se; this model is termed the "main
effect" model. This approach is based on the hypothesis that a
generalised beneficial effect of social support should occur
because large social networks provide people with regular
positive experiences and a set of stable, socially rewarding
roles within a "community". This type of support provides
positive affect, a sense of stability in a milieu and a
recognition of self worth and, therefore, promotes and
maintains a state of overall well-being. Integration in this type
of social network may also aid in the avoidance of negative
experiences that may increase the probability of psychological
or physical disorder. This perspective has received much
support over the past decade [Levinger and Huesmann, 1980;
Moos and Mitchell, 1982; Reis, 1984; Wills, 1985] and in its
most extreme form the "main effect" model postulates that an
increase in social support will result in an increase in well
being irrespective of the existing level of support.
The second model of social support proposes that support is
related to well being primarily for people under stress. This is
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termed the "buffering" model because it posits that support
"buffers" or protects against the potentially pathogenic
influence of stressful events.
Social support may intervene between the stressful event and
a stress reaction by attenuating or preventing a negative
stress response. This may occur because of the perception that
others may re-define the potential for harm posed by a
situation and/or enhance one's perceived ability to cope with
imposed demands, and hence prevent a particular situation
from being appraised as highly stressful. Secondly, "adequate"
support may intervene between the experience of stress and
the onset of the pathological outcome by reducing the stress
reaction or, by directly influencing physiological processes.
Support may, therefore, alleviate the impact of stress
appraisal by providing a solution to the problem or by
reducing the perceived importance of the problem by
"damping down" the psychoneuroendocrine system thereby
rendering the individual less reactive to perceived stress and
facilitating "healthy" behaviour [House, 1981]. It is this
"buffering" hypothesis that is the central issue of this review
and subsequent study.
Social support and adjustment
Adjustment has been viewed in a variety of different ways in
the literature. Authors studying the effects of social support in
the mental health field have considered psychological well-
being as the appropriate outcome measure [Brown et al., 1975;
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Holahan and Moos, 1981; Turner, 1981]. Others have
considered the effect of social support on social functioning
[Bloom et al., 1984; Bloom and Spiegel, 1984] or physical well-
being [Berkman and Syme, 1979; House, 1981]. This review is
principally concerned with the effects of social support on
well-being.
Support, as described earlier is a multi-dimensional construct.
In the field of adjustment to a stressful event, in this case a
serious illness, one particular type of support has been found
to be particularly important.
Emotional support, that is, the perceptions that one is cared for
and loved or has a confidant or intimate friend has been
related to lower levels of distress and depression [Gore, 1978;
Holahan and Moos, 1981]. Numerous studies have linked the
existence of emotional support provided by networks such as
relatives and friends to improved levels of mental health
[Brown et al., 1975; Holahan and Moos, 1981]. Turner [1981],
for example, have shown that this type of support is related to
improved adaptation to stressful circumstances resulting from
diverse life crises such as assuming the mothering role,
acquired hearing loss and functional psychoses and having a
disabled child within the family [Dow, 1965].
Vachon [1984] demonstrated that social support was of benefit
to women diagnosed and treated for breast cancer. Vachon
[1984] compared women recently diagnosed with breast
cancer with women who were recently widowed. The two
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groups were comparable in terms of age and socio-economic
status but differed in terms of urban-rural residence. They
were assessed soon after the particular life event and again
two years later. The outcome measure for distress was the
Goldberg, General Health Questionnaire and social support was
assessed using the subjects perceptions of emotional support
from family, friends and health professionals. The results
demonstrated that a perceived lack of emotional support
during the initial crisis was predictive of high levels of distress
at the two year follow-up interview for both groups.
Funch and Mettlin [1982] examined 151 female breast cancer
patients retrospectively. Subjects were interviewed regarding
the extent to which three forms of support (social, financial
and support from health care professionals) were related to
psychological adjustment and physical recovery. The results
demonstrated that social and professional support were
significantly positively related to psychological adjustment
whereas financial support was significantly positively related
to physical recovery.
In this study the components of both social support and
professional support included the extent to which subjects
perceived they could talk to family, friends and health care
professionals and the extent to which they could confide their
fears ad worries without being rejected or uncomfortable. The
results demonstrate that perceived social support in particular
was related to increased levels of positive affect rather than to
decreased levels of negative affect. This is an important
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distinction which demonstrates a "health" promoting effect in
psychological terms.
This finding echoes conclusions drawn from other studies in
this field. Dunkel-Schetter [1981], for example, found that
emotional support was more likely than other types of support
to be identified by cancer patients as being most "helpful".
Dunkel-Schetter, found that in excess of 90 per cent of a
sample of cancer patients mentioned the giving of emotional
support as one of the most helpful things that anyone had
done (allowing them to air their fears and worries which in
turn led to them "feeling better).
Revenson et al. [1983] in a similar study of 32 non-hospitalised
adult cancer patients with a variety of cancer types found
more varied results. Patients were interviewed at different
points during their illness and its treatment and a number of
measures of psychological adjustment and emotional support
were made. The data suggests, that for patients not
undergoing chemotherapy or radiation treatments or for those
with very limited functioning this type of supportive
behaviour may increase negative mood and decrease self
perceptions of worth. No consistent relationship was found
between support and physical limitation or between physical
limitation and adjustment. This effect, therefore, evokes the
possibility that supportive behaviours are complex and
contain elements of "true" support as well as threats to
autonomy and self worth. These patients had completed all
available active treatment and the stress of the disease was
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more chronic than short term. The results indicate that social
support is a more potent stress buffer at times of crisis,
presumably when the individual is receptive to it, rather than
in situations where the stress is long term and synonymous
with "nearness to death".
Revenson et al. [1983] conclude their study with
"paradoxically, then, social "support" may be non-supportive
and even unsupportable, in fact, it may at the same time
constitute a source of stress and source of support"(p328). This
complex and interactional view is shared by Dunkel-Schetter
and Wortman [1982] who provide detailed evidence that social
interaction with cancer patients is often coloured by
ambivalence, pity and false optimism or at least, may be
perceived by the patient as such. In this way, a seemingly
positive social interaction may carry a negative overtone.
The multidimensional nature of social support was further
validated in a study by Bloom and Spiegel [1984], They
interviewed 86 women with advanced breast cancer to
determine the way in which well being and social functioning
were affected by the social support that they received.
The authors found that the emotional support by family
members had a positive effect on the women's sense of well
being whereas the level of social activity did not. In addition,
no relationship was found between emotional support and
social activity.In other words, the impact of social support was
highly specific.
142
The effects of emotional support have been examined in other
disease entities with equivocal results. Mclvor et al. [1984]
studied a sample of 120 non-hospitalised patients who were
suffering from the spinal cord form of multiple sclerosis (M.S.).
They were particularly interested in the role of perceived
emotional support as a "buffer", which might enable the M.S.
patient to cope more effectively and deal more successfully
with negative emotions, in particular depression.
The results demonstrated that those patients with high levels
of perceived social support experienced much less depression.
This result was not found in those patients who were more
disabled, suggesting that in some circumstances social support
is unable to act successfully as a buffer against stressful
events.
Social support as non-support
Attempts at providing support for a person experiencing a life
crisis are not always helpful. Problems in social relationships
may occur because of the fear and stigma associated with
illness, the absence of a set of social norms concerning
appropriate behaviour with cancer patients or because trying
to maintain a social relationship under extreme stress may be
stressful in itself. Brickman et al. [1982] conclude a review of
social support and coping with the statement that "social
support may create a process of secondary victimization
rrA ,)
whereby victims are Victimized'' once again by awkward or
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ineffective efforts to help them"(p378). Revenson et al. [1983]
echo this view and suggest the possibility that supportive
behaviours may contain both elements of "true" support as
well as an inherent threat to autonomy and self-worth.
A study by Peters-Golden [1982] for example found that
individuals who perceived themselves as having received
adequate social support reported heightened feelings of
isolation, avoidance and feeling labelled as abnormal. These
results are largely due to the fact that the family and friends
of these patients avoided talking about the issues raised by
the disease and its treatment yet still provided a form of
support.
Wortman and Lehman [1985] investigated the difficulties in
social relationships between healthy network members and
individuals experiencing a major life crisis. Support
behaviours most commonly identified as unhelpful were
giving advice, encouragement of recovery and minimisation or
forced cheerfulness regarding the situation. Particularly
helpful were, contact with others experiencing a similar life
crisis and the opportunity for open expression of feelings.
The results of these studies demonstrate that the type of social
support should be clearly defined. From the literature
concerned with emotional social support, (the perception that
one is cared for and loved or has a confidant or intimate
friend), the generalisation can be made that this type of
support is related to decreased distress during times of life
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crises [Bloom, 1982; Bloom and Spiegel, 1984; Gore, 1978;
Holahan and Moos, 1981]. In contrast, other types of social
support may have negative effects on emotional adjustment
[Funch and Mettlin, 1982; Peters-Golden, 1982; Revenson et
al., 1983].
Models Using Individual Differences
Summarising the research on this topic it appears that
individual differences play a role in the relationship between
health and social support, but the findings are inconsistent and
weak. Individual traits probably have some impact on how
people utilise social support yet to date no clear pattern has
emerged regarding the most important ones and their true
effects.
Some theorists have argued that the buffering effect of social
support is influenced by personality traits [Lefcourt et al.,
1984] . Other researchers have examined differences such as
sex or gender [Levy, 1983], sex role [Roos and Cohen, 1987],
Locus of control [Sandler and Lakey, 1982] and age [Turner
and Wood, 1985] with equivocal results.
Social support and the family
Social support is a concept that is relevant to the family as
well as to the patient with cancer [Northouse, 1984], they are
also under stress from the illness and may need help to cope.
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The question then arises as to whether their specific needs are
different to those of the patient. The previous chapter has
described the difficulty in separating the effects of factors
such as social support and physical symptoms on the
adjustment of family members [Goldberg et al., 1984; Cassileth
et al., 1985; 1985a; Baider et al., 1986; 1989; Ell et al., 1988;
Oberst and Scott, 1988]. This difficulty in part is due to a
problem of definition and measurement of social support.
Whereas for the patient social support has been specifically
defined and emotional support found to be the most important
in adjustment to illness [Wortman and Lehman, 1985]. Few
studies exist in the area of the role of social support in family
functioning.
As Northouse [1988] states in her review of social support and
adjustment to breast cancer "although social support has been
identified as an important factor in the adjustment of women
with breast cancer, there has been virtually no research on the
relationship between social support and the adjustment of
husbands"(p91). This statement is true with respect to social
support and the family in general.
Psychiatric conditions and in particular dementia have
witnessed a rapid growth of interest regarding the influence of
social support on the adjustment of the spouse [Gilleard et al.,
1984]. Studies in this area have on the whole been
inconclusive regarding the role of social support in
ameliorating stress, however [Fiore et al., 1986]. The reasons
for these equivocal results are thought to be due to
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inconsistent measures and definitions of social support and a
lack of measurement of stress and social support at varying
time points throughout the illness [Morris et al., 1989]. It is
not yet clear what type of social support facilitates the
psychological adjustment of spouses in patients suffering from
dementia [Morris et al., 1989].
Scant information is available relating to the type of social
support that is most useful to the spouses of cancer patients.
Baider and Kaplan de Nour [1984] found that both patients
and spouses at high risk of developing psychological distress
following the mastectomy were those with family
environments that did not allow them to express their feelings
openly. Those couples whose families allowed them to disclose
and discuss their fears, worries and emotions were found to be
at less risk of prolonged psychological distress.
Northouse [1988] replicated this study with a group of 50
mastectomy patients and their husbands. She assessed
emotion immediately after surgery and again one month later
using the social support questionnaire and measured
psychological distress using the Brief Symptom Inventory.
Both patients and their husbands who reported higher levels
of social support reported fewer adjustment difficulties
immediately after surgery and a month later. Husbands,
however, perceived significantly less support from health
professionals than patients throughout the course of the study
but perceived similar levels of emotional support from family
and friends to the patient. As Northouse [1988] concludes "the
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findings of this study suggest that social support is an
important factor not only for patients but also for their
husbands during the immediate post-operative period"(p94).
Emotional support is clearly important for the patient and
their spouse at least during the early phases of cancer. High
levels of perceived emotional support appear to act as a
"buffer" against the stress of an illness such as cancer. The
evidence regarding social support and families is scarce. In
particular, the role of social support in psychological
adjustment at different time points during the illness "process"
is far from clear. Further research is required to investigate
this effect systematically and in more detail.
The measurement of social support
The measurement of social support is an important issue. In
recent years, investigators have begun to realise the
importance of employing carefully validated, reliable scales in
its assessment. This has arisen as interest in the area has
increased and as a result the number of available scales has
grown. Unfortunately, many are not based on any theoretical
perspective and assess vague, idiosyncratic aspects of the
concept [Wortman, 1984].
The standardised scales described in the literature have for
the most part been designed forA with the general population
although some have been developed and validated with
specific groups such as college students [Cohen and Haberman,
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1955] or patients with multiple sclerosis [Brandt and Weinert,
1981]. Currently, there are no scales available which have
been designed specifically for use among cancer patients.
In selecting a standardised scale to measure social support one
must decide whether the structural aspects or the functional
aspects are of prime importance. In the area of adjustment to
illness, it has already been demonstrated that emotional
support predominates. In recent years, a large number of
scales have been developed to assess perceived social support,
or the quality of social relationships. These scales differ
considerably in format and mode of completion. Some consist
of a number of items which require a forced choice response
[Procidano and Heller, 1983] whilst others may involve a
structured interview [Henderson et al., 1980] or the use of
vignettes or stories [Turner and Noh, 1983]. The variability in
the scales is considerable. Some measures are lengthy and
time consuming to complete, for example the "Interview
Schedule for Social Interaction" [Henderson et al., 1980] takes
between 30-45 minutes to complete and consists of 52 items.
Others are extremely brief such as the " The Instrumental
Expressive Social Support Scale" [Lin et al., 1979] which
contains nine items and takes between 3-5 minutes to
complete.
One aspect of these scales that is particularly important is
their psychometric properties. Many of the scales have never
had their psychometric properties fully investigated. "The
Social Support Index" [Bell et al., 1982] for example, has no
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data available in terms of test-retest reliability, internal
consistency or validity with respect to correlations with other
social support scales. This also applies to a number of other
scales including the "Social Network Index" [Berkman and
Syme, 1979], the "Social Relationships and Activities Scale"
[House et al., 1982] and the "Social Support Scale" [Blazer,
1982].
A further problem with these scales is the lack of applicability
to the area of oncology. Many have been developed using
American student populations or respondents from the
general population who have, therefore been fit and healthy
and for the most part under the age of forty; factors which
immediately limit their use.
A number of scales, however, do show more robust
psychometric properties as well as having been validated in
populations of cancer patients or other patients confronted
with life threatening illness.
Northouse [1988] developed a scale called the "Social Support
Questionnaire" for use with mastectomy patients. It included
questions related to having a person who listens to concern ,
who demonstrates understanding, who shows love and
concerns, with whom the patient could discuss difficult issues
honestly. The scale contains 40 items and subjects rate their
responses on a five point likert scale from strongly agree to
strongly disagree. It take approximately 15 minutes to
complete the questionnaire. The psychometric data available
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demonstrates high test-retest reliability (0.90-0.94) and high
internal consistency (0.93). The intercorrelation with other
scales such as the family environment scale [Moos et al., 1974]
are, however, less impressive achieving correlations of
between 0.44-0.56 with various subscales of the latter. The
latter finding is currently being investigated further.
This questionnaire rates social support from a number of
sources which include spouse, family member, friend, nurse
and physician. The instrument is newly developed and further
psychometric analysis is required in order to assess its
reliability and validity as well as the efficacy of social support
from the above sources.
One of the most widely used measures of social support is "the
Inventory of Socially Supportive Behaviours" Barrera et al.
[1981]. This scale has been found to reflect a number of
meaningful categories of supportive transactions, such as the
frequency and quality of helping behaviours including the
provision of material aid, physical assistance, guidance,
feedback, and social participation [Barrera and Amley, 1983;
Walkey et al., 1987] . The scale contains 40 items and takes
about ten minutes to complete. The reliability and validity of
this tool have been found to be excellent (0.88-0.93) [Walkey
et al., 1987] but unfortunately these validation studies have
only been conducted using students as test subjects so that
further work is required to validate its use in patient
populations.
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The expectation that this scale would aid in the prediction of
positive adjustment to stress has not received empirical
verification [Sandler and Barrera, 1984; Tetzloff and Barrera,
1987]. Cohen and Wills, [1985] postulate a number of reasons
for this. First, the tool confounds the availability of support
with the need for the use of support. A second difficulty is
that the scales assesses support received in the recent past
and how often it was given, rather than the individual's
perception of support in the present. Finally, the scale
designates supportive behaviours rather than allowing the
individual to subjectively rate their own perception of the
adequacy of supportive behaviours. A fundamental issue is
the distinction between overt behaviours performed by
members of a social network and their subjective impact on
the recipient.
Perception of social support according to Cohen and Wills
[1985] is important as the buffering qualities of support are
cognitively mediated. This means that if a person perceives
that they are loved, cared for and cherished and that in time
of adversity a supportive network is available, then this can
reduce anxieties concerned with coping alone or feeling
isolated.
The "Perceived Social Support Scale" [Procidano and Heller,
1983] was designed to meet this need. The questionnaire is
based on a theoretical perspective regarding the nature of
social support, in particular the view held by Cobb [1976] who
described social support as "information leading the subject to
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believe that he is cared for and loved esteemed and
valued....and belongs to a network of communication and
mutual obligations"(p300). The scale uses a cognitive or
attributional definition of social support to tap the subjects'
perception of social support. This approach is consistent with
current conceptualisations of coping which include a
component concerned with appraisal of situations which are
discussed earlier in this chapter [Folkman and Lazarus, 1980].
The "Perceived Social Support Scale" developed by Procidano
and Heller [1983] is composed of two sub-scales, each
comprising 20 declarative statements regarding the extent to
which subjects believe that their needs for support,
communication and feedback are being fulfilled by family or
friends respectively. The whole scale of 40 questions takes
approximately 8-10 minutes to complete.
The scale has been the subject of extensive psychometric
investigation. Factor analysis has indicated that the two sub-
scales are composed of single orthoganol factors [Sarason et
al., 1987]. The two factors identified in these studies (family
and friends) are consistent with the findings of Zimet et al.
[1988] whose factor analyses of their own perceived support
measure yielded "family", "friend" and "significant other" as
independent factors.
The inclusion in the "Perceived Social Support Scale" (PSSS) of
certain items reflecting provision of support by the subject to
A
others is consistent with finding of a relationship of reciprocity X
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and bi-directional support provision to adjustment [Maton,
1987],
Sarason et al. [1987] in a number of correlational studies using
the PSSS, found that the scale measured concepts such as
"feeling valued and esteemed". They concluded that the
concept of perceived emotional support was more likely to
predict well being and/or to buffer stress than other types of
support. A finding consistent with those from a number of
other studies [Barrera, 1986; Wethington and Kessler, 1986;
Wilcox, 1981].
The early validation studies of the PSSS were carried out using
populations of college students as subjects [Procidano and
Heller, 1983]. These studies demonstrated that the two sub-
scales (support from family and friends) were internally
consistent (0.90). This finding has been replicated by other
studies more recently [Ferraro and Procidano, 1986; Procidano
et al., 1988] with Cronbach alpha coefficients ranging from
0.84-0.91.
The test-re-test reliability has similarly been ascertained by a
number of studies over a one month period and produced
correlations ranging from 0.8-0.86 [Ferraro and Procidano,
1986; Clair, 1988; Procidano et al., 1988].
The psychometric properties of the scale have also been tested
using patients with multiple sclerosis and the family members
of the alcoholic patients. The internal consistency in these
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groups has been found to be very high (0.89-0.91) as has the
test-re-test reliability (0.84) [Louis, 1986; Clair, 1988].
In addition to the above, normative data has been collected for
24 samples of subjects. These groups consist of 13 non-clinical
samples, high school students [Sarason et al., 1987; Procidano
et al., 1988], college students [Procidano and Heller, 1983;
Ferraro and Procidano, 1986; Lyons et al., 1988], adolescents
[Clair, 1988], and mothers of young children [Wade and
Procidano, 1986] as well as 11 samples of clinical subjects i.e.
subjects with a medical or psychiatric diagnosis. The clinical
samples include patients with multiple sclerosis [Louis, 1986;
Mclvor et al., 1987], diabetes [Lyons et al., 1988], elderly
patients with various medical conditions [Zelles, 1988], male
partners of patients undergoing termination of pregnancy
[Zelles, 1988], chronic psychiatric patients [Lyons et al., 1988],
hospitalised patients attempting suicide [Frigon, 1986], drug
addicts [Grey et al., 1986] and women undergoing mastectomy
[Jones and Reznikoff, 1989]. Normative data have thus been
derived from 848 non-clinical subjects and 794 clinical
subjects. A Comparison of the means of these normative
populations reveal highly significant differences
between them (Figure 4). The clinical samples have lower
levels of perceived social support than the non-clinical ones
(lower PSSS scores= lower levels of perceived social support).
This data is currently undergoing further analysis by one of
the authors of the perceived social support scale in order to




A comparison of means of PSSS (friends) and PSSS (family) in
clinical and non-clinical populations (normative data).





The PSSS has been used to examine the relationship between
social support and adjustment to a variety of physical
illnesses. The hypothesis that social support acts as a "buffer"
in mediating the effects of stressful events predicts a negative
relationship between support and psychological distress. This
has been confirmed in patients suffering from multiple
sclerosis, where those patients with higher social support were
found to be less depressed [Mclvor et al. 1984; Louis, 1986]
and in adolescents with alcoholic fathers [Clair, 1988]. The
relationship was found to exist with respect to support given
by both family members and friends.
In summary, the evidence available on the PSSS suggests that
it is the best tool currently available to examine the
relationship between social support and adaptation to serious
illness.
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Methodological problems in the study of social
support and adjustment to stress
In addition to the specific issues raised earlier in this chapter,
namely the importance of defining the type of social support
of interest and selecting the appropriate scale for its
measurement, a number of other issues need to be considered.
1. In order to assess the buffering effects of social support it is
important to define the stress situation (ie that which is to be
buffered against). Whilst this statement may seem obvious, a
number of researchers have approached the problem of social
support and stress by measuring life events in groups of
subjects using questionnaires and then correlating social
support with psychological distress [Wilcox, 1981a]. As
stressful life events increase social support is hypothesised to
reduce the level of distress in individuals.
One of the methodological difficulties inherent in this approach
thoc
is the fact«the most commonly used life event questionnaire,
the social readjustment rating scale [Holmes and Rahe, 1967],
sums a number of different life events. The problem with this
approach is that different types of stressful events benefit
from differing types of social support., (practical support may
be the best way to help someone who is moving house and
emotional support may be the obvious choice to help someone
coping with a divorce). The findings from this type of
approach may be equivocal and confusing thus distorting our
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understanding of the the effect of social support. A specific
type of stressor, such as diagnosis of cancer may result in a
more complete understanding of the relevance of social
support by reducing some of the potential variance created by
the "life events" approach.
2. In examining the impact of support in mediating
psychological distress in a stressful situation it is important to
select a reliable and well validated measure of distress as this
may be the principle outcome variable. In practice the
assessment of psychological distress involves the
measurement of anxiety and depression. In the field of
psychosocial oncology this requires extra consideration
(discussed in a previous chapter).
3. Many early studies showing a correlation between social
support and health outcomes have been interpreted as
evidence for a causal relationship between the variables
measured, for example in facilitating adjustment [Holahan and
Moos, 1981; Thoits, 1982; Wortman, 1984; Cohen and Syme,
1985]. As numerous authors have claimed, however, other
explanations may account for these findings and contribute to
distress. These factors may include such things as the presence
of physical symptoms, personality variables, effects of
treatment on specific areas of life, the presence of a previous
psychiatric history and coping style. It is imperative,
therefore, that social support is examined within the context of
the patients' illness, personality, and lifestyle as well as that of
the family.
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4. Social support may have differential effects in mediating
distress over the course of an illness such as cancer. It is
therefore important in conducting a study in this field to take
account of this perspective [Wortman, 1984] by implementing
assessments throughout the course of the disease and its
treatment.
5. In order to examine the "buffering" effects of social support,
any instrument used must measure the subjects' perceptions of
the adequacy of that support. This is in marked contrast to the
approach taken in other studies where researchers themselves
may interpret the adequacy of support to the recipient [Cohen
and Wills, 1985],
In conclusion, therefore, this review reflects a growing
appreciation of the complexity of the social support construct
and the need for greater conceptual and research specificity.
The data relating to a stress "buffering" effect of social support
in the area of psychosocial oncology are equivocal and require
further investigation. Social support in relation to the family is
an area that has not been dealt with adequately and in
particular its role in facilitating coping responses and
mediating stress. It is clearly an area that has attracted
interest over the past decade and in the future has the
potential to contribute to the understanding of factors that
may positively influence the psychological well-being of
individual patients as well as their families. As Funch and
Mettlin [1982] conclude, more research is essential in this
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area, if we are to understand the relationship between social
support and stress, "Increased understanding along these lines
would not only make a valuable theoretical contribution, but
could have practical applications for improving the medical





The previous chapters describe and discuss the impact of
cancer and its treatment on both the patient and their family.
A number of conclusions can be extracted from this review
and the deficiencies in this body of literature can be identified.
1. Cancer is a disease consisting of stages and is, therefore a
"process" through which the patient passes from diagnosis
followed by treatment to death or "cure".
2. Patients may experience a range of emotions during the
illness and its treatment. Some of these emotions may be
regarded as "normal" and others as "abnormal", such as clinical
anxiety and depression.
3. Anxiety and depression can be modified by factors such as
the presence of physical symptoms, personality, the presence
of supportive relationships, age, previous psychiatric history
and religious affiliation.
4. The results of studies investigating the psychological impact
of cancer on the patient are often confounded by using
heterogeneous groups of patients with different cancer types
undergoing different types of treatment.
161
5. The results of these studies may be further complicated by
the failure of researchers to use standardised assessment scales
which have been found to be valid and reliable in the field of
oncology for the detection of anxiety and depression.
6. Cancer effects other areas of patients' lives such as sexual
relationships, family relationships and employment.
7. Cancer effects the family as well as the patient, yet there
has been very little research on the psychosocial impact of the
illness on family members.
8. Social support has been found to facilitate psychological
adjustment of patients to life threatening illness, in particular
perceived social support.
9. The role of perceived emotional social support in reducing
distress and facilitating the psychological adjustment of family
members to a life threatening illness has not been adequately
studied.
10. A concept such as perceived emotional social support is
often inadequately assessed using unstandardised scales.
11. Social support may have differential effects in mediating
distress over the course of an illness, this perspective is, as
yet, inadequately researched.
1 62
The deficiencies identified in this review of the literature can
be corrected using the following:
1. Longitudinal studies of cancer and its treatment on patients
and their families.
2. The use of standardised assessment tools that are reliable
and valid in the field of oncology.
3. A homogeneous group of cancer patients undergoing similar
treatments.
4. The assessment of a range of variables: physical symptoms,
side effects of treatment, social and demographic variables.
5. Assessing the impact of the illness on the lives of the
patient and their family.
6. A systematic evaluation of the role of perceived emotional
support in adjustment to cancer.
The correction of these shortcomings would enable a
comprehensive picture of the impact of cancer on the patient
and their family over the course of the illness to be obtained.
Such a study would provide useful information in furthering
our understanding of the psychosocial impact of the disease as
well as planning interventions for those who are vulnerable.
As Freidenbergs et al. [1981-82], conclude in their review of
living with cancer, "It is hoped that the plight of the cancer
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patient will be increasingly understood and that appropriate





Local background to the study
In order to study a homogeneous group of cancer patients
experiencing similar management and treatment, a specific
type of cancer was selected. Lung cancer proved to be an ideal
choice for a number of reasons. Firstly, there were suitable
numbers of available subjects treated in the department of
clinical oncology at the Western General Hospital, Edinburgh.
Secondly, the medical management of these patients was
similar due to a number of drug trials using specific cytotoxic
agents being conducted in the department at the time. Finally,
lung cancer is a disease with a relatively short median
survival time (12-14 months), as described in Chapter One, the
whole "process" can be studied from a psychosocial
perspective in a time scale compatible with a finite research
project.
Patients referred to the clinical oncology unit at the Western
General Hospital in Edinburgh have been thoroughly
investigated before their diagnosis is confirmed. During an
initial visit to an out-patient clinic, the patient and their
family are able to discuss with one of the consultants issues
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such as the diagnosis, prognosis, treatment options, side effects
of treatment and so on. Following this visit and if patients
agree to treatment they are admitted to the appropriate ward
to commence chemotherapy. The type of chemotherapy which
patients receive is dictated by several factors, primarily the
type of tumour following biopsy and secondarily by the
physical condition of the patient.
Patients then embark on a specified number of courses or
cycles of treatment. This is often referred to as "active"
treatment as the chemotherapy given during this time is the
"optimum" dose recognised to reduce the tumour. The progress
of treatment is monitored prior to each course of
chemotherapy using chest X-rays by which the size of the
tumour can be assessed, a variety of different blood count
parameters are evaluated as well as performance status and
body weight. These are routinely recorded by the medical
staff on the ward when the patient is admitted for each
treatment course. The performance status scale used in the
department is the Eastern Co-operative Oncology Group (ECOG)
scale [Zubrod et al., 1960], (see Appendix 2). This provides a
five point scale of functional status in contrast to the 10 point
Karnofsky Scale and is often used in cancer treatment trials as
it is brief, easy to use and precise [Fayers and Jones, 1983;
Maguire and Selby, 1989].
Following the completion of chemotherapy patients return on
a monthly basis to the hospitals' out-patient clinic, for "follow-
up" observation. During this period they undergo a chest X-ray
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and clinical examination at each visit, they are, therefore,
receiving no treatment for their disease but are subject to
close physical monitoring.
During this time the patient may present with troublesome
symptoms. These may be manifested in various way such as
increasing breathlessness, pain in various parts of the body,
headache, dysphagia or hoarseness to name but a few. These
signs and symptoms may indicate that the disease has
recurred and spread. At this time the physician may decide
that the disease is no longer "curable" but due to the
debilitating nature of the symptoms, palliative treatment is
required. This is treatment designed to reduce the effects of
the symptoms and thus improve the patient's quality of life. It
is seen as a temporary measure giving the patient a period of
respite. Most dictionary definitions of the word "palliate" refer
to the concept of alleviation without curing and in fact the
word is derived from the latin expression "palliare", meaning
"to cloak".
Palliative treatment in the case of lung cancer usually involves
radiotherapy although on occasion palliative chemotherapy
may be employed. Patients being given radiotherapy are
usually prescribed a course of radiotherapy involving a
specified number of individual treatments or "fractions" given
over a specified time period. Radiotherapy is the use of high
energy rays to "kill" cancer cells. Patients receive radiotherapy
to specific parts of their body to alleviate symptoms. For
example to the chest to improve breathlessness or to the back
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to help pain. The treatment causes side-effects and their type
and severity will depend on the part of the body being
treated, the dose of radiotherapy and the way the fractions
are divided.
Following palliative radiotherapy treatment, patients may be
relatively well for a period of time and then inevitably
succumb to their advancing disease. This period of the
patients' illness is almost inevitably lost to the hospital and
the care is provided by the patients general practitioner or the
hospice.
The "process" or "trajectory" of a patient with lung cancer
treated in the clinical oncology unit at the Western General
Hospital, Edinburgh may be summarised in the Figure 5.
Figure 5
"Process" or "Trajectory" of the patient with lung cancer.
First Line Management Follow Up Surveillance w Palliative Therapy
(N cycles of chemotherapy) (No treatment) ^ fractions of
radiotherapy)
Lung cancer: Cell type and chemotherapy.
A number of different chemotherapy regimens were available
to patients in the "active" phase of treatment. These were
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dependent on the histological type of the patients' disease as
well as their physical state.
Non Small Cell Lung Cancer
Patients with non small cell lung cancer received a
combination of two drugs: alfa 2b interferon (3 million units or
5 million units) and cis-platinum at 100mg/m2. This
combination consisted of the interferon being given three
times weekly and the cis-platinum given every three weeks.
Patients received either two courses or four courses of this
drug combination.
The side effects of this combination include severe nausea and
vomiting, nephrotoxicity, myelotoxicity, ototoxicity, peripheral
neuropathy and hypomagnesaemia related to the cis-platinum.
The side effects of interferon include "flu like" symptoms,
fatigue, drowsiness, impaired concentration, slowness of
cerebration, anxiety and depression.
Small Cell Lung Cancer
Patients with small cell lung cancer received one of three
different cytotoxic combinations:
1. A combination consisting of methotrexate (200mg/m2),
adriamycin (50mg/m^), cyclophosphamide(lmg/m2), VP16-
213 (120 mg/m2). The side effects of this combination include
alopecia, mouth ulcers, gastro-intestinal upset, severe nausea
and vomiting, peripheral neuropathy, hypertension,
cardiotoxicity, bone marrow suppression, tiredness and
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lethargy. This was the most aggressive combination of drugs
given to patients with small lung cancer it was commonly
referred to as MACE which were the first letters of the
component drugs.
2. A combination consisting of methotrexate (200mg/m2),
cyclophosphamide (lmg/m2), VP 16-213 (120mg/m2).
The side effects of this combination included alopecia, mouth
ulcers, gastro-intestinal upset, mild nausea and vomiting,
peripheral neuropathy, bone marrow suppression, tiredness
and lethargy.
This combination of drugs was commonly referred to as
MCVP16, which were the first letters of the component drugs
in the regimen. Patients who received this combination were
those patients who had a history of cardiac problems or who
were found to have cardiac abnormalities on routine
electrocardiogram monitoring.
3. The least aggressive drug combination used was vindesine
(3mg/m2) and VP 16-213 (120mg/m2).
The side effects of this combination included peripheral
neuropathy, constipation, minimal alopecia, hypertension, mild
nausea and vomiting and bone marrow suppression. Patients
who received this combination were patients who were the
least healthy in that the doctors judged them to be too frail to
received either of the other two combinations.
Patients receiving the treatments described above spent
between three and four days in hospital receiving infusions of
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the cytotoxic agents during this time. All courses of drugs
were repeated at 21 day intervals for a specified number of
courses.
STUDY AIMS
The aims of this study are to assess patients and their primary
oi
carers^ different stages in the illness "process" in order:
1. To describe the psychological state of patients at each
stage.
2. To describe the relationship between the psychological state
of a group of cancer patients and that of their primary carer
3. To identify factors contributing to psychological distress in
patients and primary carers.
4. To assess the impact on their psychosocial function.
5. To evaluate the role of perceived emotional social support.
6. To assess change in social support between different stages
of the illness.
7. To identify predictive factors in the development of
psychological distress.
* In the majority of cases the primary carer was the spouse of the
patient.
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Hypotheses to be tested
In addition to the aims of the study, a number of hypotheses can
be generated from the literature review:
1. There will be no significant difference in levels of anxiety and
depression in patients at different stages of the illness and its
treatment.
2. Those patients with greater levels of physical symptomatology
will experience greater levels of anxiety and depression.
3. Those patients with high levels of perceived emotional social
support will have lower levels of anxiety and depression.
4. The treatment of lung cancer will adversely affect other areas
of patients' lives.
5. There will be no difference between the levels of anxiety and
depression in patients and the levels of anxiety and depression in
their primary carers.
6. Statistically significant correlations will be found between
anxiety and depression levels in patients and their primary carers.
7. Statistically significant correlations will be found between
physical symptomatology in patients and anxiety and depression in
their primary carers.
8. Primary carers with high levels of perceived emotional social
support will have low levels of anxiety and depression.
9. The treatment of lung cancer will adversely affect other areas
of primary carers' lives.
10. The lives of patients and their primary carers will be equally
adversely affected by lung cancer and its treatment.
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11. Anxiety and depression in both patients and their primary
carers will be explained by an interaction of low social support,




The final study design described incorporating three groups of
patients and their "primary carer" was developed from an
initial pilot study. A longitudinal study of lung cancer patients
conducted in the department of Clinical Oncology had
demonstrated that it was possible to interview and assess lung
cancer patients at regular intervals following diagnosis. A high
level of compliance was obtained from these subjects thus
enabling a comprehensive picture of their illness/treatment
"process" to be obtained. It was hoped to use a similar design
with the "primary carers" of lung cancer patients using the
assessment battery described. The assessments were initially
planned at monthly intervals with the "carers" but subjects
reported that they could not cope with this level of
investigation, five "carers" were approached but following the
third administration of the battery, all five had withdrawn. As
a result of this problem, the assessment interval was changed
to a three monthly cycle. Even this level of investigation
proved to be too demanding and a further six subjects
withdrew following two administrations of the assessment
battery.The pilot study consisted of 12 subjects. No statistical
analysis was performed due to the attrition rate described above and,
as a result, none of the data was used in the final study design.
This pilot study indicated the stressful nature of lung cancer
for the carer and a modification to the study design was
essential in this light. In order to overcome this difficulty a
single assessment was introduced assessing groups of patients
and their "primary carers" on a single occasion at different
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points during the disease yet with a common experience of the
treatment "process".
The study design about to be described was felt to be the most
accurate psychosocial investigation of lung cancer and its
treatment which could have been undertaken given the
limitations imposed by the early pilot study, although it is
clear that the description of this "process" will be less than
Optimal. The resulting study, therefore, uses a "stage" model of the
illness rather than a "orocess" model.
Definitive Study
Subj ects
The subjects selected for this study were a consecutive series of patients.
The subjects selected for this study (240 in all), were patients
with a diagnosis of either small cell lung cancer or non small
cell lung cancer (120) and their primary carer (120). It
became evident, however, that some patients did not have a
next of kin but were going be cared for by friends or more
distant relatives. In view of this, the concept of "next of kin"
was replaced by the term "primary carer" i.e. the person who
undertakes to provide the majority of the physical and
emotional care of the patient.
Inclusion Criteria
1. Patients with a proven diagnosis of lung cancer and treated
on one of the above specified therapeutic drug trials (MACE,
MCVP16, Vindesine/VP16).
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2. The "primary carers" of the above.
3. Patients and carers able to give informed consent.
Exclusion Criteria
1. Subjects not wishing to take part.
2. Subjects, who in the opinion of the Consultant responsible
were unfit to take part either physically or psychologically.
3. Subjects without a "primary carer".
4. Non-English speaking subjects.
5. Subjects with a previous history of malignancy.
6. Subjects with current evidence of psychiatric impairment.
The current study aimed to describe the impact of the disease
and its treatment at different points during the "process" on
patients and their "primary carers". In order to take account of
the three phases of the illness previously described three
groups of patients and their "primary carers" were identified.
Group 1: Patients receiving active treatment.
Patients were identified and interviewed at the mid-point of
their chemotherapy regime. If, therefore, it was anticipated
that a patient would receive six cycles of chemotherapy, they
would then be interviewed following their third cycle. At the
same time the identified "primary carer" was interviewed but
in a separate room from the patient. The mid-point of the
"active" treatment period was selected in order to avoid the
contaminating effects of the initial impact of diagnosis.
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Subjects were approached during the admission to the
oncology ward prior to the mid-point of treatment. At this
time the study was explained and the printed information
sheets given out. Only those subjects who agreed to participate
in the study on their next admission were interviewed. The
interviews were conducted before the commencement of
treatment on the relevant admission. In all cases, the "primary
carer" visited the hospital at some point during the patients
admission and they were approached during this time and the
study explained.
Group 2: Patients on follow-up observation.
This group of patients and their "primary carers" had already
complete their anticipated number of cycles of chemotherapy.
They had been subject to a period of follow-up observation for
at least one month and had therefore already visited the out¬
patient clinic on a previous occasion during this period of
monitoring. On their first visit to the clinic following the
completion of treatment subjects were approached and the
study explained to them. The printed information sheet was
given to them and only those^agreed to participate were
interviewed at their next visit to the clinic. In the event of a
patient attending the clinic alone on the first occasion, an
information sheet was given to them for their "primary carer"
and only those consenting patients who attended clinic with
their "primary carer" on their next visit were interviewed.
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Group 3: Patients receiving palliative treatment.
Patients and their "primary carers" in this group had
completed their anticipated number of cycles of chemotherapy
and then entered a period of follow-up observation. During
this latter period they had developed debilitating symptoms
precipitating referral for a course of palliative radiotherapy
treatment.
On the first visit to the hospital to plan palliative treatment
patients were encouraged to bring their carers. On this first
occasion following the decision to instigate palliative therapy,
patients and their "primary carers" were approached, the
study explained to them and printed information sheets given
to them. Those subjects who agreed to participate were
interviewed at the mid-point of their treatment. If, for
example, ten fractions of radiotherapy were prescribed for a
patient then they would be interviewed following the fifth
fraction.
A review of the numbers of patients seen in the department of
clinical oncology in the previous year with a diagnosis of
either small cell lung cancer or non small cell lung cancer
enabled a realistic number of subjects to be calculated. The
numbers of patients and their "primary carers" likely to be
recruited are shown in figure 6.
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Figure 6
Numbers of subjects likely to be recruited at each







Patient 40 40 40
Primary carers 40 40 40
The subjects recruited for this study, therefore, have been
derived from three groups of patients representing different
stages of lung cancer and its treatments. Subjects in each
group have been interviewed on a single occasion and each
group has followed a similar path, in that those patients in the
follow-up observation group have been given "active"
chemotherapy and those patients in the palliative treatment
group have received "active" chemotherapy and experienced a
period of follow-up observation.
CONSENT
The nature and purpose of the project was explained to the
subjects and an information sheet given to them to read
concerning the study. Only those patients who were capable of
giving written informed consent were included in the study,
and none were excluded on these grounds (copies of the
information sheet and the consent form are included in the
Appendix 1 of this thesis).
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Procedure
A battery of scales and an interview schedule which take
approximately sixty minutes to complete was assembled, to be
completed by both the patient and their "primary carer".
These scales are shown in Figure 7, and a description and
explanation of each follows.
Figure 7
Assessment scales completed by lung cancer patients
and their "primary carers".
Domain Patient "Primary Carer"
Demographic data Brief Interview Schedule Brief Interview Schedule
Mood HAD HAD
Psychiatric No Assessment GHQ
Screening
Adjustment to PAIS PAIS
Illness
Personality EPI EPI
Social Support PSSS (Family & Friends) PSSS (Family & Friends)
Symptoms & Side Symptoms & Side effects No Assessment
Effects Scale
(HAD= Hospital Anxiety and Depression Scale, PAIS= Psychosocial Adjustment to
Illness Scale, EPI= Eysenck Personality Inventory, PSSS= Perceived Social Support
from Family and Friends, GHQ= General Health Questionnaire).
1. The Brief Interview Schedule
The interview schedule was devised by the author (see
Appendix 2). It assesses a range of demographic variables
including age, sex, marital status, occupation and past medical
and psychiatric history. It is also concerned with issues such
as attitudes to illness and treatment as well as fears and
worries resulting from this. The schedule also assesses
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variation in a number of areas of patients and their "primary
carers" lives. These include changes in personal relationships,
communication, social interaction, leisure activities, perceived
social support from family and friends and domestic
circumstances.
The researcher conducted similar interviews with both the
patient and their "primary carer". The interview schedule took
10-15 minutes to complete for both the patient and their
"primary carer".
The questions included in this schedule were devised in order
to take into account some of the methodological weaknesses
inherent in the existing research literature.The data fr°m this schedule
were not independently validated: they merely formed some descriptive insights
into the experiences of the subjects and therefore should be interpreted with
caution.
2. The Hospital Anxiety and Depression Scale (HAD),
[Zigmond and Snaith, 1983]
The HAD scale is a self assessment scale which was designed to
detect the mood disorders of anxiety and depression in non-
psychiatric populations attending hospital medical out-patient
clinics. The scale is composed of 14 items, 7 for anxiety and 7
for depression. Subjects are instructed to "place the tick in the
box opposite the reply (to each item) which comes closest to
how you have been feeling in the past week".
The scale differs from other self-assessment mood scales in a
number of important respects:
179
1. Items which reflect symptoms likely to occur in a physical
illness such as insomnia or loss of appetite (which are included
in other psychiatric assessment scales) have been excluded.
The scale, therefore, concentrates on psychic manifestations of
anxiety and depression rather than somatic ones.
2. The concepts of anxiety and depression have been
separated. Some scales fail to do this such as the Hamilton
depression rating scale [Hamilton, 1967] where symptoms of
both appear in a single scale.
3. The concept of depression is focussed on the anhedonic
state, an important indicator of depression in physical illness
[Snaith, 1987].
4. Items such as "suicidal pre-occupation" or "fear of losing
one's mind" have been excluded in order to make the scale
acceptable to physically ill patients. None of the items imply
that he or she necessarily suffers from a psychiatric disorder
and indeed Snaith developed the scale to detect the presence
of relatively mild degrees of mood disorder as well as "case"
levels.
5. The scale is brief, readily comprehensible and easily
completed by patients.
6. The scale is appropriate for use with healthy individuals in
the detection of mood disorder and is therefore suitable for
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use with the patients' "primary carer" [Snaith, 1987 personal
communication].
The HAD takes approximately five minute to complete and is
easy to score. In fact the scale is self scoring on a carbon copy
behind the front sheet. Each item is rated on a four point scale
(0-3) and the raw scores for each sub-scale are summed. The
"caseness" of each individual's total score can then be
calculated, the cut-offs for each category are shown below.





Snaith [1987] has advocated that should a "case" level score
persist for a period of a month or longer then the patient
should be considered for some form of psychiatric or
psychological intervention a view also shared by other
clinicians [Maguire, 1984].
The reliability and the validity of the HAD scale have received
considerable attention in a variety of different health care
settings. Zigmond and Snaith [1983] found that the concurrent
validity for the sub-scales on the HAD and the clinical rating of
psychiatrist were +0.70 for depression and +0.74 for anxiety,
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both being highly statistically significant. The false positive
and false negative rates were also reported in this paper. They
were found to be 1 per cent false positives and 1 per cent
false negatives for depression and 5 per cent false positives
and 1 per cent false negatives for anxiety.
Since the original paper concerning the development of the
HAD scale the scale has been thoroughly investigated. Aylard
et al. [1987] reported that the two sub-scales of the HAD were
measuring different aspects of mood disorder as the
correlation between the two was only +0.04. They also
reported significant correlations of the sub-scales with those
patients known to have definite mood disorder (depression
=0.77, anxiety =0.67). Moorey et al. [1991] on the other hand
have found that the factor structure of the scale is stable and
the two factors in the scale are correlated (r=+0.50). El Rufaie
[1987] reported high levels of correlation with clinical
psychiatric interviews in a group of 50 Saudi patients. The
author reported correlations of +0.88 for depression and +0.86
for anxiety both highly significant results.
Barczak et al. [1988] conducted a study of 100 patients
attending a genito-urinary clinic. They compared the HAD
scale against the structured clinical interview for DSMIII in
terms of its sensitivity and specificity using the cut-off scores
recommended by Zigmond and Snaith [1983]. They found that
the recommended cut-offs gave optimum specificity and
sensitivity. The specificity was 94 per cent and 68 per cent for
depressive disorders and anxiety disorders respectively and
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the sensitivity for each was 82 per cent and 70 per cent
respectively. Andrews et al. [1988] replicated this result in a
study using a population of patients with inflammatory bowel
disease. The issue of sensitivity and specificity of the HAD
scale has recently been the subject of some discussion and
debate, which as yet remains unresolved [Ibbotson, 1988;
Hopwood et al., 1991a; 1991b],
The HAD scale is, therefore, ideal in the assessment of mood
disorders in patients with physical illness. Recently,
researchers have found that it lends itself to use with cancer
patients. Slevin et al. [1987] reported that the scale was
acceptable to patients even when required to complete it
several times in a single day. Slevin reported that only the
patient can accurately measure his or her subjective state and
that the HAD is an ideal tool for such an assessment as
subjects complete it themselves.
Morris and Royle [1988] employed the HAD scale in a study of
women undergoing surgery for breast cancer and their
husbands. The HAD was completed pre-operatively and then
at 2,3, and 12 months post-operatively without difficulty by
either group. As Aylard et al. [1987] conclude " the HAD scale
is a valid instrument in the setting for which it was designed
i.e. the detection and assessment of the mood disorders of
anxiety and depression in hospital out-patient clinics. The
very small proportion of misclassifications with the scale
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suggests it may be used as a preliminary screen for disorder
in future studies and also in clinical practice"(p267).
3. The General Health Questionnaire GHQ (28 item),
[Goldberg and Hillier, 1979]
The General Health Questionnaire was originally developed to
aid in the detection of psychiatric disorder in community and
primary care settings. It was devised as a self administered
screening tool [Goldberg, 1972]. Since its introduction it has
been subject to a number of validity studies used for
prevalence estimation applied in a number of cultures and
languages and evaluated in prescriptive screening
[Tarnopolosky et al., 1979; Henderson et al., 1981; Benjamin et
al., 1982; Radovanic and Eric, 1983; Banks, 1983; Chan and
Chan, 1983; Skuse and Williams, 1984]. In addition, several
forms of the GHQ have been produced ranging in length from
12 to 60 items intended for a variety of needs. The GHQ 28 is a
scaled version of the questionnaire and is intended for
research purposes [Goldberg and Hillier, 1979].
The GHQ 28 was developed from the longer 60 item scale by
subjecting 523 completed questionnaires to a principal
component analysis. This analysis resulted in eleven
significant factors accounting for 63.4 per cent of the total
variance. A further varimax rotation resulted in four factors
accounting for 59 per cent of the total variance. These four
sub-scales consisted of somatic symptoms, anxiety and
insomnia, social dysfunction and severe depression.
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Questions refer to the past few weeks and subjects score each
item of behaviour on a scale ranging from "better then usual"
to "much worse than usual". The 28 items of the scale takes
approximately 5-10 minutes to complete. From the completed
questionnaire item scores are summed for each sub-scale or a
total single score calculated which acts as a severity score. The
total single score can be used if the scale is intended as a
screening test. A threshold score of 4/5 has a sensitivity of
85.6 percent and a specificity of 86.8 per cent [Goldberg,
1978]. The correlation between the total score and the overall
clinical assessment by a psychiatrist using a standardised
clinical interview is +0.76 [Goldberg, 1978]. Boardman [1987]
reported that the GHQ 28 was more reliable and more stable in
detecting psychiatric morbidity than general practitioners.
The GHQ has been extensively validated in general practice
populations [Goldberg et al., 1976; Johnstone and Goldberg,
1976; Benjamin et al., 1982; Boardman, 1987], it has also been
validated for use in general medical wards in hospital settings
[Maguire et al., 1974] as well as in the specialist settings such
as dermatology clinics [Hughes et al., 1983]. The GHQ has also
been found to be a useful and valid screening instrument in
the general population [Tarnopolosky et al., 1979; Hobbs et al.,
1983; Hobbs et al., 1984], making it ideal for use with the
"primary carers" of lung cancer patients.
Hardman et al. [1989] found that when used as a screening
tool with patients on a medical oncology ward had an
unacceptably high level of false negative (21%) and false
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positive (34%) identification. This unacceptably high level of
error was primarily due to the somatic items included in the
scale. In order to minimise these errors of detection subtle
manipulations of the threshold scores were required using
"relative operating characteristic analysis" and the
introduction of a "gold standard" test for psychiatric detection.
Conversely, Ellman et al. [1989] found that the GHQ 28 could
successfully be used as a screening instrument in women
attending a clinic for routine breast cancer screening. The
authors found that the scale was brief and acceptable to the
302 women attending for a potentially anxiety provoking
procedure as well as being a valid measure for use in this
population. Some doubt remains, however, concerning the use
of the GHQ with oncology patients and so in the current study
its use was confined to the primary carers.
4. The Psychosocial Adjustment to Illness Scale
(PAIS), [Derogatis, 1976, 1983].
The PAIS is comprised of 46 items designed to assess the
quality of a patients adjustment to an illness and its
treatment. The scale can be used as either a semi-structured
interview or in a self report format and takes the patient
about 15 minutes to complete. Each item in the PAIS is rated
on a four point scale (0-3) of adjustment and the reference
time period for each response is the past 30 days. For
example:
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During the past 30 days, have you lost any time at work
(school) due to your illness?
Score
(0) [ ] a) 3 days or less
(1) [ ] b) 1 week
(2) [ ] c) 2 weeks
(3) [ ] d) more than 2 weeks
The respondent is instructed to tick the appropriate box and
scores assigned to each are shown in brackets.
The scale is divided into seven primary domains of adjustment
with a specific number of items in each domain, as shown in
Figure 8.
Figure 8
Structure and scoring of the PAIS Scale.
Pais Domains Item Maximum
Number Score possible
1 Health Care Orientation 8 24
11 Vocational Environment 6 18
111 Domestic Environment 8 24
IV Sexual Relationships 6 18
V Extended Family Relationships 5 15
VI Social Environment 6 18
VI1 Psychological Distress 7 21
The scale can be reported as a series of results from each
"domain" or as a total "Global Adjustment to Illness" score. The
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higher the rating the poorer the patients adjustment to their
illness.
The raw scores obtained from each domain can be converted
to a standardised "T-score" and then summed to generate a
PAIS total score. The "T-score" is calculated by reference to
specific norms available in the test manual. These include
normative data for lung cancer patients, renal dialysis
patients, cardiac patients and mixed cancer patients. However,
there is also a non-normal conversion table for subjects who
are not easily compared to the available normative groups.
The PAIS is suitable for use with spouses of patients or other
relatives (in semi structured interview or self report form) in
order to look at their quality of adjustment. Minor
modifications are made to the question format, but screening
and translation of scores are conducted in the same way. In
some situations normative comparisons have been found to be
difficult to make (eg with healthy subjects) and the authors of
the scale recommend that the raw scores of both the patient
and the relative should be used. This method has also been
found to be more precise "since it avoids the rounding error
associated with standardised scores"(pl9), [Derogatis, 1983].
The reliability and validity of the PAIS have been subjected to
extensive scrutiny. Morrow et al. [1978] in a study of 37
patients who had been treated for Hodgkin's disease in the
previous two years and 38 parents whose children had been
treated for Hodgkin's disease or solid tumours. The inter-rater
reliability in this study for the total scale score was found to
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be +0.83. The subtest domains were found to be relatively
independent from one another but still contributed to the total
score demonstrating the construct validity of the scale. The
criterion validity of the individual domains was also assessed
by cross correlating them with other well validated scales. For
example, the psychological distress scale of the PAIS was
found to correlate significantly with the Spielberger State Trait
Anxiety Inventory, with observer rating of anxiety on the
Symptom Check List 90 Analogue Scale and the Beck
Depression Inventory indicating strong support for the
criterion validity of this sub-scale.
Derogatis [1983] reports the results of a factor analysis of the
PAIS based upon the assessments of 120 patients with lung
cancer. Seven substantive domains were identified in this
analysis accounting for approximately 63 per cent of the
variance in the orthogonal rotated factor matrix. These seven
domains equated with the seven domains of the PAIS, factor 1
accounted for 18 per cent of the variance and the remaining
factors accounted for 10, 9, 8, 7, 7, and 5 per cent respectively.
This data supports the hypothesised structure of the scale.
The PAIS has also been validated for use with patients with
other medical conditions. Kaplan de Nour [1982] used it in a
group of 102 patients undergoing chronic haemodialysis. She
concludes that; "the PAIS is indeed an adequate scale for
obtaining measured information about patients' global
adjustment as well as their adjustment in specific areas it
was comparatively easy to administer to a fairly large
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population, it covers several aspect on adjustment, and good
correlations were found between patients' reports and the
physicians assessments"(p20).
Folks et al. [1986] validated the PAIS in a group of 96 patients
who had recently undergone coronary artery bypass surgery.
They conclude that use of the PAIS to study patients
undergoing procedures such as CABG (coronary artery bypass
grafting) is advantageous in that the instrument is brief and
simple to administer, yet it reveals psychosocial functioning in
several dimensions. The seven psychosocial domains assessed
by the PAIS in the latter study were found to convey
effectively and accurately the patients global adjustment to
the disease, as well as the therapeutic impact of coronary
artery bypass surgery. Dialysis patients and cardiac patients
are two other groups for whom norms are available from the
early development studies of the scale.
The PAIS has also received substantial validation with cancer
patients. Cain et al. [1983] used it successfully to assess the
psychosocial impact of different types of gynaecologic cancer.
The scale proved useful in examining the impact of the illness
on specific areas of the subjects lives and in combination with
a number other scales provided a comprehensive description
of the impact of different types of gynaecologic cancer and
also of varying degrees of severity of disease.
Gilber and Kaplan de Nour [1989] in a study of 106 cancer
patients undergoing chemotherapy found that they were able
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to use the PAIS to predict those patients who had "dropped
out" of treatment. Those patients who had "dropped out" of
chemotherapy were found to have more adjustment problems
that those patients who complete their treatment controlling
for severity of disease and social background.
The PAIS has been validated with the partners of cancer
patients. Goldberg et al. [1984] used the PAIS with lung cancer
patients and their spouses to highlight the importance of
screening spouses of cancer patients for "psychosocial
impairment". These researchers conclude that "spouses of lung
cancer patients deserve a psychosocial assessment as a routine
element of cancer care"(p79). Baider et al. [1989] reached
similar conclusions using the PAIS in a study of 39 couples in
which one partner had colon cancer.
The PAIS therefore is a well validated and reliable assessment
scale. It has been shown to be acceptable both^cancer patients
and their partners in assessing the impact of illness and its
treatment on various areas of their lives. The available norms
and the body of literature in existence demonstrated that it is
an appropriate tool for use with both lung cancer patients and
their "primary carers".
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5. The Eysenck Personality Inventory (EPI), [Eysenck
and Eysenck, 1964]
The EPI is an extremely well validated measure of personality.
It consists of 57 questions regarding the way in which the
subject "behaves, feels and acts" after each question the
subject is instructed to answer either "yes" or "no" indicating
their usual way of acting or feeling by placing a cross in the
appropriate yes/no circle. The scale takes approximately 5-10
minutes to complete. The EPI gives a measure of
"extraversion", "neuroticism" and a "lie" scale in order to detect
those individuals demonstrating a "desirability response set".
The EPI is perhaps one of the best researched assessment
scales in British psychology. The scale was constructed
following interviews with some 30,000 people in order to
refine the questions and subject the results to a factor
analysis. The test-retest reliability of the scale are quite
satisfactory, Eysenck and Eysenck [1964] found that they were
between +0.84 and +0.94 over a nine month period. There are
parallel forms of the test and the test-retest reliability of
these ranged from +0.80 to +0.95 again an acceptable finding.
In reporting the results of factor analysis of the scale Eysenck
r\
and Eysenck [1964] state that the data clearly shows the
C. A VI
presence of two orthoganol factors.
Eysenck [1962 and 1963] has demonstrated the validity of the
EPI by comparing the results of the scale with the judgement
of expert raters. From the studies he concludes that the
192
questionnaire gives an accurate and valid picture of the
subject's habitual behaviour patterns.
The normative sample for the EPI was 2,000 respondents from
a variety of social classes and age groups. From this sample,
norms for each sub-scale were calculated and a variety of
statistical manipulations conducted to examine the effects of
parameters such as age and social class on the personality
scores.
Eysenck, himself has used the EPI (or its forerunner the MPI)
scale extensively to examine the relationship between
personality and cancer proneness. Kissen and Eysenck [1962]
examined 116 male lung cancer patients and 123 non-cancer
controls. They found that the cancer group was considerable
more extraverted than the control group and that the control
group had much higher neuroticism scores than the cancer
group. This result was further confirmed by Kissen
[1964; 1967] in lung cancer patients where he found that they
had significantly lower "N" scores than did patients with other
chest conditions.
The EPI, however, has been used in a number of studies to
predict recovery from illness, physical complications and mood
states. Glen and Cox [1968] used the EPI with 66 patients
undergoing surgery for duodenal ulcer repair. Those patients
with a higher "N" score experienced a more complicated
recovery. Similar results have been reported by Cronin et al.,
[1973] with general surgery patients, Dalrymple et al. [1972]
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with cholecystectomy patients and Parbrook et al. [1973] with
peptic ulcer patients. In these studies neuroticism was found
to correlate significantly with pain, analgesia use and
complications. In the field of oncology, Hughson et al., [1988]
have used the EPI to examine psychosocial morbidity resulting
from mastectomy in 90 women. They found that the main
predictors of morbidity at 13 months following mastectomy
were high "N" scores on the EPI, age and treatment with
chemotherapy. This was particularly strong in predicting
anxiety and depression. Morris et al. [1977] in a study of 69
women undergoing mastectomy found that patients still
distressed by mastectomy after two years had significantly
higher pre-operative "N" scores than those whose distress had
decreased.
The EPI therefore is a well validated and reliable scale and has
been used extensively in the field of psychosocial oncology
research. It has been shown to be an important predictor of
reactions to stressful event and is suitable for completion by
both lung cancer patients and their carers.The epi in this study
was not used as a predictor but as a possible moderating variable of psycho¬
logical distress.
6. The Perceived Social Support Scale (PSSS),[ Procidano
and Heller, 1983]
This is a forty item self report questionnaire which measures
perceived emotional social support from family and friends.
The scale is described in detail in Chapter 5 and details of its
scoring, psychometric properties and usage are also given. It is
brief and easy to complete taking approximately 8-10
194
minutes. Each statement regarding emotional support is scored
Yes, No or Don't know by the respondent. Scores are then
summed and can be compared to the available norms. It is the
most suitable tool for the assessment of perceived emotional
support in cancer patients and their carers (see Appendix 2).
7. Symptoms and side effects scale.
This is a brief assessment scale designed locally in the medical
oncology unit by the director of the psychosocial oncology
research programme [Cull and North, 1988]. It is designed for
use with lung cancer patients to assess the symptoms of the
disease as well as the side effects of treatment. The scale
consists of a list of symptoms and side effects and patients are
instructed to rate the severity of each on the scales provided
to describe how much they have been troubled by each during
the past week. The scale takes approximately 2-5 minutes to
complete and was easily understood in a longitudinal study of
lung cancer patients conducted in the department (see
Appendix 2).
8. Additional information.
In addition to the assessment scales described a range of
information was recorded from the patients medical notes.
This information included such items as: tumour type,
treatment status, treatment regimen, time since diagnosis,
performance status, and extent of disease.
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The design of the study is illustrated in Figure 9.
Figure 9
The psychosocial impact
treatment on patients and
design.
of lung cancer and its




































































(Interview Schedule= Brief Interview Schedule, HAD= Hospital Anxiety and
Depression Scale, GHQ= General Health Questionnaire, PAIS= Psychosocial
Adjustment to Illness Scale, PSSS= Perceived Social Support from Family and
Friends, EPI= Eysenck Personality Inventory, SSE= Symptoms and Side Effects
Scale).
Data processing
The data from the questionnaires, the interview and the
patients medical notes were collated and then entered into the
departmental main frame computer system. The programme
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used to perform the statistical analysis was the Statistical
Package for the Social Sciences (SPSS), (Nie et al., 1975) and
results were considered to be not significant where p>0.05.
Conclusion
This battery of scales and questionnaires has been chosen to
assess, mood, adjustment to illness, personality, perceived
emotional support and the number and severity of disease and
the side effects of treatment. As far as possible well validated
and reliable standardised assessment scale have been selected
for this purpose. In addition a brief interview schedule has





The three groups of subjects (first line chemotherapy, follow-
up surveillance and palliative therapy) each contained 40
patients and their "primary carers". In addition to these
subjects, three others refused to take part in the study and
were therefore excluded. These latter subjects were all
patients receiving first line chemotherapy and their reason for
refusal was that they felt too unwell to take part. As a result,
these three patients and their "primary carers" were not
approached subsequently and no data from them was included
in the analyses. There were no other refusals in the groups of
subjects receiving follow-up surveillance and palliative
therapy.
Descriptive data: patients
The ages and sex of the three groups of patients are shown in
Tables 1 and 2 combined with the results of a one way
analysis of variance and chi square.
Table 1: Age (years)
Analysis of variance of age in the three groups of
patients: means, standard deviations and F ratio (n =
40 subjects in each group).
First line Follow up Palliative F ratio Significance
Mean (SD) Mean (SD) Mean (SD)
€0.30 (9.30) 57.20 (9.90) 61.90 (8.00) 3.10 p < 0.05
Ranges: 28-74 28-72 41-74
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The analysis of variance demonstrates a significant difference
between the groups in terms of age at the 0.05 level. Further
analysis of this data using Scheffe's multiple range test reveals
the difference to be located between the follow-up group and
the palliative group (F = 5.39; df = 2,117; p < 0.01).
Table 2: Sex
Sex distribution of the three main groups of patients
(n = 40 subjects in each group).
Sex First Line Follow up Palliative
Male 32 2 1 28
Female 8 19 1 2
The sex distribution in the follow-up group is clearly different
from the distribution in the other two groups (X2 =7.06; df =4;
p<.02). The ratio of males to females is almost 1:1, compared
to 4:1 in the first line group and 2.3:1 in the palliative group.
The implications of this sex ratio variation will be considered
further later in this chapter.
The majority of patients in the three groups were married,
with only a small number being separated, divorced or single
(Table 3). There were no statistically significant differences
between the groups in terms of marital status (X2= 3.08, df =4,
N.S.).In addition, surprisingly few of the patients lived alone,
two in the first line group, one in the follow-up
group and three in the palliative therapy group.
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Table 3
Marital Status of each three groups of patients (n = 40
subjects in each group).
Marital First Line Follow up Palliative
Status
Married 35 36 33
Sep/Div 3 1 5
Widowed 0 0 0
Single 2 3 2
(Sep/Div= separated or divorced)
The social class of subjects in the study was coded from their
occupations using the Office of Population, Consenses and
Surveys (1980) classification of occupations. This divides
social class into five subdivisions (1-5, from (1) Professional to
(5) Unskilled). No statistically significant difference was
observed between the three groups in terms of the social class
distribution (X2=13.80, df =8, N.S.).
Table 4: Social Class
Distribution of the three groups of patients with that
of the carer in brackets (n = 40 subjects in each
group).
Social Class First Line Follow up Palliative
Professional 3 (4) 0 (0) 1 (1)
Intermediate 10 (11) 6 (7) 5 (7)
Skilled 15 (13) 10 (10) 16 (14)
Semi-skilled OOOO 16 (15) 12 (13)
Unskilled 4 (4) 8 (8) 6 (5)
The diagnosis of lung cancer has been divided into small cell
lung cancer and non small cell lung cancer (Table 5). The
ratios of each are almost identical across the three groups (X2
=0.20; df =2; N.S.).
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Table 5
Diagnostic categories of the three groups of patients
(n = 40 subjects in each group).
Cell Type First Line Follow up Palliative
Non-small cell 22 21 20
Small cell 18 19 20
(Non-small cell = non small cell lung cancer
Small cell = small cell lung cancer)
The first line treatment that patients received, therefore, was
dictated by their diagnosis. All patients initially received
some form of combination chemotherapy (Table 6) following
their diagnosis and there was no statistically significant
difference between the groups in terms of the drug regimen
that they had received (X2=3.83; df= 6; NS).
Table 6
Original treatment regimes received by the three
groups of patients.
Treatment First Line Follow up Palliative
Pl/Infn 22 2 1 20
MACE 1 3 1 3 9
MCVP16 4 5 2
Vind/VP16 1 1 2
(Pl/Intfn = Cisplatinum plus alpha 2b interferon;
MACE= methotrexate, adriamycin, cyclophosphamide and VP16-213;
MCVP16= methotrexate, cyclophosphamide and VP16-213;
Vind/VP16= vindesine and VP16-213)
The number of months since the patients initial diagnosis
increases across the groups as the patients progress through
the "process" of their illness.
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Table 7
Time since diagnosis (months) of the three groups of
patients.
First Line Follow up Palliative
Mean (S.D.) Mean (S.D.) Mean (S.D.)
1.1 (0.40) 5.4 (1.60) 11.6 (3.10)
Descriptive data: primary carer
The mean age of the primary carer was younger than that of
the patient in all three groups, although the difference did not
achieve statistical significance in any of the groups. This is
explained by the relationship between them, some of the
carers being the patients' offspring. Unlike the patient groups,
however, the age differences between the three groups does
not achieve any statistical significance using analysis of
variance (Table 8).
Table 8
Analysis of variance of age (years) across the three
groups of primary carers: means, standard deviations
and F ratio (n = 40 subjects in each group).
First Line Follow up Palliative F ratio Significance
Mean (S.D.) Mean (S.D.) Mean (S.D.)
57.40(1 1.90) 55.90(1 1.60) 58.10(12.70) 0.40 N.S.
The sex distribution in the three groups of carers mirrors that
seen in the patients (Table 9). The follow-up group shows a
similar ratio of males to females to that observed in the
patients and is significantly different from the distribution




Sex distribution in the three groups of carers (n = 40
subjects in each group).
Sex First Line Follow up Palliative
Male 8 20 1 2
Female 32 20 28
The marital status (Table 10) of the carers is also similar to
that of the patients, as would be expected with no statistically
significant differences between the groups (X2 = 1.67; df=4;
N.S.). There were only a small number of carers living alone,
two in the first line group, one in the follow-up group and one
in the palliative group.
Table 10
Marital status of the three groups of carers (n = 40
subjects in each group).
Marital First Line Follow up Palliative
Status
Married 38 36 38
Sep/Div 0 0 0
Widowed 1 1 1
Single 1 3 1
(Sep/Div= separated or divorced)
The social class of carers is very similar to that of all patients,
the differences occurring when the carer is an offspring or a
sibling of the patient (Table 4). There was no statistically
significant difference in the distribution os social class £
between the three groups of carers (X2=10.88; df=8; N.S.) or
between the three groups of patients and carers (X2 =22.75;
df=20; N.S.).
There was no statistically significant difference in age between
male and female carers in all three groups, despite the fact
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that a small number of carers were children of the patients
(Table 11). Overall, there were no statistical differences
between the three groups in terms of the relationship with the
carer to the patient (X2=5.00; df=8; N.S.).
Table 11
Relationship of the primary carer to the patient.
Relationship First Line Follow up Palliative
Spouse 35 36 33
Brother 0 2 1
Sister 0 0 1
Son 1 0 2
Daughter 2 1 2
Friend 2 1 1
Mood: patient
The mood state of patients and their primary carers was
assessed using the Hospital Anxiety and Depression Scale
[Zigmond and Snaith, 1983]. This scale assesses both anxiety
and depression experienced during the previous week. The
mean anxiety scores in each group of patients are shown in
Table 12.
Table 12
Analysis of variance of HAD (Anxiety) scores for
patients in each treatment group: means, standard
deviation and F ratio (n= 40 subjects in each group).
First Line Follow up Palliative F ratio Significance
5.63 (4.85) 6.90 (5.23) 6.30 (4.16) 0.70 p= 0.49 (N.S.)
The differences in mean anxiety levels between the three
groups does not achieve statistical significance using an
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analysis of variance (p= 20.49). The scores of the Hospital
Anxiety and Depression Scale (HAD) can be used to indicate
"caseness". The authors, Zigmond and Snaith have devised
"cut-off" scores dividing the scale into, normal (0-7),
borderline (8-10) and "case" level (11-21). Table 13, below,
shows the scores of patients on the anxiety subscale of the
HAD, using the cut-off scores recommended by the authors
[Zigmond and Snaith, 1983]. A chi square analysis reveals that
there is no significant difference between the three groups,
although there is a trend for more patients in the follow up
group to score in the "case" level range( X2= 3.06; df= 4; NS).
Table 13
HAD (Anxiety) scores using cut-off scores
recommended by the authors (n = 40 subjects in each
group).
HAD Score First Line Follow up Palliative
n (%) n (%) n (%)
0-7 23 (57.5) 23 (57.5) 21 (52.5)
8-10 11 (27.5) 8 (20.0) 14 (35.0)
11-21 6 (15.0) 9 (22.5) 5 (12.5)
(0-7 = normal, 8-10 = borderline, 11-21 = "case" level)
The mean depression scores in each group of patients is shown
in Table 14 below. The differences between the means across
the groups of patients did not achieve statistical significance
using an analysis of variance (p= 0.20).
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Table 14
Analysis of variance of HAD (Depression) scores for
patients in each treatment group: means, standard
deviations and F ratio (n = 40 subjects in each group).
First Line Follow up Palliative F ratio Significance
3.92 (3.76) 5.37 (4.79) 4.03 (3.39) 1.62 p=0.20 (NS)
This data can also be represented using cut-off scores
recommended by the authors, normal (0-7), borderline (8-10)
and "case" level (11-21). The patients' scores on the
depression subscale of the HAD are shown in this way in Table
15. A chi square analysis reveals no statistically significant
difference between the three groups in terms of the
distribution of patients' scoring in each category (X2 = 7.09;
df=4; N.S.).
Table 15
HAD (Depression) scores using cut-off scores
recommended by the authors (n = 40 subjects in each
group).
HAD Score First Line Follow up Palliative
n (%) n (%) n (%)
0-7 32 (80.00) 24 (60.00) 33 (82.50)
8-10 5 (12.50) 7 (17.50) 6 (15.00)
11-21 3 (7.50) 7 (17.50) 1 (2.5)
(0-7 = normal, 8-10 = borderline, 11-21 = "case" level)
Mood: primary carer
The primary carer also completed the HAD scale and in
addition the General Health Questionnaire, 28 item version
(GHQ) [Goldberg and Hillier, 1979]. Table 16 shows the mean
HAD (Anxiety) scores for each group of carers. Analysis of
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variance revealed no statistically significant difference
between the three groups (p = 0.70).
Table 16
Analysis of variance of HAD (Anxiety) scores of
primary carers in each group: means, standard
deviations and F ratio (n=40 subjects in each group).
First Line Follow up Palliative F ratio Significance
10.52 (5.49) 9.93 (5.50) 9.48 (5.69) 0.36 p=0.70 (N.S.)
There is a marked similarity in mean scores between the three
groups of carers. When the data is analysed using cut-off
scores recommended by the authors, the number scoring in
the "case" level range is extremely high, as shown in Table 17.
A chi square analysis reveals that there is no statistically
significant difference between the distribution of carers
scoring in each category across the three groups (X2 =5.62;
df=4; N.S.).
Table 17
HAD (Anxiety) score of primary carers using cut-off
scores recommended by the authors (n = 40 subjects
in each group).
HAD Score First Line Follow up Palliative
A n x i e t v n (%) n (%) n (%)
0-7 10 (25.00) 12 (30.00) 14 (35.00)
8-10 5 (12.50) 11 (27.50) 5 (12.50)
11-21 25 (62.50) 17 (42.50) 21 (52.50)
(0-7 = normal, 8-10 = borderline, 11-21 = "case" level)
A comparison between the number of patients and carers
whose HAD (Anxiety) scores fall into each category, using cut-
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off scores, reveals a striking difference between the two as
shown in Table 18.
Table 18
HAD (Anxiety) scores for patients and their "primary
carers" using cut-off scores recommended by the
authors (n = 40 subjects in each group).
First Line Follow up Palliative
HAD
score
patient carer patient carer patient carer
Anxiety n(%) n(%) n(%) n(%) n(%) n(%)
0-7 23 (57.5) 10 (25.0) 23 (57.5) 12 (30.0) 21 (52.5) 14(35.0)
8-10 11 (27.5) 5 (12.5) 8 (20.0) 11 (27.5) 14 (35.0) 5 (12.5)
11-21 6 (15.0) 25 (62.5) 9 (22.5) 17 (42.5) 5 (12.5) 21 (52.5)
(0-7 = normal range, 8-10 = borderline range, 11-21 "case" level)
The number of carers whose scores fall within the "case" level
of anxiety is significantly higher than the number of patients'
scores falling within this category. This effect is maintained
across the three treatment groups but is at its most profound
during first line chemotherapy (X2= 19.02; df= 2; p<0.001) and
during palliative radiotherapy (X2=15.51; df=2; p<0.001). The
period during which the patient is not receiving any treatment
but is returning to the hospital for follow-up surveillance is
still very stressful for both patients and their carers.
Although the number of carers scoring in the "case" level
range is slightly less in this group than the other two, the
number of patients scoring in this range has risen. The
difference between the distribution of the two still achieves
statistical significance (X2= 6.39; df= 2; p<0.05).
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The mean HAD (depression) scores for each group of primary
carers is shown in Table 19. Analysis of variance across the
mean scores of the three groups does not achieve statistical
significance (p = 0.36).
Table 19
Analysis of variance of HAD (Depression) scores of
primary carers in each group: means, standard
deviations and F ratio (n = 40 subjects in each group).
First Line Follow up Palliative F ratio Significance !
6.15 (4.83) 4.60 (4.51) 5.70 (5.52) 1.03 p=0.361(N.S.)
eSyC (
This data is shown in Table 20 using cut-off scores
recommended by the authors. A chi square analysis of the
distribution of scores between the three groups fails to
achieve statistical significance (X2= 7.30; df= 4; NS).
Table 20
HAD (Depression) scores of primary carers using cut
off scores recommended by the authors (n= 40
subjects in each group).
HAD score First Line Follow up Palliative
Depression n(%) n(%) n(%)
0 - 7 22 (55.0) 30 (75.0) 27 (67.5)
8-10 10 (25.0) 4 (10.0) 3 (7.5)
11-21 8 (20.0) 6 (15.0) 10 (25.0)
(0-7 = normal range, 8-10 = borderline range, 11-21 "case" level)
In comparing the HAD depression scores of patients and their
primary carers (Table 21), the effect is less dramatic than the
HAD anxiety scores. The results suggest that depression is less
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of a problem for both patients and carers than anxiety. It is
noticeable, however, that the number of carers experiencing
"case" levels of depression during palliative therapy is
significantly greater than the number of patients in this group
scoring in the same category (X2 = 8.96; df=2; p<0.02).
Comparison of the numbers of patients and carers scoring in
each category in the first line group (X2 = 5.79; df= 2; NS) and
the follow up group (X2= 1.81; df= 2; NS) fail to achieve
statistical significance.
Table 21
HAD (depression) scores for patients and their
"primary carers" using cut off scores recommended by
the authors (n= 40 subjects in each group).
First Line Follow up Palliative
HAD
score
patient carer patient carer patient carer
depression n(%) n(%) n(%) n(%) n(%) n(%)
0-7 32 (80.0) 22 (55.0) 26 (65.0) 30 (75.0) 33 (82.5) 27 (67.5)
8-10 5 (12.5) 10 (25.0) 7 (17.5) 4 (10.0) 6 (15.0) 3 (7.5)
11-21 3 (7.5) 8 (20.0) 7 (17.5) 6 (15.0) 1 (2.5) 10 (25.0)
(0-7 = normal range, 8-10 = borderline range, 11-21 "case" level)
A surprising finding from the Table 21 is the small number of
patients receiving palliative therapy who score in the "case"
level range for depression on the HAD. This finding can be
explained in a later section looking at the patients' perceptions
of the aims of treatment.
In addition to the Hospital Anxiety and Depression Scale,
carers also completed the GHQ (28 item) scale [Goldberg and
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Hillier, 1978]. This scale can be used as a screening tool to
assess "probable caseness" as well as providing information on
four subscales (described previously).
Table 22 shows the mean GHQ scores for each group of carers
on the four subscales of the test.
Table 22
Analysis of variance of GHQ scores for each group of
carers on each subscale: means, standard deviation
and F ratio (n=40 subjects in each group).
GHQ First Line Follow up Palliative F ratio Significance
Somatic
symptoms




3.28(1.80) 2.20(1.30) 1.80(1.20) 11.27 p<0.001
Social
dysfunction
1.83(1.60) 0.80(0.80) 0.90(0.80) 8.31 p<0.001
Severe
depression
1.20(0.90) 1.00(1.00) 1.00(0.90) 0.46 p=0.63 (N.S.)
Total score 8.00(4.90) 4.90(3.20) 5.20(3.10) 8.32 pcO.0001
An analysis of variance performed between the three groups
found significant differences on three out of the four subscales
and with respect to the GHQ total score. There was a
significant difference between the groups of carers in the
"somatic symptoms" subscale (p = 0.004). Further analysis of
this difference using Scheffe's multiple range test revealed the
difference to be between the first line management group and
the follow-up group (F = 11.42; df = 2, 117; p < 0.001) and
between the follow-up group and the palliative therapy group
(F = 4.94; df =2, 117; p < 0.01) thus suggesting that the carers
of patients who were receiving first line chemotherapy or
palliative therapy experienced more severe somatic
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symptomatology than the carers of patients in the follow-up
group. These somatic symptoms include, "feeling run down"
and "out of sorts", "feeling ill", experiencing pains and
"tightness in the head" and experiencing "hot and cold spells".
The difference between the groups on the "anxiety and
insomnia" subscale was also significant (p < 0.0001). Further
analysis using Scheffe's multiple range test revealed the
differences to lie between the first line group and the follow-
up group (F = 11.00; df = 2, 117; p < 0.001) and the first line
group and the palliative therapy group (F = 21.14; df = 2, 117;
p < 0.001) thus indicating that the carers of patients receiving
first line chemotherapy experience a greater severity of
symptoms of anxiety and insomnia than the other two groups.
These symptoms include; "losing sleep over worry", "difficulty
staying asleep", "feeling edgy and bad tempered", "feeling
scared and panicky", "finding everything getting on top of
oneself" and "feeling nervous and strung up".
The difference between the groups on the "social dysfunction"
subscale also reached statistical significance using analysis of
variance (p < 0.0001). Scheffe's multiple range test revealed
the difference to lie between the carers in the first line group
and the follow-up group (F = 13.78: df = 2, 117; p < 0.001) and
between the first line group and the palliative therapy group
(F = 11.03; df = 2,117; p < 0.001) thus indicating that the
greatest degree of social dysfunction is found in carers of
patients receiving first line chemotherapy. This includes
difficulties in "keeping oneself busy and occupied", "taking
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longer to do things", "finding it difficult to perform tasks well",
"not feeling as though one is playing a useful part in things"
and "feeling incapable of making decisions".
Analysis of variance across the three groups on the fourth
subscale of the GHQ (severe depression) did not achieve
statistical significance (p = 0.63) indicating that the groups
were similar in terms of the degree of depression experienced
by the carers in each group.
The analysis of variance across the three groups of the GHQ,
total score revealed a significant difference (p < 0.0001).
Further analysis of these differences using Scheffe's multiple
range test revealed the difference to lie between the first line
group and the follow-up group (F = 13.50; df = 2, 117; p <
0.001) and between the first line group and the palliative
therapy group (F = 11.44; df = 2, 117; p < 0.001) thus
indicating that the greatest level of distress lay in the carers of
patients receiving first line chemotherapy. It is also of
importance to note that the mean total scores for each group
(8.00, 4.90 and 5.20) all lie within the range indicating
"probable psychiatric caseness", the "cutting" score being 4/5.
The data concerning the four subscales of the GHQ is
illustrated in Graph 1, where the trend towards a reduction in




















Graph 1. GHQ subscale scores for each group of carers.
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Data concerned with the GHQ total scores is shown below in a
different form (Table 23). The scores for each group are
divided into subjects scoring within "normal" range (0-4) and
those scoring above the threshold indicative of "psychiatric
caseness" (5 or more).
Table 23
General Health Questionnaire total scores using the
cut off points recommended by the authors (n=40
subjects in each group).
First Line Follow up Palliative
GHQ
score
n (%) n (%) n (%)
0 - 4 1 1 27.5 20 50.0 1 3 32.5
5 + 29 72.5 20 50.0 27 67.5
(Normal range 0-4; possible "caseness" 5+)
This latter data demonstrate the extremely high levels of
distress found in the carers of patients with lung cancer. A chi
square analysis, however, reveals that there is no significant
difference between the three groups in terms of the number
of carers scoring in the "case" level range in each (X2= 4.80; df=
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2; NS). The number of subjects scoring at "case level" is higher
using this form of the GHQ than on the HAD. This is probably
due to the different time scales with which the two
questionnaires are concerned and the fact that the questions
are assessing different specific functions.
The relationship between the mood state of
patients and their "primary carer".
Anxiety
The scores of patients and their primary carers on the anxiety
subscale of the HAD scale are significantly different in all
three groups. These results are shown in Table 24 and
illustrated in Graph 2 where the scale of difference can be
fully appreciated.
Table 24
A comparison of HAD anxiety scores of patients and
their primary carers: means, standard deviations and
t-test results (n=40 subjects in each group).
Patient Carer
Man. Stage Mean (SD) Mean (SD) DF t Significance
First Line 5.63 (4.85) 10.52 (5.49) 76 -4.23 p<0.0001
Follow up 6.90 (5.23) 9.93 (5.50) 77 -2.52 pcO.Ol
Palliative 6.30 (4.16) 9.48 (5.69) 7 1 -2.85 p<0.005
(Man.Stage= stage of management)
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Despite these statistical differences, however, the anxiety
scores for patients and their primary carers in the first line
management group were found to be significantly correlated
(r = .450; p < 0.01), as were those in the follow-up group (r =
.375; p < 0.05). The anxiety scores of patients and their carers
in the palliative therapy group, however, just failed to achieve
statistical significance (r = .273; N.S.) (Table 25). These results
indicate that an association exists between the level of anxiety
in patients and the level of anxiety in those who care for them.
Table 25
Comparative psychological status of patients and their
carer (Anxiety:HAD) (n= 40 pairs in each group).
Management Patient Carer Correlation Significance
Stage (mean) (mean) r P
First Line 5.63 10.52 0.450 p < .01
Follow up 6.90 9.93 0.375 p < .05
Palliative 6.30 9.48 0.273 N.S.
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Depression
The pattern of test scores with respect to depression is
different to that of anxiety (Table 26). The difference in HAD
depression scores between patients and their primary carers
achieves statistical significance in the first line management
group, but fails to do so in the follow-up and palliative
therapy groups. The relationship between the HAD depression
scores of the patients and their carer is illustrated in Graph 3.
The scores in the first line and palliative groups are higher for
the carer than for the patient but this effect is reversed in the
follow up group. Despite the fact that only the difference in
the first line group is statistically significant, the trends are
interesting. Patients in the follow up group tend to be more
depressed than the other two groups. This could be due to the
uncertainty that the patient is faced with at this time and
perhaps a sense of relief or hopelessness in the carer as
treatment has ceased.
Table 26
A comparison of HAD depression scores of patients
and their primary carers: means, standard deviations
and t-test results (n = 40 subjects in each group).
Patient Carer
Man.Stage Mean (SD) Mean (SD) DF t Significance
First Line 3.92 (3.76) 6.15 (4.83) 73 -2.30 p < 0.02
Follow up 5.37 (4.79) 4.60 (4.51) 77 0.75 p = 0.46
Palliative 4.03 (3.39) 5.70 (5.52) 64 -1.64 p = 0.11
(Man.Stage = Stage of Management)
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Correlation coefficients between HAD depression scores of
patients and their primary carers failed to achieve statistical
significance (first line management r = .188; follow-up r = -






















Comparative psychological status of patients and their
carers (Depression: HAD) (n = 40 pairs in each group).
Management
Stage
Patient Carer Correlation Significance
(mean) (mean) r P
First Line 3.92 6.15 0.188 N.S.
Follow up 5.37 4.60 -0.075 N.S.
Palliative 4.03 5.70 0.131 N.S.
(r= Pearson correlation)
The impact of the patients' mood state on that of the carer is
further borne out by examining the correlation of the patients'
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HAD scores with the anxiety and depression subscales of the
General Health Questionnaire (GHQ) which was completed by
the carer only. In the first line management group the
correlation between the patients' HAD anxiety score and the
carers' GHQ, anxiety subscale score, was statistically significant
(r = .339, p < .05). This trend was continued in the follow-up
group ( r = .399, p < .02) and in the palliative therapy group (r
= .354, p < .05). This latter correlation, unlike the correlation
found between the patients' HAD anxiety score and that of the
carers does achieve statistical significance.
In interpreting this data one must consider that the relative
time periods for the HAD scale and the GHQ are at variance
with each other. The GHQ is concerned with the "past few
weeks" whereas the HAD scale is concerned specifically with
the last week. The data from the current study suggests that
the distress in the primary carer is an enduring phenomenon
rather than a short term one.
The correlation coefficients between HAD depression scores
and the GHQ depression subscale accord with the earlier
correlation coefficients of the HAD depression scores of
patients and their carers, in that none of them achieved
statistical significance.
Correlation coefficients, however, between the carers' anxiety
and depression scores measured by the HAD and the GHQ




The sex distribution of the three groups was described earlier
in this chapter. The follow-up group of patients and their
primary carers had a male to female ratio that was clearly
different to that found in the other two groups. The
implications of any sex differences in mood state was,
therefore, an important question to be investigated. This was
examined in both patients and their primary carers in all
three groups for both anxiety and depression scores of the
HAD and the subscale scores (somatic symptoms, anxiety,
social dysfunction and depression) of the GHQ.
In the three groups of patients there was no statistically
significant difference between the scores for anxiety and
depression of the HAD questionnaire, between males and
females. Amongst the three groups of primary carers there
was no statistically significant difference between the GHQ
subscale scores of males and females. The scores of the
anxiety and depression subscales of the HAD questionnaire
were not significantly different in the first line management
group and in the follow-up group. In the carers of those
patients receiving palliative therapy, however, the mean




HAD anxiety scores of primary carers of patients
receiving palliative therapy: males versus females.
(Means, standard deviations and t-test results.)
Sex N Mean (S.D.) D.F. t Significance
Male 1 2 6.50 (5.90) 1 8 -2.17 p = 0.04
Female 28 10.80C5.20">
The scores for the depression subscale of the HAD between
males and females in this group of primary carers did not
achieve statistical significance.
There appears, therefore, to be no consistent effect of sex on
mood state on patients and their primary carers across the
three groups. The female carers in the palliative therapy
group have a mean age of 59.0 years (SD = 11.9). The aim of
palliative therapy is to alleviate troublesome symptoms rather
than to prolong life. This group of women who are all
"spouses" might be preparing for the impending death of their
husbands and this heightened anxiety could be conceptualised
as a from of "anticipatory grief".
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The relationship of other significant factors to
the mood state of patients and their primary
carers
Demographic data: patients
A range of demographic data was collected on patients and
their primary carers and their relationship to mood state was
examined.
In the three groups of patients no significant associations were
found between anxiety and depression as assessed by the HAD
questionnaire and the following variables: the patients' age;
marital status (married versus not married); employment
(working versus not working); and knowing someone close to
them who had previously been treated for cancer. Those
patients who had previous treatment for anxiety/depression
(8 in the first line group, 6 in the follow-up group and 6 in the
palliative group) were not significantly more anxious or
depressed than those without such a history.
Similarly, no significant associations were found between
demographic variables of the primary carer and the patients'
HAD scores (anxiety and depression) across the three groups.
These variables included the age of the primary carer, the
employment status of the primary carer (working versus not
working) and having someone close to them treated for cancer
in the past. Finally, there was no statistically significant
differences in age between male and female patients in the
three groups.
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Demographic data: primary carer
No significant associations were found between the age of the
primary carer, their employment status (working versus not
working) and knowing someone close to them treated for
cancer in the past and their mood state. This lack of
association was maintained across all three groups of carers
and also between the aforementioned variables, the anxiety
and depression subscales of the HAD questionnaire and the
subscales of the GHQ. (In the three groups of carers there were
no statistically significant differences between male and
female carers with respect to age.)
Similarly, no significant associations were found between the
demographic variables in the patient: age; marital status
(married versus not married); employment (working versus
not working); and knowing someone close to them in the past
treated for cancer and the anxiety and depression subscales of
the HAD and the subscales of the GHQ of the carer. There was
no difference in mood state between those carers previously
treated for anxiety and depression (10 in the first line group,
8 in the follow-up group and 11 in the palliative group) and
those without such a history. This suggests that previous
treatment for emotional problems did not predispose this
group towards greater levels of distress. This data suggest
that certain demographic variables from both the patient and
their carer were not significantly correlated with their mood
state. This result was maintained in both patients and carers,
irrespective of the stage of their disease "process".
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Illness and treatment variables: patient
The contributions of a number of variables related to the
patients' illness on mood state (anxiety and depression) were
assessed across the three groups of patients. In the first line
management group and the follow-up group no significant
correlations were found between the number of symptoms
and side effects, the severity of these symptoms and side
effects, performance status and time since diagnosis (months)
and anxiety and depression. In the palliative therapy group,
however, the correlation between the number of symptoms
and side effects and anxiety (r = .364) achieved statistical
significance (p < .05). The correlation between these variables
and depression failed to achieve statistical significance. The
severity of the side effects, performance status and time since
diagnosis also failed to achieve statistical significance.
This suggests that the effect of symptomatology as assessed
both by the patient and the physician on mood state is
relatively weak throughout the course of the illness. During
palliative therapy, however, those patients who have more
symptoms tend to be more anxious. This could be related to
the type of symptoms experienced by the patient as in this
group, 32 out of the 40 patients (80 per cent) experienced
both pain and breathlessness.
This association between physical symptoms and mood state
has been reported elsewhere [Goldberg, et al. 1984]. The
relationship is clearly not related solely to the stage of the
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disease because the levels of anxiety across the three groups
of patients do not differ significantly as has been discussed
earlier.
Finally, neither the type of lung cancer (non small cell lung
cancer versus small cell lung cancer) nor the chemotherapy
combination given during first line management had any
significant effect on the patients' anxiety and depression
scores of the HAD questionnaire across all three groups. Table
29 shows the distribution of type of lung cancer across the
three groups.
Table 29
Type of lung cancer by stage of management (n = 40
subjects in each group).






Non-small cell 22 (55) 21 (52.5) 20 (50)
Small cell 18 (45) 19 (47.5) 20 (50)
(Non-small cell= non small lung cancer
Small cell = small cell lung cancer)
Illness and treatment variables: primary carer
The contributions of variables from the patients' illness to the
mood state of the primary carer were examined. No
significant correlations were found between the performance
status of the patient, the symptoms and side effects
experienced by the patient, the severity of the side effects,
time since diagnosis and the mood state of the primary carers
in all three groups. Correlations were performed between
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these illness variables and the anxiety and depression
subscales of the HAD questionnaire and the subscales of the
GHQ. No significant associations were found.
The mood state of the primary carer was examined in relation
to the type of lung cancer from which the patient was
suffering. In those carers of patients receiving first line
chemotherapy and those receiving palliative therapy there
was no significant difference in levels of anxiety and
depression in the different diagnostic groups (cell type) as
assessed by the HAD questionnaire.
In the carers of patients receiving follow-up observation the
mean anxiety level of carers of patients with non small cell
lung cancer (12.24; SD = 4.37) was significantly higher than
the mean anxiety level of carers of patients with small cell
lung cancer (7.37; SD = 5.59). This difference was found to be
highly significant (t = 3.05; p = .004).
This effect was maintained for mean depression scores as well.
The mean depression score for carers of patients with non
small cell lung cancer (6.29; SD = 4.92) was significantly higher
than the mean depression score of carers of patients with
small cell lung cancer (2.74; SD = 3.18). Again this difference
was highly significant (t = 2.73; p = .009).
The reason for this effect is not immediately obvious from the
data. There is no significant difference between the two
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diagnostic groups of the follow-up group in terms of
performance status, the number of symptoms reported by the
patient and the severity of these symptoms. One could
postulate that there was a difference between the two groups
of patients during their first line chemotherapy in terms of
performance status, the number of symptoms and side effects
and the severity of those symptoms and side effects and that
this has lead to persistently raised anxiety and depression
levels. From this data we have no way of knowing for certain.
Table 30, shows that there is a statistically significant
difference across the three groups of patients in terms of the
number of symptoms and side effects and that performance
status deteriorated over time.
Table 30
Analysis of variance of illness variables across the
three groups of patients. (Means, standard deviations,
F-ratios and significance.) (n = 40 subjects in each
group.)
First Line Follow up Palliative F-ratio Significance
Illness
variable
Mean (S.D.) Mean (S.D.) Mean (S.D.)
SSE
(number)
4.4 (2.4) 0.7 (0.9) 4.4 (2.0) 51.47 p<0.0001
SSE
(severity)
12.0 (6.5) 1.6 (2.0) 12.7 (6.6) 52.11 p<0.0001
P.S. 0.63(0.49) 0.25 (0.43) 1.82(0.54) 110.57 pcO.0001
(SSE (number) = the number of symptoms and side effects;
SSE (severity) = the severity of these side effects;
P.S. = Performance Status)
A Scheffe's multiple range test performed between the three
groups of patients with respect to the number of symptoms
and side effects reveals that the differences between the first
line group and the follow-up group (F = 76.69; df = 2, 117 ; P <
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0.001) are highly significant. The same pattern is observed
using Scheffe's test with the severity of these symptoms and
side effects (first line versus follow-up F = 72.80; df = 2, 117; p
< 0.001 follow-up versus palliative F = 83.25; df = 2, 117; p <
0.001). A Scheffe's test between the three groups with respect
to performance status reveals significant differences between
them (first line versus follow-up F = 11.48; df = 2, 117; p <
0.001, first line versus palliative F = 117.55; df = 2, 117; p <
0.001, follow-up versus palliative F = 202.50; df = 2, 117; p <
0.001).
In examining the first line management group, however, there
is no statistically significant difference between those patients
with non small cell lung cancer and those with small cell lung
cancer in terms of the number of symptoms and side effects,
the severity of these side effects and performance status as
judged by the physicians. A tentative conclusion, therefore, is
that the difference in the anxiety and depression levels of the
spouse are not related to current illness variables or illness
variables from their first line treatment.
One hypothesis might be that the effect was due to a specific
treatment side effect. Those patients with small cell lung
cancer received treatment which caused alopecia whereas
those patients with non small cell lung cancer did not lose
their hair. The lower level of anxiety and depression in the
follow-up group may be due to the fact that, at follow-up, the
patients' hair will be re-growing. This may be interpreted by
the carer as a positive sign of returning health or treatment
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success and therefore lead to a reduction of anxiety and
depression scores in this group. In the context of this study
however, this remains conjecture as the data to substantiate it
have not been collected.
The different combinations of chemotherapy given during the
patients' first line management was not found to have a
statistically significant impact on the levels of anxiety and
depression in the primary carer.
The illness and treatment variables assessed in this study do
not have any consistent impact on the mood state of the
primary carers at different stages of the illness "process".
There is however, tentative evidence of the effect of the type
of lung cancer on mood state although the reasons for this are
unclear.
Sex differences: illness variables
The variables of performance status, the number of symptoms
and side effects, the severity of these symptoms and side
effects and time since diagnosis were examined in terms of
male versus female. In the three groups of patients there was
no statistically significant difference between males and
females in any of these variables.
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Personality variables
The Eysenck Personality Inventory (EPI) assesses the
personality traits of extraversion and neuroticism. The
extraversion and neuroticism scores are shown in Table 31.
Table 31
Analysis of variance of EPI, extraversion and
neuroticism scores in patients ( n= 40 patients in each
group).
EPI First Line Follow up Palliative F
ratio
Significance
Mean (S.D.) Mean (S.D.) Mean (S.D.)
Extraversion 10.20(3.60) 12.00 (3.50) 12.10 (3.40) 3.77 p = 0.026
Neuroticism 9.50 (3.80) 11.50(3.60) 10.50 (2.90) 3.50 p = 0.033
The one way analysis of variance clearly shows that there is a
statistically significant difference between the three groups of
patients in terms of extraversion and neuroticism (The
difference in extraversion scores is located between the first
line group and follow-up group F = 5.43; df = 2, 117; p < 0.01
and the first line and palliative group F = 5.58; df = 2, 117; p <
0.01. The difference in neuroticism scores lies between the
first line and follow-up group F = 7.00; df =2, 117; p < 0.01,
using Scheffe's multiple range test). The EPI measures trait
characteristics and one could conclude that the three groups
are therefore composed of patients of different personality
types. A caveat must be applied here however when using
trait measures in life threatening illness. Eysenck and Eysenck
(1975) have shown that scores of neuroticism and
extraversion can change markedly during episodes of severe
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illness and must be treated with some caution if used to
estimate these characteristics pre-morbidly. Bianchi and
Ferguson (1977) have found that EPI are not only changed by
illness but can also be heavily influenced by anxiety states. It
can be assumed, therefore, that the pre-morbid EPI scores of
the three groups would necessarily be different.This must be treated
with caution, however, as the pre-morbid EPI scores were not obtained.
The EPI scores of the carers showed a similar trend in that
there was a statistically significant difference between the
extraversion scores of the three groups. The neuroticism
scores of the three groups, however, did not achieve statistical
significance (Table 32 using analysis of variance). Scheffe's
multiple range test revealed the difference to lie between the
first line group and the follow-up group (F = 8.06; df = 2, 117;
p < 0.001) and between the first line group and the palliative
therapy group (F = 4.30; df = 2, 117; p < 0.025).
Table 32
Analysis of variance of EPI extraversion and
neuroticism scores in carers.
EPI First Line Follow up Palliative F
ratio
Significance
Mean (S.D.) Mean (S.D.) Mean (S.D.)
Extraversion 10.60(3.60) 12.70 (3.30) 12.10 (3.00) 4.32 p <0.01
Neuroticism 10.00 (4.00) 1 1.60 (3.50) ©OO 2.23 p=0.11 (NS)
The contribution of both patients' extraversion and
neuroticism scores and those of the carers to their respective
anxiety and depression scores of the HAD questionnaire
proved not to be statistically significant in the three groups.
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Correlations between the patients' extraversion (E) and
neuroticism (N) scores and the patients' anxiety and
depression scores wets not significant in all three groups. The
same applied to the carers' "E" and "N" scores and the patients'
anxiety and depression scores across the three groups. The
carers' personality scores and anxiety and depression scores in
the three groups were not significantly correlated. Finally, the
correlation between the patients' personality scores and the
carers' anxiety and depression scores was not statistically
significant.
The results consistently demonstrate that there is no
statistically significant association between extraversion and
neuroticism and anxiety and depression in lung cancer
patients and their primary carers, irrespective of the stage in
the management process that they had reached.
Sex differences: personality variables
The EPI extraversion and neuroticism score in each patients
group were examined with respect to gender. In the three
groups there were no statistically significant sex differences in
the scores in the aforesaid traits.
In the three groups of carers, however, a statistically
significant sex difference in the EPI scores was found. In the
first line management group, female carers (n=32) were found
to have statistically higher mean extraversion scores (11.30;
SD=3.2) than the male carers' (n=8) mean extraversion score
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(7.30; SD = 3.4), (p<0.01). The correlations with anxiety and
depression, however, failed to achieve statistical significance
for both male and female carers, suggesting that the EPI scores
are not associated with mood state. In this group of carers
there was no statistically significant difference between male
and female neuroticism scores.
In the follow up group of carers there was no statistically
significant difference between the extraversion and
neuroticism scores of the sexes.
The carers of patients receiving palliative therapy followed a
similar pattern to the first line management group. There was
a statistically significant difference in the mean extraversion
scores of males (n=12) versus females (n=28). The mean score
of males in this group, however, was higher (13.75; SD=3.05)
than that of females (11.39; SD=2.86), (p=0.03). Again, the
correlations between anxiety and depression failed to achieve
statistical significance. The neuroticism scores of males versus
females failed to achieve statistical significance.
Social Support and Psychological State
The Perceived Social Support Scale (PSSS) [Procidano and
Heller, 1983] is divided into two subscales: social support from
the family and social support from friends.
There was no statistically significant difference between the
two perceived social support scales in the three groups for
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both patients and their primary carers (Table 33 and Table
34).
Table 33
Analysis of variance of perceived social support in
patients (n=40 subjects in each groups).
PSS First Line Follow up Palliative F ratio Significance
Mean (SD) Mean (SD) Mean (SD)
Family 14.70(6.20) 13.50(6.90) 13.70(6.20) 0.38 N.S.
Friends 10.00(7.40) 10.40(7.80) 11.00(7.00) 0.16 N.S.
(PSS= Source of Perceived Social Support)
Table 34
Analysis of variance of perceived social support in
carers (n= 40 subjects in each group).
PSS First Line Follow up Palliative F ratio Significance
Mean (SD) Mean (SD) Mean (SD)
Family 15.10(5.90) 13.10(6.70) 13.30(6.40) 1.2 N.S.
Friends 12.40(7.60) 1.40 (7.50) 12.50(6.50) 1.1 N.S.
(PSS= Source of Perceived Social Support)
Comparisons (using T-tests) between the perceived social
support scores for patients and their primary carers revealed
that there were no statistically significant differences between
them in the three groups. This proved to be the same when
examining patients and carers social support from both family
and friends. There were, however, significant correlations
between perceived social support scores of patients,
suggesting that if the patient has a high degree of social





The relationship between perceived social support in







(Mean) (Mean) r P
First Line Family 14.70 15.13 0.704 p<0.001
First Line Friends 10.05 12.45 0.249 N.S.
Follow up Family 13.55 13.10 0.937 p<0.001
Follow up Friends 10.43 10.38 0.618 p<0.001
Palliative Family 13.68 13.35 0.917 pcO.001
Palliative Friends 10.98 12.48 0.539 pcO.001
(Social support=perceived social support)
Graph 4.
Perceived Social Support from Family: Patient and Carer.
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The relationship between social support and mood state in
both patients and their primary carers was examined. None of
the correlations between social support from friends and
family and anxiety and depression with respect to the patients
achieved statistical significance. This pattern remained
consistent irrespective of the stage of management that the
patient had achieved (Table 36 and 37).
Table 36
The relationship of perceived social support to
anxiety (HAD): patient.
P.S.S. First Line Follow Up Palliative
r r r
Family 0.248 0.029 0.285
Friends 0.078 -0.092 -0.127
(P.S.S.= perceived social support; r=Pearson Correlation)
Table 37
The relationship of perceived social support to
depression (HAD): patient.
P.S.S. First Line Follow Up Palliative
r r r
Family 0.297 0.134 0.202
Friends 0.023 -0.011 -0.058
(P.S.S.= perceived social support; r=Pearson Correlation)
These results suggest that in terms of the patients there is no
significant association between perceived emotional social
support and anxiety and depression. Thus, for this group, the
hypothesis that social support acts as a "buffer" against
psychological distress is not supported.
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The relationship between social support and distress with
respect to the carer, however, is not so consistent (Tables 38
and 39).
Table 38
The relationship of perceived social support to
anxiety (HAD): primary carer.
P.S.S First Line Follow Up Palliative
r r r
Family 0.471 ** 0.143 0.306
Friends 0.177 0.212 0.063
(P.S.S.= perceived social support;
**p<0.01; r= Pearson correlation)
Table 39
The relationship of perceived social support to
depression (HAD): primary carer.
P.S.S. First Line Follow Up Palliative
r r r
Family 0.333* 0.337* 0.169
Friends 0.205 0.329* 0.207
(P.S.S.= perceived social support;
*p<0.05; r= Pearson correlation)
There is clearly a highly significant positive correlation in the
first line group between social support from family and
anxiety (Table 38). The remainder of the correlations between
social support and anxiety fail to achieve statistical
significance.
The relationship between social support and depression
(Table 39) also demonstrates some significant correlations.
Once again the relationship between family and mood state
achieves significance as it does in the follow up group. In this
latter group, however, their is a significant relationship
between social support from friends and depression.
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These positive correlations are contrary to the expected
results. A prevalent view of perceived social support is that it
acts as a "buffer" mechanism against distress [Procidano and
Heller, 1983]. One would, therefore, expect significant inverse
correlations to be achieved i.e. that high levels of social
support would be correlated with low levels of distress. The
results from the current study indicate that at specific times
during the illness "process" high levels of perceived emotional
social support are associated with high levels of distress.
Further support for this association is found if the relationship
between perceived social support and the total score of the
General Health Questionnaire (GHQ) of the carer is examined.
In the first line group the correlation between perceived social
support from family and the GHQ score is highly significant
(r=0.435; p<0.01). The relationship between perceived social
support from friends and the GHQ fails to achieve significance
(r=0.144). In the follow up group the relationship fails to
achieve statistical significance (support from family, r=0.024;
from friends, r=0.101). In the palliative therapy group there is
no statistically significant association (family, r=0.229; friends,
r=0.014).
Procidano and Heller [1983], in their original paper concerning
the Perceived Social Support Scale, recommend that in
addition to using correlation co-efficients to assess the scale, a
median split should be performed in the scores of the scale. In
this way, the impact of social support can be assessed using a
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comparison of the two groups: high social support versus low
social support.
A median split was, therefore, performed comparing the
anxiety and depression scores of the HAD scale in patients and
carers with high and low social support. There were no
statistically significant differences in anxiety and depression
scores in the three groups of patients when a median split was
used in both subscales (family and friends) of the
questionnaire.
In the three groups of carers, the results support the findings
of the correlational data. The difference between anxiety
scores of carers in the first line management group with high
versus low social support from family achieve statistical
significance. Likewise, when comparing the depression scores
in the follow up group there is a statistically significant
difference between patients with high versus low social
support from both family and friends.
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Table 40
A comparison of anxiety and depression scores of
carers with high and low perceived social support
scores.
Low Social Support High Social Suppori




First Line 1 1 7.73 (5.39) 29 11.59 (5.23) -2.04*
Follow up 14 8.36 (6.74) 26 10.77 (4.62) -1.20
Palliative 14 7.71 (5.90) 26 10.42 (5.46) 0.56
Depression
(HAD):
First Line 1 1 4.09 (4.30) 29 6.93 (4.80) -1.80
Follow up 14 2.93 (3.32) 26 5.50 (4.85) -1.98*




First Line 1 7 9.82 (5.51) 23 11.04 (5.54) -0.69
Follow up 23 8.87 (5.53) 1 7 11.35 (5.28) -1.44
Palliative 14 9.93 (4.91) 26 9.23 (6.15) 0.39
Depression
(HAD):
First Line 1 7 5.00 (4.00) 23 7.00 (5.29) -1.36
Follow up 23 3.30 (3.36) 1 7 6.35 (5.31) -2.08*
Palliative 14 5.00 (5.20) 26 6.08 (5.74) -0.60
(* p<0.05)
The results, shown in Table 40, demonstrate that in all the
comparisons made (with the exception of one), the trend is for
those carers with high perceived social support to have higher
scores on the anxiety and depression subscales of the HAD
questionnaire.
One explanation for this effect is that the social support is a
reaction to the distress of the carer. Such an explanation could
be postulated for the carers of the first line group of patients
where the anxiety score of carers with high social support is
significantly higher than those with low social support
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(p<0.05). This group of patients have only recently been
diagnosed (mean score since diagnosis is 1.1 months; S.D. 0.4
months) and the initial distress following diagnosis may act as
a catalyst for increased levels of social support.
A similar explanation could be applied to the follow up group
in that these patients have finished treatment within the last
2-3 months and carers may find the uncertainty of the future
difficult to cope with and distressing. During this latter stage
of management, patients (and, perhaps their carers) return to
the clinic each month for tests and investigations to monitor
their progress. It is a time of great uncertainty which many
people find extremely stressful [Koocher and Malley, 1981].
One would also expect this effect to be true in the palliative
therapy group as during this stage the patient is often very
unwell with multiple symptoms.
The question regarding the effect of distress on the level of
social support can be answered to some extent by analysing
some of the data from the brief interview schedule relating to
perceived changes in social support.
Carers were asked if there had been any change in the support
that they had received from people since their husband's/
wife's/ or friend's diagnosis (Table 41). The first line
management group clearly indicate that the majority of carers
(70 per cent) perceive that there has been an increase in
support. In the follow up group the majority (52.5 per cent)
perceive that there has been a decrease in support. In the
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palliative therapy group the dominant perception (60 per
cent) is that there has been an increase in support. Chi square
analysis reveals that these differences between the groups are
highly significant (X2= 37.82; df=4; p<0.001).
Table 41
Perceived changes in support since diagnosis: primary
carer (n= 40 subjects in each group).
Support First Line Follow up Palliative
n (%) n (%) n (%)
No change 12 (30.0) 10 (25.0) 1 1 (27.5)
Increase 28 (70.0) 9 (22.5) 24 (60.0)
Decrease 0 (0.0) 2 1 (52.5) 5 (12.5)
In addition, carers were asked if they felt there had been any
change in the support received from family and friends in the
past month (Tables 42 and 43). In the three groups of carers
the predominant response was that there had been no change
in support from either family or friends, although a significant
number in the follow up group report that there has been a
decrease in support from family (X2=17.45; df=4; p<0.01) and
friends (X2= 9.56; df= 4; p<0.05).
Table 42
Perceived change in support from family during the
previous month: primary carer (n= 40 subjects in each
group).
Support First Line Follow up Palliative
n (%) n (%) n (%)
No change 33 (82.5) 24 (60.0) 30 (75.0)
Increase 5 (12.5) 6 (15.0) 10 (25.0)
Decrease 2 (12.5) 10 (25.0) 0 (0.0)
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Table 43
Perceived changes in support from friends during the
previous month: primary carer (n=40 subjects in each
group).
Support First Line Follow up Palliative
n (%) n (%) n (%)
No change 34 (85.0) 32 (80.0) 33 (82.5)
Increase 3 (7.5) 2 (5.0) 7 (17.5)
Decrease 3 (7.5.) 6 (15.0) 0 (0.0)
These questions are very general in nature in that they ask
about "support". A further question was phrased more
specifically in that it asked about perceived changes in
availability of family and friends in whom one could confide
and share worries over the past month (Tables 44 and 45).
Table 44
Perceived changes in the availability of family
members in whom one could confide or share worries:
primary carer (n=40 subjects in each group).
Support First Line Follow up Palliative
n (%) n (%) n (%)
No change 22 (55.0) 29 (72.5) 27 (67.5)
Increase 15 (37.5) 2 (5.0) 8 (20.0)
Decrease 3 (7.5.) 9 (22.5) 5 (12.5)
Table 45
Perceived changes in the availability of friends in
whom one could confide or share worries: primary
carer (n=40 subjects in each group).
Support First Line Follow up Palliative
n (%) n (%) n (%)
No change 26 (65.0) 30 (75.0) 29 (72.5)
Increase 11 (25.5) 2 (5.0) 6 (15.0)
Decrease 3 (7.5) 8 (20.0) 5 (12.5)
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The results show that the majority of subjects report no
change in the availability of social support from family and
friends in the past month. A significant number of
respondents, however, in the first line and palliative therapy
groups report an increase in the availability of family
members in whom they could confide, whereas a significant
number in the follow up group report a decrease in the
availability in family members (X2=14.45; df= 4; p<0.01). A
similar pattern of response is found in relation to the
availability of friends, although the difference between groups
fails to achieve statistical significance (X2= 9.10; df=4; N.S.).
A comparison of Perceived Social Support Scale scores
between those who perceived an increase and those who did
not perceive any change in the past month did not reveal any
statistically significant differences (family and friends).
The data concerning the relationship between social support
and psychological state suggest that for the carer there is a
statistically significant relationship between social support
from family and friends and anxiety and depression. The data
suggest that high levels of support are associated with high
levels of distress. The perceptions of carers regarding recent
changes in the availability of support suggest, tentatively, that
social support changes may not necessarily be in response to
distress. These associations have not been found when looking
at the relationship between social support scores in the patient
and anxiety and depression.
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Social support and physical symptoms
The impact of symptomatology on social support was
examined in patients and their carers at different stages of the
illness "process".
The most striking effect of symptomatology on perceived
social support was found in the first line management group of
patients (Table 46). Statistically significant associations were
found between the number and severity of symptoms that
patients complained of and perceived social support from
family and friends. The results suggest that the more
symptom complaints the patient has the greater the degree of
social support that they experience.
Table 46
The relationship between symptoms and their
severity and perceived social support in patients









(Performance = Performance Status; * p<0.05; ** p<0.02; *** p<0.01;
r= Pearson Correlation).
In the follow up group of patients and those receiving
palliative care no statistically significant correlations were
found between symptoms and side effects, performance status
and perceived social support from family and friends.
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The increased level of social support in the first line group
could be due to the relatively recent diagnosis and the start of
treatment. Friends and family may be very aware of the
situation and may be responding to the initial effects of
chemotherapy (nausea, vomiting and hair loss) in giving
increased social support to the patient by caning to see them.
This hypothesis is supported by some of the data from the
brief interview schedule of the patient. Patients were asked if
there had been any change in the support that they had
received since they first became ill. In response to this, 12
patients (30 per cent) felt that there had been no change, 20
patients (50 per cent) felt that there had been an increase in
social support and 8 patients (20 per cent) felt that there had
been a decrease in social support.
The impact of the patients' symptoms and side effects and
performance status on the carers' perceived social support
scores failed to achieve statistical significance. The finding was
consistent in the three groups of primary carers and for
perceived social support from both family and friends.
Social support and age
The relationship between social support and age revealed
some interesting associations. No statistically significant
correlations were found between age of the patient and
perceived social support scores from family and friends in the
three groups.
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The primary carers, however, demonstrated the opposite. In
the first line group the correlations between the carers age
and social support from family and friends failed to achieve
statistical significance. In the follow up group and the '
palliative group, however, statistically significant inverse
correlations were found between social support from both
family and friends and age (Table 47).
Table 47
The relationship between age and perceived social
support in primary carers (n=40 subjects in each
group).
P.S.S. First Line Follow up Palliative
r r r
Family -0.09 -0.337* -0.326*
Friends -0.07 -0.404** -0.418***
(P.S.S.= perceived social support;
* p<0.05; ** p<0.02; *** p<0.01; r= Pearson Correlation).
In the follow up group and the palliative therapy group the
older the primary carer, the less social support they perceive
themselves to have both from family and from friends.
Interestingly, the stronger statistical relationships can be seen
when correlating age with social support from friends.
Social support and personality
No statistically significant correlations were found between
perceived social support and extraversion or neuroticism
scores of the EPI in patients and their carers in any of the
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groups. This suggests that social support is not a reaction to
personality type in the respondents at any stage of the illness.
Perceived social support: sex differences
The perceived social support scores of the three groups of
patients were examined in terms of sex differences. No
statistically significant differences were found between males
and females in social support from family and friends in any
of the groups. The result remained consistent when the social
support scores of the primary carers were subjected to the
same analysis. No effect of sex was observed in any of the
groups in terms social support from family and from friends.
Attitudes and mood
Patients were asked a series of questions regarding their
attitude to their illness and its treatment. The effect of these
attitudes on mood state was then examined.
The first question that patients were asked was whether they
felt that it was better to try to "accept" their illness or try to
"fight" it. The responses are shown for each of the three
groups in Table 48.
249
Table 48
Attitudes of patients to their illness: "accept" versus
"fight" (n=40 subjects in each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Accept 10 (25.0) 5 (12.5) 20 (50.0)
Fight 27 (67.5) 3 3 (82.5) 18 (45.0)
Don't know 3 (7.5) 2 (5.0) 2 (5.0)
A chi square test reveals that there is a statistically significant
difference between the distribution of attitudes of the patients
in the three groups (X2=14.67; df=4; p<0.01). Comparisons
between the mean anxiety and depression scores of the HAD
scale of the those who accepted their illness versus those who
felt that they should fight it failed to achieve statistical
significance. This result was the same in the first line
management group and the palliative therapy group. The
unequal distribution of attitudes in the follow up group
resulting in extremely small numbers in the "accept" and
"don't know" categories rendered a statistical comparison
between the groups invalid.
The second question that the patients were asked was
whether they felt hopeful or pessimistic about the future. The
responses are shown in Table 49.
Table 49
Attitudes of patients to their future: pessimistic
versus hopeful (n=40 subjects in each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Pessimistic 4 (10.0) 3 (7.5) 17 (42.5)
Hopeful 34 (85.0) 30 (75.0) 23 (57.5)
Don't know 2 (5.0) 7 (17.5) 0 (0.0)
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A chi square test between the groups reveals that there is a
statistically significant difference between the responses of
the groups (X2= 26.05; df=4; p<0.001). This can be seen in the
palliative therapy group where the distribution of responses is
more even than the two other groups.
The distribution of attitudes in the palliative therapy group is
such that a comparison can be made between the mood state
of those patients who are pessimistic about the future and
those who are hopeful. In fact, comparisons between the
anxiety and depression scores of the HAD scale in these two
groups failed to achieve statistical significance. The
distributions of attitude in the first line management group
and follow up group made comparisons of mood state invalid.
The third question that patients were asked was whether they
preferred to leave decisions about their treatment to the
doctors or whether they preferred to have a say in these
decisions. The responses are shown in Table 50.
Table 50
Attitudes of patients to participation in their
treatment decisions: "passive" versus "active" (n=40
patients in each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Passive 1 1 (27.5) 4 (10.0) 11 (27.5)
Active 27 (67.5) 3 1 (77.5) 26 (65.0)
Don't know 2 (5.0) 5 (12.5) 3 (7.5)
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A chi square test between the responses of the three groups
failed to achieve statistical significance suggesting that there is
no significant difference between the distribution of attitudes
of the three groups of patients (X2=5.67; df=4; p=0.30).
A comparison of anxiety and depression scores on the HAD
scale between those who were passive and those were active
in the first line group and the palliative therapy group failed
to achieve statistical significance. The distribution of responses
in the follow up group was such that comparisons of the
impact of attitude on mood state were invalid.
The results of the analysis of the impact of patients attitudes
to their illness and its treatment on anxiety and depression
suggest that there is no significant effect at any of the three
stages.
The primary carers were asked a similar series of questions
concerning attitudes to illness and treatment. The first
question was concerned with whether they felt it better for
their husband/ wife/ friend to try to accept the illness or to
try to fight it (Table 51).
This data represents a very crude division of attitudes in patients and
primary carers. This data, therefore, must be treated with caution as
independent ratings were not obtained to confirm the allocation of patients




Attitudes of carers to illness: "accept" versus "fight"
(n= 40 subjects in each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Accept 3 (7.5) 4 (10.0) 21 (52.5)
Fight 35 (87.5) 28 (70.0) 18 (45.0)
Don't know 2 (5.0) 8 (20.0) 1 (2.5)
A chi square test between the distribution of responses in the
three groups reveals that there is a statistically significant
difference between the groups (X2=35.15; df=4; pcO.OOl). The
distribution of attitudes is more even in the palliative group. A
comparison of anxiety and depression scores from the HAD
scale between the "accept" and "fight" responders in this latter
group failed to achieve statistical significance. No comparisons
were made in the first two groups due to the extremely
skewed distributions of attitudes creating extremely small
numbers in some of the categories.
The second question that carers were asked was whether they
felt hopeful or pessimistic about the future (Table 52).
Table 52
Attitudes of carers to the future: hopeful versus
pessimistic (n=40 subjects in each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Pessimistic 19 (47.5) 3 (7.5) 29 (72.5)
Hopeful 19 (47.5) 27 (67.5) 9 (22.5)
Don't know 2 (5.0) 1 0 (25.0) 2 (5.0)
A chi square test between the distribution of responses of the
three groups achieved statistical significance (X2=38.25; df=4;
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p< 0.001), thus indicating that there is a difference in attitudes
in three groups. A comparison of the HAD scale, anxiety and
depression scores in the first line group and the palliative
therapy group between attitudes (pessimistic versus hopeful)
showed no statistically significant difference. The distribution
of responses in the follow up group was so skewed as to
render a comparison of mood state invalid.
The third question that the carers were asked was whether
they preferred to leave decisions about their husband's/
wife's/ friend's treatment to the doctor or whether they
preferred to have a say in these decisions (Table 53).
Table 53
Attitudes of carers to participation in treatment
decisions: passive versus active (n=40 subjects in
each group).
Attitude First Line Follow up Palliative
n (%) n (%) n (%)
Passive 25 (62.5) 3 (7.5) 22 (55.0)
Active 10 (25.0) 29 (72.5) 17 (42.5)
Don't know 5 (12.5) 8 (20.0) 1 (2.5)
A chi square test revealed there to be statistically significant
differences between the groups in the distribution of attitudes
to participation in treatment decisions (X2 =32.26; df=4;
p<0.001). The distribution of attitudes in the first line group
and the palliative group enabled the effect of attitude on HAD
scale, anxiety and depression scores to be examined. No
statistically significant difference was found between the
mood state scores of carers who were "passive" in treatment
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decisions versus those who were "active". The distribution of
attitude responses in the follow up group was too skewed to
enable a valid comparison of mood state scores to be
performed.
The distribution of attitude responses in carers, therefore, is
significantly different between the three groups. The data
suggest^ however, that attitudes do not significantly affect
anxiety and depression scores of carers at any stage of the
illness "process".
The impact of the illness and its treatment on
psychosocial adjustment.
Patients
Patients in the three "management" groups completed the
Psychosocial Adjustment to Illness Scale (PAIS) [Derogatis,
1976; 1983]. The data from the three groups was then
subjected to an analysis of variance (Table 54). In analysing
data from the PAIS, raw scores were used as recommended by
the authors in the Test Manual [Derogatis, 1983 (pl9)]. Higher
scores on this test suggest greater adjustment problems.
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Table 54
Analysis of variance of PAIS scores by domain:
patient (means, standard deviations and F ratios)












1.30 (1.40) 1.12 (1.22) 3.82 (3.51) 17.33 p< 0.0001
Vocational
Environment
5.75 (5.40) 1.22 (1.39) 7.02 (4.98) 19.95 p< 0.0001
Domestic
Environment
4.32 (3.44) 1.57 (1.66) 5.50 (3.94) 16.20 p< 0.0001
Sexual
relationship
9.60 (3.64) 1.87 (2.55) 9.47 (4.83) 54.53 p< 0.0001
Extended
family
3.07 (2.37) 1.50 (2.08) 5.00 (3.41) 17.06 p< 0.0001
Social
Environment
5.97 (3.57) 1.52 (1.55) 3.97 (3.47) 21.93 p< 0.0001
Psychologic.
Distress
4.22 (3.06) 2.10 (2.26) 6.00 (3.57) 16.79 p< 0.0001
Total 34.25 (9.69) 10.93 (10.64) 40.80(20.58) 46.92 p< 0.0001
The analysis of variance by PAIS domain reveals that there is
a statistically significant difference between the three groups
in each domain and including the total. These relationships are
illustrated in Graph 6, where it can clearly be seen that the
follow up group tends to experience less impact on adjustment
than the other groups.
256






HOO VOC DOM SEX EXT SOC PSY
PAIS Domain
(HCO= Health care orientation; VOC= Vocational environment;
DOM= Domestic environment; SEX= Sexual relationships; EXT= Extended
family relationships SOC= Social environment; PSY= Psychological
Scheffe's multiple range test was utilised to investigate further
these significant differences between the three groups.
Psychosocial adjustment in "health care orientation" was found
to be significantly poorer in the palliative therapy group than
in the first line group and the follow up group (First line
versus palliative: F= 24.19; df = 2, 117; p <0.001. Follow up
versus palliative: F= 27.66; df = 2, 117; p <0.001.)
This suggests a deterioration in "health care posture" when the
patient relapses but a preservation of health seeking




The patients' "vocational environment" score which reflects
the impact of the illness and its treatment on employment
demonstrates a different pattern. Not surprisingly, there is a
statistically significant difference between the first line
management group and the follow up group (F= 22.06; df = 2,
117; p <0.001) and between the follow up group and the
palliative group in this domain (F= 36.17; df= 2, 117; p<0.001).
This suggests that the impact on the respondent's work is
greater during initial chemotherapy but this impact is not
significantly different between these two stages.
The same picture emerged in the "domestic environment"
domain which assesses illness induced difficulties that arise in
the home or family environment. The most significant impact
was found during first line chemotherapy and palliative
therapy (first line versus follow up F= 15.12; df= 2, 117;
p<0.001; follow up versus palliative F= 30.88; df=2,117;
p<0.001) but the difference between these two did not achieve
statistical significance.
The same pattern of results emerged again in the "sexual
relationship" domain which assesses the impact of the illness
on sexual functioning. The most significant impact was found
during first line chemotherapy and palliative therapy (first
line versus follow up F=82.99; df=2, 117; p<0.001; follow up
versus palliative therapy F=80.20; df= 2, 117; p<0.001) but
again the difference between these two was not statistically
significant.
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The pattern of results for the domain "extended family" was
slightly different. This domain assesses the disruption in
relationships with extended family relationships that are
associated with the illness and its treatment. There was a
statistically significant difference between all three
comparisons. The first line management group showed
significantly poorer adjustment than the follow up group
(F=6.80; df=2,117; pcO.OOl). The follow up group showed
significantly better adjustment than the palliative group
(F=34.02; df=2,117; pcO.OOl) and the palliative therapy
showed significantly poorer adjustment than the first line
group (F=10.35; df=2,117; p<0.001). This data suggest,
therefore, that the palliative therapy stage of the illness has
the greatest derangement of extended family relationships.
In the "social environment" domain, however, the greatest
effect was seen during the first line chemotherapy.
Adjustment between the first line group and follow up group
was significantly poorer in the first line group (F=43.80;
df=2,117; pcO.OOl). The palliative group showed greater
disruption than the follow up group (F=13.28; df= 2,117;
pcO.OOl) and the first line group showed greater disruption
than the palliative group (F=8.85; df=2,117; pcO.OOl).
The "psychological distress" domain which is a global measure
of distress (with components of anxiety, depression, hostility,
reduced self esteem, body image problems, and guilt) showed
the greatest impact to be in the palliative therapy group. The
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scores in this domain were significantly worse than in the first
line group (F=6.98; df=2,117; p<0.01) and the follow up group
(F=33.50; df=2,117; pcO.OOl). The first line group also had
more distress than the follow up group (F=9.89; df= 2,117;
pcO.OOl).
The total score which gives a global measure of psychosocial
adjustment to illness was found to be significantly worse in
the palliative therapy group when compared to the first line
group (F=4.18; df= 2,117; p <0.025) and the follow up group
(F=87.04; df =2,117; p<0.001). The first line group also showed
poorer adjustment than the follow up group (F=53.05;
df=2,l 17; p<0.001).
This suggests that the patients undergoing palliative therapy
experience the poorest adjustment to their illness and its
treatment.
Primary carers
The primary carers in the three groups also completed the
Psychosocial Adjustment to Illness Scale (PAIS) and the data
was subjected to an analysis of variance (Table 55).
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Table 55
Analysis of variance of PAIS scores by domain : carer.
Means, standard deviations and F-ratios (n=40












3.22 (2.29) 2.05 (2.71) 5.0 (3.01) 12.19 p <0.0001
Vocational
Environment
5.52 (3.62) 1.70 (1.84) 7.72 (3.28) 40.87 p<0.0001
Domestic
Environment
3.37 (3.13) 2.50 (3.00) 4.62 (2.77) 5.16 p=0.007
Sexual
relationship
6.67 (3.93) 3.62 (3.87) 7.35 (3.57 10.93 p<0.0001
Extended
family
4.27 (3.65) 2.37 (2.69 4.90 (2.93) 7.09 p<0.001
Social
Environment
7.37 (4.01) 2.37 (2.27) 7.72 (4.25) 27.32 p<0.0001
Psychologic.
Distress
5.32 (3.08) 4.12 (3.55) 7.97 (4.30) 11.47 p<0.0001
Total 35.78 (7.37) 18.75 (16.64) 45.30(12.00) 45.69 p<0.0001
The analysis of variance reveals that there are statistically
significant differences between the groups in each domain of
the PAIS scale. These differences are illustrated in Graph 7
where the trend suggests that the follow up group experience
less impact on adjustment than the other two groups.
These significant differences were then examined more closely
using Scheffe's multiple range test.
In the "health care orientation" domain the palliative therapy
group had significantly higher scores and therefore poorer
adjustment than either of the other two groups (palliative
therapy versus first line group F=8.70; df=2,117; p<0.001: and
versus the follow up group F=24.04; df=2,117; p<0.001). There
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was however no statistically significant difference in scores
between the first line group and the follow up group.
In the "vocational environment" domain, there was a
statistically significant difference between all three groups.
The first line group had significantly higher scores (F=32.15;
df=2,117; PcO.OOl) but significantly lower than the palliative
therapy group (F=10.63; df=2,117; p<0.001). The difference
between the follow up group and palliative group was also
significant (F=79.78; df=2,117; pcO.OOl). This suggests that the
palliative therapy group have poorer adjustment than either
of the others.
The "domestic environment" domain scores were highest in
the palliative therapy group. There was no statistically
significant difference between the first line group and the
follow up group. However, differences between the first line
group and the palliative group (F=3.53; df=2,117; p<0.05) and
the follow up group and the palliative group (F=10.20;
df=2,117; p<0.001) did achieve statistical significance.
Sexual relationship scores were highest in the first line group
and the palliative therapy, there was no statistically
significant difference between them. However, both the first
line group and the follow up group (F=12.92; df=2,117;
p<0.0001) and the follow up group and the palliative group
(F=19.27; df=2,117; p<0.001) had statistically significant
differences between them.
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A similar picture was found in the "extended family" domain
where both the first line group and the palliative group had
significantly higher scores than the follow up group (F=3.90;
df= 2,117; p<0.05; and F= 13.09; df= 2, 117; p<0.001). This
pattern was also repeated in the "social environment" domain
where both the first line group and the palliative group had
higher scores than the follow up group (F=38.00; df=2,117;
p<0.001 and F=43.69; df=2,l 17; P<0.001).
The domain of "psychological distress" revealed that the scores
between the first line group and the follow up group were not
significantly different. The palliative therapy group, however,
had significantly higher scores than either of the other two
groups ( palliative therapy versus the first line group F= 10.40;
df=2,117; p<0.001 and versus the follow up group F=21.95;
df=2,117; p<0.001). This suggests that like the patient groups
the greatest degree of psychological distress is found in the
palliative therapy group.
The "total" score of the PAIS was found to be significantly
worse in the palliative therapy group when compared to the
first line group (F=11.47; df=2,117; p<0.001) and the follow up
group (F=89.22; df=2,117; p<0.001). There was also a
significant difference between the first line group and the
follow up group (F=36.71; df=2,117; p<0.001). This pattern
mirrors that seen in patients, the highest level of disruption
found in the palliative therapy group followed by the first line
group and the follow up group.
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Graph 7. PAIS Scores by Domain: Carers
■■ Palliative
PAIS Domain
(HCO= Health care orientation; VOC= Vocational environment; DOM=
Domestic environment; SEX= Sexual relationships; EXT= Extended




Psychological Adjustment to Illness Scale (PAIS):
differences between patients and their primary
carers.
Comparisons were made between the PAIS domain mean
scores of patients and their primary carers. The statistically




Statistically significant differences in PAIS domains:
patient and primary carer (first line management).




Mean (S.D.) Mean (S.D.)
Health Care
Orientation
1.30 (1.40) 3.22 (2.29) -4.53 p<0.0001
Sexual
relationship
9.60 (3.64) 6.67 (3.93) 3.45 p=0.0009
Comparisons using T-tests between the remaining domains for
the first line management group failed to achieve statistical
significance. The statistically significant differences (Table 56)
suggest that the primary carer experiences greater disruption
of "health care posture" than the patient. It suggests that the
carer has more negative views about the doctors, the
treatment, and the future. In addition, it suggests that the
primary carer feels that they are more lacking in information
concerning the illness and its treatment than the patient.
The patient, however, experiences greater disruption of sexual
relationships and sexual interest than the primary carer
during this time. This result may not be surprising given that
the patient is receiving chemotherapy at this time.
Correlations between the patients' PAIS domain score and the
number of symptoms (r = -0.28) and their severity (r = -0.26)
fail to achieve statistical significance. This is also the case
when examining the relationship of number of symptoms (r =
0.007) and their severity (r = 0.51) and health care orientation
scores of the primary carer.
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The relationship between the PAIS domains of the patient and
their carers in the first line management group are illustrated
in Graph 8. This graph not only includes those domains where
the difference achieves statistical significance but also includes
those where it does not.
Graph 8. PAIS Domain Scores: Patient and Carer,
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PAIS Domain
PSY
(HCO= Health care orientation; VOC= Vocational environment; DOM=
Domestic environment; SEX= Sexual relationships; EXT= Extended
family relationships SQC= Social environment; PSY= Psychological
distress)
The patients and their primary carers in the follow up
surveillance group demonstrated a different pattern of
significant differences in PAIS domain mean scores. These are
shown in Table 57.
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Table 57
Statistically significant differences in PAIS domains:
patient and primary carer (follow up surveillance), (n






Mean (S.D.) Mean (S.D.)
Health Care
Orientation
1.12 (1.22) 2.05 (2.71) -1.96 p< 0.05
Sexual
relationship
1.87 (2.55) 3.62 (3.87) -2.39 p< 0.02
Social
environment
1.52 (1.55) 2.37 (2.27 -1.95 p< 0.05
Psychological
distress
2.10 (2.26) 4.12 (3.55) -3.04 p = 0.003
Total score 10.93(10.64) 18.75(16.64) -2.5 1 p< 0.01
The differences between the means of the remaining PAIS
domains failed to achieve statistical significance. The results
shown in Table 57 suggest that adjustment in these domains
in the carer is significantly poorer than in the patient. In
addition to higher scores in health care orientation and sexual
relationships, carers experience a greater disruption to their
social environment and experience higher levels of
psychological distress than the patient. They also have a
higher "total" score suggesting greater adjustment problems
generally.
The relationship between the PAIS domain scores of the
patient and their carers in the follow up surveillance group is
illustrated in Graph 9. This includes all the PAIS domains,
those where the difference between patient and carer achieve
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statistical significance and those where it does not.
Correlations between the number of symptoms and severity of
symptoms and PAIS domains of both the patient and the carer
fail to achieve statistical significance.
Graph 9. PAIS Domain Scores: Patient and Carers,
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PAIS Domain
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(HCO= Health care orientation; VOC= Vocational environment; DOM=
Domestic environment; SEX= Sexual relationships; EXT= Extended
family relationships SOC= Social environment; PSY= Psychological
distress)
A comparison of the PATS domain score s in the palliative
therapy group presents yet another picture. The statistically
significant differences are shown in Table 58.
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Table 58
Statistically significant differences in PAIS domains:
patient and primary carer (palliative therapy). (n= 40






Mean (S.D.) Mean (S.D.)
Sexual
relationship
9.47 (4.83) 7.35 (3.57) 2.24 p = 0.02
Social
environment
3.97 (3.47) 7.72 (4.25) -4.32 p<0.0001
Psychological
distress
6.00 (3.57) 7.97 (4.30) -2.23 p = 0.02
Differences between the patient and the primary carer in the
remaining PAIS domains failed to achieve statistical
significance. The results from Table 58 suggest that the patient
experiences greater disruption in sexual relationships than the
primary carer during palliative therapy. The carer, however,
experiences greater disruption in social environment and
psychological distress during this time.
The relationship between the PAIS domain scores of the
patient and their carer in the palliative therapy group are
shown in Graph 10. This graph includes all the PAIS domains:
those where the difference between patients and carer
achieves statistical significance and those where it does not.
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Graph 10. PAIS Domain Scores: Patient and Carer,
Palliative Therapy Group.
10 -i
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PAIS Domain
(HCO= Health care orientation; VOC= Vocational environment; DOM= Domestic
environment; SEX= Sexual relationship; EXT= Extended family relationship;
SOC= Social environment; PSY= Psychological distress).
Correlations between the PAIS domain scores of the patient
and the PAIS domain scores of the carer failed to achieve
statistical significance in any of the three groups. This suggests
that there is little association between the patient and carer in
terms of psychosocial adjustment.
Correlations between symptoms and their severity achieved
statistical significance with respect to the "vocational
environment" of the patient, not surprisingly. Correlations
with both the number of symptoms (r-0.36; p<0.05) and their
severity (r= 0.38; p<0.05) and the vocational domain were
significant. Similarly, a correlation between the severity of
symptoms and the extended family domain (r= 0.37; p<0.05)
achieved statistical significance, again not surprisingly. No
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correlations between symptoms and their severity and PAIS
domain scores in the carer achieved statistical significance.
None of the correlations between measures of perceived social
support from family and friends and any of the PAIS domains
achieved statistical significance. This effect was consistent for
both patients and carers at all stages of the illness "process".
The same result was found when correlations were performed
between age and PAIS domains, none achieved statistical
significance.
Psychosocial Adjustment to Illness Scale
(PAIS): sex differences.
The effect of sex was examined in each of the PAIS domains in
both domains in both patients and their primary carers. There
were no statistically significant differences between males and
females in any of the PAIS domains. This result remained
consistent in both patients and the primary carer in the three
stages of the illness/treatment process. (This included the
PAIS domains and the PAIS "Total" score.)
The impact of the illness and its treatment on
different aspects of patients and carers lives:
questionnaire data.
A series of questions was asked concerning the impact of the
illness and its treatment on different aspects of patients and
their primary cards' lives. These questions formed Part 1 of
the Brief Interview Schedule.
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Questions were posed concerning the main worries of patients
and carers regarding their illness and its treatment. The
results are shown in Table 59 and 60 for the three
management groups.
Table 59
The main worries of patients and carers regarding
their illness (n= 40 subjects in each group).
Main
Worry
First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Not getting better 16 (40) 14(35) 0 (0) 0 (0) 8(20) 9(22.5)
Effect on family 13(32.5) 13(32.5) 8(20) 10(25) 14(35) 15(37.5)
Pain/suffering 6(15) 3(7.5) 0(0) 0(0) 15(37.5) 10(25)
Perm, disabled 0(0) 3(7.5) 0(0) 0(0) 0(0) 0(0)
Death 3(7.5) 4(10) 2(5) 6(15) 2(5) 6(15)
Return of disease 0(0) 0(0) 18(45) 18(45) 0(0) 0(0)
None 2(5) 3(7.5) 12(30) 6(15) 1(2.5) 0(0)
The results shown in Table 59 show a remarkable similarity
between the worries of the patient and the carer regarding the
illness. There is a statistically significant change in the nature
of concerns across the group of both patients (X2=69.74; df=12;
p<0.001) and carers (X2= 63.03; df=12; p<0.001). The first line
and palliative therapy groups are predominantly concerned
with the patient "not getting better", "the effect of the illness
on the family" and "pain and suffering". The follow up group
who are not receiving treatment and have fewer symptoms
and side effects and a better performance status are
concerned predominantly with return of the disease, effects on
the family or have no concerns at all.
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Table 60
Main worries of patients and their carers about
treatment (n= 40 subjects in each group).
Main First Line Follow up Palli ati ve
Worry Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Side effects 24(60) 16(40) 2(5) 5(12.5) 6(15) 3(7.5)
Non control of 5(12.5) 5(12.5) 6(15) 6(15) 12(30) 23(57.5)
symptoms.
Treat, ineffective 3(7.5) 7(17.5) 2(5) 9(22.5) 12(30) 7(17.5)
Pain /suffering 4(10) 6(15) 2(5) 6(15) 6(15) 5(12.5)
Effect of lifestyle 0(0) 4(10) 0(0) 5(12.5) 0(0) 0(0)
Req. more treat. 0(0) 0(0) 10(25) 3(7.5) 3(7.5) 0(0)
None 4(10) 2(5) 18(45) 6(15) 1(2.5) 2(5)
(Treat. ineffective= treatment ineffective at shrinking tumour
Req. more treat.= requiring more treatment)
Table 60 shows the main worries of patients and carers
regarding the treatment. There is a statistically significant
difference across the groups of patients (X2 = 75.83; df=
12;p<0.001) and carers (X2= 44.64; df= 12; p<0.001). In the
first line group the patients are more concerned with side
effects of their treatment than carers. In the follow up group
the majority of patients say they do not have any worries
regarding treatment whereas the carers tend to be distributed
across a range of concerns. In the palliative therapy group,
carers are predominantly concerned with the treatment not
controlling the patients symptoms (57.5 per cent) whereas 60
per cent of patients are divided between the treatment not
controlling their symptoms and the treatment being
ineffective in shrinking their tumour.
Patients and their carers were also asked about their hopes
and expectations of treatment and the aims of treatment. The
responses to these questions are shown in Tables 61 and 62.
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Table 61
The hopes and expectations of treatment of patients




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n( %) n(%) n(%)
Relieve
symptoms
3(7.5) 1(2.5) 6(15) 3(7.5) 9(22.5) 25(62.5)
Long term
control





16(40) 7(17.5) 3(7.5) 3(7.5) 13(32.5) 1(2.5)
Cure disease 3(7.5) 6(15) 1(2.5) 12(30) 5(12.5) 1(2.5)
Don't know 0(0) 0(0) 5(12.5) 3(7.5) 0(0) 0(0)
Chi square analysis shows a significant change between groups
of patients (X2= 28.25; df= 8; p<0.001) and carers (X2= 61.74;
df=8; p<0.001). These results indicate that in the first line
group, patients are divided in their requirements of treatment
between long term control of the disease and a combination of
symptom control and long term control. The majority of carers,
on the other hand, require long term control of the illness. In
the follow up group, however, the majority of patients require
long term control as do the carers. In this latter group it is
noticeable that 12 (30 per cent) of the carers said that they
required "cure" of the disease as a treatment requirement. In
the palliative group, the majority of carers require treatment
to relieve symptoms (62.5 per cent) although about a third
still require long term control. The patients, on the other hand,
are distributed between the relief of symptoms (22.5 per
cent), long term control (32.5 per cent) and a combination of
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the two (32.5 per cent). Interestingly in this group five
patients (12.5 per cent) still require cure of the disease.
Table 62
The patients and their primary carers' perceptions of
the aims of treatment.(n= 40 subjects in each group)
Perception of First Line Follow up Palliative
Treatment Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Control disease 27(67.5) 32(80) 3(7.5) 4(10) 12(30) 5(12.5)
Cure disease 9(22.5) 6(15) 0(0) 0(0) 14(35) 5(12.5)
Monitor 0(0) 0(0) 35(87.5) 32(80) 0(0) 0(0)
progress
Relieve 0(0) 0(0) 0(0) 0(0) 10(25) 21(52.5)
symptoms
Don't know 4(10) 2(5) 2(5) 4(10) 4(10) 9(22.5)
Chi square analysis across the three groups of patients
(X2=125.38; df=10; p<0.001) and carers (X2=155.65; df=10;
p<0.001) reveals statistically significant differences. The
majority of patients and their carers in the first line
management group understood that the aim of treatment was
to control the disease. A significant number of both patients
and carers in this group, however, report that the aim of
treatment is to cure the disease. In the follow up group the
majority of both patients and their carers reported that the
aim of treatment was to monitor progress and that this
involved a policy of "watch and wait". In the palliative therapy
group the majority of carers understood that the aim of
treatment was to relieve symptoms and a quarter of the
patients understood this to be the aim of treatment. A
significant number of carers, however, thought that the aim of
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treatment at this stage was to control the disease (12.5 per
cent), 22.5 per cent did not know the aim of treatment and
12.5 per cent believed that the aim was to cure the illness. In
the patient group, 30 per cent thought that the aim of
treatment at this stage (palliative therapy) was to control the
disease and 35 per cent that the aim was "cure". The scores
for anxiety and depression of those patients and carers who
thought the aim of palliative therapy was to cure the disease
were compared with those who believed the aim of treatment
was to control it or relieve symptoms. There was no
statistically significant difference between them (Tables 63
and 64).
Table 63
Analysis of variance of patients HAD anxiety and
depression scores and aim of treatment: means,







(n = 1 2) (n = 1 0) (n=14)
Anxiety 7.33(3.34) 5.30(3.30) 6.79(5.26) 0.68 N.S.
Depression 3.17(3.82) 4.60(3.66) 4.14(3.41) 0.56 N.S.
Table 64
Analysis of variance (non-parametric) of carers' HAD
anxiety and depression scores and aim of treatment:









IT)IIe (n = 21 (n = 5)
Anxiety 14.00 12.00 14.00 0.723 N.S.
Depression 4.00 4.00 3.00 0.435 N.S.
(adj= adjusted H value)
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Those patients and relatives, therefore, who believed that the
aim of treatment during palliative therapy was "cure" did not
display significantly different scores for anxiety and
depression. Thus, if this belief is regarded as the coping style
"denial" if does not appear to be associated with elevated or
reduced levels of distress. There is however, no firm evidence
that this is denial.
Patients and carers were invited to comment on the amount of
time that they gave to thinking about the illness (Table 65).
Table 65
The amount of time spent thinking about the illness
(n=40 subjects in each group).
Time
First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
On mind all time 4(10) 18(45) 10(25) 26(65) 13(32.5) 23(57.5)
Sometimes on
mind
20(50) 11(27.5) 21(52.5) 6(15) 11(27.5) 12(30)
Try not to think
about it
15(37.5) 10(25) 4(10) 3(7.5) 5(12.5) 3(7.5)
Don't think about
i t
1(2.5) 1(2.5) 5(12.5) 5(12.5) 11(27.5) 2(5)
Chi square analysis between the three groups of patients
reveals that there is statistically significant difference
between them (X2= 26.36; df =6; pcO.OOl). There is, likewise, a
statistically significant difference between the three groups of
carers (X2=12.98; df =6; p<0.05). The carers in the three groups
are also more likely than the patients to be thinking about the
illness all the time (X2=17.55; df=2; p<0.001).
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Talking about the illness was investigated in a similar fashion
(Table 66).
Table 66
Attitudes of patients and carers to talking about their
illness (n=40 subjects in each group).
Attitude
First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n( %) n(%) n(%)
Talk about illness
openly
12(30) 15(37.5) 18(45) 11(27.5) 10(25) 15(37.5)
Selected people at
selected times
20(50) 14(35) 10(25) 17(42.5) 12(30) 20(50)
Only if asked 3(7.5) 7(17.5) i 5(12.5) 9(22.5) 9(22.5) 2(5)
Avoid the subject 5(12.5) 4(10) 7(17.5) 3(7.5) 9(22.5) 3(7.5)
Chi square analysis across the three groups of patients and the
three groups of carers reveals that there is no statistically
significant difference in each case. Thus, this suggests that the
stage of the illness does not effect the willingness to talk about
it.
When asked to identify the person who most helped them
cope with difficulties relating to the illness and its treatment,
some interesting differences were highlighted (Table 67).
278
Table 67
The person who has helped patients and carers cope
with difficulties arising from the illness and its
treatment (n= 40 subjects in each group), (see question 9, p477
and question 9, p483.)
Person First Line Follow up Palli ati ve
Patient Carer Patient Carer Patient Carer
Doctor 3 4 1 3 0 0
Nurse 3 3 2 14 0 0
Other Patient 0 0 1 16 9 0
Spouse 16 1 3 27 5 23 10
Relative 8 2 3 2 6 19
Friend 7 15 6 1 2 1 1
Minister 3 3 0 0 0 0
Both patients and their primary carers identify each other
(spouse) as being the person who has helped them cope. This
is consistent across the groups. In the follow up groups of
carers, however, they identify other patients and nurses as
being the person who has helped them most. Further
questioning of this group revealed that as they perceived the
"patient" to be physically well, they felt that they could not
burden them with their fears and worries and therefore
tended to turn elsewhere for support. The carers of patients
receiving palliative therapy described relatives and friends as
being the people who helped them most. This is not surprising
given that the patients are physically quite unwell at this time
although 25 per cent of carers still describe the "patient" as
being the person who has helped them most.
The majority of patients and carers felt that they knew people
who could give them support if they needed it. This was
consistent, irrespective of the stage of the illness. Very few
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people responded that they did not know anyone who could
give them help and support (Table 68).(See question vi, p478 and
question VI, p484.)
Table 68
People identified by patients and carers as able to




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n (%) n(%) n(%) n(%) n(%)
No support 1(2.5) 2(5) 4(10) 5(12.5) 7(17.5) 3(7.5)
Friends 10(25) 12(30) 5(12.5) 6(15) 10(25) 10(25)
Relatives 15(37.5) 12(30) 17(42.5) 15(37.5) 10(25) 12(30)
Friends&rels. 4(10) 14(35) 14(35) 14(35) 13(32.5) 15(37.5)
(rels= relatives)
Chi square analysis between the three groups of patients
reveals a statistically significant difference (X2=13.00; df=6;
p<0.05) but this fails to achieve statistical significance across
the three groups of carers (X2=3.90; df=6 ).
When asked who or what patients and carers perceived as
their main social support a significant number in the three
groups identified the church (Table 69). This is further
supported by a previous question regarding the importance of
religious beliefs to patients and carers. In the first line group,
30 patients and 28 carers said that religious beliefs were
important (75 per cent, and 70 per cent). In the follow up
group, 25 patients and 28 carers (62.5 per cent and 70 per
cent) answered in the same way and in the palliative group 20
patients and 22 carers (50 per cent and 55 per cent) felt
religious beliefs to be important.
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Table 69
Main social supports identified by patients and their




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Spouse 11(27.5) 21(52.5) 4(10) 5(12.5) 7(17.5) 3(7.5)
Family 12(30) 6(15) 5(12.5) 6(15) 10(25) 10(25)
Friend 11(27.5) 7(17.5) 17(42.5) 15(37.5) 10(25) 12(30)
Church 6(15) 6(15) 14(35) 14(35) 13(32.5) 15(37.5)
Chi square analysis reveals no statistically significant
difference between the responses of the three groups of
patients (X2=11.92; df=6) but a significant difference between
the groups of carers (X2=28.65; df=6; p<0.001).
Patients and carers were pressed further on the issue of
emotional support and were asked if in the past they had
they
a particular person with whom A shared their worries and
problems (Table 70).
Table 70
Individuals with whom patients and carers have
shared worries and problems in the past (n=40




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
No one 0(0) 0(0) 8(20) 1(2.5) 8(20) 5(12.5)
Friend 9(22.5) 3(7.5) 13(32.5) 9(22.5) 10(25) 16(40)
Spouse 26(65) 29(72.5) 18(45) 24(60) 19(47.5) 18(45)
Relative 4(10) 5(12.5) 1(2.5) 5(12.5) 3(7.5) 1(2.5)
Parent 1(2.5) 3(7.5) 0(0) 1(2.5) 0(0) 0(0)
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One particularly striking aspect of the data from Table 70 is
the importance of the spouse as a confidant. The majority of
patients and carers report that the person with whom they
shared their worries and problems in the past is the spouse. In
a life-threatening illness such as cancer where the patient or
carer is one's usual confidant, this sharing of fears and
worries may be compromised so as not to cause distress to the
other. At this time the emotional support from family and
friends becomes important and, as described previously, most
patients and carers report that they have access to such
support (Table 68).
A series of questions was posed regarding perceived changes
in the relationship between carer and patient, the amount of
communication between them and the effect of the illness and
its treatment on the family as a whole.
The majority of patients and carers felt that the relationship
between them was closer since the diagnosis and that
communication between them had increased. On the other
hand, a significant number of patients and carers perceived
that they had become more distant and that communication
between had decreased. These latter effects were always
reported accompanied by some distress on the part of the
respondent. (Table 71 and 72).
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Table 71
Perceived changes in the relationship between




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Closer 25(62.5) 25(62.5) 19(47.5) 24(60) 27(67.5) 28(70)
More distant 9(22.5) 8(20) 0(0) 9(22.5) 3(7.5) 0(0)
No change 6(15) 7(17.5) 21(52.5) 7(17.5) 10(25) 12(30)
Chi square analysis reveals a statistically significant difference
between the three groups of patients (X2=21.75; df=4; p<0.001)
and between the three groups of carers (X2 = 10.85; df=4;
p<0.05).
Table 72
Perceived changes in communication between patient




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
More 25(62.5) 25(62.5) 18(45) 24(60) 25(62.5) 23(57.5)
Less 9(22.5) 7(17.5) 1(2.5) 10(25) 7(17.5) 0(0)
No change 6(15) 8(20) 21(52.5) 6(15) 8(20) 17(42.5)
Chi square analysis reveals a statistically significant difference
between the three groups of patients (X2 = 18.93; df= 4;
p<0.001) and between the three groups of carers (X2= 16.02;
df=4; p<0.01).
The two tables 71 and 72 describe the perceptions of patients
and carers across the groups with respect to the relationship
and communication change. It is interesting to note, for
example, that in the follow up group of patients only one
respondent indicates that the relationship and communication
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are negatively affected, presumably because the patient is
relatively well at this time.
Carers' perceptions differ at this time as 22.5 per cent and 25
per cent perceived that there are negative consequences of the
illness. The carers in the palliative group, however, perceive
that there are no adverse consequences of the illness and its
treatment on the relationship and communication
In assessing the impact of the disease and its treatment on the
family as a whole, a range of responses were given (Table 73).
Table 73
The perceived impact of the illness on the entire





First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
Brought closer 14(35) 5(12.5) 6(15) 10(25) 4(10) 3(7.5)
Caused
distress
10(25) 15(37.5) 6(15) 5(12.5) 22(55) 21(52.5)
Appreciation
of other person
15(37.5) 20(50) 13(32.5) 16(40) 14(35) 12(30)
Pushed further
apart
1(2.5) 0(0) 2(5) 2(5) 0(0) 4(10)
No effect 0(0) 0(0) 13(32.5) 7(17.5) 0(0) 0(0)
The commonest responses of both patients and carers are that
the illness has either brought the family closer together,
caused emotional distress in the family or made them
appreciate the other person and not take them forgranted. Not
surprisingly, the majority of patients and carers in the
palliative group perceive that the illness has caused significant
emotional distress in the family.
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The final series of questions from the brief interview schedule
relate to the perceived changes outside the home with friends
and relatives, the effect on leisure activities and the carers'
perceptions of their role in the treatment of the illness.
Most patients and carers felt that since the illness had been
diagnosed interaction outside the home with friends and
relatives had either decreased or that there was no change
(Tables 74 and 75). There were certain deviations from this
pattern in that those patients and carers in the follow up
group were more likely to report an increase in interaction
outside the home. Similarly, carers in the first line treatment
group were more likely to report an increase in social
interaction outside the home with relatives. This is probably
due to the fact that the patient had been in hospital sometimes
for several days at a time receiving chemotherapy and
relatives had increased their level of support and contact with
the carer.
Table 74
Perceived changes in social interaction outside the




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n (%) n(%) n(%) n(%)
No change 19(47.5)17(42.5) 18(45) 12(30) 15(37.5) 12(30)
Increase 4(10) 4(10) 11(27.5) 9(22.5) 2(5) 3(7.5)
Decrease 17(42.5) 19(47.5) 11(27.5) 19(47.5) 23(57.5) 25(62.5)
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Chi square analysis across the three groups of patients reveals
a significant difference between them (X2=12.62; df=4; p<0.02).
The same analysis across the three groups of carers , however,
does not achieve statistical significance (X2=6.24; df=4).
Table 75
Perceived changes in social interaction outside the




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
No change 14(35) 10(25) 18(45) 12(30) 13(32.5) 15(37.5)
Increase 5(12.5) 17(42.5) 6(15) 14(35) 0(0) 3(7.5)
Decrease 21(52.5) 13(32.5) 16(40) 14(35) 27(67.5) 22(55)
Chi square analysis reveals that there is no statistically
significant difference between the three groups of patients
(X2=9.41; df=4), whereas the same statistical analysis between
the three groups of carers does achieve statistical significance
(X2=13.59; df=4; p<0.02).
The analysis of the data from Tables 74 and 75 suggests that
the illness and its treatment has a significant impact on
patients' interaction with friends outside the home but not
with relatives. The effect on carers is that there is a significant
effect on social interaction with relatives but not with friends.
The patients tend to decrease interaction with friends
throughout the illness and carers to increase their interaction
with relatives through the course of the illness.
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Patients report a significant change through the illness in
leisure interests and activities (Table 76) (X2 = 12.66; df=4;
p<0.02). Carers, however, do not report a significant change
(X2=5.46; df=4 ). The majority of carers in all three groups
report a decrease in the time that they have given to their
leisure activities.
Table 76
Perceived changes in leisure activities of patients and




First Line Follow up Palliative
Patient Carer Patient Carer Patient Carer
n(%) n(%) n(%) n(%) n(%) n(%)
No change 11(27.5) 11(27.5) 19(47.5) 12(30) 21(52.5) 8(20)
Increase 29(72.5) 29(72.5) 18(45) 26(65) 19(47.5) 32(80)
Decrease 0(0) 0(0) 3(7.5) 2(5) 0(0) 0(0)
The majority of both patients and carers report either no
change in their leisure activities or a decrease, very few report
an increase. The only group where patients and carers
reported any increase was in the follow up group.
Only the primary carer was asked how they perceived their
role in the treatment of the disease (Table 77).
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Table 77
The primary carers perception of their role in the
treatment of the disease (n= 40 subjects in each
group).
Role First Line Follow up Palliative
n (%) n (%) n (%)
No role 0 (0) 1 (2.5) 3 (7.5)





12 (30) 12 (30) 17 (42.5)
Help fight
disease
22 (55) 18 (45) 5 (12.5)
Chi square analysis reveals a statistically significant difference
between the three groups (X2=19.45; df=6; p<0.01). There is a
clear change in the perception of the carers role across the
three groups. In the first line group and the follow up group
the majority of carers report their role to be to help the
patient fight the disease. In the palliative group, however, the
carers are divided between supporting the patient and helping
them come to terms with the illness. Interestingly, very few
carers feel that they have no role to play in the illness.
The data from the brief interview schedule augments data
from some of the other assessment tools used e.g. the
Psychological Adjustment to Illness Scale. This data aids the
understanding of the impact of the illness and its treatment on
the lives of patients and their carers.
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Variables contributing to anxiety and
depression scores in patients and their primary
carers
First line management group
The variables contributing to anxiety and depression in
patients and their carers were further examined using an
automated stepwise multiple regression analysis, with alpha to
enter at the 0.05 level of significance and alpha to remove
0.1 [Dillon and Goldstein, 1984]. All the variables assessed
were entered including data from the brief interview schedule
(coding the latter as dummy variables, as described by
Armitage and Berry, 1987). The dependent variables for
patients receiving first line chemotherapy were anxiety and
depression scores from the Hospital Anxiety and Depression
Scale. Four variables emerged from this analysis as
contributing to the patients' anxiety score (Table 78).
Table 78
Stepwise multiple regression analysis using patients'









.398 .450 .203 .203
2 Had (dep):
carer
.441 .598 .155 .358
3 Performanc
e Status




.340 .714 .064 .510
(P.S.S.= Perceived Social Support)
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The four variables significantly associated with anxiety in the
patient were the HAD anxiety and depression scores of the
carer, the performance status of the patient, and the carers'
perceived social support from friends. These four variables
explained 51 per cent of the variance of the independent
variable and in combination produced a significant association
(F=9.11; df=4, 35; p<0.001). High levels of distress in the carer,
poorer performance status and higher perceived social support
from friends on the part of the carer were associated with
elevated anxiety levels in the patient.
An automated stepwise procedure using the same levels of
inclusion and exclusion was performed using the patients' HAD
depression score as the dependent variable (Table 79),
Table 79
Stepwise multiple regression analysis using patients'









.284 .414 .172 .172
In the latter analysis only the carers' HAD anxiety score
emerged as contributing significantly to the patients' HAD
depression score (F=7.88; df=l, 38; p<0.01). This single
variable, however, only explains 17.20 per cent of the
variance of the patients' depression score.
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Automated stepwise regression analysis was then utilised to
examine the contribution of variables to HAD anxiety and
depression scores in the carers (Table 80 and 81).
Table 80
Stepwise multiple regression analysis using carers'









.510 .450 .203 .203
2 Performance
Status
.434 .594 .150 .353
3 P.S.S. from
family(carer)
.355 .659 .081 .434
(P.S.S. = Perceived Social Support)
Table 81
Stepwise multiple regression analysis using carers'










.209 .314 .099 .099
(P.S.S.= perceived social support)
The stepwise analysis of the carers' anxiety score produced
three variables which significantly contributed to it. These
variables were: the HAD anxiety score of the patient; the
performance status; and the carers' perceived level of social
support from the family. These variables in combination
explained 43.40 per cent of the variance of the dependent
variable (F= 9.22; df=3, 36; P<0.001). In examining the
contribution of variables to the carers' HAD depression score,
however, only one emerged, namely the carers' perceived
social support from the family. This single variable was only
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able to explain 9.90 per cent of the variance of the dependent
variable (F= 4.15; df = 1, 38; p<0.05).
Clearly, in examining the combined contribution of variables to
the anxiety and depression scores of patients and their carers
several factors emerge. The psychological state of the
"significant other" (patient or carer), the patients' performance
status, and the carers' perceived emotional social support
emerge in explaining the relevant dependent variable,
particularly patient anxiety and anxiety in the carer. The
variables which contribute to distress are similar in both
patient and carer.
Follow up surveillance
The same automated stepwise regression analysis was
performed on the HAD anxiety and depression scores of
patients in the follow up group (Table 82 and 83).
Table 82
Stepwise multiple regression analysis using patients'









.357 .375 .141 .141
2 PAIS(Total)
rpatient
.394 .523 .133 .274
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Table 83
Stepwise multiple regression analysis using the HAD










.224 .427 .237 .237
2 Severity of
symptoms
.379 .589 .110 .347
3 HAD (anx):
carer
.3 24 .644 .068 .415
4 Number of
symptoms
.336 .694 .066 .48 1
The stepwise analysis of the patients' anxiety score produced
two emergent variables which produced
a significant combined association.
These variables were the HAD anxiety score of the carer and
the total score of the patient on the Psychological Adjustment
to Illness Scale (PAIS). These two variables explained 27.4 per
cent of the variance of the dependent variable ( F = 6.98; df
=2, 37; p< 0.01).
The stepwise regression analysis of the patients' depression
score produced four variables explaining 48.1 per cent of the
variance of the dependent variable (F= 8.12; df=4, 35;
p<0.001). The four variables were the patients' total score on
the PAIS, the number of symptoms and severity of these
symptoms, and the HAD anxiety score of the carer.
An automated stepwise regression analysis was then
performed on the HAD anxiety and depression scores of the
ftt.w i < I <l> u •




Stepwise multiple regression analysis using the HAD









.142 .431 .186 .186
2 HAD (anx):
patient
.389 .556 .123 .309
3 Extraversion:
carer




.416 .712 .103 .507
5 Severity of
symptoms
.373 .759 .069 .576
(P.S.S.= Perceived Social Support)
Table 85
Stepwise multiple regression analysis using the HAD











.271 .472 .223 .223
(P.S.S.= Perceived Social Support)
The stepwise regression analysis of the carers' HAD anxiety
score produces five variables that contribute significantly in
combination (F=9.22; df= 5, 34; p<0.001). The five variables are
the carers' total score on the PAIS, the HAD anxiety score of
the patient, the Eysenck Personality Inventory (EPI)
extraversion score of the carer (negative beta indicates lower
scores i.e. introversion), the patients' perceived social support
from friends and the severity of the patients' symptoms.
These five variables account for 57.6 per cent of the variance
of the dependent variable.
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The stepwise regression analysis of the carers' HAD depression
score, on the other hand, only produces a single variable which
contributes significantly (F=10.89; df=l, 38; p<0.01). The single
variable is the patients' perceived social support from friends
and this explains 22.3 per cent of the variance of the
dependent variable.
Once again in explaining the variance associated with distress
in patients and their carers the presence of anxiety or
depression in the other assumes importance. For the patient
the number of symptoms and their severity are implicated
along with the global adjustment to illness. In the case of the
carer, however, symptom severity, aspects of their own
personality and the presence of social support from friends
may contribute to the distress.
Palliative therapy group
Finally, the HAD anxiety scores of the patients were subjected
to a stepwise multiple regression analysis. The results of this
analysis are shown in Table 86.
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Table 86
Stepwise multiple regression analysis using patient









-.731 -.390 .152 .152
2 HAD (anx):
carer
.353 .5 07 .105 .257
3 Performance
Status
.368 .598 .101 .358
4 P.S.S. from
friends:patient
.456 .701 .133 .491
5 P.S.S.from
family :patient
.429 .765 .094 .585
6 Number of
symptoms
.405 .808 .068 .653
7 Age of patient -.357 -.835 .044 .697
(P.S.S.= Perceived Social Support)
A stepwise multiple regression analysis using the patients'
HAD depression score was also performed. In this analysis no
variables were able to be entered as the amount of variance
explained by each alone or in combination was not sufficient
to achieve statistical significance.
The stepwise analysis using the patients' anxiety score as the
dependent variable revealed seven variables. These variables
in combination accounted for 69.7 per cent of the variance of
the patients' anxiety score (F= 10.53; df=7, 32; p<0.001). The
seven variables included the extraversion score of the carer
from the EPI (negative Beta value indicates lower scores i.e.
introversion), the HAD anxiety subscale, the patients'
performance status, the patients' perceived social support
from family and friends, the number of symptoms reported by
the patient and the age of the patient (negative Beta value
indicates younger patients). Again, the psychological state of
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the carer plays a significant role in contributing to the
psychological state of the patient.
The HAD anxiety and depression scores of the carer were also
subjected " ^ to a stepwise
multiple regression analysis (Tables 87 and 88).
Table 87
Stepwise multiple regression analysis using the HAD









.205 .429 .184 .184
Table 88
Stepwise multiple regression analysis using the HAD










.266 .337 .114 .114
2 PAIS(Total):
patient
.344 .468 .105 .219
3 Neuroticism:
carer
.321 .547 .080 .299
(P.S.S.= Perceived Social Support)
The stepwise analysis of the carers' anxiety scores shows that
only one variable emerges, explaining 18.4 per cent of the
variance. This single variable is the PAIS total score of the
carer (F=8.55; df=l, 38; p<0.01).
The stepwise analysis of the carers' depression score? however,
produced three variables explaining 29.9 per cent of the
variance. These three variables included the patients'
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perceived social support from friends, the PAIS score total
from the patient and the carers' neuroticism score from the
EPI (F=5.13; df=3, 36; p<0.01).
Conclusions from stepwise multiple regression
analysis in the three groups of patients and
their carers.
The stepwise regression analysis across the three groups of
patients and their carers demonstrates a number of important
factors. In the analysis of the patients' HAD anxiety score, the
carers' psychological state makes an important contribution. In
the first line group of patients, the carers' anxiety and
depression score account for 20.3 per cent and 15.5 per cent of
the variance respectively. In this group, performance status
accounts for 8.8 per cent and the carers' perceived social
support from friends account for 6.4 per cent.
In the follow up surveillance group of patients the anxiety of
the carer accounts for 14.1 per cent of the variance and the
patients' total score of the PAIS scale accounts for 13.3 per
cent. This latter variable represents the global impact of the
illness and its treatment on the patients' life. In this analysis, a
higher score is associated with higher levels of anxiety.
Interestingly, in this group physical symptoms and social
support fail to achieve statistical significance and thus are not
entered into the regression analysis.
In the group of patients receiving palliative therapy (anxiety
score) the carers' anxiety score contributes 10.5 per cent.
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Performance status contributes 10.1 per cent and the number
of symptoms 6.8 per cent. The patients' perceived social
support from friends and from family contribute 13.3 per cent
and 9.4 per cent. In addition, however, aspects of the carers'
personality (lower extraversion score) contribute 15.2 per cent
and the patients' age 4.4 per cent. One hypothesis regarding
the contribution of the carers' personality type to the patients'
anxiety is that the more introverted carers (i.e. those with the
lower extraversion scores) may show their distress more than
those who are extraverted and therefore are able to disguise
their distress. The more introverted carers therefore may
appear to be more anxious and/or depressed which in turn
effects the patient.
These combinations of variables account for 51 per cent of the
variance of the patients' anxiety score in the first line group
and almost 70 per cent in the palliative group (69.7 per cent).
In the follow up group, however, they account for less than a
third (27.4 per cent) and may, therefore, be considerably less
important.
The carers' anxiety score, when subjected to the same analysis,
reveals different clusters of variables. In the first line group
the variables contributing to the anxiety score are similar to
those of the patient. The patients' anxiety accounts for 20.3
per cent of the variance, performance status 15 per cent and
the carers' perceived social support from family 8.1 per cent.
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In the follow up group (of carers) a completely different
picture to that of the patient emerges. The carers' total score
on the PAIS accounts for 18.6 per cent and the patients'
anxiety score 12.3 per cent. These are similar to those found in
the patient group at the same stage of treatment. In addition,
however, the carers' own extraversion score (lower score is
equivalent to introversion) accounts for 9.5 per cent, their
perceived social support from friends accounts for 10.3 per
cent and the severity of symptoms 6.9 per cent of the
variance. These results suggest that the relationship of a
number of variables to dependent variables such as anxiety
may be complex and that trait and state factors in both
patients and carers such as aspects of personality,
symptomatology and social support may interact with a
number of other factors to explain anxiety.
In the palliative therapy group of carers only one factor, the
carers' PAIS total score, emerged, explaining 18.4 per cent of
the variance. This is in contrast to the cluster of variables
found in the patient group. The PAIS total score reflects the
fact that those carers whose lives are the most severely
affected experience the greatest anxiety. This one variable,
however, only accounts for 18.4 per cent of the variance
compared to the cluster of variables in the other two groups
where they account for 43.4 per cent in the first line group
and 57.6 per cent in the follow up group.
This series of analyses demonstrate the importance of the
psychological state of the significant other, physical symptoms
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and performance status, social support from family and
friends, the impact of the illness on lifestyle and specific
personality factors.
When the depression scores of patients and their carers are
used as the dependent variable a different set of variables
emerge although the variance in this case is not explained so
satisfactorily using stepwise multiple regression analysis. In
the first line group of patients only 17.2 per cent of the
variance is satisfactorily explained by a single variable: the
anxiety score of the carer. In the first line group of carers only
9.9 per cent of the variance is explained by a single variable:
the carers' perceived social support from family. The variance
explained in these two groups is so small as to be of very little
significance.
In the follow up group of patients 48.1 per cent of the
variance is explained by four variables: the patients' PAIS
total score (23.7 per cent); the number of symptoms (6.6 per
cent); the severity of the symptoms (11 per cent); and the
anxiety of the carer (6.8 per cent). This is a more significant
explanation of the variance in this group. In the carers' group
only 22.3 per cent of the variance is explained by a single
variable, the patients' perceived social support from friends.
In the palliative therapy group of patients, no variables were
entered into the stepwise analysis as none of the partial
correlations achieved the required level of significance for
inclusion. An option to overcome this would have been to
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"force" variables into the equation but this would only have
explained extremely small amounts of the variance and would,
therefore, have had very little importance. In the group of
carers, however, 29.9 per cent of the variance was explained
by the patients' perceived social support from friends (11.4
per cent), the patients' PAIS total score (10.5 per cent) and the
carers' neuroticism score (8.0 per cent). These stepwise
analyses again demonstrate the importance of variables
related to "significant other" in the explanation of patients' or
carers' psychological state. The results show that the anxiety
scores are explained more successfully than those of
depression.
Stepwise multiple regression analysis and the
carers' General Health Questionnaire Score
(GHQ).
An additional measure of distress in the carer that was
collected was the General Health Questionnaire (GHQ) score.
As described earlier, this is a global measure of distress
covering four subscales. An automated stepwise regression
analysis was carried out using this score as the dependent
variable in all three groups of carers (Tables 89, 90, and 91).
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Table 89
Stepwise multiple regression analysis using the










.643 .488 .238 .238
2 Extraversion:
carer
-.391 -.596 .117 .355
Table 90
Stepwise multiple regression analysis using the










.117 .604 .365 .365
2 Age: carer -.342 -.663 .074 .439
Table 91
Stepwise multiple regression analysis using the










.293 .418 .175 .175
2 PAIS(Total):
carer
.428 .57 1 .151 .3 26
The stepwise analysis of the first line group reveals that two
variables emerge explaining 35.5 per cent of the variance. The
two variables are the HAD depression score of the patient
which explains 23.8 per cent of the variance and the
extraversion score (the negative Beta value indicates that it is
introversion) of the carer from the EPI which explains 11.7
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per cent of the variance (F= 10.17; df=2, 37; p<0.001). This
suggests that those carers who tend to be less extraverted but
look after patients who are more depressed tend to be more
distressed.
In contrast, the stepwise analysis of the follow up group
revealed two different variables explaining 43.9 per cent of
the variance. The two variable are the PAIS (total) score of the
carer which explains 36.5 per cent of the variance and the
(younger) age of the carer which explains 7.4 per cent (F=
10.17; df= 2, 37; p<0.001). This suggests that those carers who
have higher PAIS total scores but who are younger (Beta value
= -.342) have a higher level of distress.
The palliative therapy group present a different picture again.
Two variables emerge explaining 32.6 per cent of the variance.
These two variables are the HAD anxiety score of the patient
which explains 17.5 per cent of the variance and the PAIS
total score of the carer which explains 15.1 per cent (F=9.95;
df= 2, 37; p<0.001).
In explaining the GHQ score, the psychological state of the
significant other, the PAIS score of the carer, age of the carer
and specific personality characteristics of the carer are
implicated. The perceived social support from family and
friends of patients and carers and the number and severity of
patients' symptoms fail to contribute significantly to the
regression analysis. Clearly, therefore the HAD scale and the
GHQ are not assessing exactly the same phenomenon but
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represent different aspects of distress explained by different
variables. The contribution of the "significant others'"
psychological state is implicated in the explanation of both
scales.
Reduction of the data: factor analysis
The present study has examined a large number of variables
in three groups of patients with lung cancer and their carers.
One way of reducing these data sets and therefore exploring
the possible underlying structure and interrelationships
between variables is to embark on a factor analysis [Child,
1990].
The variables for each group of patients and their carers were
subjected to a factor analysis and the optimum explanation of
the variance obtained.0111^ the standardised questionnaire data were entered
into the factor analysis and certain., demographic data. The Brief Interview
Schedule data were not included due to its descriptive nature and due to thi
lack of indeoendent validation of it.«... ,Faciui analysis: urst line group of patients and carers
The data from the first line group of patients and carers are
shown in Table 92 and 93. The number of factors was
restricted to those factors having an eigenvalue of one or
greater than one. The data ars shown as an unrotated factor
matrix (Table 92) and then are. subjected to an orthogonal,
varimax rotation thus producing factors which are
independent of each other (Table 93).
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Table 92
Unrotated factor matrix of variables associated with
the first line management group, including
eigenvalues and the percentage of variance explained
by each.
Factor Factor Factor Factor Factor Factor Factor
Variable 1 2 3 4 5 6 7
Patients' age -0.26 0.15 0.65 0.22 0.31 0.01 -0.39
Carers' age -0.32 0.61 0.75 0.19 0.20 -0.06 -0.33
Anx(patient) 0.51 -0.15 0.07 0.57 -0.44 -0.14 0.09
Anx (carer) 0.64 -0.52 0.09 0.20 0.18 0.30 0.11
Dep (patient) 0.55 -0.27 0.21 0.45 -0.44 -0.13 -0.08
Dep (carer) 0.55 -0.20 0.17 -0.17 0.24 0.62 0.03
Family Supp.
(patient)
0.57 0.34 0.23 0.29 0.32 -0.21 0.12
Family Supp.
(carer)
0.64 -0.11 -0.13 0.12 0.40 -0.10 -0.18
Friends Supp
(patient)
0.35 0.54 0.02 0.07 0.31 | -0.48 0.17
Friends
Supp. (carer)
0.54 0.20 0.15 0.03 -0.08 -0.10 0.01
Symptom
number
0.25 0.87 -0.03 -0.07 -0.04 0.17 0.22
Symptom
severity
0.12 0.90 0.03 -0.05 -0.06 0.21 0.15
PAIS(Total)
(Patient)
-0.39 -0.22 0.13 0.63 0.03 0.18 0.34
PAIS(Total)
(Carer)
0.21 0.08 0.42 -0.27 -0.17 0.37 0.16
Extraversion
(Patient)
-0.11 0.33 -0.51 0.52 0.02 0.34 -0.18
Neuroticism
(Patient)
0.37 0.11 0.52 -0.35 -0.21 0.08 -0.36
Extraversion
(Carer)
0.23 -0.09 -0.64 0.11 0.48 0.10 -0.31
Neuroticism
(Carer)
-0.48 0.08 0.40 0.41 0.29 0.15 0.33
Performance
Status
0.12 -0.53 0.21 -0.40 0.35 -0.21 0.46




17.55 15.48 13.22 10.53 7.93 6.64 6.10
Total variance explained = 77.45 per cent
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Table 93
Varimax rotated factor matrix: first line management
group.
Factor Factor Factor Factor Factor Factor Factor
V ariable 1 2 3 4 5 6 7
Patients' age -.08 -0.00 -0.8 9 -0.20 0.08 -0.00 -0.11
Carers' age -0.01 -0.05 -0.9 0 0.14 -0.01 -0.08 -0.14
Anx(patient) 0.89 -0.02 0.11 -0.05 0.13 0.05 -0.09
Anx (carer) 0.37 -0.29 0.13 0.03 0.17 0.7 8 -0.07
Dep (patient) 0.89 -0.13 -0.02 0.03 0.07 0.13 0.08
Dep (carer) 0.00 0.09 0.01 0.05 0.02 0.91 0.12
FamilySupp.
(patient)
0.26 0.24 -0.15 0.01 0. 75 0.17 -0.03
Family Supp.
(carer)
0.14 -0.23 0.06 -0.22 0.57 0.39 0.23
FriendsSupp.
(patient)
-0.01 0.30 0.01 0.05 0.8 0 -0.21 0.06
Friends
Supp. (carer)
0.34 0.24 0.01 0.09 0.33 0.15 0.24
Symptom
number
-0.07 0.89 0.10 -0.10 0.29 -0.01 0.07
Symptom
severity
-0.10 0.91 -0.02 -0.12 0.19 -0.06 0.04
PAIS(Total)
(Patient)
0.17 -0.12 -0.12 -0.08 -0.17 -0.01 -0.82
PAIS(Total)
(Carer)
0.07 0.37 -0.12 0.37 -0.19 0.39 0.09
Extraversion
(Patient)
0.02 0.23 0.10 -0.82 -0.60 -0.05 -0.23
Neuroticism
(Patient)
0.19 0.22 -0.39 0.29 -0.06 0.24 0.5 8
Extraversion
(Carer)
-0.23 -0.30 0.25 -0.6 6 0.29 0.24 0.15
Neuroticism
(Carer)
-0.14 0.10 -0.41 0.09 -0.00 -0.02 -0.77
Performance
Status
-0.23 -0.42 0.19 0.68 0.22 0.28 -0.10
(Italicised figures = most significant factor loading variables per
factor)
The eigenvalues, percentage of variance explained by each
factor and the cumulative variance for the related factor
matrix are shown in Table 94. The criterion for item selection was those
variables with a loading of 0.6. Table 94 is included to show more clearly
the seven factors, their eigenvalues and the variances they account for. This
table is necessary to interprest accurately Table 93 as it provides the values
resulting from each factor in this latter table. Table 94 can then be _linked
to Table 95 to show how the factors have been named. Table 94 is essential




Factor eigenvalues, percentage of variance explained
by each factor and the cumulative variance for the
rotated factor matrix (first line group).




1 2.16 11.35 11.35
2 2.54 13.35 24.70
3 2.13 11.22 35.92
4 1.93 10.14 46.06
5 2.02 10.66 56.72
6 2.06 10.85 67.57
7 1.88 9.88 77.45
The factor analysis of these variables have produced seven
principle factors accounting for 77.45 per cent of the total
variance. An examination of the rotated factor matrix shows
the factor loadings. Variables loading most highly on factor
one are the HAD anxiety and depression scores of the patient.
This factor, therefore, represents a measure of patient distress.
The two variables loading most highly on factor two are the
number of symptoms and their severity. This factor therefore
represents the symptomatology of the patient. Interestingly,
performance status does not load significantly on this factor.
Factor three is a general age factor as the two variables
loading most highly are age of the patients and age of the
carer. Factor four is a factor represented by the extraversion
scores of the patient and the carer on the EPI, and
performance status. This factor probably represents a measure
of "sociability of the family" as the personality variables of
patient and carer and the physical state of the patient as
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assessed by performance status indicate the potential to
socialise as a family unit.
Factor five represents a general measure of social support as
three of the four social support subscales load on it (perceived
social support from family and friends as perceived by the
patient and social support from family as perceived by the
carer). Factor six represents a measure of carer distress as the
two variables loading on it are the HAD anxiety and
depression of the carer. Factor seven is represented by the
neuroticism scores of the patient and carer (from the EPI) and
the patients' PAIS total score. As neuroticism from the EPI can
be equated with anxiety [McGuire et al., 1963] this may
represent a general measure of adjustment to illness on the
part of the patient.
These seven factors represent a considerable degree of
reduction of redundancy in explaining almost 75 per cent of
the variance of the data from an initial large pool of variables
(Table 95).
Table 95
Factors derived from the rotated factor matrix and
the variance explained: first line management.
Factor Name Variance
explained (%)
1. Patient distress 11.35
2. Symptomatology 13.35
3. Age 11.22
4. Sociability of the family 10.14
5. Perceived social support 10.66
6. Carer distress 10.85




The variables from the follow up surveillance group were then
subjected to the same statistical approach.
Factor analysis: follow up surveillance group
Factor analysis of the variables from the follow up group
revealed a different factor structure. The unrotated and
rotated factor matrices are shown in Tables 96 and 97.
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Table 96
Unrotated factor matrix of variables associated with
the follow up surveillance group, including
eigenvalues and the percentage of variance explained
by each.
Factor Factor Factor Factor Factor Factor Factor Factor
Variable 1 2 3 4 5 6 7 8
Patients' age -0.53 0.11 -0.21 -0.05 0.74 0.04 -0.01 0.07
Carers' age -0.54 -0.10 -0.38 -0.60 0.65 0.02 -0.20 0.07
Anx(patient) 0.33 -0.74 0.25 0.08 0.09 -0.05 0.24 0.17
Anx (carer) 0.55 -0.05 0.25 0.57 0.29 -0.10 -0.21 0.13
Dep (patient) 0.34 -0.76 0.15 -0.12 0.20 -0.10 0.24 0.19
Dep (carer) 0.61 0.32 0.26 0.20 0.10 0.02 -0.31 -0.02
Family Supp.
(patient)
0.67 0.16 -0.22 -0.46 0.09 0.09 -0.20 0.32
Family Supp.
(carer)
0.68 0.24 -0.22 -0.45 0.21 0.10 -0.12 0.32
FriendsSupp.
(patient)
0.67 0.38 0.02 0.00 0.17 0.06 0.22 -0.19
Friends
Supp. (carer)
0.58 0.34 0.13 0.10 0.15 0.26 0.48 -0.17
Symptom
number
-0.30 0.25 0.75 0.11 0.19 0.33 0.06 0.10
Symptom
severity
-0.35 0.32 0.77 0.11 0.12 0.24 -0.09 0.19
PAIS(Total)
(Patient)
0.03 -0.47 0.46 -0.26 0.09 -0.17 0.11 0.25
PAIS(Total)
(Carer)
0.41 0.02 0.07 0.22 0.34 -0.49 -0.19 -0.33
Extraversion
(Patient)
-0.06 0.52 0.24 -0.19 0.06 -0.57 0.28 0.03
Neuroticism
(Patient)
0.13 -0.10 -0.43 0.45 0.09 0.52 0.32 0.10
Extraversion
(Carer)
0.03 -0.31 0.19 -0.41 0.36 0.13 0.15 -0.63
Neuroticism
(Carer)
-0.28 0.49 -0.11 -0.10 0.08 -0.27 0.53 0.26
Performance
Status
-0.04 -0.05 -0.30 0.71 0.08 -0.29 0.12 0.13




19.31 13.77 11.88 9.86 8.11 6.94 6.30 5.75
(Total variance explained = 81.92 per cent)
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Table 97
Varimax rotated factor matrix: follow up surveillance
group.
Factor Factor Factor Factor Factor Factor Factor Factor
Variable 1 2 3 4 5 6 7 8
Patients' age -0.05 -0.10 -0.14 0.06 -0.91 0.14 0.02 0.06
Carers' age -0.09 -0.08 0.07 0.07 -0.9 3 -0.08 -0.14 0.01
Anx(patient) 0.10 0.86 0.07 0.06 0.13 -0.19 0.10 0.00
Anx (carer) 0.7 6 0.23 -0.17 -0.09 0.07 -0.19 0.19 -0.31
Dep (patient) 0.05 0.9 0 0.17 -0.08 0.00 -0.13 0.05 0.09
Dep (carer) 0.62 -0.14 -0.22 -0.37 0.27 -0.10 0.11 -0.06
Family Supp.
(patient)
0.08 0.04 0.18 -0.92 0.09 -0.03 0.05 -0.01
Family Supp.
(carer)
0.11 0.30 0.14 -0.9 4 0.00 0.05 0.16 0.01
FriendsSupp.
(patient)
0.39 -0.10 0.03 -0.40 0.24 0.19 0.5 3 0.19
Friends
Supp. (carer)
0.21 -0.04 -0.04 -0.24 0.23 0.17 0.7 8 0.16
Symptom
number
-0.01 0.01 -0.9 2 0.16 -0.04 0.07 0.20 0.09
Symptom
severity
0.01 -0.06 -0.9 5 0.18 -0.02 0.09 -0.12 -0.03
PAIS(Total)
(Patient)
-0.04 0.69 -0.19 0.03 0.05 0.08 -0.26 0.11
PAIS(Total)
(Carer)
0.80 0.05 0.21 0.02 -0.02 0.11 -0.19 0.13
Extraversion
(Patient)
0.15 -0.10 -0.11 -0.03 0.07 0.84 -0.12 0.04
Neuroticism
(Patient)
-0.14 0.01 0.14 0.07 -0.15 -0.35 0.12 -0.3
Extraversion
(Carer)
0.05 0.22 0.03 0.09 -0.14 -0.08 0.09 0.88
Neuroticism
(Carer)
-0.26 -0.13 -0.04 0.02 -0.18 0.7 7 0.17 -0.19
Performance
Status
0.29 0.03 0.25 0.40 -0.17 0.05 0.21 -0.5 8
(Italicised figures= most significant factor loading variables per
factor)
The eigenvalues and percentage of variance explained by each
factor is shown in Table 98.
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Table 98
Factor eigenvalues, percentage of variance explained
by each factor and the cumulative variance for the
rotated factor matrix (follow up group).
Factor Eigenvalue Percentage of Cumulative
variance variance (%)
1 2.06 10.83 10.83
2 2.22 11.70 22.53
3 2.12 11.18 33.71
4 2.31 12.15 45.86
5 2.04 10.76 56.62
6 1.66 8.72 65.34
7 1.70 8.94 74.28
8 1.45 7.64 81.92
The factor analysis of this data set produced eight principle
factors accounting for 81.92 per cent of the total variance. The
variables loading most significantly on factor one are: carers'
HAD anxiety and depression scores; and the carers' PAIS total
score. This factor, therefore, represents carer distress and
adaptation to illness. Factor two loads most heavily on the
patients' HAD anxiety and depression score and the patients'
total PAIS score. This factor represents patient distress and
adaptation to illness. Factor three loads most heavily on the
number and severity of the patients' symptoms and therefore
represents general symptomatology. Factor four loads most
heavily on patients' and carers' perceived social support from
family and therefore represents a general measure of family
support. Factor five represents a measure of age as it loads on
the ages of patients and carers. Factor six loads on the EPI
extraversion score of the patient and the neuroticism score of
the carer and could therefore be viewed as a measure of
"family personality". Factor seven loads on patients' and
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carers' perceived social support from friends and therefore
represent^ a measure of social support from friends. Factor )c
eight loads on the carers' extraversion score of the EPI and
performance status and therefore represents a "sociability"
factor as the performance status scale assesses the patients'
ability of carry out certain daily tasks and the personality
variable assesses how outgoing a person is generally.
These eight variables and the variance that they represent are
shown in Table 99.
Table 99
Factors derived from rotated factor matrix and the
variance explained: follow up group.
Factor Name Variance
explained (%)
1. Carer distress and adaptation
to illness.
10.83




4. Support from family. 12.15
5. Age. 10.76
6. Family personality. 8.72
7. Support from friends. 8.94
8. Sociability. 7.64
Factor analysis: palliative therapy group
Factor analysis of the data from the palliative therapy group
again revealed seven factors but with a different structure
again. The unrotated and rotated factor matrices are shown in
Tables 100 and 101.
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Table 100
Unrotated factor matrix of variables associated with
the palliative therapy group, including eigenvalues
and the percentage of variance explained by each.
Factor Factor Factor Factor Factor Factor Factor
Variable 1 2 3 4 5 6 7
Patients' age -0.32 0.44 0.22 0.08 0.49 0.33 -0.05
Carers' age -0.50 0.13 0.29 0.47 0.33 0.25 0.07
Anx(patient) 0.48 0.41 0.05 0.34 -0.37 -0.19 -0.34
Anx (carer) 0.53 -0.36 0.59 0.25 -0.02 0.06 0.03
Dep (patient) 0.19 0.10 0.03 0.36 0.07 0.29 -0.62
Dep (carer) 0.45 -0.40 0.37 0.37 -0.01 -0.10 0.21
Family Supp.
(patient)
0.80 -0.13 -0.18 0.02 0.36 0.07 -0.22
Family Supp.
(carer)
0.80 -0.13 -0.19 -0.07 0.27 0.13 -0.28
FriendsSupp.
(patient)
0.61 -0.39 -0.19 -0.08 0.04 0.34 0.36
Friends
Supp. (carer)
0.62 0.01 -0.43 -0.20 0.03 0.20 0.21
Symptom
number
0.46 0.64 0.38 -0.22 -0.07 0.19 0.05
Symptom
severity
0.31 0.75 0.34 -0.25 0.01 0.14 0.25
PAIS(Total)
(Patient)
0.44 0.32 0.19 0.12 -0.01 -0.60 0.12
PAIS(Total)
(Carer)
0.27 -0.17 0.44 0.25 0.09 -0.08 0.27
Extraversion
(Patient)
-0.31 -0.11 0.39 -0.23 -0.46 0.44 -0.13
Neuroticism
(Patient)
-0.11 0.15 -0.38 0.60 0.21 -0.02 0.08
Extraversion
(Carer)
0.01 0.32 -0.36 0.37 -0.10 0.28 0.47
Neuroticism
(Carer)
-0.35 -0.48 0.34 -0.06 0.02 0.19 -0.00
Performance
Status
-0.03 -0.04 0.25 -0.44 0.69 -0.25 0.00




20.33 12.41 10.49 9.09 7.68 6.78 6.58
Total variance explained = 73.36 per cent
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Table 101
Varimax rotated factor matrix: palliative therapy
group.
Factor Factor Factor Factor Factor Factor Factor
Variable 1 2 3 4 5 6 7
Patients' age -0.29 0.45 -0.13 0.32 0.27 -0.39 0.25
Carers' age -0.53 0.11 0.17 0.29 0.15 -0.36 0.19
Anx(patient) 0.03 0.23 0.11 0.02 -0.33 0.26 0.66
Anx (carer) 0.16 0.05 0.8 4 0.25 0.17 0.18 0.18
Dep (patient) 0.05 0.01 0.02 -0.05 -0.19 -0.12 0.8 0
Dep (carer) 0.16 -0.12 0.80 0.02 -0.14 0.19 0.00
Family Supp.
(patient)
0.7 7 0.02 0.21 -0.07 0.24 0.27 0.37 |
Family Supp.
(carer)
0.79 0.03 0.14 0.04 0.18 0.26 0.19
F riendsSupp.
(patient)
0.7 8 -0.01 0.32 0.03 -0.16 -0.20 -0.18
Friends
Supp. (carer)
0.79 0.15 -0.07 -0.07 -0.13 0.09 -0.11
Symptom
number
0.14 0.87 0.07 0.18 -0.12 0.20 0.12
Symptom
severity
0.04 0.9 4 -0.01 0.04 0.03 0.17 -0.08
PAIS(Total)
(Patient)
0.00 0.25 0.30 -0.12 0.16 0.73 -0.09
PAIS(Total)
(Carer)
-0.02 0.08 0.69 -0.09 0.03 0.03 -0.04
Extraversion
(Patient)
-0.09 0.18 0.07 0.63 -0.32 -0.29 0.10
Neuroticism
(Patient)
-0.06 -0.15 -0.02 ■0.7 2 -0.16 0.03 0.15
Extraversion
(Carer)
0.11 0.23 -0.06 ■0.5 6 -0.06 -0.19 -0.17
Neuroticism
(Carer)
-0.25 -0.25 -0.21 ■0.42 0.09 -0.32 -0.06
Performance
Status
0.03 0.01 0.00 0.04 0.87 -0.08 -0.14




Factor eigenvalues, percentage of variance explained
by each factor and the cumulative variance for the
rotated factor matrix (palliative therapy group).
Factor Eigenvalue Percentage of Cumulative
variance variance (%)
1 3.00 15.81 15.81
2 2.20 11.58 27.39
3 2.21 11.63 39.02
4 1.74 9.14 48.16 I
5 1.50 7.91 56.07
6 1.85 9.73 65.80
7 1.47 7.56 73.36
The factor analysis of this data set produced seven orthogonal
factors accounting for 73.36 per cent of the variance of the
data. The variables loading on factor one are the patient and
carers' perceived social support from family and friends. This
represents a factor of perceived social support for the family.
Factor two loads most heavily on the number and severity of
symptoms and therefore represents a factor called
symptomatology. Factor three loads on the HAD anxiety and
depression scores of the carer and the carers' PAIS total score.
This represents carer distress and adjustment to illness. Factor
four loads most significantly on the EPI (extraversion and
neuroticism) scores of the patient and the carer. This
represents family personality. Factor five is a "unique factor"
loading on a single variable, performance status. Similarly,
factor six is also a "unique factor" loading on the single
variable concerned with the PAIS total score of the patient.
The final factor, factor seven loads most heavily on the HAD
anxiety and depression scores of the patient. This, therefore,
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represent patient distress. The seven factors and the variance
accounted for each are shown in table 103.
Table 103
Factors derived from the rotated factor matrix and
the variance explained: palliative therapy group.
Factor Name Variance
explained (%)
1. P.S.S. for the family 15.81
2. Symptomatology 11.58
3. Carer distress and
adjustment to illness
11.63
4. Family personality 9.14
5. Performance status 7.91
6. Patients' adjustment to
illness
9.73
7. Patient distress 7.56
(P.S.S. = perceived social support)
Factor analysis: conclusions
Factor analysis is a statistical technique developed by
psychologists to reduce large amounts of data. The aim of this
procedure is to identify structure within a set of observed
variables without imposing any preconceived structure on the
data. The technique can reduce the number of variables while
maintaining as much of the original information as possible.
This is particularly useful for understanding data and for
testing the findings out in the future.
The variables from the three groups of patients and their
carers in this study have been reduced using factor analytic
techniques producing remarkably similar results. The same
sets of data in the three groups produce optimum explanations
of the variance of the data. In each case, in excess of 70 per
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cent of the variance of each set of variables is explained.
Interestingly, variables from the brief interview schedule such
as attitudes to the illness and its treatment and demographic
variables such as social class, marital status and sex do not
enter the factor analysis. The factors instead support the
results of the stepwise multiple regression analyses.
A number of common factors emerge in the three groups of
patients and carers. Each group contains independent factors
assessing distress of the patient, distress of the carer,
symptomatology, perceived social support from family and/ or
friends and specific personality characteristics in the patient
and their carers. In the first line group, the factor
"symptomatology" accounted for the largest amount of
variance (13.35 per cent) followed by patient distress (11.35
per cent) and age (11.22 per cent). Carer distress (10.85 per
cent) and perceived social support (10.66 per cent) were
placed immediately after these three in terms of the variance
they explained.
The follow up group indicates a different pattern of factors.
Whereas symptomatology accounted for the most variance in
the first line group, in the follow up group support from the
family accounts for the most variance (12.15 per cent). This is
then followed by patient distress (11.70 per cent),
symptomatology (11.18 per cent), carer distress and
adaptation to illness (10.83 per cent) and age (10.76 per cent).
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If the first line management of lung cancer is considered,
particularly the administration of very toxic chemotherapeutic
agents, it is not surprising that symptomatology assumes its
position in the factor analysis. In the follow up group, the
patient is no longer receiving primary treatment for the
disease and therefore the role of symptomatology decreases
slightly, to be replaced by social support from the family.
In the palliative therapy group a general factor of perceived
social support explains the optimum amount of variance
(15.81 per cent) followed by carer distress and adjustment to
illness (11.63 per cent) and symptomatology (11.58 per cent).
It is interesting to note that in this group of patients they
experience a similar degree of perceived symptomatology to
the first line management group (see Table 30) but this factor
maintains two different positions in the two analyses. In the
palliative therapy group it is social support that explains most
of the variance followed by carer distress, whereas in the first
line group and the follow up group patient distress has been a
more significant factor.
The three factor analyses also reveal some interesting findings
regarding the interrelationships of some of the other variables.
In two of the three analyses, performance status and
extraversion of the carer and/ or patient load on the same
factors (first line group and follow up group). Performance
status is assessed by the physician and is concerned with the
functional state of the patient, in terms of how much the
person can do for themselves. This scale has, for many years,
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been the most widely used tool in cancer care, "its status as a
measure of quality of life rests upon its longevity and its
widespread usage, rather than on any demonstrable
methodological soundness" [Kind, 1988, pi8]. The fact that it
loads on the same factor as extraversion suggests that the
physician may be reacting to this aspect of the patients' or the
carers' personality rather than any objective measure of the
distress. It is noteworthy that performance status does not
load on the same factor (in any of the analyses) as
symptomatology, reported by the patient, or the PAIS which
may be a more direct measure of the disease impact. The
physician may be making a judgement about the effect of the
illness on the personality variables i.e. a person who is
normally extraverted may appear to be less so and therefore
they may assigned a poorer performance status.
Another relevant finding from the factor analysis is that carer
distress and the PAIS total score of the carer load on the same
factor in two out of the three factor analyses (follow up group
and palliative therapy). This suggests that distress in the carer
and the impact of the illness on their lifestyle are very closely
linked, rather than consisting of separate independent entities.
This is not necessarily the case for patient distress, however,
which loads with the PAIS in the follow up group only and
loads with personality variables in the first line group and
stands alone as a unique factor in the palliative therapy group.
These three factor analyses considerably reduce the number
of variables from the original data set suggesting that there is
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considerable redundancy present. In addition, some
interesting interrelationships between variables have been
described as well as the changing importance of certain factors
throughout the course of the illness and its treatment.
The factor analyses used with these data should be viewed with some caution.
There are a large number of variables and a relatively small N which may
distort the results. The factor analyses have been included as fr&Jj support
the results derived from the multiple stepwise regression analyses described
earlier. The caution in interpreting the analyses should extend to the data
from the three stages of lung cancer and its treatment as the small N extends
to each data set compared with the large number of variables. Despite these
limitations in the factor analysis however, the results are consistent with the
regression analyses described earlier.
322
Summary of the results
1. Three groups of forty patients undergoing treatment for
lung cancer and their primary carers have been assessed using
a variety of measures.
2. Patients were either undergoing first line chemotherapy,
were on follow up surveillance following chemotherapy, or
were receiving palliative radiotherapy following
chemotherapy and a period of surveillance.
3. The ages of the patients in the three groups were similar.
4. There was a more even distribution of males and females in
the follow up group of patients and carers than in the other
two groups.
5. Demographic data for the three groups of patients showed
very similar distribution (marital status, social class, diagnosis,
original treatment regimen).
6. There was no statistically significant age difference between
the three groups of carers.
7. Demographic data for the three groups of carers showed
similar distributions.
8. The majority of carers were spouses or other close relatives.
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9. There were no statistically significant differences in mean
HAD anxiety and depression scores between the three groups
of patients.
10. A significant number of patients scored above the cut off
level for anxiety on the HAD (possible "case") in the three
groups of patients with the largest number in the palliative
therapy group (47.5 per cent versus 42.5 per cent in the other
two groups).
11. A significant number of patients scored above the cut off
level for depression (possible "case") on the HAD in the three
groups of patients (20 per cent in the first line group, 35 per
cent in the follow up group and 17.5 per cent in the palliative
group).
12. There were no statistically significant differences in mean
HAD anxiety scores between the three groups of carers.
13. The majority of carers scored above the cut off score
(possible "case") for anxiety on the HAD (65-75 per cent).
14. There were no statistically significant differences between
the HAD depression scores of the three groups of carers.
15. A significant number of carers scored above the cut off
level for depression (possible "case") on the HAD in the three
groups of carers (32.5 per cent to 45 per cent).
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16. A significant number of carers scored in the "probable
case" level on the General Health Questionnaire (GHQ) and its
subscale.
17. The HAD anxiety scores of the carers is significantly higher
than the patients in all three groups.
18 There are statistically significant relationships between the
mean HAD anxiety scores of the patients and those of the
carers in the first line and follow up group.
19. The mean HAD depression scores of the patients and their
carers are not significantly different in any of the groups.
20. The mean HAD depression scores of the patients and carers
are only correlated significantly in the first line treatment
group.
21. There were no consistent significant effects of gender on
mood scores in any of the groups of patients and carers (but
female carers in the palliative therapy group displayed
significantly higher anxiety scores than male carers).
22. No significant effect of demographic variables on mood
was observed in any of the groups of patients and carers.
23. The effects of self reported symptomatology on HAD
anxiety in the patient only achieved significance in the
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palliative therapy group. No effect of symptomatology on the
HAD depression scores of the patient was observed.
24. The lung cancer cell type was not observed to have a
consistent significant effect on mood state of the patient or
carer
25. Lung cancer cell type was found to have a significant effect
on carers' HAD anxiety and depression scores in only the
follow up group.
26. Symptomatology reported by the patient was not found to
be significantly associated with HAD anxiety or depression
scores in the carer.
27. There are statistically significant differences between self
reported symptoms of the patients in the three groups. This
effect is also observed for performance status.
28. There were no statistically significant differences between
male and female patients in the variables related to
symptomatology.
29. There were statistically differences between the three
groups of patients on the extraversion and neuroticism scores
of the EPI.
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30. There was a statistically significant difference between the
three groups of carers on the extraversion score of the EPI but
not on the neuroticism score.
31. There were no statistically significant associations between
the extraversion and neuroticism scores of patients and their
carers and HAD anxiety and depression scores.
32. There was no effect of gender on the extraversion and
neuroticism scores of the EPI in the patients.
33. Female carers in the first line management group had
higher extraversion (EPI) scores than male carers in the same
group. This effect was reversed in the palliative therapy group
with males having higher extraversion scores than female. No
difference was observed in the follow up group.
34. There was no effect of gender on neuroticism scores in the
three groups of carers.
35. Perceived social support from family and friends was not
found to differ between the three groups of patients and their
carers.
36. Highly significant associations were found between the
social support scores of the patient and the social support
scores of the carer.
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37. No significant associations between social support from
friends and family and anxiety and depression in the patient
were found across the three groups.
38. At certain stages of the illness, significant associations
were observed between social support from family and
friends and anxiety and depression.
39. Dividing the results into high versus low social support
continues to support the view that at certain stages of the
illness high levels of social support are associated with higher
levels of anxiety and depression in carers.
40. This does not support the view that social support acts as a
"buffer" to stressful events.
41. Questionnaire data from carers regarding recent changes in
social support do not support the view that the social support
is a reaction to distress.
42. In the patients receiving first line chemotherapy, only
those patients with greater symptomatology tended to have
higher levels of social support from family and friends.
43. There was no statistically significant effect of patients'
symptomatology on social support for the carer.
44. No association between age and social support in the
patient was observed in any of the three groups.
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45. Older carers had less social support from family and
friends in the follow up surveillance groups and the palliative
therapy group.
46. There was no effect of gender on social support in either
patients or their carers.
47. No effect of attitudes to the illness and its treatment were
observed in patients and their carers at any stage of the
illness.
48. Lung cancer and its treatment was found to have a
significant impact on all domains of the Psychosocial
Adjustment to Illness Scale (PAIS) in the three groups of
patients.
49. Lung cancer and its treatment was found to have a
significant impact on all domains of the PAIS in the three
groups of carers.
50. In a number of different PAIS domains the effect of the
illness and its treatment is greater on carers than on patients.
Patients in the first line group and palliative group, however,
report a greater effect on their sexual relationship than the
carer.
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51. Symptomatology and certain PAIS domains were found to
be correlated significantly in the palliative therapy group of
patients only.
52. Correlations between symptomatology and PAIS domains
of the carers did not achieve statistical significance in any of
the groups.
53. There was no effect of gender in any of the PAIS domains
of patients and their carers in any of the three groups.
54. Patients and their carers report significant fears and
worries concerning the impact of the illness and its treatment
and its effect on their lives.
55. The majority of patients and their carers hope for long
term control of the disease at all stages of the illness.
56. The majority of patients and their carers understand the
aims of treatment except in the palliative therapy group.
57. Patients and carers with an over-optimistic view of
treatment do not experience any effect of this view on their
anxiety and depression scores.
58. Patients and carers give a significant amount of time to
thinking about the illness which changes over time.
59. Most patients and carers talk to others about their illness.
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60. Patients perceive their spouse as giving them the most
help during the illness and its treatment.
61. Carers perceive a variety of significant others as having
helped them with the difficulties of the illness and its
treatment.
62. Most patients and carers identify a source of help and
support should they need it.
63. Most patients and carers have shared their fears and
worries with each other during the illness.
64. Most patients and carers report that their relationship has
become closer since the illness was diagnosed.
65. Most patients and carers report an increase in
communication since diagnosis.
66. Patients and carers report that the main effects of the
illness on the family are to cause distress or to create a greater
appreciation of people.
67. Patients and carers report significant changes in their
social interactions with friends and relatives outside their
homes depending on the stage of the illness.
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68. Patients and carers report significant changes in their
leisure activities resulting from the illness.
69. Most carers perceive that they have a significant role to
play in helping the patient fight the disease or come to terms
with it.
70. The psychological state of the patient or the carer is
contributed to significantly by the psychological state of the
significant other.
71. Symptomatology, perceived social support, personality
characteristics and age also may contribute significantly to
psychological distress of the patient or their carer.
72. The General Health Questionnaire (GHQ) score of the carer
is contributed to significantly by the depression and/ or
anxiety score of the patient.
73. The GHQ score of the carer is contributed to significantly
by their PAIS score.
74. The data in all three groups of patients and their carers
can be successfully reduced using factor analysis.
75. The factor analysis can reduce the data to seven or eight
factors accounting for between 73-82 per cent of the variance
of each data set.
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76. The factor analysis suggests some interesting
interrelationships between some of the variables.
77. The data from the study raises some interesting questions
for future cross validation research.
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The hypotheses: accepted or rejected?
The hypotheses described in the methods chapter are now
discussed briefly below in the light of the results of the study.
Hypothesis 1. There will be no significant difference in levels of
anxiety and depression in patients at different stages of the illness
and its treatment.
A s there were no statistically
significant differences in mean HAD anxiety and depression scores
between the three groups of patients, it is therefore confirmed.
Hypothesis 2. Those patients with greater levels of physical
symptomatology will experience greater levels of anxiety and
depression.
This hypothesis was supported in the palliative therapy group of
patients only, where anxiety was found to correlate with physical
symptoms. In the other two groups of patients the hypothesis was
rejected as no significant association was found between anxiety
and depression and physical symptoms.
Hypothesis 3. Those patients with high levels of perceived
emotional social support will have lower levels of anxiety and
depression.
This hypothesis was not supported in any of the three groups of
patients and was therefore rejected.
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Hypothesis 4. The treatment of lung cancer will adversely affect
other areas of patients' lives.
This hypothesis was confirmed in the three groups of patients.
Hypothesis 5. There will be no difference between the levels of
anxiety and depression in patients and the levels of anxiety and
depression in their primary carers.
This hypothesis was rejected as primary carers were found to have
significantly higher levels of anxiety in the three groups than
patients and a trend towards higher levels of depression.
Hypothesis 6. Statistically significant correlations will be found
between anxiety and depression levels in patients and their
primary carers.
This hypothesis was confirmed in the first line and follow up
groups of patients and primary carers but rejected in the palliative
group, with respect to anxiety only. In terms of depression, it was
confirmed in the first line group but rejected in the other two
groups.
Hypothesis 7. Statistically significant correlations will be found
between physical symptomatology in patients and anxiety and
depression in their primary carers.
This hypothesis was rejected in all three groups of primary carers.
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Hypothesis 8. Primary carers with high levels of perceived
emotional social support will have low levels of anxiety and
depression.
This hypothesis was rejected in all three groups of primary carers.
Hypothesis 9. The treatment of lung cancer will adversely affect
other areas of primary carers' lives.
This hypothesis was confirmed in all three groups of primary
carers.
Hypothesis 10. The lives of patients and their primary carers will
be equally affected by lung cancer and its treatment.
This hypothesis was rejected in all three groups of patients and
primary carers.
Hypothesis 11. Anxiety and depression in both patients and their
primary carers will be explained by an interaction of low social
support, high physical symptomatology and anxiety and depression
in the 'significant other'.
This hypothesis was rejected in all three groups of patients and
their primary carers as the interaction tended to consist of high
social support, high physical symptomatology and anxiety and




Lung cancer is a major cause of death in industrialised
countries the incidence has been steadily increasing since the
early 1940's [Garfinkel and Silverberg, 1991]. Despite the
numbers of people who are affected by this disease there have
been few systematic studies of its' psychological and social
impact on patients and their families. In contrast, research in
breast cancer has examined areas such as quality of life,
supportive care, coping strategies and coping styles as well as
a wide range of psychosocial issues [Fallowfield and Clark,
1991]. There are several possible explanations for the limited
amount of psychosocial research with lung cancer patients.
Metastatic disease is common at the time of diagnosis and the
limited survival time, therefore, diminishes the opportunity
for psychosocial investigations. Similarly, psychosocial
interventions for patients with cancer are more likely to be
applied to those with longer survival times. In addition, it has
been noted that poor performance status and rapid disease
progression in many lung cancer patients precludes studies
that require patients' attentiveness and cognitive effort
[Bernhard and Ganz, 1991]. Bernhard and Ganz also put
forward the view that until recently, lung cancer has primarily
affected men, and male patients may be more reluctant to
participate in psychosocial research in which their emotional
concerns are discussed.
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The present study has attempted to redress this balance by
conducting a study into the effects of lung cancer and its
treatment on the patient and their primary carer at different
times during the course of the disease. The illness has a
rapidly fatal course and forces the patient and their family to
confront many fundamental changes in everyday life. The
treatment regimens are highly toxic and can produce their
own psychosocial sequelae for all concerned. Family members
play an important role in the physical and emotional care of
the patient, yet little is currently known about the impact of
the disease on their psychological and social function. The
current study has been prompted by these concerns, and has
viewed the patient and their primary carer both as
individuals, and also as a "unit" in furthering the
understanding of the impact of the illness and its treatment on
a number of different areas of their lives.
Initial difficulties
The initial study design for this project was amended
following early pilot work (see "Methods" chapter). In this
preliminary study, patients and their primary carers would
have been identified at the diagnosis of their illness and then
assessed at monthly and subsequently three monthly
intervals. This would have given a clear picture of the
changing needs of the subjects as well the changing effects of
the illness and its treatment. The model for this design had
been a study conducted earlier in the same department where
patients with lung cancer had been interviewed monthly from
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the diagnosis of their illness. This study had worked
successfully with good compliance from the patients
themselves in the interviews in the completion and return of
the questionnaires.
In the study described here, however, the carers had
found the continual interviewing too onerous and stressful
and, therefore, had not been able to comply. This in itself is an
indication of the stressful nature of the illness and treatment.
This early study led to a radical change in design in which
patients and carers were identified at predetermined stages of
the illness process. This design proved to be highly successful
in terms of data collection and compliance.
The study cannot give a dynamic picture which regular
assessment would have facilitated but the experience of the
illness can still be described. The subjects have all experienced
a very similar approach to treatment, whereby all the
patients have received first line chemotherapy, or first line
chemotherapy and follow-up surveillance, or first line
chemotherapy, follow-up surveillance and palliative therapy.
The effects, therefore, of each of these treatment stages on the
patients and their carers can be assessed and compared and a
description of the illness as a "process" constructed. In
addition, the study required a single assessment when
patients were either in the ward or attending out-patient
clinics. Compliance was, as a result, ereatlv enhanced. The current
study could more accurately be described as a "stage" model and not a "process"
model as a longitudinal design was not able to be used.
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Three groups of subjects
The three groups of patients and their carers are very well
matched on a range of demographic variables (social class,
marital status, diagnosis, original treatment regimen and
relationship to the patient). There is a difference in the mean
ages of the three groups of patients: the palliative therapy
group are older than the follow-up group. This age difference
is not apparent in the three groups of carers. In the analyses,
however, there are no significant effects of age on the
psychological and psychosocial variables and this difference
does not significantly effect the interpretation of the results.
A potentially more vexing difference between the three
groups of patients is the sex distribution, which is quite
different in the follow-up group to the other two. There is no
consistent effect of gender and this unequal distribution does
not confound the results of this study. The three groups of
patients and their carers can be viewed as three similar
groups having had similar experiences of treatment.
Mood: Patient
The three groups of patients were not significantly different in
terms of their mean HAD anxiety and depression scores. A
trend was found for higher mean anxiety and depression
scores in the follow up surveillance group although, this did
not achieve statistical significance. Studies using other groups
of cancer patients have reported a different pattern of
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distress. Hughes [1985b], for example, reported a decrease in
the prevalence of depression in a group of lung cancer
patients over a three month period. This study assessed
patients at diagnosis and later following treatment. Initially 26
per cent of patients were depressed but this had fallen to 16
per cent three months later. Silberfarb et al. [1980] reported
higher levels of anxiety and depression at the time of
recurrence of breast cancer than at other stages of the illness
process. Cassileth et al. [1985], in a heterogeneous group of
cancer patients, found that those receiving palliative therapy
displayed "the highest anxiety levels, the most severe
disturbance in mood and the poorest overall mental health"
(p74).
A longitudinal study by Ell et al. [1988; 1989a; 1989b]
conducted over a two year period found a pattern of
increasing distress over time.
The literature, therefore, supports a view of steadily declining
psychological functioning over the course of the illness. The
current study describes a more complex picture of distress
which it appears is exacerbated by the uncertainty of
completing first line chemotherapy.
The view of increased psychological distress following the
cessation of treatment is supported by other research
[Futterman and Hoffman, 1973; Stone 1975; Wheatley et al.,
1974; Koocher and Malley, 1981]. This period of "watching
and waiting" has been termed the "Damocles Syndrome" by
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the latter authors and is characterised by a time of great
uncertainty, fear and apprehension. This is exacerbated by
frequent investigations (X-rays, blood tests etc). It has been
likened to an "emotional roller coaster" with levels of distress
which continually rise and fall. This is further supported by
findings from a study by Schag and Heinrich [1989], who
interviewed 320 patients with cancer, a significant proportion
of whom did not have active disease and were returning for
out-patient follow-up consultation. Fifty six per cent of the
sample reported that they were nervous on visiting the
hospital and of these 30 per cent reported significant anxiety.
Forty per cent reported anxiety when waiting to see the doctor
and 56 per cent reported anxiety when waiting to find out the
results of tests. These authors report that improved
communication skills on the part of both the patient and the
physician can help reduce some of the patients' anxiety. The
most significant factor here, they suggest, is the uncertainty of
the patients disease status.
In addition, many "survivors" of cancer have been found to
fear recurrence of their disease and death [Northouse 1981,;
Maher 1982; Cella and Tross, 1986]. Commenting on the
importance and prominence of this fear, Northouse [1981]
considered the role of communication. She noted that
insufficient knowledge of when and if symptoms will recur
reduces the individuals' overall sense of mastery and control
of their life. In a study of 60 male survivors of Hodgkin's
disease and 20 age-matched controls, Cella and Tross [1986]
found greater death related anxiety in "survivors" in the first
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two years after therapy when compared with those coping
with a more protracted survival. Maher [1982] has also
reported the presence of this existential anxiety during the
active treatment phase of certain types of cancer and found
that it persists for several months after the completion of
therapy. This ranges from generalised anxiety to worry and
anger and even thoughts of suicide. These findings suggest a
general lessening of anxiety over time but lends support to the
results of the current study in which the anxiety level remains
elevated during the "no treatment, follow up period".
Such a pattern may be related to the specific type of cancer
and its treatment. Tross et al. [1987] studied cancer specific
and general psychological distress in survivors of testicular
cancer (who had an excellent prognosis) and acute leukemia
(poor prognosis). The results showed that the leukemia group ^
A
had greater cancer specific distress and higher anxiety, chiefly
C\ .
related to persistent fears of recurrence. The leukemia group *
have certain similarities to patients with lung cancer in that
the disease may not be detectable but in the future is likely to
recur [Tross et al., 1987]. These effects may persist for many
years in cancer patients. Fobair and Mages [1981], for
example, found significantly lower levels of anxiety in long
term survivors of cancer six years following diagnosis
compared with those patients who had completed treatment in
the previous year. The disease type and time since diagnosis
are therefore important variables to consider in any
longitudinal study of the psychological impact of cancer.
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Many patients anticipating and attaining the completion of
therapy do so with ambivalence and heightened anxiety
[Maher, 1982]. Elation that the treatment is over is coupled
with the anxiety of losing close contact with the treatment
team. Maher speculates that this can be viewed as a
"separation anxiety" and a fear of potential loss of medical
control over the disease. In addition, Fobair et al. [1986] have
found that any persisting disability or impairment of physical
function following treatment serves to increase anxiety in the
follow up period. These results are consistent with the data
collected in the current study following the first line
management phase when the patients move into a very
uncertain period of repeated out patient clinic visits and
routine monitoring, and a degree of persisting
symptomatology.
The data from the current study also examines patients who
score above the "case" level on the HAD (11-21). The number
who score above this point for anxiety are statistically similar
in each group, but a trend towards an increased number in the
group undergoing follow up surveillance is found. It is also
noteworthy that only one patient in the palliative therapy
group falls in the "case level" of depression. This could be due
to the alleviation of the distressing effects of physical
0
symptoms for the patient by radiotherapy. This group have a
poorer performance status than the other groups and an
increased severity of symptoms. The fact that treatment is
being administered to reduce the symptomatology may give
the patients some hope.
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An alternative "cut off' score to select on the HAD is 8+. When
the distribution of patients is examined using this division, a
slightly different pattern emerges. The number scoring above
this level on the anxiety subscale demonstrates a trend
towards increased anxiety during palliative therapy and it is
noteable that the follow up group do not show a significant
reduction: in the first line group 42.5 per cent score in the
"case level" range; the follow up group 42.5 per cent and the
palliative therapy group 47.5 per cent. The distribution of the
depression subscale shows a different pattern. Twenty per
cent in the first line group score above this level, 35 per cent
in the follow up group and 17.5 per cent in the palliative
therapy group. Again this demonstrates the psychological
impact of the follow up surveillance period as well as that of
palliative therapy# Other studies have reported that between
25-30 per cent of patients experience a significant degree of
anxiety and/ or depression [Plumb and Holland, 1977; Maguire
et al., 1978; Holland, 1981; Bukberg et al., 1984; Devlen et al.,
1987b] and a raised levels of distress in patients undergoing y
palliative therapy have been noted [Hinton, 1963; Cassileth et
al., 1985]. Increased anxiety in those patients undergoing
palliative therapy may not be surprising. They often
experience many distressing symptoms such as pain,
breathlessness, dysphagia or weight loss and may be
functionally limited. The results of the current study, for
example, demonstrate an association between symptoms
reported by the patient and anxiety in this group. In addition
the aim of treatment is not to prolong life but to alleviate
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these symptoms, in fact, this period has been regarded as
representing "nearness to death" [Cassileth et al., 1985].
Direct comparison with other studies is complicated as they
often utilise heterogeneous groups of patients, different
assessment tools and do not specify the stage of the illness
that the patient has reached. The current study assessed
patients and carers at carefully defined times during the
illness process with a common treatment approach. Other
studies such as those by Ell et al. [1988; 1989a; 1989b] and
Goldberg et al. [1984] have selected assessments based on
convenient time points (one year, two years or three months)
rather than on the timetable dictated by treatment regimens.
This necessarily complicates comparison of results. In the
studies by Ell et al. enormous variation could occur between
time points which is not detected. A further factor is the range
of treatment approaches that patients were subjected to in the
studies by Ell et al. as the patient groups were selected from
23 hospitals in Southern California with no "single treatment
setting" defined.
Mood: Primary Carer
One of the principal findings of this study has been the effect
of lung cancer and its treatment on the mood state of the
carer. There have been very few studies examining both the
patients and the carers in the world literature despite the
obvious importance of the latter in the patient's life and
concerns. The studies that have been undertaken in this field
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have produced equivocal findings and have suffered from a
number of serious methodological shortcomings.
In the present study carers demonstrated consistently high
mean anxiety scores at the three stages of the illness. In fact,
the mean scores for the three groups placed them above the
cut off scores of the HAD scale and into the clinically
significant range. There was, however, no statistically
significant difference between the mean scores of the three
groups.
When the data is examined in terms of cut off scores, high
levels of distress are revealed. In the first line chemotherapy
group 75 per cent score above the "normal" range, in the
follow up group 70 per cent, and in the palliative therapy
group 65 per cent. These percentages are much greater than
those found in the groups of patients. The data for the
depression subscale is less dramatic but still represents a
significant degree of mood disturbance. In the first line group
45 per cent scored above the "normal" range, in the follow up
group 25 per cent, and in the palliative therapy group 32.5
per cent. This represents an enormous burden of distress
amongst the carers of patients with lung cancer. Currently,
there are no studies suitable in design with which these
figures can be compared.
The data from the present study suggests that throughout the
course of the disease and its treatment carers experience high,
unremitting levels of anxiety. This is the first time that such a
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finding has been produced and has important implications for
planning interventions which will be discussed further later.
The pattern of mean HAD depression scores for the carer is
different from that of anxiety. There is no statistically
significant difference between the three groups, but the trend
is towards a lower mean score in the follow up group of carers.
The decrease in mean depression score could be due to the
fact that the patient is not undergoing treatment and
therefore, may be relatively well when compared with the
period when they were receiving chemotherapy. They may be
more active and able to live a more "normal" life. This may
mediate depression but worrying thoughts regarding the
illness and the future may persist, which would explain the
persistent anxiety. Not surprisingly, the mean depression score
then rises in the palliative therapy group although not to the
level found in carers in the first line management group.
The mean depression scores for carers is less than that of
anxiety, yet a significant number in each group still score
above the "cut off' level and it still remains a significant
problem over the course of the illness process.
Mood: The Relationship between Patients and their
Primary Carers.
When the mean anxiety scores of the patients and their carers
are compared, at each stage of the illness there is a highly
significant difference between them, the carer having a higher
mean score on each occasion. This is contrary to the findings of
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a number of studies. Cassileth et al. [1985] investigating cancer
patients and their next of kin, reported that "as a group,
patients displayed greater mood disturbance...than did
relatives" (p 74). Goldberg et al. [1985] in a study of lung
cancer patients and their spouses, found that over a six month
period following diagnosis, the psychological distress in the
spouses reduced significantly. These findings are not
supported in the current study. A reduction in the mean
anxiety score of the carer is seen but this fails to achieve
statistical significance.
The relationship between the psychological state of the patient
and that of the carer is clearly complex. Despite the fact that
there are significant differences between their anxiety and
depression scores in the current study, there are also
significant associations.
The anxiety scores of the patient and carer are significantly
correlated in the first line management group and in the
follow up groups, whereas the correlations between their
depression scores fails to achieve statistical significance.
Despite the correlation in anxiety scores only 20 per cent of
the variance in the first line group and 14 per cent of the
variance in the follow up group is explained by them.
This relationship has been explored further using a series of
multiple stepwise regression analyses. This suggests that in
the three stages of the illness studied, the psychological state
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of the carer contributes significantly to anxiety and/ or
depression in the patient. In the same way the psychological
state of the patient contributes significantly to the anxiety
and/ or depression in the carer, but this effect is only found in
the first line management and follow up surveillance groups.
In the palliative therapy group the contribution of the
psychological state of the patient is displaced in the regression
analysis by other factors which include the patients' total PAIS
score (which is indicative of a more global impact of the illness
on the patients' life affecting the carers' mood). In addition,
The aim of palliative therapy is to relieve symptoms rather
than to prolong life and it has been suggested that this stage is
associated with "nearness to death" [Cassileth et al., 1985]. This
fact may be a significant contributory factor to carer distress
at this time. The majority of them (65 per cent), for example,
accurately report that the aim of treatment was to relieve
symptoms rather than to prolong life.
The data suggests that the interaction of the psychological
state of the patient and their carer may be mediated by a
range of other factors in addition to the stage of the illness
and its treatment.
Studies examining the relationship between the psychological
state of the patient and the psychological state of the carer or
spouse have produced equivocal results. Cassileth et al. [1985]
found that the psychological status of patients and relatives
was significantly correlated across various cancer types
(including lung cancer). Cassileth et al. conclude that, "It may
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be inferred that relatives do provide a psychosocial
environment to which the patient reacts and, conversely, that
patients similarly influence the level of distress or
adaptability exhibited by their relatives"(p76).
These results are supported by Keitel et al. [1990] in a group
of patients with mixed cancer types undergoing surgery. The
results demonstrated that the "pattern of distress was
strikingly similar in patients and spouses" (pi50). In addition,
this study also found that spouses reported greater distress
than did patients both pre and post-surgery, but both had
lowered their distress at the post surgical assessment.
Unfortunately, this study only deals with surgery and does not
continue the assessment thereafter. Oberst and Scott [1988]
reported similar results in a group of cancer patients
undergoing surgery, again with a very short follow up period.
Similarly, Northouse and Swain [1987], using a short follow up
period (three days following surgery for breast cancer and one
month later), found significant correlations between the mood
scores of patients and their spouses. The mood disturbance
reported by the husbands was similar to that reported by the
wives who underwent surgery. These researchers also found
that there was no significant improvement over time in the
distress levels for either wives or their husbands.
Coursey et al. [1975], on the other hand, found that family
members scored higher on measures of state anxiety than did
the patients but that there was no significant correlation
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between the two. Goldberg et al. [1984] also found little
relationship between the psychological state of the patient and
their spouse, but rather that the psychological state of each
were mediated by quite different factors independently of the
other. For the patient, mood disturbance was correlated with
physical symptoms and for the spouse distress was correlated
with low levels of social interest and involvement and not the
patients' symptomatology.
Comparison of studies in this area is extremely difficult and
each must be assessed on its own merits. The range of study
designs is extremely diverse using different groups of patients
undergoing different treatments assessed by different
assessment schedules. Even studies with lung cancer patients
are difficult to compare due to their varying designs. Goldberg
,for example, assessed lung cancer patients having a range of
treatments every two months for six months. Each cancer type
and treatment approach may impose its own stresses upon the
sufferers and their families and thus mediate the relationship
between the interaction of their respective mood states.
Mood: the contribution of other factors.
One of the major factors associated with psychological distress
in cancer patients, according to the literature, is
symptomatology related to the disease and its treatment. In
the current study no significant associations were found
between the number of symptoms and side effects of
treatment, the severity of these symptoms and side effects,
performance status and time since diagnosis in the first line
349
management and follow up surveillance groups. In the
palliative therapy group, however, there was a statistically
significant association between the number of symptoms and
side effects and anxiety, but not depression. The predominant
symptoms experienced by this group of patients were pain
and breathlessness. Both of these symptoms are recognised as
having a marked effect on the psychological state of the
patient [Burns and Howell, 1969; Foley, 1985; Sandhu, 1986;
Jay et al., 1986; Breitbart, 1989]. The physical symptoms
alone, therefore, do not produce a consistent association with
distress in the patient groups.
Symptomatology present in the patient had no effect on the
mood state of the carer. None of the illness variables when
correlated with the carers' anxiety and depression achieved
statistical significance. This finding remained consistent across
the three groups of carers.
These results, to some extent, are consistent with other
findings reported in the literature, although the caveats
previously described must not be ignored. Goldberg et al.
[1984] found that six months after diagnosis, depression in
lung cancer patients was highly correlated with the Karnofsky
Performance Status, yet no significant correlations were
observed at two months and four months after diagnosis. In
the same study no significant correlations were observed
between the Karnofsky Performance Status of the patient and
the depression score of the spouse. From this paper, however,
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no details regarding type of treatment or the stage of disease
are given.
Hughes [1985a] found that there was a highly significant
association between Karnofsky Performance Status and
depression, and between the presence of hypercalcaemia at
the time of diagnosis but before the start of treatment. This
assessment would have been conducted approximately 4-6
weeks before the assessment of the first line management
group in the current study. At six month follow up there was
still a significant association between depression and degree of
physical disability. A significant number of these patients (30
per cent) were still receiving combination chemotherapy for
their disease, again, complicating comparison.
Numerous studies examining the early period (up to six
months after diagnosis) have reported a significant association
between physical symptoms and psychological distress in
patients [McCorkle and Quint-Benoliel, 1983; Hughes, 1985a;
Bukberg et al., 1984; Cella et al., 1987]. Some studies, however,
have failed to describe such an association [Taylor et al., 1985;
Cassileth et al., 1984]. The discrepancies may be related to the
different types of cancer studied, the different assessment
tools used and the different treatment approaches employed
[Cassileth et al., 1984].
Beyond this early period, however, little published data exists
regarding the relationship between physical symptoms and
distress. Pettingale et al. [1988], failed to find an association
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between symptomatology, extent of disease and distress at 12
months following diagnosis and treatment of breast cancer and
Hodgkin's disease but did find some evidence of a trend
towards an association in Non-Hodgkin's lymphoma. Espie et
al. [1989] failed to find an association between symptoms and
anxiety and depression several years after patients underwent
surgery for the intra-oral cancers, whereas Hinton [1963]
reports an association between pronounced symptoms and
depression in patients with terminal illness.
The results from the published literature regarding the effect
of symptoms on distress in the patient are far from clear. For
the effect on the relative there is even less support. The
current study finds no association at any stage of the disease
between symptoms and mood state. This supports the study of
Goldberg et al. [1984] who also examined a group of carers of
patients with lung cancer but fails to support the research of
Cassileth et al. [1985] who found that carers of patients
receiving palliative therapy, and therefore had more
symptoms, tended to be more distressed.
In the current study the type of lung cancer and the treatment
regimen employed during the initial management do not have
an effect on the mood state of the patients. This finding is
contrary to a number of studies which report a differential
effect of cytotoxic chemotherapy on mood [Silberfarb et al.,
1983; Van Praag 1982; Adams et al.,1984; McDonald et al.,
1987].
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The effect of the type of lung cancer (cell type) on the carer
was not evident in the first line management group or the
palliative therapy group but was evident in the follow up
group. At this stage of treatment the carers of those patients
with non small cell lung cancer were significantly more
anxious and depressed than those with small cell lung cancer.
This is a difficult finding to interpret and may be due to a
range of possible reasons such as chance, the interpretation of
a specific side effect or symptom by the carer, or even subtle
differences in the information given to those carers at some
time during or following first line management.
Gender and age have no consistent effect on mood in either
the patients or the carers. The only effect of note with respect
to age and mood was that female carers in the palliative
therapy group had significantly higher anxiety levels than
male carers. This finding has been reported previously, and is
viewed as a form of "anticipatory grief", [Holland, 1976;
Goldberg et al., 1984]. Female carers during palliative therapy,
it has been argued may be preparing for life alone, and for
many this is extremely worrying as they may have always
been dependent on their husbands [Goldberg et al., 1984].
Many middle aged women in the current study, for example,
had never worked in their lives. The lack of a consistent effect
of gender on mood in this study, however is supported by data
from other studies in the field of lung cancer which have
produced similar findings [Hughes, 1985a; Cassileth et al.,
1985]. Previous studies with heterogeneous groups of cancer
patients, have usually found that females are more distressed
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than males and that younger aged patients are more distressed
than older patients [Coursey et al., 1975; Goldberg et al. 1984;
Plumb et al., 1977; 1981; Cassileth et al., 1984]. This suggests
that the relationship between variables such as gender, age
and mood, therefore, may be an effect which varies according
to cancer type. This is clearly an area for further investigation.
Adjustment and Coping
Studies have often invoked a concept of "coping" to explain the
adjustment of patients and/ or their families to cancer and its
implications [Weisman and Worden, 1976-77; Lloyd et al.,
1984; Ell et al., 1989; Keitel et al., 1990]. In these studies
adjustment is often associated with a reduction in distress
over time following diagnosis. In the current study no such
reduction in distress is observed across the groups. In this
study, as in numerous other studies described in the
literature, the diagnosis of cancer is regarded as a crisis for all
concerned and a number of theoretical models are available to
explain the coping and adjustment reaction to this [McCorkle
and Quint-Benoliel, 1983]. A commonly used model is that of
Lazarus [1980] and Folkman and Lazarus [1980] in which the
subject makes cognitive appraisals of the "threat" of the
illness. At the diagnosis of cancer, the patient and carer would
make an appraisal based on "life-threat" probably derived
from fears of death, physical suffering, deterioration,
recurrence and spread of the disease. The theory would
predict that this would relate negatively to adjustment and
would create a disruption to the subjects' equilibrium.
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Following this initial period of crisis, secondary appraisal
would take place where the subject evaluates their coping
resources and the available options towards resolution of the
crisis. The introduction of treatment options to the patient and
their carer, coupled with information, may help the
development of the perception of control over the situation.
This perceived control has been explained in terms of
providing a source of mastery over the situation [Taylor, 1983]
which in turn leads to a state of reduced distress and
increased coping [Taylor et al., 1984],
This theoretical perspective explains the findings of reduced
distress over time. Obviously as the illness progresses and new
crises occur a continual process of re-appraisal takes place
leading to a reduction in levels of distress.
The results from the current study suggest that such a
process may not be occurring effectively, or that the
assessment points used do not detect it. The diagnosis of lung
cancer for the patient and the carer may be imposing multiple
stresses including pain, threat to life, hospitalisation, effect on
employment, effect on family and special treatment
procedures. In addition, the patient and carer must try to
preserve emotional equilibrium as well as to maintain
relationships with friends, family and hospital staff. A key
feature for facilitating a coping response is the type and
amount of information that is given at diagnosis. Obviously,
the informational needs of patients and carers change
throughout the illness "process" and new information may
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need to be assimilated as the clinical picture changes. Mages
and Mendelsohn [1979] found that the informational needs at
diagnosis are concerned with the implications of the disease on
the patients' life and the hopes and expectations of treatment.
Following this early period, patients tend to seek maximum
information regarding prognosis [Feldman, 1978], effects on
current and future lifestyle [Jones, 1981], and the effect on the
family [Feldman, 1978].
In the current study the prevalent practice in the oncology
department was to give patients the most accurate
information possible about their illness. Patients were,
therefore, told that their illness was incurable and that the
aim of treatment was control of the disease for as long as
possible. From the data collected in this study there is no
objective assessment of the actual information given at
diagnosis. In the first line group of patients and carers and the
follow up group, however, the majority accurately report the
aim of treatment suggesting that the information has been
correctly assimilated. The majority of carers in the palliative
therapy group also follow this pattern in accurately reporting
the aim of treatment but this is not reflected in the patients'
reports. A significant proportion of the latter (35 per cent)
report that the aim of treatment is "cure". This suggests that
for most patients and their carers, accurate information has
been communicated, at least about the aims of treatment.
Some people, however, could be regarded as using "denial" as
a coping style particularly in the later stages of the disease.
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Interestingly, the mean anxiety scores of these patients were
not significantly different from those who accurately reported
treatment intent. In addition, those carers who believed that
the aim of treatment was curative at this stage (palliative)
were not significantly more anxious or depressed than those
who correctly reported the aims of treatment.
If a diagnosis of lung cancer carries with it a high level of
uncertainty, then perhaps this uncertainty persists throughout
the illness and maintains the level of distress in patients and
their carers. Certainly the patients and their carers in the
current study do not demonstrate obvious adjustment leading
to a reduction in distress. A further explanation put forward
by McCorkle and Quint-Benoliel [1983] concerns the effect of
symptoms that are continually present. They speculate that
even though patients may have completed treatment they
may still be experiencing symptoms, either from the illness or
treatment (as in the current study), these symptoms serve as
a constant reminder of the illness and its implications and,
therefore, mediate against any reduction in distress. This, in
turn, may have an effect on the carer, who will be very aware
of the symptoms and may have very clear recollections of
information given at diagnosis (that the illness is incurable).
These data hava implications for the type and timing of
information that may need to be imparted by health care
professionals to patients and their carers during visits to the
hospital. It also suggests that patterns of adjustment may vary
depending on the type of cancer from which the patient is
suffering and treatment approach that is being used.
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Social Support
The data described in this study show that there is no
statistically significant difference between the three groups of
patients and carers with respect to perceived social support
from family and friends. The data also indicate that the
perceived social support from family members and friends
between patient and carer are, not surprisingly, correlated.
In the present study social support does not follow a pattern
of reduction over time which has been reported by other
researchers. In such studies typical expectations about
independent functioning, for example, have been found to
colour supporters' reactions to the victims of crisis and thus
limit the support given, there is an expectation that distress is
"time limited". Vachon [1979] reported that women with
breast cancer are expected to resume quickly their normal
functioning once medical intervention has been completed,
despite the fact that many women are distressed long after
successful surgery. Walker et al. [1977] found that widows
frequently report that close family members expect them to
limit their grieving following the loss, and reduce their
supportive behaviours accordingly.
Perceived social support and anxiety and depression in the
patient were not found to be significantly correlated at any
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stage of the illness process. The association between social
support and mood in the carer is more complex.. There is a
highly significant (positive) correlation between anxiety and
social support from the family in the first line management
group only. The correlation between social support and
anxiety at other stages of the illness process fails to achieve
statistical significance. The correlations between depression
and social support from family achieved significance in the
first line management group and the follow up group but not
in the palliative therapy group and the correlations between
social support from friends and depression achieve
significance only in the follow up surveillance group.
These significant associations indicate that high levels of
distress in these groups are associated with high levels of
social support. The measure of social support employed in this
study was the Perceived Social Support Scale developed by
Procidano and Heller [1983]. The scale, unlike many other
scales available, uses a specific definition of social support,
that of "perceived emotional social support". Numerous studies
have found that high levels of emotional support are related to
improved levels of distress [Brown et al., 1975; Vachon, 1984;
Punch and Mettlin, 1982]. The Perceived Social Support Scale
has been used to examine the stress buffering effects of other
disorders and illnesses such as multiple sclerosis [Mclvor et
al., 1984], alcoholism [Clair, 1988], and breast cancer [Jones
and Reznikoff, 1989]. These studies support the "buffering"
hypothesis of social support in that high levels of perceived
emotional social support are associated with lower levels of
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distress (a significant inverse correlation). How then are we to
explain the results of the current study which appear to
contradict those from the literature?
One explanation of the results could be that the level of social
support is a reaction to the distress exhibited by the
individual involved. The significant associations between social
support and anxiety and depression in the carer are found in
the first line group and the follow up group. These periods are
associated with the recent diagnosis of the illness and a time
of great uncertainty. The perceptions of the carer in the first
line group also support the supposition that support is a
reaction to level of distress, as they feel that support has
increased. The follow up group of carers, however, feel that
there has been a decrease in support. In addition, when asked
about perceived changes, specifically from family and friends
in the past month, the majority of carers in each group felt
that there had been no change. This pattern of response was
also found in answer to questions concerning the availability
of family and friends in whom they could confide. This
suggests that the social support is not a reaction to distress or
one would expect the carer to recognise an increase in the
availability ana amount of support.
Some caution must be exercised in arriving at this conclusion
as the current study may not provide enough data to
substantiate it. The responses are concerned with perceptions
of change in support over a relatively recent time period, the
last month. The distress exhibited by patients and their carers
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may have persisted for a longer period of time. The increase in
support, therefore, may have occurred some time ago in
response to this and the respondent may not be including this
in answer to the questions. Even in the first line management
group, the levels of distress may have been rising for some
time, for example, since the patients first developed their
symptoms. Aitken-Swan and Paterson [1955] reported that
many patients suspect their diagnosis when their symptoms
first occur, before they visit their doctor. Other researchers
have reported that levels of distress rise during this period of
time [Green, 1976]. The social support in this first line group
may, therefore, have been a reaction to this early rise in
distress but there is no way of detecting whether the distress
preceded the social support or vice versa.
Researchers have commented that not only the stressor but
also the "victims'" distress can elicit support but this
distinction can be very difficult to make [Shinn et al., 1984].
These authors have commented that both the recipient and
the giver of support themselves, may not be aware of whether
they are reacting to the fact of having cancer, or to the distress
of its victims.
An alternative explanation of the data, therefore, could be that
the social support from family and friends is a reaction to both
the diagnosis of cancer and the distress in the carer. The
significant correlations, after all, are seen in the first line
management group and the follow up group of carers. The
data from the present study are unable to answer the question
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with certainty but some of the responses suggest that there
have not been noticeable changes in social support for carers.
Another explanation that could be postulated to explain these
results is that social support is indeed stressful in itself. Those
carers with high levels of social support are more distressed as
a result of it. Blau [1964] suggests that social interaction
involves benefits and costs for both recipients and providers
of support. Providers may obtain intrinsic satisfaction for
providing support, but they expend time, energy, and
resources in the process. Recipients can clearly benefit by
receiving supportive resources but may also experience stress
as a result of supportive interactions as the norms of
reciprocity and equity suggest that they should repay the
support received. This inability to reciprocate can create stress
and distress in the receiver [Shumaker and Brownell, 1984].
Another explanation of the deleterious effects of social support
is that it may threaten the recipients' self esteem. The social
support may imply a superiority-inferiority relationship
which conflicts with values of self reliance and independence,
or may lead the recipient to admit to distress and therefore
vulnerability or a perception of weakness [DiMatteo and Hays,
1981; Fisher et al.,1982; Chesler and Barbarin, 1984;
Shumaker and Brownell,1984].
Croog [1970] reported that social support from the family can
serve as a source of distress due to a conflict of role or value.
The emotional support provided by the family may accentuate
to the recipient the reversal of roles created by their illness
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and its treatment which may in turn lead to distress. DiMatteo
and Hays [1981] have reported this effect in a number of
other serious illnesses (such as heart disease and multiple
sclerosis). Hyman [1971] in a study of patients with a variety
of chronic illnesses, found that those people whose families
were more attentive to them or allowed them to express their
fears and worries more often, tended to be more disabled and
more distressed than those without this form of support.
One study in particular produced very similar results to the
present study. Revenson et al. [1983] found that emotional
support had very little effect on adjustment in patients with
cancer. In patients not undergoing chemotherapy or radiation
treatment, or with limited functioning, this type of support
increased negative mood and decreased self-perceptions of
worth or mastery. Revenson et al. suggest that at certain times
supportive behaviours may represent threats to the recipients'
autonomy and self worth. Social support may actually
constitute a source of stress. The expression of a warm
empathetic environment from family or friends may serve to
highlight the recipients' inability to reciprocate that support.
This may be complicated further in an illness such as lung
cancer which has a poor prognosis, if the recipient (patient or
carer) does not foresee a possibility of returning that support
in the future.
The results of the present study could be interpreted in this
light particularly in view of the respondents' perception that
social support has been relatively stable in the recent past.
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This would lead us to conclude, in a similar vein to Revenson
et al., that, at certain times of the illness process, social
support acts as "non support" and could be viewed as a source
of distress in itself. This is consistent with a view shared by
several other authors [Heller, 1979; Billings and Moos, 1981].
In fact, Heller [1979] suggests that social support may serve as
both a source of, and a buffer against stress and, therefore, it
may not be possible to identify consistently "positive" or
consistently "negative" effects.
One could speculate that the emotional support in the current
study is being provided by people who are distressed
themselves by the patients' illness (family and friends).
Certainly the impact of cancer may affect a wide range of
individuals. This may mean that those people who are
providing the support are too stressed or distressed to provide
effective support to each other.
In a study of the effects of war, for example, on women whose
"loved ones" were in the armed forces, Hobfall and London
[1986] found that higher levels of perceived emotional support
were related to more, not less psychological distress. The
findings could be interpreted that social support leads to
greater distress and is stressful in itself. Hobfall and London,
however, found that there was a "pressure cooker effect",
whereby those with greater social support were exposed more
frequently to rumours and to constant confrontation with the
reality of war through their interaction with others in similar
circumstances. Other studies have suggested that individuals
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exposed to a common crisis may compound their distress
through interaction with each other [Myers and Lamm, 1976].
Marlowe [1979] found that soldiers exposed to a combat
situation often develop psychological distress in groups.
Marlowe discovered that rather than behaving as a supportive
confidant to those who develop distress, the supporter, who is
also vulnerable, may develop distress themselves and a
circular reaction is formed.
A similar effect could be taking place with lung cancer
patients and their carers. The emotional support being
assessed here, is support provided by family and friends who
may be distressed themselves. However, in this current study
we have no way of identifying this. They may be still
providing emotional support, but their distress, interacts in a
negative fashion with the recipient of that support and it
therefore fails to "buffer" the stressful effects of the illness
and its treatment. This area is certainly worth further
investigation to ascertain the validity of such a supposition.
The present study suggests that social support may be
associated with other variables in addition to the stigma of
cancer and the presence of psychological distress. In those
patients receiving first line chemotherapy, for example,
significant correlations are found between self reported
symptoms and their severity and perceived social support
from family and friends. This association, however, is not
sustained at other stages of the illness, nor is the social
support for the carers associated with the patients' symptoms
365
and their severity. This group of patients undergoing first line
chemotherapy are prone to a number of influences. Their
illness has been diagnosed relatively recently, their carers
tend to be very distressed, they are undergoing
chemotherapy, and as a result, may be experiencing a range of
symptoms and side effects. It is, therefore, difficult to
disentangle these complex effects precisely.
A number of studies have reported, however, that those
patients who are more debilitated by their illness and/ or its'
treatment, report lower levels of social support than those
who have completed their treatment. Peters-Golden [1982]
found that patients with breast cancer undergoing palliative
chemotherapy were more likely to report inadequate levels of
social support than those who had received curative
treatment. More recently Willey et al. [1990], in a large study
of 1,581 newly diagnosed patients with cancer reported that
those patients who were more impaired, received less social
support. These patients complained principally of pain and
had a poorer prognosis. Closer examination of this data,
however, reveals that the patients with lower levels of social
support also reported more days spent in bed, which in turn
led to lower levels of social activity. In reality, therefore, this
latter study is actually measuring an individuals' ability to
obtain social support rather than the direct effect of symptoms
on social support.
The present study reports the opposite of this result. The
correlation is a positive one: the more symptoms one has and
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the more severe they are, the more likely the patient is to
1
receive social support. The fact that this situation is only found
in the first line management group of patients suggests that it
is not merely the presence of symptoms that increases social
support but other factors as well.
Social support in carers was found to be inversely related to
age in the follow up and palliative therapy groups. The older
carers received less social support from both family and
friends in these groups. This finding is consistent with a
number of studies reporting the same type of statistically
significant inverse correlation [Zautra, 1983; Heller and
Mansback 1985; Vaux 1985; Cutrona, 1986].
The social support in both patient and carer in the present
study does not correlate with personality variables. This
suggests that social support or the reporting of social support
by the respondent cannot be explained by specific
characteristics of the individual. Henderson et al. [1981], for
example, found that characteristics such as neuroticism can
negatively affect the evaluation of support availability in a
spurious manner.
The failure of perceived emotional social support to "buffer"
the distress associated with lung cancer in the present study
may also be related to the nature of lung cancer itself. The
beneficial effects of emotional social support have been
reported in illnesses such as breast cancer [Bloom, 1982; Jones
and Reznikoff, 1989), multiple sclerosis [Mclvor et al., 1984],
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alcoholism [Clair, 1988], and intestinal malignancies [Dunkel-
Schetter, 1984]. These illnesses tend to have a longer duration
than lung cancer. One could postulate that lung cancer, because
of its demanding treatment regimens and its extremely poor
prognosis, imposes a complex array of stressors on both
patients and their carers.
Driever and McCorkle [1984] suggest that the diagnosis of lung
cancer affects every aspect of life during the initial period,
with continuing difficulty in adaptation over many weeks or
months. Hughes [1985a] found that 16 per cent of patients,
prior to having the diagnosis confirmed had symptoms of
depression, suggesting a suspicion of the seriousness of their
situation and perhaps an anticipation of the diagnosis.
Rowland [1989] supports the view that the diagnosis and
treatment of lung cancer is composed of multiple complex
stressors. She views this in relation to the developmental stage
that the adult has reached in their life. As lung cancer tends to
be an illness of "middle age", the issues it raises are related to
survival, coping with treatment, attractiveness, sexuality,
financial concerns, ability to work, ability to socialise and
perhaps seeing ones"' children establish their own
independence in the world. In addition, there may be difficult
issues relating to having to be "cared for" and "caring for" and
a period of "invalidism".
368
These multiple stresses may be further complicated by the
fact that there is a very strong association between lung
cancer and cigarette smoking. This may lead patients to
believe that they "brought the illness on themselves" or for
those people who are not smokers, they may feel they have
developed the illness as a result of inhaling others' smoke.
This complicating factor may present a difficult and complex
problem for patients and their family alike [Lebovitz et al.,
1983; Cooper, 1984]. Some authors have viewed the reaction
of patients to a diagnosis of cancer as a "grief" reaction which
may persist through the treatment of the illness and beyond
[Holland, 1976].
Revenson et al. [1983] describe this pattern of multiple
stressors persisting well beyond the diagnosis. The treatment
may lead to strained, disrupted interpersonal relationships as
well as diminished social contact. Revenson and her colleagues
questioned their sample of patients about the range of stresses
that the disease imposed. Fifty per cent of respondents
reported fears and anxieties related to death, 38 per cent
reported stress related to disease and treatment symptoms
(nausea, weakness, hair loss and fatigue), 31 per cent reported
stresses related to limitation of mobility and activity, and 25
per cent reported stresses related to problems with social
relationships. They also found a series of more minor stresses
related to emotional reactions to being ill and complaints
about the quality of health care received. In Revenson's study
respondents tended to identify a number of these stresses
rather than one.
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The present study demonstrates that lung cancer and its
treatment is associated with a wide range of psychosocial
sequelae for patients and their families. Given the complex
nature of the illness, it is unreasonable to expect social support
to be able to reduce the distress that this may produce.
Perhaps the stress buffering effects of emotional social
support would be more apparent if the stressors were not so
interwoven. Certainly, some aspects of the illness have been
linked to greater distress than others. Meyerowitz et al.
[1979], for example, have found that undergoing
chemotherapy and being physically limited in one's ability to
perform daily functions of living have been associated with
greater emotional distress than some other aspects of the
disease and its treatment (undergoing radiotherapy). However,
Revenson's results demonstrate that social support alone is
inadequate in reducing the distress associated with this
complex array of stressors.
In the present study ample evidence is presented of the
complex nature of the illness and its treatment. The stepwise
multiple regression analyses that have been performed
indicate that a range of variables contribute to the distress in
both patients and their carers.
The psychological state of the "significant other" was
consistently found to have a significant impact on the other
person. In addition, other variables such as perceived social
support, the number and severity of symptoms, psychological
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adjustment to illness and certain demographic factors (age)
and personality traits were also found to contribute
significantly to distress in the patient or their carer. These
combinations of variables support the complex nature of
cancer and its treatment. Other studies have concentrated
upon other constellations of variables contributing to distress
in other types of cancer. Ell et al. [1989] found that social
support and a sense of personal control over the disease were
associated with a better psychological status. Goldberg et al.
[1984] found that depression in patients with lung cancer was
associated with a poor physical status whereas the spouses'
depression was associated with low levels of social interest
and involvement.
The present study indicates that aspects of the patients'
environment adversely affect the carer and vice versa.
Although such a statement may seem an obvious one to make,
other studies in the literature fail to consider the reciprocal
effects of patient and carer variables.
Further support for this multistressor view of lung cancer can
be found in the factor analyses performed in the current
study. At each stage of the illness and its treatment the large
data sets can be reduced to either seven or eight independent
factors. These factors support the findings of the multiple
stepwise regression analyses performed on the data. In each
of the three groups, distress in the carer and distress in the
patient form independent factors as does social support and
symptomatology. Other factors including age, adjustment to
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illness and certain personality characteristics also can be
found as independent factors.
Given the complex nature of the illness and its treatment it is
not surprising that a single variable such as social support is
unable to reduce significantly the distress associated with it.
In fact the current study suggests that emotional support may
actually contribute to anxiety and depression in both patients
and their carers.
The distress associated with the illness and its treatment may
require other types of social support to ameliorate it. Social
support, after all, is a complex concept itself composed of a
number of different types. These include:
1. The expression of positive affect which may include
information that one is cared for, loved or esteemed;
2. Encouraging the open expression of beliefs and feelings;
3. Acknowledging the appropriateness of a person's beliefs or
feelings;
4. Offering advice or information;
5. The provision of material aid;
6. The provision of information.
These different types of social support have been described by
Wortman [1984] who makes the point that there is
considerable overlap between them. In addition, other authors
have argued that not all types of support are equally effective
in reducing distress [Thoits, 1982].
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The current study utilised a measure of perceived emotional
support as this had been found to be the most helpful to
patients in reducing distress and giving reassurance [Moos and
Tsu, 1977; Jones and Reznikoff, 1989]. In addition, Dunkel-
Schetter [1984] in a study of 79 patients with breast or colo¬
rectal malignancies found that emotional support was reported
as being the most helpful. Eighty one per cent of respondents
in her sample reported that the most valuable emotional
support came from family and friends. In contrast to this,
Dunkel-Schetter found that 44 per cent of respondents
reported that provision of information and advice by family
and friends was unhelpful. This result was replicated more
recently by Dakof and Taylor [1990] in a group of 55 patients
with mixed cancer types.
Lung cancer may present a different or more complex range of
difficulties for patients and their carers, which may require
more than just emotional social support. This is consistent with
the view of researchers who maintain that each component of
social support should be considered as potentially important
and that its' impact on well being should be treated as an
empirical question [House, 1981]. In a later thesis, House and
Kahn [1985] make the point that it can be very difficult to
discriminate satisfactorily among the different types of
support and support providers. There may be considerable
overlap as people generally receive multiple types of support
from the same persons. Those who give emotional support are
the ones who also can be turned to for instrumental aid,
information and affirmation or appraisal. House and Kahn
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conclude that this does not mean that the analysis of different
types of support should be forsaken.
In the present study, the measurement of other types of social
support may have revealed some complex interactions. In the
case of lung cancer, for example, a patient or their carer who is
no longer able to meet family responsibilities as a result of
certain aspects of the illness, may benefit from specific help
with household tasks (tangible support). The variety of
uncertainties and fears that the patient and their family may
be experiencing regarding the effects of chemotherapy may
benefit from clarification of what is happening (informational
support) as well as the reassurance that the feelings and fears
are a normal consequence of the illness (validation).
The issue of the value of social support in lung cancer may be
more complex than has been considered in this study.
Structural and functional measures of support may help to
investigate the differential effects of support more thoroughly.
In addition, the patient with lung cancer and their carer may
be in a position of inequality where they may be thrust into
relationships that are not egalitarian or reciprocal as a result
of the stigma of the illness. Dunkel-Schetter and Wortman
[1982] for example, have reviewed evidence indicating that
family members and friends have conflicting feelings about
cancer, which may lead them to behave in contradictory ways.
The patient and their family may receive subtle mixed
messages as supporters try to be reassuring, comforting and
give emotional support on the surface, yet, at the same time
374
exhibit negative non-verbal behaviours. Furthermore, the
positive behaviours perceived by the recipient and the
providers of that support may be mixed with subtle signs of
strain or even occasional negative outbursts. This may lead the
recipient to report positive high levels of emotional support
which he or she relies upon, but which are also tinged with
strong negative inflections.
These hypotheses suggest that a range of different types of
support need to be assessed as well as both the positive and
negative aspects of these supportive behaviours. This is
particularly true in lung cancer where each stage of the
patients' management may provide different types of stress.
Cohen and McKay [1984] put forward the view that only when
supportive relationships provide the appropriate forms of
support, will they operate to "buffer" the effects of stress and,
in so doing, reduce levels of distress.
Finally, Dunkel-Schetter [1982] advises caution in immediately
interpreting a positive correlation between emotional support
and distress as evidence of social support causing this
distress. She puts forward a plausible alternative explanation,
in that patients with poor prognoses (including lung cancer)
may make more demands for support than those with better
health or a less threatening illness. As a result they may elicit
more support but still be exhibiting high levels of
psychological distress. As yet, this hypothesis remains
untested although a recent study by Rose [1990] partially
supports this view. Rose found that if cancer patients
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perceived their prognosis to be poor then they had a
heightened desire for emotional support from friends and
family, but the study was unable to ascertain whether they
actually received this support. The results, however, did
support the view of distinct types of social support
(instrumental and emotional) potentially serving different
functions at different times during the illness and, therefore,
requiring separate examination.
The impact of lung cancer on the lives of patients and
their carers.
The data from the current study suggest that the greatest
impact of lung cancer and its treatment on psychosocial
adjustment of the patient occurs during the first line
management and during palliative therapy. This finding is
consistent for the seven domains assessed by the Psychosocial
Adjustment to Illness Scale (PAIS). The trend of the scores in
these domains indicates a worsening of adjustment problems
in the palliative therapy group. This trend is seen in "health
care orientation", "vocational environment", "domestic
environment", "sexual relationships", "extended family
relationships" and "psychological distress". The patients' social
environment, however, reverses this effect and a significantly
greater impact is seen during first line chemotherapy.
The PAIS domain scores of the three groups of primary carers
follows a similar pattern to that of the patients. In all seven
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domains the trend is towards a worsening of scores during the
time of palliative therapy. The carer is clearly adversely
affected by the illness during first line management and
palliative therapy. In comparing the PAIS scores of patients
and their carers some interesting differences emerge.
In the first line management group, the carer experiences
greater problems in terms of "health care orientation" than the
patient . In terms of "sexual relationships", however, the
patient reports greater difficulties than the carer. This
suggests that the carer has a more negative view of the illness,
expectations of treatment and attitude to health care than the
patient. The patient, however, has experienced a more marked
adverse change in sexual interest, frequency of sexual activity,
sexual satisfaction and interpersonal "sexual conflict" than the
carer during this phase of the illness.
In the follow up surveillance group who have completed
treatment, the carer displays greater problems of adaptation
in the domains of "health care orientation", "sexual
relationships", "social environment" and "psychological
distress". The domain of "social environment" assesses the
respondents current social and leisure time activities and the
degree to which they have suffered impairment or reduction.
The domain assesses actual participation and interest in
participating in individual leisure activities, family leisure
activities and social leisure activities. The domain of
"psychological distress" assesses a range of psychological
sequelae (anxiety, depression, hostility, guilt, worry, self
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devaluation and body image distortion). In the follow up
group, the carers show greater adjustment problems than the
patient in these areas.
In the palliative therapy group the patient demonstrates
significantly poorer adjustment than the carer in terms of
sexual relationships. The carer, however, demonstrates
significantly greater adjustment problems than the patient in
the domains of "social environment" and "psychological
distress".
Lung cancer and its treatment has a significant impact on the
psychological adjustment of the patient's carer. Whilst a
number of studies have used the PAIS to assess the impact of
different cancer types on the patient [Baider et al., 1983; Cain
et al., 1983; Baider et al., 1989; Gilber and Kaplan de Nour,
1989], the adjustment of the carer has been largely neglected
and those which have been conducted have been
methodologically weak. In a study of the carers of patients
with cancer of the colon [Baider et al., 1989] it was found that
the adjustment of male carers was worse than that of female
carers on all the PAIS domains. Unfortunately, this study
relies on a single assessment and no information is given
about the physical symptoms, time since diagnosis or current
treatment.
The results of the current study demonstrate a marked impact
of the illness on the carer at a time when the patient is not
receiving any active treatment (follow up surveillance). It has
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been recognised for some time that this is time of uncertainty
for the patient [Koocher and Malley, 1981] but is clearly an
extremely difficult period for the patients as well.
A number of studies describe the wide ranging effects of other
types of cancer on the lives of patients. Fobair et al. [1986] in a
study of patients who had been treated for Hodgkin's
lymphoma in the past ten years, found that 43 per cent
reported difficulties with their leisure and social activities, 42
per cent reported employment problems, 32 per cent were
experiencing marital problems and 20 per cent reported
decreased sexual activity and interest. Unfortunately this
study did not examine the impact of the illness and its
treatment on the patients' partner or carer, so the perspective
is necessarily limited.
Moynihan [1987], in an elegant study of the psychosocial
impact of testicular cancer, examined both patients and their
carers. In her sample of 102 patients having undergone
treatment for testicular cancer she found that 29 per cent of
patients complained of sexual problems, 43 per cent of
employment problems with their current job, and 60 per cent
of difficulties in obtaining new employment. In the group of
carers, only 18 per cent complained of sexual problems and
figures for relationship and employment difficulties were not
reported. In the group of carers, however, 69 per cent
reported that they would have liked additional emotional
support. Whilst this study demonstrates high levels of
379
psychosocial morbidity in patients, the picture for their carers
still remains unclear.
A large literature exists which examines the impact of
different types of cancer on sexual relationships [Cain et al.,
1983; Anderson and Hacker, 1983; Wise, 1987; Gritz et al.,
1989; Schover et al., 1989]. A common finding in this
literature is that the partner of the patient perceives fewer
sexual problems than the patient themselves [Moynihan, 1987;
Gritz et al., 1989], which, to some extent, is echoed by the
current study in the first line management group and the
palliative therapy group of carers. Other areas adversely
affected by cancer and its treatment are employment [Houts et
al., 1986; Fobair et al., 1986; Welch-McCaffery et al., 1989],
insurance coverage [Mor, 1986; Crothers, 1987], and social
relationships [Peters-Golden, 1982; Stam et al., 1986]. These
studies, while describing the impact on the patient, fail to
recognise the wide ranging impact of the disease on the carer.
Recent studies and review papers have commented on the
dearth of information relating to the impact of cancer on the
psychosocial environment of the carer [Moynihan, 1987; Redd
and Jacobsen, 1988; Lewis, 1990]. Yet studies consistently fail
to take account of the importance of this fact in their design
concentrating exclusively on the patient [Liang et al., 1990].
Paradoxically, however, one of the principal findings
consistently reported is the patients' concern of the impact of
the illness on the family [Stam et al., 1986; Liang et al., 1990].
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The current study not only demonstrates the needs of patients
and their relatives using the PAIS scale but also describes a
number of other psychosocial needs using the brief interview
schedule.
The responses to the questions in this interview schedule
provide additional insights into the perceived impact of the
disease on the patient and their carer. A significant number of
both patients and carers in each of the three groups report
that their main worry concerning the illness, is its effect on
the family. This concern is consistent at each phase of
treatment, whereas specific additional worries are present
only at certain times during the illness. It is not surprising, for
example, that the predominant worry for patients and carers
in the first line management group, is the fear of "not getting
better". On the other hand, the main worry of the palliative
therapy group is the effect of the illness on the family and the
presence of pain and suffering.
The concern regarding the effect of the illness on the family
has been reported in a number of previous studies. Stam et al.
[1986] found that the most frequent concern in a sample of
449 newly diagnosed patients assessed over a period of one
year, was the impact of the illness on the family.
A similar study conducted by Wellisch et al. [1983] in a group
of patients who were "housebound" as their illness was more
advanced found that their most frequent concern was somatic
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side effects of the illness, and, in particular, the presence of
pain.
The present study also demonstrates that patients and carers
have a number of worries concerning treatment. In the first
line group, the most common concern was the side effects of
the treatments; in the follow up group, the majority of patients
and carers reported that they did not have any worries about
the treatment. In this latter group, however, 25 per cent of
patients were concerned that they may require further
treatment in the future. In the palliative therapy group of
patients and carers, the most common concern was the fear
that the treatment would be ineffective in controlling
symptoms or "in shrinking the tumour".
The effect of treatment on fears, worries and mood state has
been reported in numerous studies [Lloyd et al., 1984; Love et
al., 1989; Gilbar and Kaplan de Nour, 1989; Christ and Siegel,
1990]. Holland and Lesko [1989] describe the fears and
worries that patients experience when they first hear that
treatments such as chemotherapy are required. These fears
and worries, they claim, are the result of more general societal
fears of cancer treatment which have persisted and grown
over many years. In addition to the generic or societal fears of
cancer treatment patients also develop additional concerns
following any previous cancer treatment they may have
received. Meyerowitz et al. [1983] found that women who had
received chemotherapy for breast cancer still had lingering
fears and concerns of the possibility of future treatment up to
382
two years after the cessation of therapy. Those patients who
later received further treatment found that their distress was
compounded by the fears and worries developed during their
earlier experiences.
Patients, it appears, make some form of "cost-benefit analysis"
when considering the effects of treatment. Despite the fact
that treatment in the current study was a major source of
concern, the majority of patients and their carers hoped that
this would enable them to achieve long term control of their
disease as well as relieving troublesome symptoms. These
types of hopes and aspirations presumably help the patients
and their families cope with the fears, concerns, and rigours
imposed by chemotherapy and radiotherapy. These hopes and
aspirations are probably formed at the stage of diagnosis
based on information imparted by members of the health care
team.
When reporting the actual aims of treatment a surprising
perception was noted. In the first line group the majority of
patients and carers recognised that the aim of treatment was
to control the disease (a correct perception). In the follow up
group the majority of respondents correctly identified the
monitoring of progress as the aim of treatment. In the
palliative therapy group, 35 per cent of patients perceived the
aim of treatment as being "curative". In contrast to this only
12.5 per cent of carers responded in this way. Fifty two and a
half per cent of carers correctly reported that the aim of
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treatment was to relieve troublesome symptoms, whereas
only 25 per cent of patients responded in this way.
Similar findings have been reported by Mackillop et al. [1988].
In this study, 100 patients with advanced cancer were
interviewed, 33.3 per cent believed that the therapeutic
intention was to cure their disease, whereas, in reality, the aim
was palliation. Whereas the majority of the physicians (90 per
cent) treating these patients were not aware of this
misunderstanding and felt that they had accurately informed
the patient of the extent of the disease and the aims of
treatment.
An earlier study by Eidinger and Schapara [1984] interviewed
190 patients with metastatic disease. Only 55 per cent of this
sample were aware that their cancer had spread and only 48
per cent knew the location of their metastases. The group
were receiving supportive care only or palliative treatment,
yet 37 per cent reported that the goal of treatment was to
"cure them". In this sample of patients, however, 84 per cent
reported being satisfied with the amount of information they
had received from their physician with regard to their disease
and its treatment.
These studies, including the present one, consistently report
that about one third of patients "misperceive" the aim of
treatment. In the present study, there is no objective
assessment of the information that patients were actually
given. Certainly the prevalent view in the department was
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that patients were told honestly and openly the facts about
their illness and its treatment.
Perhaps then, this 30 per cent of patients represent those
people who utilise "denial" as a coping strategy. Cassileth et al.
[1980] has reported that some patients who are seriously ill,
never fully acknowledge the gravity of their situation, no
matter how well it is explained to them. Some authors have
regarded denial as an adaptive process which enables the
individual to cope with an otherwise untenable situation
[Hacket and Cassem, 1970; Taylor, 1983]. Unfortunately, in the
present study it is not possible to discern the relative
contributions of failed communications and/ or denial in the
observed effect.
Both patients and their carers report a significant impact of
the illness and its treatment on their personal lives. The effect
is clearly different for the patients than for the carers. In the
first line management group, 50 per cent of the patients
reported that the illness was sometimes on their mind, 10 per
cent found it was always on their mind, and 37.5 per cent
reported that they tried not to think about it. The carers, on
the other hand, were more evenly distributed in their
responses: 45 per cent said it was on their mind all the time,
27.5 per cent that was sometimes on their mind, and 25 per
cent tried not to think about it.
In the follow up group 52.5 per cent of the patients reported
that it was sometimes on their mind but 25 per cent reported
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that it was on their mind all the time and only 10 per cent
tried not to think about it. In this group, 12.5 per cent
reported that they did not think about it. The majority of the
carers, however, reported that the illness was on their mind
all the time (65 per cent). The carers clearly found themselves
preoccupied by the illness even when the patient was not
receiving treatment. The same number of carers as patients in
this group reported that they did not think about it (12.5
per cent).
In the palliative therapy group further support for the view
that some patients may use denial as a coping strategy can be
found. Almost a third of patients reported that the illness was
on their mind all the time and a similar number reported that
they did not think about it. In contrast, the carers reported
that the illness was either on their mind all the time (57.5 per
cent) or on their mind some of the time (30 per cent) and only
a small number reported that they did not think about it (5
per cent).
In addition to the amount of time that patients and carers give
to thinking about the illness, they also reported that they were
usually prepared to discuss the illness with others. In the
three groups of patients and carers, the majority reported that
they were prepared to talk openly about the illness or, that
they would talk to selected people about it at selected times.
Few of the carers reported that they would avoid the subject,
but the trend among the three groups of patients was for a
significant number to adopt this latter approach. In the first
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line management group 12.5 per cent avoided the subject, in
the follow up group 17.5 per cent, and the palliative therapy
group 22.5 per cent. Again, this avoidant coping strategy may
be a form of "denial".
Few studies have looked at these specific issues in any
systematic way for either patients or carers. Howell [1986]
studied the spouses of patients with advanced cancer
receiving supportive care only. She reported that over half
the carers experienced frequent unpleasant thoughts about
the illness. Wright and Dyck [1984] interviewed the next of
kin of 45 cancer patients at three points during their illness:
diagnosis; recurrence; and during the terminal stages. They
found that in the family members, a significant number felt
that it was important to talk about the illness with others.
Vachon et al. [1977] compared the problems experienced by
widows of cancer patients with the problems encountered by
the widows of cardiac patients during the final illness. The
widows of the cancer patients were preoccupied with the
illness and experienced a greater sense of helplessness and
impotence than those of the cardiac patients.
Most patients and carers in the current study had access to
others who could offer them help and support. Both described
a range of other people or institutions providing this. A
significant number identified the church as their main social
support. This has been reported in a number of other studies
as playing a significant supportive role for patients with
cancer [Carey, 1974b]. Religious affiliation has also been shown
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to reduce anxiety in patients following their diagnosis and
during treatment [Yates et al., 1981].
The current study demonstrates the interrelatedness of
patient and their carer and the mutual supportive functions
they offer each other. It also supports other studies which
have identified family members as being the primary source
of psychological support for the patient with cancer
[Guiacquinta, 1977; Northouse, 1981; Stolar, 1982]. This is
often viewed from a "family systems perspective" which
describes the effects of an illness such as cancer as
reverberating throughout the family [Minuchin, 1974;
Northouse, 1988b].
Whilst many of the effects of the illness and its treatment on
the patient and their carer are negative, there are some
positive effects. The majority of patients and their carers
perceived that the illness had brought them closer together. A
similar finding was noted with respect to communication: the
majority of patients and their carers perceived that
communication between them had increased. These results are
consistent with those of Leiber et al. [1976] who demonstrated
that patients and their carers reported closer relationships
following their diagnosis.
During certain phases of the illness and its treatment, a
substantial percentage of patients and their carers (in the
current study) perceived that they had become more distant
and that communication between them had decreased. In the
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first line management group, for example, about 20 per cent of
patients and their carers reported this effect. Interestingly, in
the follow up group of carers about 25 per cent reported the
same perception. The latter group are of interest as carers
clearly find the follow up surveillance period difficult to cope
with. They display high levels of anxiety and report significant
problems related to psychosocial adjustment.
Communication problems have been reported between
patients and their carers in other studies. Jamison et al. [1978]
found that 89 per cent of patients before mastectomy reported
little or no discussion of emotional concerns with their spouse.
These researchers also found that 87 per cent of patients
reported communication problems while in hospital and 50
per cent continued this pattern at home. Other researchers
have commented on communication difficulties during other
stages of the illness. Checkryn [1984] in a sample of patients
whose cancer had recurred found that couples seldom talked
about the recurrence of the disease or, only discussed it to a
limited degree. Continued communication difficulties have
been reported in the terminal phases of cancer [Vachon, 1977;
Krant, 1977-78; Hinton, 1981], and estimates indicate that
approximately 60-78 per cent of couples never discuss death
with their partner at all [Krant, 1977-78; Hinton, 1981]. Krant
and Johnston [1977-78] reported significant difficulties with
communication between patients and carers during the
terminal stages of the illness. Patients in the latter study,
however, were receiving supportive care only, whereas the
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patients in the present study with advanced cancer were
receiving palliative treatment to alleviate symptoms.
Certainly, in the current study fewer patients report a
reduction in communication than can be found in the
literature: the majority of patients and their carers report an
increase in communication. This may be due to: specific
aspects of lung cancer in that survival tends to be around 12
months following diagnosis (a less protracted illness than in
most studies); or may relate to the inclusion of patients in
clinical trials. As a result patients were closely monitored and
had regular contact with the health care team which may have
indirectly helped communication between the patient and the
carer.
The importance of communication has been stressed in other
studies. Investigators have found that open communication
between partners is a significant predictor of adjustment
following the diagnosis of breast cancer [Baider and Kaplan de
Nour, 1984; Northouse, 1988b]. The latter researchers have
also reported that higher levels of family expressiveness have
been associated with better adjustment for mastectomy
patients and their husbands. Vess [1985] has found that open
communication has also been associated with better
negotiation of altered family roles following a cancer diagnosis
and Cohen et al., [1977] have found that families with open
communication styles have a better adjustment following
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bereavement. Whilst the current study does not examine
adaptation and communication, the importance of the latter is
clearly vitally important in the arena of cancer care.
There are, however, still aspects of communication which
require further study. Vachon [1977] found that 59 per cent of
the widows in one study reported that they had not discussed
death with their husbands, and this was found not to
adversely affect their adjustment. Thome [1977] reported that
some people actively choose a communication style which
inhibits the discussion of the illness. Orr [1986], in contrast to
other studies, found that breast cancer patients with an "open"
communication style had poorer adjustment than those who
avoided communication about their feelings towards their
illness. On the other hand, those patients who sought facts
about their illness from the health care team had a better
adjustment in the form of reduced distress. The issue of
communication therefore requires a considerable amount of
further research.
The present study demonstrates the range of perceived effects
that lung cancer and its treatment can have on the family. In
the first line management group and the follow up group the
majority of patients and their carers reported that the illness
had led the family to have a greater appreciation of each
other. In these two groups, however, a significant number of
respondents reported that the illness had either caused
distress, or had brought them closer together. In the palliative
therapy group, the majority of patients and carers reported
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that the main effect of the illness was to have caused distress
but that a significant number reported a greater appreciation
of other family members. Interestingly, only a small number
of respondents reported that the illness had caused division in
the family. These data broadly support a range of other reports
which indicate that families are often brought closer together
by cancer [Leiber et al., 1976], creates distress in the family
unit [Checkryn, 1984; Cassileth et al., 1985], and leads to a
change in values and priorities among family members who
become less interested in "trivia" and more interested in
spending time together [Cooper, 1984].
Patients and their carers in the current study report
significant decreases in their social interaction with family and
friends at all stages of the illness process. In addition, a
significant number report decreasing leisure activities
throughout the illness. Few patients and relatives report an
increase in these activities, although a number reported that
there had been no change in them. Other studies have
reported a marked decrease in the patients' social and leisure
activities [Maguire, 1981; Fobair et al., 1986; Moynihan, 1987].
A small number of studies have commented on the impact on
the social and leisure activities of the carer. Haggmark et al.
[1987] reported that the relatives of patients with cancer tend
to reduce their contacts with friends and family outside the
home, which in turn can lead to distress. These researchers
offered relatives the opportunity to increase their social
activity patterns and, in so doing, increased the ability of these
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relatives to deal with their feelings of hopelessness and
distress.
Howell [1986] in a study of 30 spouses of patients with
advanced cancer (mainly lung cancer) found that lifestyle
changes were the most frequently reported problem area..
The specific problems identified were the lack of social
interaction outside the home and being confined to the house
for long periods. This created difficulties for spouses as it
limited the opportunities for the ventilation of distress to
other people and feelings of inadequate support began to
develop.
Oberst and James [1985] found that lifestyle disruption was a
concern for over 50 per cent of spouses of newly diagnosed
cancer patients following surgery. Spouses reported that their
employment and household schedules were altered,
arrangement for child care changed, and social activities were
curtailed. During the period of the study (three months) these
changes in lifestyle persisted.
The effects of illness on the carer has most often been
reported in relation to psychiatric illness or dementia [Fadden
et al., 1987b]. These studies report profound effects of an
illness such as depression on the lives of the carers. Fadden et
al. [1987], in a study of the carers of 24 depressed patients,
found that 71 per cent reported a reduction in social activities.
These carers reported feeling socially isolated and
experiencing periods of low mood themselves. The incidence of
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reduced social and leisure activities in these groups
(depressed patients versus cancer patients) may be similar
but the reasons for this are completely different. In the cancer
patient the carers' activities are reduced because the patient is
physically unwell [Howell, 1976] and in the psychiatric setting
it is reported to be either due to the patient being regarded as
"unsafe" to be left alone or to the stigma that society attaches
to mental illness which causes the carer to limit their social
interaction with others [Fadden et al., 1987]. The important
point in this comparison is that the plight of the carer in
psychiatry is well documented [Brown and Harris, 1978;
Falloon et al., 1982; Fadden et al., 1987], in contrast to the
plight of the carer of the cancer patient.
Most of the carers in the current study clearly perceive
themselves as having a specific role to play in helping the
patient cope with the illness and its treatment. In the first line
and follow up surveillance groups the majority perceived their
role to be helping the patient fight the disease (55 per cent
and 45 per cent respectively) and about a third perceived
their role to be helping the patient come to terms with their
illness. In the palliative therapy group the picture changes:
only 12.5 per cent reported that their role was to help the
patient fight the disease and 42.5 per cent reported their role
to be helping the patient come to terms with it whilst 37.5 per
cent reported that their role was to support the patient. This
suggests that the carer understands the severity of the
situation during palliative therapy as their perceptions of role
have changed. At the same time the carer may experience
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conflicts if they perceive themselves as failing to fulfill these
roles. Vachon [1977] reported that carers often experience
feelings of despair and isolation as they watch the patient
suffer and feel helpless if they do no know how to help them
or fail to live up to their own expectations of themselves.
Spouses of patients with lung cancer have been found to
report feelings of helplessness as they watch their partners
deteriorate [Cooper,1984], Compared to patients with other
serious illnesses, they report a greater sense of impotence and
despair with their situation. This occurs because with other
illnesses, such as heart disease, the spouses can be active, for
example by attending to the patients' diets and their activity
needs, whereas the spouses of cancer patients feel that there
is very little they can do to help the patient [Vachon, 1979].
Although the carer may perceive themselves as having a role
to play in the patient cope with the illness, they may find
themselves overwhelmed with other demands. Cancer, as
described earlier, imposes a wide range of stressors on the
carer. Each stage of the illness and its treatment introduces its
own fears, worries and stress [Weisman, 1979]. These may
include the existential threat of cancer and its associated
images of pain and death, suffering and distress from
treatment, effects on lifestyle, uncertainty of the future and
impending death [Lewis, 1990]. Wright and Dyck [1984] found
that the four most commonly cited concerns of family
members were: fear of the future; the problem of obtaining
information; the stress of watching the patient suffer and the
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stress of waiting. Given this range of problems, the carer may
not be able to fulfill all the expectations they may have of
themselves.
Clearly the current data do;* not elucidate whether carers are
able to realise their role expectations in the patients' illness
and its treatment. Role conflict, however, may be an area that
would benefit from further research and investigation.
The relevance of the findings of the current study to
clinical practice
The current study demonstrates the impact of lung cancer and
its treatment on the psychological state of the patient. There is
clearly an adverse effect on the mood state of certain patients
and a range of factors have been shown to contribute to this
distress. In particular the mood state of the patient's carer has
been shown to have a significant contribution to this.
These results suggest the need for psychological intervention
with these patients. This is not a novel suggestion and has
been put forward by researchers in the past with respect to
the psychological impact of other types of cancer [Maguire,
1980; 1984]. In the area of lung cancer, however, there have
been few studies examining the psychological impact of the
disease. Bernhard and Ganz [1991b] in a review of the area
recently commented, "to our knowledge, there are no
comprehensive reviews on psychiatric distress in lung cancer
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patients"(p481). They would like to see more research
conducted, particularly research concerning the effects of
psychological therapy in these patients.
There is a comprehensive literature concerning the impact of a
range of psychological interventions with cancer patients (as
well as psychotropic drug use) [Derogatis et al., 1979; Jaeger et
al., 1985]. Gordon et al . [1980] compared standard hospital
care (i.e. no formal psychosocial intervention) with supportive
psychotherapy and found a number of benefits stemming
from the latter approach. The psychotherapeutic intervention
was associated with a more rapid decline in negative affect
and a higher level of general activity.
Bridge et al. [1988] in a six week randomised controlled trial
of 154 women with breast cancer examined the impact of
relaxation and imagery alone and in combination, on anxiety.
At six weeks after the start of the interventions, it was found
that mood disturbance was significantly less in both
intervention groups than in the control group. Women in the
combined intervention group showed a greater improvement
in mood than those receiving relaxation only.
More recently, interest has centred on a newly developed
cognitive-behavioural treatment, adjuvant psychological
therapy (APT). The method has been described and evaluated
by Greer and Moorey in a series of papers [Greer and Moorey,
1987; Greer, 1989; Moorey and Greer, 1989; Greer et al., 1991].
Most recently Greer et al. [1991] have shown that even a small
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number of sessions of therapy can reduce anxiety and
depression as well as promoting positive changes in mental
adjustment to cancer.
Counselling is another intervention that has been used.
Attempts to evaluate its' efficacy, however, has suffered from
a range of problems related to its definition and assessment
[Fallowfield, 1988; 1991]. A number of studies report its' use,
particularly in women with breast cancer [Maguire, 1980a],
although interpretation of such studies can be very difficult
for the reasons specified previously.
Clearly then, a range of psychological therapies exist which can
be used to improve the quality of life of patients with cancer.
The current study suggests that a proportion of patients at all
stages of the illness and its treatment might benefit from such
input.
Perhaps the most striking findings is the effect of the illness
and its treatment on the patient's carer. Not only are there
profound effects on anxiety and depression in this group but
there is also a significant impact on lifestyle when compared
with the patient.
This suggests that the carer should be at least screened for the
presence of psychological disturbance with a view to
intervening with those people who show high levels of
distress. The same psychological techniques described
previously could be used with carers. There is no reason why
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APT, for example, could not be used with them as the therapy
was developed from the cognitive therapy techniques
described by Beck for use with a wide range of emotional
disorders [Beck, 1976].
The implications of the data presented in this thesis suggest
that the patient and their carer cannot be viewed in isolation
flomeach other as they have a significant impact on the other's X
mood state. As Northouse [1984] states, "The reactions of the
cancer patient affect family members, and family members'
reactions affect the patient families are in a dynamic state
of change, constantly responding to events inside and outside
the family" (p216). The patient and their carer therefore may
need to receive some form of psychosocial intervention.
Many reviews of the literature concerning the impact of
cancer on the family conclude that the primary carer is
neglected in terms of research and psychosocial interventions
[Freidenbergs et al., 1981-2; Naysmith et al., 1983; Keitel et al.,
1990].
The current study also demonstrates that the illness has a
significant adverse effect on the carer's lifestyle when
compared to the patient. Again, this is an area which can be
addressed by the health care team in a number of different
ways such as social work, psychology and self help groups.
Health care professionals may find it useful to view the illness
of lung cancer as a "process". This process is composed of a
399
number of different stages and each can be viewed as a series
of stressors which may interact to promote and/ or maintain
distress in both patients and their carers.
This study suggests that the value of social support in
adjustment is complex. It has been noted that health care
professionals often regard the presence of a confidant(e) as
very positive and may, therefore, reduce their attention to the
patient and their family [Veiel, 1985; Lichtman and Taylor,
1986]. This study indicates that this may not always be the
case and the source of support may need to be assessed more
fully.
The patient's carer is especially vulnerable to the latter effect
and particularly prone to being overlooked if they describe
themselves as having "adequate social support" [Lichtman and
Taylor, 1986]. Yet, as described here, the presence of social
support may not always be beneficial to that person. In
addition, social support may change in response to certain
variables such as symptoms of the illness and may need
continual assessment and monitoring, particularly as the
illness progresses.
More comprehensive assessments are, therefore, required in
clinical practice of both patients and their carers. These
assessments need to be wide ranging and be continually
updated over time.
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The current study evaluated
The current study of the psychosocial impact of lung cancer on
patients and their primary carer has improved on many of the
methodological shortcomings of other studies in this area. The
research design has used a homogeneous group of cancer
patients and assessed them at different points during the
illness and its treatment. In addition, the patient's primary
carer has also been included in the study at the same time
points. The assessments have used standardised, well
validated, reliable scales, some of which have been specifically
designed for use with patients suffering from a physical
illness such as cancer.
The current study could be seen as a pilot study and a number
of improvements could be made. The number of subjects in
each group is relatively small and could be increased. The
sample size reflects the total number of suitable patients
available at the time the study was being carried out in the
department.
The design is, as far as can be ascertained, unique in the way
that the "process" of the illness is represented. This suggests
that until a cross validation study of the same design is carried
out the results must be viewed tentatively.
The subjects in the current study may not be representative of
lung cancer patients generally. All the patients were taking
part in a trial of specific combination chemotherapy regimens.
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This means that they received careful follow up care and
monitoring in the department and may not represent the
typical picture of patients with lung cancer.
This study also made no attempt to control variables beyond
those specified: it was designed as a descriptive study and all
suitable lung cancer patients within the department were
included. This lack of control of variables may weaken some of
the findings and is an obvious criticism of the current research
design. Future studies in this area would benefit from more
rigorous control of variables and better matching of patients in
the groups (first line management group, follow up group, and
palliative therapy group). For example, the group of patients
are not exactly matched for age and the group of carers are
quite diverse with few friends and children represented.
Greater control of some of these variables may give a greater
understanding of the impact of the illness.
The three groups selected have been used to represent the
"process" of the disease and its treatment. The implicit
assumption that is being made, however, is that the subjects in
these groups have undergone similar experiences. This
assumption cannot be validated and may not be accurate. The
study would have been enhanced by a longitudinal design that
followed patients and their carers through the "process".
The current design is unable to assess change as it provides
s,/C
"snapshots" at different time points. The data is able to
provide some insights into the impact of the illness at these
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times but is not able to detect any pattern of effects between
these times. A longitudinal study may have given a clearer
picture of the changing psychosocial impact of the disease over
time.
The study first assesses patients at the midpoint of their first
line management. It is not possible, therefore, to know how
many patients and their carers were depressed or anxious
before the diagnosis of lung cancer was made. The assumption
that has to be made with the present data is that the mood
state of the subjects is related to the diagnosis. Hughes
[1985b], however, in a study of 134 patients with lung cancer
found that 22 (16 per cent) fulfilled the criteria for depressive
illness. In this group, 13 of the 22 patients gave a clear history
of having been depressed before their physical symptoms
began, apparently in reaction to life stress unrelated to their
cancer. In the current study the number of respondents
experiencing clinical levels of depression and/ or anxiety
before their diagnosis is unknown.
A control group may have added an important dimension as
the results are difficult to place into a contextual framework.
Such a control group may have included patients with a
serious, non-malignant chest disease such as chronic
obstructive airways disease (chronic bronchitis, or bronchial
asthma). These illnesses are also recognised as having marked
psychosocial sequelae for the patient and their family [Sandhu,
1986] and may have proved to have been an interesting
comparison group.
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On the other hand, some researchers consider that the
introduction of a control group into such a study unnecessarily
introduces a source of bias [Bloom and Ross, 1982]. Comparing
distress in patients with lung cancer with distress in other
patients with chest disease may reveal marked differences on
some preselected assessment tool. The interpretation of this
type of result, however, requires the comparison of each group
with appropriate normative data rather than each other. In
fact, Bloom and Ross [1982], in reviewing the field of
psychosocial oncology conclude that;
"
Using between subject designs to look for differences
between cancer patients and other groups of people is
that the specific questions asked are likely to be
motivated toward finding that cancer patients are
indeed suffering more and differently Use of cancer-
specific items or instruments may bias results in such a
way that need for support programmes will be a logical
inference of the study. Researchers working with
individuals in the health care system (not only those
with cancer) would do well to avoid having to
demonstrate that one group of patients is suffering more
than another." (p260)
There are, therefore, arguments for and against using control
groups in a study of the type described in this thesis. Bloom
and Ross advocate the definition of a clear question to be
answered in a specific group of cancer patients, rather than
the introduction of a group of patients with another illness for
comparison.
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The issue of the measurement of social support in this study
could be criticised. In retrospect, the single measure of
perceived emotional support from family and friends could be
regarded as inadequate. Additional measures assessing other
dimensions of social support could have been included. It must
be remembered, however, that the current study was testing a
specific hypothesis concerning emotional social support and
that the addition of extra scales or questionnaires would have
confused and complicated the research design as well as
making the assessment procedure unwieldy, thereby reducing
compliance. Further research in the area of social support in
oncology is dealt with in the next section.
The current study examines the impact of lung cancer on the
"primary carer" only. The purpose of concentrating on a
designated person was to try to replicate other studies in this
area [Plumb and Holland, 1977; Baider and Kaplan de Nour,
1984; Goldberg et al., 1984; Cassileth et al., 1985; Oberst and
James, 1985] who utilised the primary carer or the patients'
spouse. The study may have benefited from the inclusion of
other family members in the design such as children, brothers,
sisters or parents. Studies that have attempted such ambitious
designs have, on the whole, "been singularly unsuccessful in
their task [Northouse, 1988b]. These designs have typically
been difficult to implement in a society where families are
often geographically separated and where other family
members, particularly children, are regarded as tangential to
or even excluded from the patient's treatment plans. To
include these other family members in the current study may
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have been extremely difficult and have led to a reduction in
the quality and quantity of data collected.
As far as possible this study has utilised standardised, valid
and reliable assessment tools. The assessment of symptoms
and side effects in the patients was undertaken using a scale
developed in the Edinburgh department [Cull and North,
1988]. This scale has been utilised in a number of "in-house"
studies of lung cancer patients and at the time that the current
study was being planned, its use was thought to be
appropriate. Since this time, however, other scales have been
developed, in particular the Rotterdam Symptom Checklist
(RSCL) [Haes et al., 1983]. This scale has become widely used
since the latter half of the 1980's and assesses both physical
and psychological symptoms. The RSCL has good reliability and
validity and is recommended as the tool best suited to assess
the key dimensions of quality of life [de Haes et al., 1983; van
Knippenberg and de Haes, 1988; Maguire and Selby, 1989; de
Haes et al., 1990]. If details on the reliability and validity of
the RSCL had been more widely available at the planning
stage of the current study it would have been a valuable tool
to include.
The Hospital Anxiety and Depression Scale [Zigmond and
Snaith, 1983] is an assessment tool designed specifically for
use with patients who are physically ill. The tool has proved to
be very robust across studies and has been shown to be
composed of two distinct but correlated factors, anxiety and
depression [Barczak et al., 1988; Maguire and Selby, 1989;
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Moorey et al., 1991]. The scale performed very well in the
present study and patients and their carers found it easy to
understand and complete. One of the items, however, concerns
the statement "I feel as if I am slowed down". The response
most often scored by patients for this item was "Nearly all the
time" , this was particularly noticeable in those receiving
chemotherapy or palliative radiotherapy.
This item has caused some concern as it may reflect the
somatic effects of the illness and its treatment rather than
psychological distress. This concern has been investigated by
Ibbotson et al. [1988. This study suggests that minor X
adjustments to the HAD "cut off" scores may be required
(depending on the stage of the disease that the patient has
reached) in order to improve the sensitivity and specificity of
the scale. Ibbotson et al. [1988] compared the HAD with the
General Health Questionnaire and the Rotterdam Symptom
Checklist (RSCL). All three scales were evaluated by
comparison with the Psychiatric Assessment Schedule, a gold
standard. The data suggested that the HAD scale produced the
best overall performance but the RSCL performed better as a
screening instrument for patients with "stable disease".
More recently this issue has been investigated by Hopwood et
al. [1991a]. They compared the HAD and the RSCL in women
with advanced breast cancer. It was found that the scales
detected different groups of patients as "cases"; only 43 per
cent (of "cases") being detected by both questionnaires.
Hopwood et al. conclude that "these questionnaires are not yet
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sufficiently robust in their psychometric properties to give
precise prevalence rates" (p352). In a refinement of this
study, Hopwood et al. [1991b] found that both scales were
suitable for use as screening instruments in the detection of
psychiatric morbidity. They suggest that both warrant
refinements to their "cut off" scores to improve their
sensitivity and specificity. They conclude that;
"In using either questionnaire as a screening instrument
careful preparation is advisable: sensitivity, specificity
and cut off values should be checked, and the predictive
value should be calculated according to the known
prevalence of affective disorder in the population of
patients to be screened. Used in this way, these two
instruments will provide a valuable clinical tool in the
detection of psychological morbidity." (p355)
This area requires extensive further investigation particularly
in relation to different treatments and specific diagnostic
groups. In this way, the requirements of Hopwood and her
colleagues for the use of scales in cancer care would be
satisfied. At the current time the HAD scale continues to be
used with the thresholds recommended by the authors and as
a result these have been retained and utilised in this study as
the current state of the research data is insufficient to warrant
their adjustment.
The study design was developed to provide a comprehensive
picture of the psychosocial impact of lung cancer and its
treatment. In conducting a study of this type it is necessary to
work within the constraints imposed by the clinical
environment and the subjects. The initial design, for example,
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was modified from a longitudinal one, in response to the
carers' predicament. A further refinement that may have
yielded a more representative picture of day to day life would
have been to interview some of the respondents in their own
homes, particularly in the follow up group. This was not
possible as the patients were drawn from South-East Scotland
and the Borders, a large geographical area. This resulted in all
the interviews being conducted in hospital wards or the
outpatient clinic. One could argue that this may have
artificially increased anxiety and depression scores as it has
frequently been recorded that visits to hospital and out
patient clinics can have this effect [Schag and Heinrich, 1989].
None of the scales used in this study were concerned with the
immediate time scale: all concerned with emotions or
difficulties that were experienced during the previous week or
previous few weeks. These instructions were impressed on the
respondents and the assumption has to be made that this had
been understood and followed.
The clinical situation may, however, have led to contamination
of scores but not to such an extent that all the results could be
dismissed. The group most susceptible to this effect would
have been the follow up group, who only visited the clinic
once a month. In contrast, the. other two groups would have
had frequent contact with hospital clinics and departments
thus leading to an adaptation to the clinical environment and
possibly a reduction in the anxiety that this provokes.
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The final way in which the study could have been improved
would have been to have included a group of bereaved carers.
This would have completed the picture of the "process" of the
disease and provided some important insights into the long
term effects on the carer. Unfortunately, this proved to be
untenable due to the geographical spread from which carers
came and because of the very vulnerable and distressed state
of this group. It was felt by the researcher to be unethical to
assess such a group on a "one off" basis without offering them
further opportunities for ventilation of emotions and support.
Such a situation may have been avoided if the study had been
longitudinal and a rapport had been developed over the
course of the illness.
The current study has provided some important and valuable
data regarding the psychosocial impact of lung cancer and its
treatment. The data concerning the impact on the carer are
particularly important and carry with it a range of service
implications. The interaction between the psychosocial
variables of patient and carer is also very revealing and again
has implications for service provision. Finally, the data suggest
that the effects of social support may be more complex than
was previously thought and warrants considerable further
investigation.
The current study has described a difficult and sensitive area
of cancer care overcoming many methodological problems of
previous studies to produce a coherent piece of work.
Respondent fatigue and non-compliance have been overcome
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and the essential elements of the disease/ treatment "process"
have been investigated and described to form the basis of
future research studies in this area.
Future Research Directions
The current study represents a pilot study in this area of
psychosocial oncology and the results must be treated with
some caution. The results of the project suggests a number of
avenues for further research in this area.
The study would benefit from a replication using a similar
design but with a much larger sample. Such a cross validation
study would be essential before embarking on the provision of
services based on the current findings.
The subjects in this study were entered into clinical trials and
as a result may have received a different type of health care
than lung cancer patients who are not participating in a
clinical trial. Future research projects may give greater
insights into the impact of lung cancer if non-trial patients and
their carers were studied in order to compare the two
experiences. Researchers have for some years speculated that
the care and attention given to patients in trials is quite
different to that offered to other patients [Mackillop and
Johnston, 1986; Mackillop et al., 1988], this question therefore
should be addressed.
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The present study suggests that the patient's carer
experiences high levels of anxiety and depression throughout
the course of the illness and its treatment. The study,
however, is unable to provide detailed information into the
nature of this distress in terms of behavioural changes and
effects on cognitions. This information would be extremely
important in understanding the carer's plight. It would also
aid the development of intervention strategies particularly if
the pattern that they follow over the course of the illness
could be described.
The role of information in patient adjustment to a diagnosis of
cancer has been thoroughly researched [Feldman, 1978;
Weisman and Worden, 1980; Hogbin and Fallowfield, 1989].
This topic, however, has not been examined in relation to
family members, despite the fact they place a high priority on
obtaining full and accurate information about the patient's
condition [Wright and Dyck, 1984; Northouse, 1988b; Liang et
al., 1990]. Family members often feel that they are denied
access to information by nursing and medical staff which
merely serves to exacerbate their distress [Bond, 1982; Bond,
1982b; Dyck and Wright, 1986]. The role of information,
therefore, in the adjustment of the patients carer is a
necessary and important study to undertake.
An intervention study with distressed carers would be
important to undertake and a range of therapeutic techniques
are available for evaluation. Unfortunately, these studies can
sometimes be complicated and costly to carry out, particularly
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if they are randomised and controlled. The feasibility of this
would need to be carefully considered and may require
considerable co-operation from a number of professions such
as psychiatry, psychology, social work and nursing.
Social support and its role in adjustment to cancer has been
shown to be a complex issue. Cancer can be seen as presenting
multiple stressors which are interwoven and which change
over time. Because of the complexity of these stressors, an
evaluation of the role of different types of social support
throughout the illness is required. Such a study is necessary
because to examine a single form of social support is clearly
inadequate.
This would necessarily entail an investigation into the
negative as well as the positive qualities of social support. The
majority of studies concentrate on the positive qualities [Funch
and Mettlin, 1982; Bloom, 1982; Bloom et al., 1984; Vachon,
1984; Mclvor et al., 1984] yet there are clearly negative
aspects to be considered as well [Blau, 1964; Revenson et al.,
1983] which are not fully understood. The present study
suggests that there may be negative aspects to social support
yet it has not been possible to investigate this finding with
complete satisfaction.
A future study of this type may be able to describe the
mechanisms by which social support acts. The prevalent
debate concerning the "main effect" versus the "buffering
mechanism" has not been resolved adequately. Future
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research, testing the effectiveness of specific support
resources in response to specific stressors would help to
clarify the operative mechanisms of the concept. These studies
need to be based on clear theoretical models and a clear
understanding of the stressors being faced.
Longitudinal research designs in this field are essential as the
changes in social support over time have never been
researched fully [Wortman, 1984], In so doing, the
determinants of social support could be investigated as there
is evidence to suggest that social support is affected by such
factors as age, gender, disease status and symptomatology
[Vaux, 1985; Dakoff and Taylor, 1990; Willey and Silliman,
1990]. Such a study would have implications for enhancing or
manipulating the type of social support that patients and their
families receive. It may also reveal why, for some people,
social support is not always provided, as well as the "cost" of
"giving" social support by the provider [Shumaker and
Brownell, 1984].
A question central to all these studies is the use of appropriate
social support scales. Kobasa et al. [1991] suggest that "there
would probably never be a single social support scale that had
all of the dimensions required by existing theoretical and
methodologic considerations" (p789). This assertion suggests
that it is very important to select suitable scales, particularly
if the aim of the study is to assess the contribution of different
types of social support in facilitating adjustment to cancer. The
selection of tools, with satisfactory psychometric properties, is
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one of the most important considerations in any study of social
support [Wortman, 1984].
Social support from family and friends has been shown to
reduce psychological distress, resulting from a stressful event
[Procidano and Heller, 1983]. Such a clearcut finding was not
forthcoming in the present study. In fact, it has been
suggested that social support from family and friends may
itself lead to distress, particularly if the providers of that
support are distressed themselves. This explanation is a
tentative hypothesis which requires further investigation. In
particular, the psychological state of these support providers
needs to be assessed. In addition, a comparison of the efficacy
of support provided by family and friends and the support
provided by "strangers" such as health care professionals or
people outside the immediate family is essential. Dunkel-
Schetter [1984] for example, reports that emotional support
from family and friends is regarded as the most useful source
of support by the patient, yet this type of social support may
inadvertently maintain distress in the patient.
Cohen and Wills [1985] suggest that these perceptions of the
most useful sources and types of support require further
investigation themselves. The authors would like to
investigate the source of perceptions of adequate support.
They suggest that these perceptions must be based on actual
social exchanges and supportive transactions, either personally
experienced or observed, yet there is little direct evidence of
these exchanges. Cohen and Wills suggest that useful future
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research should attempt to elucidate which aspects of the
social environment are perceived as supportive, and how and
where supportive transactions occur. This, they state, will aid
the understanding of the mechanisms of social support in the
general process of coping with stress.
This theme is expanded by Kobasa et al. [1991] who put
forward the view that future research in this area should be
concerned with the larger issues of the social environment. In
particular, they recommend that future research be conducted
in populations beset by poverty with poor social support and
health care networks. Such an undertaking would need to be
on a vast scale, supported by large funding bodies and, in
reality, would be moving the focus of social support from the
"micro" level to the "macro" level, involving whole
communities. Such an undertaking would require multicentre
collaboration from a large number of highly motivated
institutuions. In the current economic and political climate
such a research project is not feasible.
A competing area of research has arisen recently in assessing
the impact of perceived social support on immune function.
Levy et al. [1990] have reported that breast cancer patients
with high levels of perceived social support were found to
have higher levels of "natural killer cell activity" than with
those with low social support. Related to this, Baron et al.
[1990] have reported that the spouses of cancer patients with
high levels of social support also showed higher levels of
"natural killer cell activity". These studies both suggest that
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individuals experiencing a severe and chronic life stress
showed evidence of a more efficient and effective immune
system if they had high levels of perceived social support.
Findings such as these, if replicated, may have important
implications for the role and mechanisms of social support.
These effects would not only help to explain adjustment to
stress but would also have important implications for the role
of social support in promoting and maintaining health. This
research is, as yet, in its infancy and requires a considerable
sustained research effort in the years ahead.
Future research in this area must aim at a greater
understanding of the experience of the cancer patient and
their family throughout the course of the illness. In addition,
emphasis must be focussed on ways of reducing distress and
improving their quality of life. Social support is one area
where further investigation and intervention is needed, as the
concept, at present, is still at an early stage of understanding.
As Kessler et al. [1985] so aptly point out;
"to date, studies of specific life crises have not realised
their potential, either as a means of increasing our basic
understanding of fundamental support processes or as a
foundation on which interventions can be built. Most
studies of this sort have simply attempted to show that
support is associated with subsequent adjustment
without linking support to other variables that might
help elucidate causal processes. For progress to be made,
the advantages of this research design will have to be
more fully exploited in the future." (p545)
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Cohen and Wills [1985] go even further in the conclusion to
their review on social support;
"New research in this area will have important
implications for the understanding of stress and coping,
the determinants of psychological adjustment and
physical health, and the social structure of communities.
Such knowledge will serve to strengthen the supportive
aspects of informal helping networks and may provide a
basis for a new partnership between lay helping
resources and professional helpers. This work, we think,
will contribute in many ways to the well being of
individuals, families and the larger society." (p353)
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INFORMATION FOR PATIENTS AND RELATIVES
In this unit we feel it is important not simply to treat disease but to care
for the whole patient and his/her family. This by necessity involves
understanding how an illness and its treatment affects the patients and those
closest to that person.
In order to achieve a better understanding of this process from your point of
view we are undertaking a study asking people to tell us a bit more about
themselves. We should like to do this some time in the next few weeks to see
if there are any problems or difficulties arising for you as a result of this
illness and its treatment for yourself and your family.
If you are willing to take part in this project it will involve giving some
background information about yourself and your situation and then completing
some brief questionnaires for us. These will be concerned with how you have
been feeling in the past month, the impact the illness has on certain aspects
of your life (social life and family relationships) and finally the type of
support that you have found useful from family and friends.
These questionnaires help us to understand some aspects of the illness's
impact on you but we should also like to interview you directly. These
interviews will take place at your convenience and will aim to ask you about
your experiences to date.
You are under no obligation to take part in this study and you can of course




The information you give will be treated in strictest confidence and will not
affect treatment in any way. If the interviewer feels that you are expressing
worries which may be helped by medical care, the interviewer may wish to
discuss this with your own doctor. This would only be done however after
consultation with you. The information given will be analysed anonymously
along with that from other people who have agreed to help us in our study. We
hope that information gained from this study may help us improve the care we
provide to patients and their families.
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CONSENT FORM
have had the attached study explained to me by
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Physical illness not only causes symptoms but often affects other aspects of people's
lives e.g. their families or their work. For this reason we are asking patients to
tell us a bit more than usual about themselves to help us put research on the effects
of illness and treatment into the context of people's lives as a whole.
I Biographical Data
1■ Age:
2. Sex M - 1 F - 2

















5. Are religious beliefs an important part of your life? No - 0
II Occupation
I would now like to ask you some questions about your work.
1. Occupation:














Did you need any special training for that? No qualifications 0
School certificates 1
Some further training 2
Full college/univ/prof. 3
training
III Health and Illness
















3a. Has anyone close to you been treated for cancer? No - 0 Yes - 1
b. If Yes, how long ago was that? Within past year 0
Within 5 years 1
More than 5 years 2
N/A 9
c. Did that involve hospital treatment? No - 0 Yes - 1 N/A - 9
d. If Yes, was that in this hospital? No - 0 Yes - 1
e. How satisfactory was that? N/A - 9
Very Positive Satisfactory Unsatisfactory Very Negative
0 12 3
4. Have you ever needed treatment in the past for any 'nervous trouble', e.g.
anxiety, depression? If Yes, clarify:
None G.P. Psychiatric O.P. Psychiatric I.P.
0 12 3
How long ago was that? Episode in last year 0
Episode in past 5 years 1
Episode more than 5 years ago 2
Chronic history (1 year duration) 3
N/A 9
IV The Illness and its Treatment - Attitudes and Evaluation
People differ in their attitude to illness and treatment.
la Do you feel it is better for you to try to accept this illness or
try to fight it?
Accept - 0 fight - 1 D.K. - 9
b In general, do you feel hopeful or pessimistic about the outlook at present?
Pessimistic - 0 Hopeful - 1 D.K. - 9
c Do you prefer to leave decisions about your treatment to the doctors or do you
prefer to have a say in those decisions?
Passive - 0 Active - 1 D.K. - 9
2. What is your main worry in relation to your illness at this stage?
476
3
3. What is your main worry about treatment just now?
4. What do you require most from treatment at this stage?
a) That it should relieve troublesome symptoms as soon as possible
b) That it should concentrate on longer term control of the disease, even if it
means feeling unwell for a time now
c) That short-term relief and longer term control are equally important
d) Other (specify):
5. Have you felt any benefit from treatment so far? No - 0 Yes - 1
If Yes, what was that?
6. What is the aim of treatment at the moment?
7. People differ in the amount of time they give to thinking about an illness.
Do you:
Find it is on your mind all the time? 3
Find it is sometimes on your mind and sometimes not? 2
Try not to think about it? 1
Find you don't think about it? 0
8. People also differ in their attitude to talking about illness. Do you:
Talk to anyone about it quite openly? 3
Talk to selected people at selected times? 2
Not volunteer anything but reply if asked? 1
Prefer to avoid the subject? 0
9. Who has helped you most to cope with difficulties that have arisen for you in




10. Apart from the medical care itself, is there more that the hospital services




1. Do you feel that you know people who can give you help and support if you need
it?
No Friends Relatives Friends & Relatives Other (specify) ...
0 1 2 3 4
2. Who or what do you now see as your main social support?
Spouse Family Friends Church Other (specify)
1 2 3 4 5
VI. Staff Support
1. Do you feel you have had adequate contact with the doctors? No - 0 Yes - 1
In what way could it be improved?
2. Do you feel you have had adequate contact with the nurses? No = 0 Yes - 1
In what way could it be improved?
VII. Personal and Social Relationships
The following questions are all concerned with your feelings since you first
learnt what your illness was.
1. Since you first found out what was wrong with you, have you noticed any
changes in your relationship with your husband/wife/friend? No -= 0 Yes - 1
If Yes, in what way?
Closer More Distant Other (specify):
1 2 3
2. Have you noticed any difference in the amount of communication between the
two of you? No - 0 Yes - 1
If Yes, in what way?
More Less Other (specify):
1 2 3
3. Has there been any change in the amount of social interaction outside the
home?
a) With friends? No Change Increase Decrease
0 12
b) With relatives? No Change Increase Decrease
0 12
4a. Has there been any change in the support you have received from people since
you first'became ill?




b. In the past month do you feel that there has been any change in the support you
have received from friends and family?
Family No Change Increase Decrease
0 12
Friends No Change Increase Decrease
0 12
c. In the past month do you feel that there has been any change in the availability
of family and friends in whom you can confide or share your worries?
Family No Change Increase Decrease
0 12
Friends No Change Increase Decrease
0 12
5. How do you feel the illness and its treatment has affected the family as a whole?
6. Has the amount of time that you have given to your leisure interests and activi¬
ties changed during this time?
No change Decrease Increase Other (specify):....
0 1 2 3
7. In the past, have you had a particular person with whom you have shared your










PATIENT DETAILS - NOTES
NSCLC - 1
SCCB - 2
Active Treatment - 1
Follow-up - 2
Palliative Treatment - 3










INTERVIEW SCHEDULE "PRIMARY CARER"
Physical illness not only causes distress in patients but often affects other aspects
of their lives e.g. their families. For this reason we are asking relatives to tell
us about themselves to help us put research on the effects of illness and treatment
into a wider context.
I Biographical Data
1. Relationship to patient?
1 - Spouse 2 - Relative (specify;. ) 3 - Friend
2. Age:
3. Sex M - 1 F - 2
4. Marital Status: M/Cohab Sep/Div Wid S
1 2 3 4
5. How would you describe your relationship generally?
Good Fair Poor V. Poor N/A
1 2 3 4 9
6. Are religious beliefs an important part of your life? No - 0 Yes - 1
II Occupation
I would now like to ask you some questions about your work.
1. Occuption:
Do you work at the moment? No - 0 Yes - 1
F/T P/T U R H/W Other (specify):
1 2 3 4 5 6
2. Have you been working in the past year? No - 0 Yes — 1
If Yes, specify:
F/T - 1 P/T - 0
3. Reason for giving up job:
Ill Health and Illness
1. In general, do you enjoy good health? No - 0 Yes - 1





3a. Has anyone else close to you ever been treated for cancer? No - 0 Yes - 1
If Yes, specify:
b. How long ago was that? Within past year 0
Within past 5 years 1
More than 5 years 2
N/A 9
c. Did that involve hospital treatment? No - 0 Yes - 1 N/A - 9
d. If yes, was that in this hospital? No - 0 Yes - 1
e. How satisfactory was that?
Very Positive Satisfactory Unsatisfactory Very Negative
0 12 3
4. Have you ever needed treatment in the past for any 'nervous trouble', e.g.
anxiety, depression?
None G.P. Psychiatric O.P. Psychiatric I.P.
0 12 3
How long ago was that? Episode in last year 0
Episode in past 5 years 1
Episode more than 5 years ago 2
Chronic history (1 year duration) 3
N/A 9
IV The Illness and its Treatment - Attitudes and Evaluation
People differ in their attitude to illness and treatment.
la Do you feel it is better for your husband/wife/friend to try to accept this
illness or try to fight it?
Accept - 0 Fight - 1 D.K. - 9
b In general, do you feel hopeful or pessimistic about the outlook at present?
Pessimistic - 0 Hopeful - 1 D.K. - 9
c Do you prefer to leave decisions about your husband's/wife's/friend's
treatment to the doctors or do you prefer to have a say in those decisions?
Passive - 0 Active - 1 D.K. - 9






3. What is your main worry about your husband's/wife's/friend's treatment just now?
U. What are your hopes and expectations of the treatment at this stage?
a) That it should relieve troublesome symptoms as soon as possible
b) That it should concentrate on longer term control of the disease, even if it
means feeling unwell for a time
c) That short-term relief and longer term control are equally important
d) Other (specify):
5. Do you feel your husband/wife/friend has benefitted from treatment so far?
No - 0 Yes - 1
If Yes, what was that?
6. What is the aim of your husband's/wife's/friend's treatment at the moment?
7. People differ in the amount of time they give to thinking about an illness. Do
you:
Find it is on your mind all the time? 3
Find it is sometimes on your mind and sometimes not? 2
Try not to think about it? 1
Find you don't think about it? 0
8. People also differ in their attitude to talking about illness. Do you:
Talk to anyone about it quite openly? 3
Talk to selected people at selected times? 2
Not volunteer anything but reply if asked? 1
Prefer to avoid the subject? 0
9. Who has helped you most to cope with difficulties that have arisen for you in






10. AparC from the medical care Itself, is there more that the hospital services
could do to help families cope with this sort of illness?
V. Social Support
1. Do you feel that you know people who can give you help and support if you need
it?
No Friends Relatives Friends & Relatives Other (specify)
0 1 2 3 4
2. Who or what do you now see as your main social support?
Spouse Family Friends Church Other (specify)
1 2 3 4 5
VI. Staff Support
1. Do you feel you have had adequate contact with the doctors? No - 0 Yes - 1
In what way could it be improved?
2. Do you feel you have had adequate contact with the nurses? No - 0 Yes - 1
In what way could it be improved?
VII. Personal and Social Relationships
The following questions are all concerned with your feelings since you first
learned what your husband/wife/friend's illness was.
1. Since you first found out what was wrong with your husband/wife/friend, have
you noticed any changes in your relationship? No - 0 Yes - 1
If Yes, in what way?
Closer More Distant Other (specify):
1 2 3
2. Have you noticed any difference in the amount of communication beetween the
two of you?
No - 0 Yes - 1
If Yes, in what way?




3. Has there been any change in the amount of social interaction outside the home?
a) With friends? No Change Increase Decrease
0 12
b) With relatives? No Change Increase Decrease
0 12
4a. Has there been any change in the support you have received from people generally
during this time? No Change Increase Decrease
0 12
b. In the past month do you feel that there has been any change in the support you
have received from friends and family?
Family No Change Increase Decrease
0 12
Friends No Change Increase Decrease
0 12
c. In the past month do you feel that there has been any change in the availability
of family and friends in whom you can confide or share your worries?
Family No Change Increase Decrease
0 12
Friends No Change Increase Decrease
0 12
5. How do you feel the illness and its treatment has affected the family as a whole
so far?
6. At this stage, how do you see your own role in the treatment of your husband's/
wife's/friend's disease?
None Support Help come to Help fight Other (specify):
terms with disease
disease
0 12 3 4
7. Has the amount of time that you have given to your own leisure interests and
activities changed during this time?
No change Decrease Increase Other (specify):
0 1 2 3
8. In the past, have you had a particular person with whom you have shared your




PERCEIVED SOCIAL SUPPORT SCALE
Directions: The statements which follow refer to feelings and experiences which
occur to most people at one time or another in their relationships with friends. For
each statement there are three possible answers: Yes, No, Don't know. Please circle
the answer you choose for each item.
Yes No Don't know 1. My friends give me the moral support I need.
Yes No Don't know 2. Most other people are closer to their friends
than I am.
Yes No Don't know 3. My friends enjoy hearing about what I think.
Yes No Don't know 4. Certain friends come to me when they have
problems or need advice.
Yes No Don't know 5. I rely on my friends for emotional support.
Yes No Don't know 6. If I felt that one or more of my friends were
upset with me, I'd just keep it to myself.
Yes No Don't know 7. I feel that I'm on the fringe in my circle of
friends.
Yes No Don't know 8. There is a friend I could go to if I were just
feeling down, without feeling funny about it
later.
Yes No Don't know 9. My friends and I are very open about what we
think about things.
Yes No Don't know 10. My friends are sensitive to my personal needs.
Yes No Don't know 11. My friends come to me for emotional support.
Yes No Don't know 12. My friends are good at helping me solve
problems.
Yes No Don't know 13. I have a deep sharing relationship with a number
of friends.
Yes No Don't know 11). My friends get good ideas about hew to do things
or make things from me.
Yes No Don't know 15. When I confide in friends, it makes me feel
uncomfortable.
Yes No Don't know 16. My friends seek me out for companionship.
Yes No Don't know 17. I think that my friends feel that I'm good at
helping them solve problems.
Yes No Don't know 18. I don't have a relationship with a friend that
is as intimate as other people's relationships
with friends.
Yes No Don't know 19. I've recently had a good idea about how to do
something from a friend.
Yes No Don't know 20. I wish my friends were much different.
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Perceived Social Support Scale
Directions: The statements which follow refer to feelings and experiences which
occur to most people at one time or another in their relationships with their
families. For each statement there are three possible answers: Yes, No, Don't know.
Please circle the answer you choose for each item.
Yes No Don't know 1. My family gives me the moral support I need.
Yes No Don't know 2. I get good ideas about how to do things or make
things from my family.
Yes No Don't know 3. Most other people are closer to their family
than I am.
Yes No Don't know 4. When I confide in the members of my family who
are closest to me, I get the idea that it makes
them uncomfortable.
Yes No Don't know 5. My family enjoys hearing about what I think.
Yes Mo Don't know 6. Members of my family share many of my interests.
Yes No Don't know 7. Certain members of my family come to me when
they have problems or need advice.
Yes No Don't know 8. I rely on my family for emotional support.
Yes No Don't know 9. There is a member of my family I could go to if
I were just feeling down, without feeling funny
about it later.
Yes No Don't know 10. My family and I are very open about what we
think about things.
Yes No Don't know 11. My family is sensitive to my personal needs.
Yes No Don't know 12. Members of my family come to me for emotional
support.
Yes No Don't know 13. Members of my family are good at helping me
solve problems.
Yes No Don't know 14. I have a deep sharing relationship with a
number of members of my family.
Yes No Don't know 15. Members of my family get good ideas about how to
do things or make things from me.
Yes No Don't know 16. When I confide in members of my family, it makes
me uncomfortable.
Yes No Don't know 17. Members of my family seek me out for
companionship.
Yes Mo Don't know 18. X think that my family feels that I'm good at
helping them solve problems.
Yes No Don't know 19. I don't have a relationship with a member of my
family that is as close as other people's
relationships with family members.
Yes No Don't know 20. I wish my family were much different.
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Symptoms and Side Effects Scale
Date
Please answer each of these questions about your health by
circling the number which best applies to you.
In the past week, how have you been troubled by the
following?:
Not at A Little Quite Very
all a bit Much
1.Shortness of breath 1 2 3 4
2. Pain 1 2 3 4
3. Difficulty sleeping 1 2 3 4
4. Tiredness 1 234
5. Nausea 1 2 3 4
6. Poor appetite 1 2 3 4
7. Hair loss 1 2 3 4
8. Feeling generally unwell 1 2 3 4
Have you been feeling troubled by any others symptoms or side-effects
from your treatment this week? If so, please mention these here and
circle the appropriate number as before to show how much of a
problem this has been to you this week.a) 1 2 3 4b) 1 2 3 4c) 1 2 3 4
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ECOG Performance Status Scale
0. Fully active, able to carry out all pre-disease activities
without restriction and without the aid of analgesia.
1. Restricted in strenuous activity but ambulatory and able to
carry out light work or pursue a sedentary occupation.
Patients who are fully active but require analgesia.
2. Ambulatory and capable of all self care but unable to carry
out any work. Up and about more than 50 per cent of waking
hours.
3. Capable of only limited self care, confined to bed or chair
more than 50 per cent of waking hours.
4. Completely disabled. Unable to carry out any self care and




CORRELATION MATRIX (FIRST LINE MANAGEMENT)
paael saael panxl sanxl pdeol sdeDl pDssfal sossfal
agel 1
agel .742 1
anxl -.104 -.097 1
anxl -.145 -.145 .45 1
depl -.072 -.007 .709 .414 1
depl -.048 -.099 -.011 .644 .188 1
pssfal .109 .035 .248 .306 .297 .201 1
pssfal -.019 -.09 .393 .471 .333 .317 .704 1
pssfrl .007 .036 .078 -.109 .023 -.116 .558 .405
pssfrl .054 -.067 .284 .177 .246 .205 .253 .543
sel -.021 -.153 .005 -.258 -.176 .064 .351 .278
ev1 .066 -.029 -.061 -.318 -.205 .024 .281 .185
ghql -.311 -.436 .476 .671 .487 .421 .35 .372
ghq2 -.111 -.168 .339 .869 .32 .678 .328 .439
ghq3 -.193 -.335 .448 .594 .486 .547 .348 .42
ghq4 -.104 -.082 .258 .574 .293 .279 .203 .089
paael saael aanxl sanxl adeol sdeDl Dossfal sossfal
ghqt -.221 -.325 .469 .831 .485 .614 .383 .435
pip .114 .25 .115 -.021 .034 .08 -.095 -.002
p2p -.038 -.169 .09 .075 .021 .026 .011 .053
p3p .124 .157 -.082 .057 -.226 -.091 -.372 -.182
p4p -.057 .026 .096 -.197 .195 -.334 -.107 -.065
p5p .032 .012 -.011 -.169 -.192 -.223 -.064 -.117
p6p .256 .254 .036 .168 .048 .04 .16 .016
p7p .305 .281 .293 .168 .316 .003 -.086 -.076
ptp .216 .225 .177 .059 .079 -.17 -.164 -.107
pis .198 .3 -.098 -.311 .067 -.144 -.358 -.248
p2s .007 -.022 -.05 -.037 -.168 .022 .158 .029
p3s .238 .300 -.031 -.161 -.004 -.066 -.099 -.128
p4s -.1 -.148 -.009 .206 .075 .185 -.048 -.043
p5s -.077 -.075 .033 .067 -.207 .13 -.122 -.036
p6s -.192 -.217 .081 .151 .182 .222 .148 .119
p7s .296 .301 .175 .188 .272 .083 .159 .038
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CORRELATION MATRIX (FIRST LINE MANAGEMENT)
.094 .171 .061 .121 .086 .256 -.015 -.077
-.081 -.184 .03 -.097 -.033 -.108 -.008 -.013
.177 .211 .044 .15 .204 .295 .197 .034
-.142 -.32 -.023 .226 -.159 .108 .014 .195
.365 .436 -.125 -.086 -.203 -.074 .127 -.052
-.067 -.065 -.136 .323 -.071 .208 -.055 -.01
.102 .124 -.172 .037 -.067 .031 -.036 -.021
possfrl SDSsfrl ssel sevl 1 ahal 1 aha2 1 aha3 1 aha4
spssfrl 1
;pssfr1 .249 1
;se1 .437 .299 1
;ev1 .384 .182 .903 1
Ighql .096 .165 -.103 -.213 1
ghq2 -.072 .104 -.115 -.159 .729 1
ghq3 .089 .163 .072 .051 .725 .669 1
lghq4 .018 -.001 -.229 -.258 .518 .406 .227 1
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CORRELATION MATRIX (FIRST LINE MANAGEMENT)
DDSSfrl SDSsfrl ssel sev1 1 ahal 1aha2 1 aha3 1 aha4
ghqt .037 .144 ! -.091 -.154 .915 .893 .849 .566
pip -.147 .201 .007 -.051 -.162 -.104 -.178 -.17
p2p -.129 .108 .188 .067 .192 .149 .111 -.007
p3p -.273 -.233 -.278 -.256 -.075 .047 -.126 -.062
p4p -.111 -.096 -.14 -.06 -.019 -.111 -.056 -.115
p5p .216 -.146 .137 .144 -.218 -.166 -.067 -.118
p6p -.014 -.106 -.159 -.134 .037 .16 .056 .207
p7p -.091 -.149 -.334 -.25 -.049 .123 .159 .023
ptp -.212 -.152 -.176 -.176 -.005 .1 .025 -.039
pis -.194 -.028 .024 .001 ' -.264 -.268 -.189 -.161
p2s .068 -.216 .333 .316 -.03 .114 .307 -.135
p3s .028 .109 -.146 -.077 -.259 -.15 -.185 -.259
p4s -.109 -.139 .012 -.046 .186 .088 -.049 .248
p5s .028 .026 .151 .142 .158 .174 .088 -.152
p6s .193 .3 .162 .089 .046 .056 .151 .127
p7s -.024 .13 -.207 -.092 .195 .108 .224 .121
possfrl sossfrl ssel sevl 1 ahal 1 aha2 1 aha3 1 aha4
pts .035 .087 .192 .178 .077 .118 .207 -.049
epep .083 -.05 .185 .24 .206 .01 .1 .02
epnp .046 .234 .126 .126 .1 .176 .264 .068
epes .116 .001 -.039 -.143 .347 .128 .11 .292
epns -.056 -.217 -.044 .041 -.189 .069 -.187 -.186
s1 .048 .046 -.337 -.412 .142 .235 .008 .217
time -.118 -.062 -.308 -.263 -.058 .053 -.108 .239
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CORRELATION MATRIX (FIRST LINE MANAGEMENT)
1 ahat IdId 1d2d 1d3d 1d4d 1d5d 1d6d 1 p7p
Ighqt 1
1 pi P -.179 1
1p2p .151 .02 1
p3p -.059 .16 .314 1
1p4p -.086 -.016 .112 .07 1
1p5p -.173 -.015 .11 .183 -.077 1
lp6p .126 -.229 -.327 -.221 -.224 -.118 1
1p7p .088 .044 -.055 .176 .352 .093 .134 1
Iptp .037 .132 .603 .598 .47 .325 .004 .557
1p1s -.273 .106 -.107 —i o 00 -.066 .091 -.053 -.198
1p2s .112 -.32 .146 -.113 -.12 .07 .219 .119
1p3s -.244 .126 -.186 .091 -.283 -.035 .086 -.02
1p4s .118 .06 .391 .209 .127 -.028 -.198 .173
1p5s .116 .039 -.157 .078 -.487 -.213 .14 -.32
1 p6s .108 .025 .065 -.266 -.076 .186 -.019 -.001
1p7s .197 .232 -.204 -.122 .083 -.218 .448 .133
1 ahat lalD 1 d2d 1d3d 1 d4d 1d5d 1d6d 1d7d
Ipts .128 .091 .039 -.028 -.38 -.062 .269 -.023
lepep .105 -.166 .495 .046 .189 .19 -.355 -.186
lepnp .197 .128 -.276 -.385 -.314 -.378 .306 -.041
lepes .244 -.22 .249 .035 -.251 .108 -.161 -.192
lepns -.129 .349 .266 .386 .201 oco -.075 .123
psl .172 .056 -.181 .12 -.216 .025 .302 .109
1 time .008 -.142 -.072 .042 .203 -.103 .142 .154
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-.143 .216 -.038 1
.323 -.242 -.162 -.364 1
-.338 .072 .095 .31 -.384 1
-.045 -.322 .055 .001 .175 -.35 1
.062 -.051 -.192 .202 -.093 .044 .036 1
1 dtd 1 dl s 1 d2s 1 d3s 1 d4s 1d5s 1 d6s 1 d7s
pts -.041 .058 .35 .519 .089 .321 .406 .386
epep .196 -.034 .104 -.282 .081 .015 -.158 -.168
epnp -.382 .198 .087 .241 -.343 .331 -.172 .448
epes -.068 -.108 -.062 -.343 .313 -.029 -.083 -.268
epns .496 -.052 -.055 .11 -.01 -.123 -.173 .126
si .02 -.242 -.146 .094 .148 .059 .243 .049
time .106 .082 -.042 .017 -.127 -.265 -.181 -.114
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-.215 .413 -.254 1
-.104 .101 -.181 -.333 1
.153 -.574 .002 -.04 -.013 1
-.333 -.066 -.073 .033 .104 .036 1
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CORRELATION MATRIX (FOLLOW UP SURVEILLANCE)
Daae2 saae2 oanx2 sanx2 odeD2 sdeo2 D0ssfa2 sossfa2
age2 1 1
age2 .809 1
anx2 -.222 -.201 1
anx2 -.123 -.209 .375 1
dep2 -.135 -.052 .785 .224 1
dep2 -.244 -.317 -.007 .575 -.075 1
pssfa2 -.227 -.167 .029 .112 .134 .294 1
ossfa2 -.105 -.11 .011 .143 .111 .337 .937 1
pssfr2 -.158 -.337 -.092 .358 -.011 .472 .341 .442
pssfr2 -.191 -.326 .026 .212 .022 .329 .282 .39
se2 .151 -.037 -.053 .04 -.134 .025 -.26 -.219
ev2 .136 -.027 -.154 .097 -.25 .105 -.245 -.245
ghql -.168 -.242 .177 .478 .071 .339 .03 .026
ghq2 -.296 -.453 .399 .567 .106 .425 -.019 .007
ghq3 -.007 -.031 .076 .38 -.02 .265 .011 -.011
ghq4 -.163 -.138 .124 .448 .038 .41 .061 .046
oaae2 saae2 oanx2 sanx2 DdeD2 sdeo2 D0ssfa2 sossfa2
ghqt -.234 -.321 .284 .635 .075 .49 .025 .024
pip -.021 -.038 .206 -.048 .377 -.079 -.133 -.095
p2p -.122 -.121 .417 .157 .57 .011 -.132 -.107
p3p .037 -.001 .373 .12 .394 .079 -.071 -.074
p4p .03 -.023 .185 .076 .245 .056 .013 -.052
P5p -.167 -.051 .308 -.001 .455 .003 .157 .106
P6p -.153 -.121 .31 -.209 .397 -.131 -.037 -.064
p7p -.138 -.02 .359 -.131 .484 -.237 -.035 -.048
ptp -.09 -.058 .363 -.007 .488 -.051 -.023 -.048
pi s -.079 -.067 -.001 .347 .148 .282 .165 .157
p2s -.281 -.167 .154 .438 .112 .229 .023 .001
p3s .039 .077 .171 .317 .204 .102 .135 .109
p4s -.067 -.087 .07 .437 .082 .375 .085 .102
p5s -.053 -.099 .063 .305 .027 .08 .162 .179
p6s -.118 -.135 -.118 .255 -.065 .343 .274 .221
p7s -.086 -.067 -.013 .409 .069 .205 .059 .088
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CORRELATION MATRIX (FOLLOW UP SURVEILLANCE)
paae2 saae2 panx2 sanx2 pdep2 sdep2 ppssfa2 spssfa2
-.096 -.085 .055 .436 .103 .281 .15 .147
.083 -.104 -.176 -.076 -.199 .079 -.001 .042
.059 .061 .101 .13 .042 -.029 .004 .015
.111 .103 .234 -.161 .249 -.083 -.02 -.02
.279 .078 -.296 -.238 -.268 -.154 -.097 -.002
.034 .149 .034 .253 -.034 -.065 -.208 -.209
.095 .135 -.118 -.239 -.093 -.117 .174 .026
3pssfr2 spssfr2 sse2 sev2 2aha1 2aha2 2aha3 2aha4
>pssfr2 1
pssfr2 .618 1
se2 -.069 .049 1
ev2 -.167 -.05 .896 1
'ghql .047 -.063 -.099 .068 1
?ghq2 .164 .18 .022 .088 .403 1
'ghq3 -.069 .121 .124 .25 .617 .228 1
?ghq4 .111 .053 -.069 -.019 .536 .265 .61 1
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CORRELATION MATRIX (FOLLOW UP SURVEILLANCE)
DDSsfr2 sossfr2 sse2 sev2 2aha1 2aha2 2aha3 2aha4
2ghqt .103 .101 -.016 .114 .828 .692 .747 .769
2p1p .173 -.067 .145 .034 .007 -.092 -.185 -.1
2p2p .085 -.08 .171 .111 .098 .089 -.051 -.004
2p3p -.033 -.114 .261 .296 .356 .173 .207 .178
2p4p -.096 -.147 .102 .3 .512 .172 .343 .198
2p5p .02 -.223 -.092 -.025 .258 .087 -.047 -.029
2p6p -.156 -.112 .023 .037 .132 .029 -.038 -.023
2p7p -.104 -.155 .123 .073 .045 -.006 -.132 -.138
2ptp -.038 -.164 .116 .153 .272 .089 .044 .025
2p1 s .26 .243 -.044 -.076 .495 .188 .47 .5
2p2s .071 -.029 -.157 -.052 .651 .24 .556 .367
2p3s .119 -.066 .091 -.034 .339 .041 .345 .282
2p4s .258 .241 -.074 -.046 .574 .161 .678 .717
2p5s .049 .123 -.066 -.049 .534 .159 .541 .342
2p6s .237 .223 -.078 -.052 .454 .214 .442 .343
2p7s .283 .199 -.257 -.284 .541 .146 .365 .47
possfr2 sossfr2 sse2 sev2 2aha1 2aha2 2aha3 2aha4
2pts .233 .173 -.102 -.111 .612 .189 .585 .543
2epep .155 .092 .177 .169 .008 .008 .033 .081
2epnp .094 .273 -.119 -.23 -.215 -.115 -.088 .116
2epes .051 .096 .075 -.042 .065 -.19 .112 -.077
2epns .019 .07 .041 .128 -.118 -.111 -.002 -.066
ps2 -.076 .056 -.125 -.161 .095 .142 .222 .095
2time -.204 -.252 -.117 .086 .246 -.158 .217 .108
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.3 .632 .743 1
.391 .424 .493 .827 1
.101 .617 .686 .735 .709 1
.039 .653 .611 .754 .573 .613 1
-.066 .653 .638 .652 .508 .684 .664 1
.146 .769 .811 .917 .813 .877 .818 .826
.524 -.033 -.03 .084 .212 .072 -.085 -.084
.574 -.108 .067 .058 .183 .027 -.069 .02
.308 .003 -.028 .09 .072 -.008 -.146 .015
.662 .053 .083 .265 .314 .068 -.026 -.007
.489 -.193 -.202 -.067 .115 -.08 -.195 -.208
.462 -.036 -.068 .084 .269 .127 -.108 -.037
.486 -.08 -.094 -.06 .005 -.064 -.212 -.059
2ahat 2d1d 2d2d 2d3d 2d4d 2d5d 2d6d 2d7d
2pts .605 -.058 -.045 .086 .197 .02 -.146 -.062
2epep .041 -.097 -.182 -.069 .075 .047 -.26 -.001
2epnp -.102 -.114 -.122 -.167 -.277 -.268 -.17 -.082
2epes -.055 .124 .19 .184 .019 .058 .229 .224
2epns -.107 -.108 -.341 -.101 .075 -.141 -.022 -.027
ps2 .177 -.155 -.053 -.097 -.109 -.14 -.198 0 --
2time .105 0 -.007 .385 .581 .352 .223 .266
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CORRELATION MATRIX (FOLLOW UP SURVEILLANCE)
2ptp 2d1s 2p2s 2p3s 2d4s 2d5s 2d6s 2d7s
ptp 1
pis .04 1
p2s .049 .551 1
.p3s .008 .694 .584 1
.p4s .142 .696 .505 .554 1
.p5s -.12 .764 .689 .723 .588 1
!p6s .066 .74 .499 .607 .672 .671 1
!p7s -.086 .716 .597 .587 .695 .605 .636 1
2ptp 2p1 s 2p2s 2p3s 2p4s 2p5s 2p6s 2p7s
Zpts .018 .89 .731 .813 .838 .852 .823 .849
Zepep -.057 .219 -.024 .059 .036 .256 .208 .001
Zepnp -.216 -.212 -.292 -.143 .156 -.266 -.09 .109
Zepes .165 .193 .177 .166 .098 .072 -.062 .097
Zepns -.091 -.092 -.25 -.252 -.059 -.005 -.003 -.045
ds2 -.122 .011 .254 .117 .162 .114 .289 .226
Ztime .357 .074 .023 .092 .336 .051 .263 .121
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CORRELATION MATRIX (FOLLOW UP SURVEILLANCE)
2ots 2eoeD 2eonD 2eoes 2eons ps2 2time
2pts 1
2epep .122 1
2epnp -.089 -.375 1
2epes .128 -.073 -.125 1
2epns -.113 .44 -.011 -.174 1
ps2 .195 -.046 .272 -.314 .05 1
2time .179 .056 -.074 .052 .159 -.105 1
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CORRELATION MATRIX (PALLIATIVE THERAPY GROUP)





panx3 -.168 -.148 1
sanx3 -.171 .02 .273 1
pdep3 .094 .013 .258 .098 1
sdep3 -.219 -.006 .127 .667 .131 1
ppssfa3 -.158 -.293 .285 .345 .202 .189 1
spssfa3 -.11 -.404 .269 .306 .21 .169 .917 1
ppssfr3 -.316 -.263 -.127 .351 -.058 .337 .504 .48
spssfr3 -.16 -.417 .139 .063 .012 .207 .453 .498
3sse .112 -.128 .364 .169 .2 .042 .161 .16
3sev .267 -.014 .25 -.001 -.013 -.121 .025 .007
3ghq1 -.067 -.067 .34 .683 .19 .459 .158 .184
3ghq2 -.311 .060 .354 .79 .203 .519 .374 .295
3ghq3 .11 .006 .2 .521 .292 .304 -.002 .14
3ghq4 .374 .233 .184 .54 .144 .475 -.032 .035
oaae3 saae3 panx3 sanx3 odeo3 sdeD3 DDSsfa3 sossfa3
3ghqt -.007 .048 .368 .852 .265 .59 .195 .229
3p1p .043 .055 .042 .209 -.165 .28 .027 ! -.003
3p2p .001 -.147 .518 .136 .021 .138 .323 .326
3p3p -.164 -.369 .263 .092 .034 .246 .154 .153
3p4p .006 -.185 .256 .248 -.09 .467 .14 .183
3p5p -.065 -.15 .246 .24 -.075 .183 .227 .144
3p6p .073 -.277 .097 -.067 -.107 .02 .136 .114
3p7p -.028 -.025 .371 .079 -.063 .189 -.046 .002
3ptp -.026 -.216 .364 .187 -.079 .304 .197 .194
3p1 s .142 .113 -.047 .299 .369 .176 .184 .258
3p2s .016 -.099 .188 .294 .219 .284 .104 .084
3p3s -.17 -.077 -.168 -.05 -.465 00oT~ -.027 -.076
3p4s .015 -.006 .036 -.003 -.068 -.056 .131 .045
3p5s -.011 .262 -.201 .345 .08 .355 .012 -.127
3p6 -.271 -.223 .016 -.007 -.168 -.081 .026 .054
3p7s .16 .149 .15 .568 .063 .258 .24 .226
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ppssfr3 spssfr3 3sse 3sev 3ahg1 3aha2 3aho3 3aha4
ppssfr3 1
spssfr3 .539 1
Bsse .104 .24 1
3sev -.027 .176 .84 1
Bghql .18 .076 .265 .144 1
3ghq2 .186 -.043 .115 .032 .652 1
3ghq3 .032 .005 .11 .014 .385 .32 1
3ghq4 -.131 .006 -.049 -.046 .396 .258 .623 1
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CORRELATION MATRIX (PALLIATIVE THERAPY GROUP)
D0ssfr3 sossfr3 3sse 3sev 3aha1 3aha2 3aha3 3aha4
3ghqt .107 .014 .154 .054 .834 .788 .703 .702
3p1p -.057 -.003 .11 .186 > .328 .261 -.025 .214
3p2p -.104 .187 .36 .379 .171 .235 .007 .147
3p3p .04 .037 .128 .142 .23 .195 -.075 .003
3p4p .075 .178 .228 —i CD CO .312 .227 -.008 .289
3p5p .009 .065 .288 .366 .206 .359 -.106 .056
3p6p -.09 .236 .132 .177 -.186 -.049 -.048 .125
3p7p -.187 .1 .322 .299 .216 .07 .046 .25
3ptp -.056 .161 .31 .331 .255 .255 -.037 .214
3p1s .245 -.004 .051 -.122 .226 .2 .131 .261
3p2s -.049 -.1 .226 .161 .152 .312 .28 .328
3p3s .278 .026 -.033 -.043 -.129 -.14 -.054 -.082
3p4s .01 -.105 -.024 .094 -.08 -.009 .096 .093
3p5s .153 -.228 .038 -.048 .071 .262 .164 .156
3p6 .049 -.166 -.102 -.005 -.202 -.013 .069 -.027
3p7s .016 -.153 .037 .136 .546 .564 .291 .447
possfr3 sossfr3 3sse 3sev 3aha1 3aha2 3aha3 3aha4
3pts .176 -.223 .047 .067 .186 .362 .295 .353
3epep .024 -.121 .116 -.024 .113 .043 .317 .041
3epnp -.024 -.016 -.14 -.119 -.065 -.033 -.175 -.059
3epes .031 .21 .018 .151 -.082 -.061 -.103 -.017
3epns -.001 -.141 .026 .007 -.002 .132 .174 .109
ps3 .005 .125 .089 .141 .159 .123 -.102 .041
3time .099 .295 .091 -.042 -.078 .002 .153 .031
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CORRELATION MATRIX (PALLIATIVE THERAPY GROUP)
3ahat 3p1 p 3p2p 3p3p 3p4p 3p5p 3p6p 3p7p
3ghqt 1
3p1p .28 1 -
3p2p .201 | .31 1
3p3p .143 .461 .489 1
3p4p .288 .437 .591 .56 1
3p5p .207 .648 .483 .657 .437 1
3p6p -.061 .311 .378 .471 .393 .438 1
3p7p .193 .543 .69 .279 .64 .309 .296 1
3ptp .249 .69 .79 .756 .809 .749 .619 .738
3p1 s .272 -.068 -.068 .002 .042 -.15 .032 -.038
3p2s .347 .098 .299 .122 .287 .053 .182 .212
3p3s -.14 .083 .07 .098 .117 .033 -.022 .052
3p4s .02 .052 -.091 .078 -.176 .168 .114 -.166
3p5s .217 -.029 -.232 -.027 -.024 -.038 -.013 -.144
3p6 -.069 -.247 .154 .076 -.037 -.122 .189 -.01
3p7s .627 .387 .266 .22 .183 .309 .12 .225
3ahat 3p1 p 3p2p 3p3p 3p4p 3p5p 3p6p 3p7p
3pts .39 .088 .147 .179 .11 .093 .194 .053
3epep .149 -.12 -.106 -.224 -.042 -.002 -.232 -.017
3epnp -.098 .234 -.06 .043 .089 -.161 .073 .192
3epes -.084 -.091 .008 -.063 -.127 -.205 .159 -.009
3epns .128 .003 -.239 -.142 -.184 -.074 -.077 -.255
os3 .093 .117 .199 .03 .1 .109 -.043 .013
3time .02 .024 .029 -.199 .085 -.022 -.043 .149
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CORRELATION MATRIX (PALLIATIVE THERAPY GROUP)
3ptp 3d1s 3d2s 3d3s 3d4s 3d5s 3d6 3d7s
3ptp 1
3p1s -.044 1
3p2s .256 .158 1 -
3p3s .088 -.24 -.037 1
3p4s -.021 -.024 .15 .-.113 1
3p5s -.105 .415 .069 .099 .106 1
3p6 .011 -.052 .397 .23 .045 -.035 1
3p7s .326 .364 .348 -.229 .191 .195 .176 1
3dtd 3d1 s 3d2s 3d3s 3d4s 3d5s 3d6 3d7s
3pts .168 .445 .632 .151 .417 .48 .571 .659
3epep -.141 .028 -.183 .24 -.235 .185 -.103 -.058
3epnp .073 -.046 -.126 .043 -.094 -.017 -.172 .023
3epes -.064 .135 -.111 -.101 -.115 .2 .061 .111
3epns -.197 .151 .044 -.251 .202 .268 -.027 .106
ps3 .11 -.139 .143 -.011 -.098 .084 -.142 -.034
3time .008 -.005 .01 -.123 -.155 .046 -.199 -.287
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.056 -.164 .234 1 ,
.146 -.026 .024 -.041 1
-.07 -.184 -.271 -.247 .204 1
-.235 .089 -.176 .19 .045 -.114 1
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KEY TO CORRELATION MATRICES
Page Age of patient
Sage Age of carer
P a n x Patient anxiety
S a n x Carer anxiety
P d e p Patient depression
S d ep Carer depression
Ppssfa Patient perceived support from family
Spssfa Carer perceived support from family
P p s s f r Patient perceived support from friends
Spssfr Carer perceived support from friends
S s e Number of symptoms and side effects
S e v Severity of symptoms and side effects
g h q 1 GHQ: somatic symptoms
g h q 2 GHQ: anxiety and insomnia
g h q 3 GHQ: social dysfunction
g h q 4 GHQ: severe depression
g h q t GHQ: total
Pip PAIS (health care orientation): patient
P 2 p PAIS (vocational environment): patient
P 3 p PAIS (domestic environment): patient
P 4 p PAIS ( sexual relationship): patient
P 5 p PAIS (extended family): patient
P 6 p PAIS (social relationships): patient
P 7 p PAIS (psychological distress): patient
P t p (PAIS (total): patient
Pis PAIS (health care orientation): carer
P 2 s PAIS (vocational environment): carer
P 3 s PAIS (domestic environment): carer
P 4 s PAIS(sexual relationship): carer
P5s PAIS(extended family): carer
P 6 s PAIS( social relationships): carer
P 7 s PAIS(psychological distress): carer
P t s PAIS(total):carer
e p e p EPI(extraversion): patient
e p n p EPI(neuroticism):patient
e p e s EPI(extraversion): carer
e p n s EPI(neuroticism): carer
P s performance status
time time since diagnosis
509
